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A B S T R A C T
Background
Up to one percent of people in industrialised countries will suffer from a leg ulcer at some time. The majority of these leg ulcers are due
to problems in the veins, resulting in an accumulation of blood in the legs. Leg ulcers arising from venous problems are called venous
(or varicose or stasis) ulcers. The main treatment is the application of a firm compression garment (bandage or stocking) in order to
aid venous return. There is a large number of compression garments available and it was unclear whether they are effective in treating
venous ulcers and, if so, which method of compression is the most effective.
Objectives
To undertake a systematic review of all randomised controlled trials (RCTs) evaluating the effects on venous ulcer healing of compression
bandages and stockings.
Specific questions addressed by the review are:
1. Does the application of compression bandages or stockings aid venous ulcer healing?
2. Which compression bandage or stocking system is the most effective?
Search methods
For this second update we searched: the CochraneWounds Group Specialised Register (31May 2012); theCochrane Central Register of
Controlled Trials (CENTRAL) (The Cochrane Library Issue 5, 2012); OvidMEDLINE (1950 toMayWeek 4 2012); OvidMEDLINE
(In-Process & Other Non-Indexed Citations 30 May 2012); Ovid EMBASE (1980 to 2012 Week 21); and EBSCO CINAHL (1982
to 30 May 2012). No date or language restrictions were applied.
Selection criteria
RCTs recruiting people with venous leg ulceration that evaluated any type of compression bandage system or compression stockings
were eligible for inclusion. Eligible comparators included no compression (e.g. primary dressing alone, non-compressive bandage) or
an alternative type of compression. RCTs had to report an objective measure of ulcer healing in order to be included (primary outcome
for the review). Secondary outcomes of the review included ulcer recurrence, costs, quality of life, pain, adverse events and withdrawals.
There was no restriction on date, language or publication status of RCTs.
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Data collection and analysis
Details of eligible studies were extracted and summarised using a data extraction table. Data extraction was performed by one review
author and verified independently by a second review author.
Main results
Forty-eight RCTs reporting 59 comparisons were included (4321 participants in total). Most RCTs were small, and most were at unclear
or high risk of bias. Duration of follow-up varied across RCTs. Risk ratio (RR) and other estimates are shown below where RCTs were
pooled; otherwise findings refer to a single RCT.
There was evidence from eight RCTs (unpooled) that healing outcomes (including time to healing) are better when patients receive
compression compared with no compression.
Single-component compression bandage systems are less effective than multi-component compression for complete healing at six
months (one large RCT).
A two-component system containing an elastic bandage healed more ulcers at one year than one without an elastic component (one
small RCT).
Three-component systems containing an elastic component healed more ulcers than those without elastic at three to four months (two
RCTs pooled), RR 1.83 (95% CI 1.26 to 2.67), but another RCT showed no difference between groups at six months.
An individual patient data meta-analysis of five RCTs suggested significantly faster healing with the four-layer bandage (4LB) than the
short stretch bandage (SSB): median days to healing estimated at 90 and 99 respectively; hazard ratio 1.31 (95% CI 1.09 to 1.58).
High-compression stockings are associated with better healing outcomes than SSB at two to four months: RR 1.62 (95% CI 1.26 to
2.10), estimate from four pooled RCTs.
One RCT suggested better healing outcomes at 16 months with the addition of a tubular device plus single elastic bandage to a base
system of gauze and crepe bandages when compared with two added elastic bandages. Another RCT had three arms; when one or two
elastic bandages were added to a base three-component system that included an outer tubular layer, healing outcomes were better at
six months for the two groups receiving elastic bandages.
There is currently no evidence of a statistically significant difference for the following comparisons:
·alternative single-component compression bandages (two RCTs, unpooled);
·two-component bandages compared with the 4LB at three months (three RCTs pooled);
·alternative versions of the 4LB for complete healing at times up to and including six months (three RCTs, unpooled);
·4LB compared with paste bandage for complete healing at three months (two RCTs, pooled), six months or one year (one RCT for
each time point);
·adjustable compression boots compared with paste bandages for the outcome of change in ulcer area at three months (one small RCT);
·adjustable compression boots compared with the 4LB with respect to complete healing at three months (one small RCT);
·single-layer compression stocking compared with paste bandages for outcome of complete healing at four months (one small RCT)
and 18 months (another small RCT);
·low compression stocking compared with SSB for complete healing at three and six months (one small RCT);
·compression stockings compared with a two-component bandage system and the 4LB for the outcome of complete healing at three
months (one small, three-armed RCT); and,
·tubular compression compared with SSB (one small RCT) for complete healing at three months.
Secondary outcomes: 4LB was more cost-effective than SSB. It was not possible to draw firm conclusions regarding other secondary
outcomes including recurrence, adverse events and health-related quality of life.
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Authors’ conclusions
Compression increases ulcer healing rates compared with no compression. Multi-component systems are more effective than single-
component systems. Multi-component systems containing an elastic bandage appear to be more effective than those composed mainly
of inelastic constituents. Two-component bandage systems appear to perform as well as the 4LB. Patients receiving the 4LB heal faster
than those allocated the SSB. More patients heal on high-compression stocking systems than with the SSB. Further data are required
before the difference between high-compression stockings and the 4LB can be established.
P L A I N L A N G U A G E S U M M A R Y
Compression bandages and stockings to help the healing of venous leg ulcers
Venous leg ulcers can occur when blood returning from veins in the legs to the heart is slow or obstructed. These ulcers can take a
long time to heal (weeks or months) and can cause distress to patients, as well as being very costly to the health service. Compression
bandages help blood to return to the heart from the legs, and there are a variety of types of bandage systems available; some are just
a single bandage, while others require the application of several different types of bandages to the leg. Compression stockings are
sometimes used as an alternative to compression bandages. This review examined the effectiveness of compression bandages versus no
compression, and compared different types of compression bandages and stockings. We looked at how well these different treatments
work in terms of ulcer healing. We found that applying compression was better than not using compression, and that multi-component
bandages worked better than single-component systems. Multi-component systems (bandages or stockings) appear to perform better
when one part is an elastic (stretchy) bandage. A very detailed analysis showed that a system called the ’four-layer bandage’ or ’4LB’
(i.e. four different bandages applied to the leg, including an elastic one) heals ulcers faster than the ’short-stretch bandage’ or ’SSB’ (a
type of bandage with very minimal stretch).
B A C K G R O U N D
Venous leg ulcers: the extent of the problem
and management with compression
Leg ulceration is typically a chronic recurring condition with du-
ration of episodes of ulceration ranging from a matter of weeks to
more than 10 years (Callam 1985; Moffatt 1995; Noonan 1998;
Lorimer 2003; Moffatt 2004; Vowden 2009b).
A systematic review of the epidemiological literature from devel-
oped countries reported prevalence rates for any aetiology of open
lower limb ulceration ranging from 1.2 to 11.0 per 1000 popula-
tion (cases validated) (Graham 2003). Recent surveys undertaken
in the UK collected data from populations in Wandsworth, Lon-
don (Moffatt 2004), Hull and East Yorkshire (Srinivasaiah 2007),
and Bradford and Airedale primary care trust (Vowden 2009a).
The prevalence of venous leg ulceration was estimated as 0.23 per
1000 population in London (Moffatt 2004), 0.44 per 1000 in
Hull and East Yorkshire (Srinivasaiah 2007), and 0.39 per 1000 in
Bradford (Vowden 2009a; Vowden 2009b). The lower estimates
in the recent UK surveys relative to the earlier worldwide literature
(Graham 2003) - searches done during 2000 - might be explained
by improvements in treatment as well as the broad versus narrow
selection criteria for leg ulcers (Vowden 2009b). The epidemio-
logical data have consistently suggested that prevalence increases
with age and is higher among women (Callam 1992a; Graham
2003; Lorimer 2003; Moffatt 2004; Vowden 2009b).
Leg ulcers are associated with considerable cost to patients and to
healthcare providers. Two systematic reviews summarised the lit-
erature on health-related quality of life in patients with leg ulcers;
one included 24 studies (Herber 2007), and the other 37 (Persoon
2004). Both reviews included qualitative and quantitative evalua-
tions, and reported that presence of leg ulceration was associated
with pain, restriction of work and leisure activities, impaired mo-
bility and social isolation.
The estimated annual cost of leg ulcer treatment to the National
Health Service (NHS) in the UK was between GBP 230 million
and GBP 400 million during 1990-1991 (Bosanquet 1992). A
later study estimated the cost of leg ulcer care within individual
UK district health authorities at GBP 212,700 to GBP 333,377
annually per district (price year 1999) (Ellison 2002). Ragnarson
Tennvall 2005 estimated that the average cost of treating a venous
leg ulcer in the UK was between EUR 814 and EUR 1994 (price
year 2002), with higher costs associated with larger and more
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chronic wounds. Drew et al estimated that GBP 3.21 million was
spent on dressings and other materials in Hull and East Yorkshire
during 2005-2006; the cost of nursing time for wound care during
the same period was GBP 6.08 million (Drew 2007). Vowden et
al estimated that in Bradford, GBP 1.69 million was spent on
dressings and compression bandages and GBP 3.08 million on
nursing time (2006-2007 prices) (Vowden 2009c). The latter two
reports relate to the care of all types of wounds, not just venous leg
ulcers. Posnett 2007 estimated the costs of venous ulcers to theUK
NHS atGBP 168million to GBP 198million annually (price year
2005-2006). The differences between the 1990-1991 estimates
and those from 2005-2006 may be explained by limitations of the
source data (Posnett 2007), or a true reduction in costs attributable
to lower prevalence.
Most leg ulcers are associated with venous disease. A history of
deep vein thrombosis is widely regarded as a predisposing factor
to venous insufficiency and, hence, venous ulceration, however,
the aetiology of leg ulceration remains poorly understood. Venous
insufficiency has been shown to be associated with increased hy-
drostatic pressure in the veins of the leg, and it is in an attempt
to reverse this and aid venous return that external compression, in
various forms, is applied as a therapy for venous leg ulcers (Moffatt
2007).
Various forms of bandaging have been applied over the years. In
the 17th Century, compression was applied as rigid lace-up stock-
ings, and elasticated bandages were first produced in the middle
of the 19th Century (Thomas 1995). At the beginning of the 21st
century wide variation remains in the management of venous leg
ulcers within local areas (Srinivasaiah 2007; Vowden 2009b), and
across countries (Cullen 2009). In North America, Unna’s boot is
a popular choice of device (Meyer 2003). This is a type of paste
bandage, often impregnated with preparations such as glycerin,
zinc oxide and calamine lotion (Rubin 1990; BNF 2012). Such
devices can be completely inelastic or may have a degree of plia-
bility (Moffatt 2007). In the UK the four-layer bandage (4LB) -
which includes elastic components - is widely used (Meyer 2003),
whilst in mainland Europe and Australia the short-stretch ban-
dage (SSB) is standard practice (Weller 2010). This review sum-
marises the evidence for the effectiveness of the different forms of
compression bandaging and compression stockings for venous leg
ulcers. Devices that apply intermittent or pulsed compression to
the limb were specifically excluded from this review and have been
assessed in a separate Cochrane review (Nelson 2011).
Classification of different types of compression
There are many ways of applying compression, including single
components (i.e. one type of bandage or stocking) and systems
consisting of multiple components (different types of bandages
and stockings used together or separately). The interpretation of
comparisons between compression systems has been hindered by
the lack of internationally agreed performance standards, for ex-
ample the classification systems for compression stockings differ
between the UK and Europe. In the UK, performance indica-
tors for bandages and compression stockings have been developed
(British Standards Institute1995). Bandages are categorised as re-
tention, support or compression, depending on their performance
in standardised laboratory tests. Compression bandages are further
sub-divided according to the amount of force required to extend
them, and, therefore, the level of compression that they can apply
to a limb. Furthermore, the laboratory performance of a bandage
may not reflect its performance in clinical use, as this might de-
pend upon operator training and application technique (specifi-
cally whether applied as a spiral or figure-of-eight, the numbers
of layers applied and the amount of extension used). Compres-
sion systems commonly used for venous leg ulcers are listed below
(from Thomas 1995).
Classification of bandages:
• Class 1: retention bandages. Used to retain dressings.
• Class 2: support bandages. Used to support strains and
sprains, e.g. crepe. Other bandages in this category can apply
mild to moderate compression, e.g. Setocrepe (Mölnlycke),
when particular application techniques are used and the
bandages are reapplied frequently.
• Class 3a: light compression. These bandages exert 14 to 17
mmHg at the ankle when applied in a simple spiral, e.g. Elset
(Mölnlycke).
• Class 3b: moderate compression. These bandages apply 18
to 24 mmHg at the ankle when applied as a simple spiral, e.g.
Granuflex Adhesive Compression Bandage (ConvaTec).
• Class 3c: high compression. These bandages apply 25 to 35
mmHg at the ankle when applied as a simple spiral, e.g.
Setopress (Mölnlycke), and Tensopress (Smith and Nephew).
• Class 3d: extra high compression. These bandages apply up
to 60 mmHg at the ankle when applied as a simple spiral.
Compression stockings (or hosiery) can be used to treat open ul-
ceration and to reduce the risk of recurrence post-healing. They
are classified in a similar way to bandages, according to the level of
compression applied to the limb. Importantly, stockings are sub-
ject to less operator variability than bandages:
• Class 1: light support, provides 14 to 17 mmHg at the
ankle. Used to treat varicose veins.
• Class 2: medium support, provides 18 to 24 mmHg at the
ankle. Used to treat more severe varicosities, and to prevent
venous leg ulcers.
• Class 3: strong support, provides 25 to 35 mmHg at the
ankle. Used to treat severe chronic hypertension and severe
varicose veins, and to prevent venous leg ulcers.
Recent developments in the classification of
compression systems
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An international, expert consensus group debated the validity of
the bandage classificationdescribed above, and recommended clas-
sification based on alternative criteria (Partsch 2008b). In partic-
ular, the group made a distinction between layers and compo-
nents of compression bandage systems.Whereas previously, differ-
ent compression systems had been described as ’single-layer’, two-
layer’, ’four-layer’ and so on, this report proposed that application
of all bandages involves some degree of overlap and therefore it is
misleading to categorise any bandage system as ’single-layer’. The
group recommended that the components of compression should
be described, such as orthopaedic wool, crepe bandage or cohe-
sive elastic bandages. Other recommended classification criteria
include sub-bandage pressure (measured in the medial gaiter area
with the patient supine) and the elastic property of the overall
compression system. In terms of sub-bandage pressure, the group
proposed alternative categories to those described by the British
Standards Institute (British Standards Institute1995), based on in
vivo measurements. Overall, the ranges of pressure proposed by
the consensus group are higher than those from the British Stan-
dards Institute. The recommendation to assess the elastic property
of the compression system overall has arisen from the notion that,
although individual parts of a compression bandage systemmay be
elastic, the interaction between different components might result
in a system that is inelastic. In order to assess this, a measurement
called the ’static stiffness index’ (SSI) has been proposed; this is
defined as the difference in sub-bandage pressures measured in
standing and supine positions. A pressure increase of more than
10 mmHg when the patient moves from supine to standing has
been suggested to indicate inelasticity (high stiffness), and an in-
crease of less than 10 mmHg corresponds to elasticity (low stiff-
ness) (Partsch 2008b). Findings from a study of haemodynam-
ics in 42 patients with chronic venous insufficiency treated with
class II compression stockings suggested that the quotient of max-
imum working pressure to resting pressure (a measure of stiffness)
is closely related to haemodynamic improvement, with increasing
quotient representing reduced venous reflux (Häfner 2001). The
relationship between any of these parameters and ability to aid
healing remains unknown. Where compression bandages are used
as a single component, they can still be defined as ’elastic’ and
’inelastic’ (Partsch 2008b). The following are examples of multi-
component bandage systems (listed for illustrative purposes only;
not intended as practice recommendations):
• short stretch/inelastic systems - orthopaedic padding plus
one or two rolls of SSB;
• inelastic paste systems - paste bandage plus support
bandage, e.g. Setocrepe® (Mölnlycke);
• two-component bandage systems - orthopaedic padding
plus elastic bandage, e.g. ProGuide® (Smith & Nephew);
• four-component bandage systems - orthopaedic padding
plus support bandage (crepe) plus class 3a bandage, e.g. Elset®
(Mölnlycke) plus cohesive bandage, e.g. Coban® (3M).
The earliest version of this review defined different compression
systems in terms of the number of layers, whereas, in line with
the recommendations of the consensus group outlined above, sub-
sequent versions refer to components. Nonetheless, where a trial
treatment is the original Charing Cross four-layer bandage, or a
close variant of it, we have continued to use the term ’four-layer
bandage’ (4LB), as this is an internationally recognised bandage
system. It ismore difficult to classify different compression systems
in relation to sub-bandage pressures or the SSI since, in general,
this information is not available from clinical trial reports. In or-
der to gain further insights into the optimal way to classify differ-
ent compression systems, we consulted experts in tissue viability
at the outset of the previous update of this review, and invited
them to complete a survey. The survey listed different types of
compression against various classifications and respondents were
asked to provide the best choice of classification in their opinion.
In addition, free text comments were invited. As far as possible,
the information gleaned from this exercise has been used in classi-
fying and grouping different types of compression therapy in this
review, and in aiding interpretation of findings.
Risks associated with use of compression
The use of compression to enhance venous return and aid the heal-
ing of venous ulcers is not without risk. The application of external
compression has been reported to lead to pressure damage in some
cases (Callam 1987; Callam 1992b; Barwell 2004). This may be
due to application of excessive pressure or application of pressure
in the presence of arterial insufficiency. National clinical guide-
lines in the UK and USA recommend that all patients present-
ing with a leg ulcer be screened for arterial disease using Doppler
measurement of the ankle-brachial pressure index (ABPI) by suit-
ably trained staff (Royal College of Nursing 2006; AAWC 2010;
SIGN 2010). Clinically significant arterial disease is often defined
using a cut-off of the ABPI of below 0.8. Patients with venous leg
ulceration who have ABPI between 0.5 and 0.7 may be eligible to
receive modified (reduced) compression (Moffatt 2007). As part
of this review, data on baseline ABPI and adverse events related to
treatment have been recorded, where available.
O B J E C T I V E S
Toundertake a systematic reviewof all randomised controlled trials
(RCTs) investigating the effects of compression systems (bandages
and stockings) on the healing of venous leg ulcers.
Specific questions addressed by the review, and the related treat-
ment comparisons are outlined below.
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Question 1: Does the application of compression
bandages or stockings aid venous ulcer healing?
• 1.1 Compression compared with primary dressing alone.
• 1.2 Compression compared with non-compressive
bandages.
• 1.3 Compression compared with usual care that did not
routinely include compression.
Question 2: Which compression bandage or
stocking system is the most effective in terms of
ulcer healing?
2.1 Single-component compression bandage systems
• 2.1.1 Comparison between different single-component
bandage systems.
• 2.1.2 Single-component bandage systems compared with
multi-component bandage systems.
2.2 Two-component compression bandage systems
• 2.2.1 Comparison between different two-component
bandage systems.
• 2.2.2 Two-component bandage systems compared with the
4LB.
2.3 Three-component compression bandage systems
• 2.3.1 Comparison between different three-component
bandage systems.
2.4 Compression bandage systems comprising four
components including an elastic component (the
’4LB’)
• 2.4.1 Comparison between different versions of the 4LB.
• 2.4.2 4LB compared with multi-component systems
including an inelastic bandage (the SSB).
• 2.4.3 4LB compared with bandage systems having a paste
bandage as the base.
2.5 Adjustable compression boots compared with
compression bandages
• 2.5.1 Adjustable compression boots compared with paste
bandages.
• 2.5.2 Adjustable compression boots compared with the
4LB.
2.6 Compression stockings or tubular devices
compared with compression bandage systems
• 2.6.1 Compression stockings compared with paste
bandages.
• 2.6.2 Compression stockings compared with inelastic
bandages (the SSB).
• 2.6.3 Compression stockings compared with multi-
component bandage systems.
• 2.6.4 Tubular compression compared with inelastic
bandages (the SSB).
• 2.6.5 Tubular compression compared with or added to
elastic bandages.
For most comparisons, data analysis was undertaken on the basis
of group level (aggregate) data extracted from each trial report.
The exception to this was the comparison of 4LB and SSB (Sec-
tion 2.4.2) for which patient level data were available, enabling a
meta-analysis of individual patient data (IPD). Methods for this
were based on those developed by the Cochrane Individual Par-
ticipant Data Meta-analysis Methods Group (Stewart 1995), and
were pre-specified in a separate protocol from the main review
(available on request). Advantages of IPD meta-analyses include
the opportunity to: conduct powerful time-to-event analyses; ad-
just for prognostic patient-level variables; update outcome data;
verify the accuracy of data; and reinstate missing data (Stewart
2002). The use of patient-level data usually allows for a more sen-
sitive analysis, enabling the best, unbiased, estimate of treatment
effect to be obtained (Stewart 1993). The following sections refer
to methods used for the main review of aggregate data. An outline
of the methods used for the IPD meta-analysis is provided at the
end of the main methods section.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Prospective RCTs evaluating compression bandaging or stockings
in the treatment of venous ulceration were eligible for inclusion.
Studies using quasi-randomisation methods to allocate treatment
(e.g. alternation or odd/even case numbers) were excluded. Trials
were included if: the compression therapies under investigation
were the only systematic difference between study arms; and if
they reported an objective measure of ulcer healing such as time to
complete healing, frequency of complete healing, change inwound
size or healing rate. Trials reporting only subjective assessments of
improvement/deterioration of the wound were excluded. There
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were no restrictions on the basis of language or publication status
of articles.
Types of participants
RCTs recruiting people of any age with venous leg ulceration (may
also be described as stasis or varicose ulceration) in any care setting
were eligible for inclusion. As the method of diagnosis of venous
ulceration can vary between studies, no standardised definition
was applied, but each study had to refer to the use of compression
for venous rather than other types of leg ulcers e.g. arterial, mixed
or vasculitic.
Types of interventions
Trials evaluating any formof compression bandage or compression
stockings in patients with venous leg ulcers were eligible, including
those assessing the following: single-component elastic or inelas-
tic bandage systems; multi-component bandage systems; tubular
compression devices; compression boots; and compression stock-
ings. Comparators included no compression (e.g. primary dress-
ing alone or non-compressive bandages), or an alternative type of
compression. Since the focus of Review Question 2 was to assess
the relative effectiveness of different types of compression therapy,
trials comparing compression with other therapies (e.g. surgery,
pharmacological treatment) were excluded. In addition, trials re-
porting the use of intermittent pneumatic compression were ex-
cluded, as this therapy is the focus of another Cochrane review
(Nelson 2011).
Types of outcome measures
In order to be eligible for inclusion, trials had to report at least one
primary outcome.
Primary outcomes
Objective measures of healing such as:
• Time to complete healing.
• Proportion of ulcers healed within trial period.
• Change in ulcer size (surface area or volume).








Search methods for identification of studies
Electronic searches
Details of the search strategy for the original version of this review
are available in Appendix 1.
The following electronic databases were searched, without date or
language restrictions, to identify RCTs that investigated the use of
bandages or stockings for the treatment of venous leg ulcers:
• Cochrane Wounds Group Specialised Register (searched 31
May 2012);
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library Issue 5, 2012);
• Ovid MEDLINE (1950 to May Week 4 2012);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations 30 May 2012);
• Ovid EMBASE (1980 to 2012 Week 21);
• EBSCO CINAHL (1982 to 30 May 2012).
The following search strategy was used in the The Cochrane Cen-
tral Register of Controlled Trials (CENTRAL):
#1 MeSH descriptor Occlusive Dressings explode all trees
#2 MeSH descriptor Stockings, Compression explode all trees
#3 (compression or bandag* or stocking* or hosiery or wrapp*):
ti,ab,kw
#4 (#1 OR #2 OR #3)
#5 MeSH descriptor Leg Ulcer explode all trees
#6 (varicoseNEXTulcer*) or (venousNEXTulcer*) or (legNEXT
ulcer*) or (foot NEXT ulcer*) or (stasis NEXT ulcer*):ti,ab,kw
#7 (#5 OR #6)
#8 (#4 AND #7)
The search strategies for Ovid MEDLINE, Ovid EMBASE and
Ovid CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4 respectively. The Ovid MEDLINE search was com-
bined with the Cochrane Highly Sensitive Search Strategy for
identifying randomised trials in MEDLINE: sensitivity- and pre-
cision-maximizing version (2008 revision); Ovid format (Lefebvre
2011). The EMBASE and CINAHL searches were combined with
the trial filters developed by the Scottish Intercollegiate Guidelines
Network (SIGN) (SIGN 2012).
Searching other resources
We searched the reference lists of all new studies identified in
this update to reveal any further studies that were not identified
through the electronic searches. For the first version of this review,
experts in wound care and pharmaceutical companies were con-
tacted to enquire about unpublished, ongoing and recently pub-
lished trials. An Advisory Panel was also established that assisted
by checking our reference lists for any omissions, and informed us
of any unpublished, ongoing or recently completed trials. For this
update we have not contacted experts or industry representatives
as part of the search.
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Data collection and analysis
Data extraction and management
References identified from searches were entered into a biblio-
graphic software package (ProCite). Two review authors, work-
ing independently, screened the references. If either review author
considered a reference to be potentially relevant, the full report
was retrieved for further scrutiny. Two review authors made in-
dependent decisions about inclusion and exclusion of studies by
referring each retrieved report to the selection criteria described
above. Disagreements were resolved by discussion.
Details of eligible studies were extracted and summarised using a
data extraction sheet. The following data were extracted:
• country of study;
• source population;
• unit of investigation (e.g., wound, limb, patient);
• patient selection criteria;
• care setting;
• baseline variables by group, e.g. age, sex, baseline area of
ulcers, duration of ulceration;
• description of the interventions and numbers of patients
randomised to each intervention;
• descriptions of any co-interventions or standard care;
• follow-up period;
• primary and secondary outcomes measured;
• primary and secondary outcome data;
• withdrawals from treatment, with reasons.
Attempts were made to obtain data missing from reports by con-
tacting the authors. Studies that had been published in duplicate
were included only once and all relevant data extracted. Data ex-
traction was performed by one review author and verified inde-
pendently by a second review author. Disagreements were resolved
by discussion.
Assessment of risk of bias in included studies
For this review update all included trials were individually as-
sessed using the Cochrane Collaboration tool for assessing risk
of bias (Higgins 2011). This tool addresses six specific domains:
sequence generation; allocation concealment; blinding (outcome
assessment of healing); incomplete outcome data; selective out-
come reporting; and other issues (for this review, baseline compa-
rability of groups for prognostic factors such as ulcer surface area
and duration). We completed a risk of bias table for each eligible
trial. RCTs were classified as being at an overall high risk of bias
if they were rated as ’high risk’ for any one of three key domains:
allocation concealment; blinded outcome assessment of healing;
and completeness of outcome data. The overall classification was
rated as ’unclear’ if any of the key domains was individually rated
as being at ’unclear risk of bias.’ RCTs were classified as being at
an overall low risk of bias only if all key domains were rated as ’low
risk of bias’. We have presented assessment of risk of bias using a
risk of bias summary figure, which presents all of the judgements
in a cross-tabulation of RCT by risk of bias domain.
Data synthesis
Included trials were grouped in the narrative synthesis according to
the types of compression they compared. Within each comparison
group, studies were pooled when they appeared similar in terms of
methods, participant characteristics, interventions and outcomes.
A test of statistical heterogeneity was generated for each pooled
outcome. Significant statistical heterogeneity was defined as a chi-
squared P value of 0.1 or less and the I2 statistic was generated in
order to estimate the percentage of the variability in estimates of
effect due to heterogeneity rather than chance (Higgins 2003). It
has been suggested that when the I2 estimation is greater than zero,
both fixed-effect and random-effects analyses should be under-
taken, and any difference in estimates noted (Sterne 2008).Where
clinical, methodological and statistical heterogeneity were not ap-
parent, similar studies were pooled using a fixed-effect model.
A random-effects model was additionally applied where I2 was
greater than zero in the absence of apparent clinical or method-
ological heterogeneity. Where pooling was not possible or appro-
priate, individual estimates from trials were reported in the narra-
tive synthesis.
For dichotomous outcomes (e.g. frequency of complete healing
during the trial period), risk ratio (RR) estimates with 95% con-
fidence intervals (CI) were calculated for each trial individually
and pooled if considered appropriate. The RR was presented in
preference to the odds ratio (OR), as the latter gives an inflated
impression of the size of effect when event rates are high, as is the
case for most trials reporting healing of chronic wounds. In stud-
ies where trial authors excluded randomised patients from their
own analyses we assumed that the ulcer did not heal in these cases
(therefore they were included in the denominator but not the nu-
merator for the RR estimate of healing). Where a trial did not
specify the number of patients per group prior to withdrawal, we
presented complete case data.
For continuous outcomes (e.g. percentage change in ulcer surface
area, healing rate in cm2 per week), the difference in means with
95% CI was calculated for each trial individually. Where appro-
priate, trials were pooled using the weighted difference in means.
When trials assessed the same outcome using different scales (e.g.
change in ulcer area in cm2 and as a percentage) but otherwise did
not appear to be methodologically, clinically or statistically hetero-
geneous, estimates were pooled using the standardised mean dif-
ference (SMD). Where sufficient information was available from
the trial report, we presented data according to intention to treat;
otherwise we presented a complete case analysis.
In terms of time-to-event outcomes, it was planned to plot (and,
if appropriate, pool) estimates of hazard ratio (HR) and 95% CI
as presented in the trial reports using the generic inverse variance
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method in RevMan version 5.1.
Methods for the individual patient data meta-analysis
The methods used were broadly similar to the above with the
following additional considerations.
The primary outcome was time to healing, defined as the time
from the date of randomisation to the date of healing, with heal-
ing defined as complete epithelialisation of the reference wound.
Data for patients with ulcers not healing within the trial period
were censored on the date of last follow-up. Secondary outcomes
included time to ulcer recurrence (defined as the time interval be-
tween healing and recurrence) and adverse events.
Trialists who contributed original data were asked to provide de-
tails of any additional or unpublished trials that they knew of,
that had not been identified by the main search strategy described
above.
Data extraction was carried out for each RCT on the basis of in-
formation provided in published trial reports. In addition, trialists
were asked to provide anonymised baseline and outcome data for
each randomised patient, including those excluded from their own
analyses. Baseline data included sex, age, primary or recurrent ul-
ceration, ulcer duration, ulcer area, ulcer diameter, appearance of
wound bed, ulcer infection, ankle brachial pressure index (ABPI),
ankle circumference, ankle mobility, patient mobility, and history
of co-morbidities such as deep vein thrombosis.Outcome variables
included healing status (healed or not), date of healing, recurrence
status, date of recurrence, ulcer area at follow-up points during
the trial, and adverse events. In addition, the trialists were asked
to provide date of randomisation, allocated treatment, date of last
follow-up, and details of exclusion from analysis. The risk of bias
assessment was informed by published reports plus additional in-
formation from each trialist. Data from each trial were also subject
to additional systematic checks to determine completeness, du-
plication, consistency, feasibility, and integrity of randomisation
(Stewart 1995). Queries were resolved with the relevant trialist.
The patient was the unit of analysis (Altman 1997). In cases where
patients had multiple wounds included in the trial, we selected
the largest for inclusion in the meta-analysis. Analyses were un-
dertaken on an intention-to-treat basis (that is, according to ran-
domised allocation group with inclusion of all patients as the aim).
Imputation was not undertaken for missing data.
In order to provide an analysis that was congruent with others in
this review, we pooled data from trials for the outcome of complete
healing during the trial period. We then generated a preliminary
(unadjusted) analysis of time to healing using non-stratified Ka-
plan-Meier survival curves for both treatment groups. The depen-
dent variable was time to healing in days, the event was a healed
ulcer, and the factor was bandage type.
Next, we generated a Cox proportional hazards model with time
to healing in days as the dependent variable, healing as the event,
and bandage type as a covariate. This preliminary model did not
include adjustment for baseline characteristics. The main, formal,
preplanned analysis entailed a Cox proportional hazards model
as described above with additional covariates of sex, age, primary
or recurrent ulceration, ulcer duration, ulcer area, ulcer diameter,
appearance of wound bed, ulcer infection, ankle brachial pressure
index, ankle circumference, ankle mobility, patient’s mobility, and
history of deep vein thrombosis. Covariates found to be significant
at the 5% level in univariate analyses were entered simultaneously
into the model. We then used a backward elimination method
to generate HR estimates of treatment effect. The model was ex-
tended to include tests of statistical interaction between type of
bandage and baseline characteristics using a statistical significance
threshold of p<0.05. To take account of any differences in healing
rate between study centres, we entered centres into the model as
strata. This automatically included trials as strata also as no centre
was in more than one trial.
The proportional hazards assumption requires that the hazard ra-
tio is constant over time (Altman 1991). We carried out checks to
assess the proportional hazards assumption by generating survival
curves for each category of a covariate found to be significant dur-
ing univariate analyses using the log minus log of the hazard func-
tion on the vertical axis, and the log of time to healing in days on
the horizontal axis. The event was ulcer healing. Any continuous
covariates were dichotomised at the median in order to be able
to generate the required curves which were examined visually to
determine whether the proportional hazards assumption had been
upheld. This was judged to be the case if the curves represent-
ing different categories of a covariate were approximately parallel
(Elashoff 1983). In addition, each covariate was assessed analyti-
cally by fitting a time-dependent Cox model for each covariate of
interest. The proportional hazards assumption was considered to
be upheld if, when a given variable was entered as a time depen-
dent covariate, it failed to make a statistically significant contribu-
tion to the model (Kalbfleisch 2002). For any covariate where the
proportional hazards assumption was not met, it was planned to
re-run the model entering it as a time dependent covariate.
We also carried out checks to assess the linearity of the relation be-
tween the dependent variable and continuous covariates; whether
time to healing was similar during early and late accrual (Bland
1998); and adequacy of model fit with regard to the relation be-
tween the number of events and the number of covariates included
in each model (Peduzzi 1996).
To generate a forest plot showing the relative contribution of each
trial to themeta-analysis, we derived individual trial estimates from
the IPD using Cox regression with covariate adjustment as per the
final adjusted model. These HR estimates were converted into the
log HR and its standard error, and combined using the generic in-
verse variance method. This allowed assessment of statistical het-
erogeneity between trials, using the chi-squared test (threshold P
value 0.1) and the I2 statistic (Higgins 2002;Higgins 2003).When
I2 was greater than zero, the analysis was repeated using a random-
effects model and sources of heterogeneity were investigated using
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sensitivity analysis.
In terms of secondary outcomes, it was planned to repeat the anal-
yses described above for time to healing with respect to time to
ulcer recurrence. Adverse events were defined in two ways: as any
adverse event or those considered by the trialists to be related to the
bandage. For each of these outcomes, we assessed the effect of ban-
dage type on the prevalence of adverse events using the OR with
associated 95% CI. We compared the number of adverse events
per patient for the two different bandage systems using a weighted
difference in means with associated 95% CI. For all pooled analy-
ses of adverse events, we defined statistical heterogeneity between
individual trial estimates using the criteria described above.
Survival analyses were conducted with SPSS (version 15.0). The
Kaplan-Meier plot was generated with Stata SE (version 10). Ad-
verse event analyses and forest plots were generated using RevMan
(version 5.1).
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
Forty-eight RCTs reporting 59 comparisons were included in this
review (4321 participants in total). Three evaluations were pub-
lished as conference proceedings only (Colgan 1995; Kralj 1996;
Knight 1996). Details of each included RCT have been tabulated
(Characteristics of included studies). Of the 48 included RCTs,
nine were identified during this review update (Zuccarelli 1997;
Harley 2004; Taradaj 2007; Mariani 2008; Moffatt 2008; Taradaj
2009; Brizzio 2010; Milic 2010; Szewczyk 2010); four of these
were listed as “Studies awaiting classification” in the previous ver-
sion of this review (Zuccarelli 1997; Harley 2004; Taradaj 2007;
Moffatt 2008).
Thirty-eight studies were excluded from this review. The reasons
for exclusion were:
• participants in the study were not randomised (17 studies)
(Sikes 1985; Horakova 1994; Nissinen-Paatsamala 1995;
Cameron 1996; Baccaglini 1998; Marston 1999; Scriven 2000;
Vowden 2001; Kucharzewski 2003; Torra i Bou 2003; Alvarez
2005; Brizzio 2006; Jull 2009; Luo 2009; Szewczyk 2009;
Hjerppe 2010; Van Laere 2010);
• irrelevant comparison (9 studies) (Blair 1988; Sironi 1994;
Sabolinski 1995; Robson 2004; Zamboni 2004; Smith Strom
2006; Kuznetsov 2009; Heinen 2010; Serra 2010;
• participants did not have venous leg ulcers (4 studies)
(Jünger 2006; Partsch 2008a; Lee 2009; Hamel-Desnos 2010);
• treatment groups differed systematically other than in terms
of compression devices used (3 studies) (Northeast 1990;
Olofsson 1996; Falanga 1998);
• only available as abstract (2 studies) (Walker 1996; Russo
1999);
• commentary article (2 studies) (Fuessl 2009; Ivanovic
2011);
• and healing not reported (1 study) (Cherry 1990).
Of the 38 excluded studies, 17 were identified during this review
update (Falanga 1998; Robson 2004; Alvarez 2005; Brizzio 2006;
Partsch 2008a; Fuessl 2009; Jull 2009; Kuznetsov 2009; Lee 2009;
Luo 2009; Szewczyk 2009; Hamel-Desnos 2010; Heinen 2010;
Hjerppe 2010; Serra 2010; Van Laere 2010; Ivanovic 2011); two
of these were awaiting classification previously (Alvarez 2005; and
Jawien 2008, now secondary reference to Szewczyk 2009). See
Characteristics of excluded studies for full details.
One RCT previously listed as awaiting classification remains in
this category (Moffatt 2003b); in addition, there are six new
evaluations awaiting classification as a result of this review up-
date (Bertaux 2010; Mosti 2010; Harrison 2011; Mosti 2011;
Taradaj 2011; Wong 2012), Characteristics of studies awaiting
classification.
Previously, no ongoing studies were recorded, but three were iden-
tified for this update (Dumville 2009; Weller 2010; Matos de
Abreu 2011), Characteristics of ongoing studies.
Just over a third of the included RCTs (18/48 or 38%) were con-
ducted in the UK (Charles 1991; Callam 1992b; Travers 1992;
Duby 1993;Wilkinson 1997; Gould 1998;Morrell 1998; Scriven
1998; Taylor 1998; Moffatt 1999; Moody 1999; Vowden 2000;
Meyer 2002; Meyer 2003; Moffatt 2003a; Franks 2004; Iglesias
2004; Nelson 2007a). Two were performed in Ireland (Colgan
1995; O’Brien 2003), 17 in mainland Europe (Eriksson 1984;
Eriksson 1986; Kralj 1996; Zuccarelli 1997; Danielsen 1998;
Partsch 2001;Ukat 2003; Jünger 2004a; Jünger 2004b; Polignano
2004a; Polignano 2004b; Milic 2007; Taradaj 2007; Mariani
2008; Taradaj 2009; Milic 2010; Szewczyk 2010), one in Turkey
(Koksal 2003), one in Tasmania, Australia (Harley 2004), one in
Argentina (Brizzio 2010), and seven in the USA (Hendricks 1985;
Kikta 1988; Rubin 1990; Cordts 1992; Knight 1996; DePalma
1999; Blecken 2005). One international trial was conducted in
the UK, USA and Canada (Moffatt 2008). In terms of the type
of setting, all RCTs (where described) were conducted in outpa-
tient and community settings, with three trials recruiting some
hospitalised patients as part of the sample (Kralj 1996; Ukat 2003;
Polignano 2004a).
The number of patients in the included RCTs ranged from 10
to 387. Forty percent of the included trials had sample sizes of
50 patients or fewer, and the majority of trials (67%) recruited
100 patients or fewer. Nine trials reported an a priori sample size
estimation in relation to a healing outcome (Morrell 1998; Partsch
2001; Meyer 2003; Moffatt 2003a; O’Brien 2003; Ukat 2003;
Franks 2004; Iglesias 2004;Nelson2007a). Three evaluationswere
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designed as non-inferiority trials and presented a proposed non-
inferiority margin (Moffatt 1999; Jünger 2004a; Jünger 2004b).
Non-inferiority trials are designed to establish whether the study
(or new) treatment is not worse than the control treatment by
more than a small, pre-specified amount; this amount is known as
the non-inferiority margin (European Medicines Agency 2005).
Two more studies included some information about the intended
sample size but did not show the full details of the estimation
(Milic 2007; Brizzio 2010); one failed to recruit the entire intended
sample (Polignano 2004a); one included a post hoc assessment
of statistical power with respect to healing (Meyer 2002); and
one included an a priori estimation for a non-healing outcome
(bandage slippage) (Moffatt 2008). The remaining 31 trials (65%)
did not report any information about statistical power or sample
size estimation.
All patients in the included RCTs were deemed to have venous
ulceration, and the majority of trials (39/48 or 81%) specified a
cut-off value of ankle brachial pressure index (ABPI) to exclude
clinically significant arterial disease at baseline. The cut-off point
for application of compression was 0.8 in the majority of these
studies (27/39 or 69%), other values being 0.7 and 0.75 in one
trial each, 0.9 in nine trials and 1.0 in one trial. Most of the trial
reports provided some information on patient selection criteria.
Four trials presented minimal details, describing only the cut-off
value for ABPI (Charles 1991; Duby 1993; Taylor 1998; Ukat
2003), and three early trials did not include any details at all
relating to inclusion and exclusion of patients, apart from the
stipulation of having a venous leg ulcer (Hendricks 1985; Eriksson
1986; Knight 1996).
The amount of pressure applied to a leg depends on bandage ap-
plication or stocking-fitting technique. Overall, few details relat-
ing to the techniques used for applying compression or relevant
staff experience and training were reported in the included RCTs.
Some reports stated that compression devices were applied accord-
ing to the manufacturers’ instructions (Hendricks 1985; Kikta
1988;Moody 1999; Franks 2004; Jünger 2004a; Polignano 2004a;
Moffatt 2008); in other RCTs this was established through contact
with the trial authors (Scriven 1998; Partsch 2001; Ukat 2003;
Iglesias 2004). In some evaluations, nurses with prior experience
of at least one of the evaluated compression systems provided care
(Callam 1992b; Scriven 1998;Taylor 1998; Vowden 2000; Meyer
2002; Meyer 2003; Jünger 2004a; Harley 2004; Nelson 2007a;
Brizzio 2010); in others training was provided in the use of at least
one device for the purposes of the trial (Wilkinson 1997; Morrell
1998; Moody 1999; O’Brien 2003; Iglesias 2004; Jünger 2004b;
Harley 2004; Moffatt 2008).
Information on the techniques used for bandage application was
seldom presented in the included RCTs, but when available in-
cluded a spiral technique (Charles 1991; Callam1992b; Zuccarelli
1997; Moody 1999; Mariani 2008; Milic 2010; Szewczyk 2010),
figure-of-eight application (Meyer 2002; Meyer 2003; Mariani
2008; Taradaj 2009), and Putter technique (two bandages applied
in opposite directions) (Partsch 2001). In some trials, patients or
their relatives were involved in the application of compression de-
vices: in a trial of compression boots, patients adjusted the straps
between clinic visits in order to help maintain the original de-
gree of compression (DePalma 1999); in other RCTs, patients or
relatives were instructed to reapply bandages between clinic visits
(Eriksson 1986; Ukat 2003; Jünger 2004b), or were involved in
the application of compression stockings (Hendricks 1985; Jünger
2004b; Polignano 2004b; Mariani 2008).
For Review Question 1 (does the application of compression ban-
dages or stockings aid venous ulcer healing?), eight RCTs were
identified. Specific comparisons were as follows:
1.1 Compression compared with primary dressing alone (Eriksson
1984; Kikta 1988; Taradaj 2007).
1.2 Compression compared with non-compressive bandages (
Rubin 1990).
1.3 Compression compared with usual care that did not routinely
include compression (Charles 1991; Taylor 1998; Morrell 1998;
O’Brien 2003).
For Review Question 2 (which compression bandage or stocking
system is the most clinically effective?), six comparison categories
were considered,withRCTs assembled into groups and sub-groups
as follows:
For category 2.1 (single-component compression bandage sys-
tems) seven RCTs were identified overall which were grouped into
the following comparisons:
2.1.1 Comparison between different single-component bandage
systems (Cordts 1992; Zuccarelli 1997).
2.1.2 Single-component bandage systems compared with multi-
component bandage systems (Eriksson 1986; Travers 1992;
Colgan 1995; Kralj 1996; Nelson 2007a).
For category 2.2 (two-component compression bandage systems)
six RCTs were identified and grouped as follows:
2.2.1Comparison between different two-component bandage sys-
tems (Danielsen 1998; Moody 1999).
2.2.2 Two-component bandage systems compared with the 4LB
(Moffatt 2003a; Harley 2004; Moffatt 2008; Szewczyk 2010).
For category 2.3 (three-component compression bandage sys-
tems), four RCTs were identified.
2.3.1 Comparison between different three-component bandage
systems (Callam 1992b; Duby 1993; Gould 1998; Meyer 2002).
For category 2.4 (four component compression bandage system
including an elastic component - i.e. the 4LB) 13 RCTs were
identified and were grouped as follows:
2.4.1 Comparison between different versions of the 4LB (
Wilkinson 1997; Moffatt 1999; Vowden 2000).
2.4.2 4LB compared with multi-component bandage systems in-
cluding an inelastic bandage (the SSB) (Duby 1993; Scriven 1998;
Partsch 2001; Ukat 2003; Franks 2004; Iglesias 2004).
2.4.3 4LB compared with bandaging systems having a paste ban-
dage as the base (Duby 1993; Colgan 1995; Knight 1996; Meyer
2003; Polignano 2004a).
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For category 2.5. (adjustable compression boots compared with
compression bandages), two trials were identified.
2.5.1Adjustable compressionboots comparedwith paste bandages
(DePalma 1999).
2.5.2 Adjustable compression boots compared with the 4LB (
Blecken 2005).
For category 2.6 (Compression stockings or tubular devices com-
pared with compression bandage systems), 11 trials were identified
overall and were grouped into the following comparisons:
2.6.1 Compression stockings compared with paste bandages : (
Hendricks 1985; Koksal 2003).
2.6.2 Compression stockings compared with inelastic bandages
(the SSB) (Jünger 2004b; Polignano 2004b;Mariani 2008;Taradaj
2009; Brizzio 2010).
2.6.3 Compression stockings compared with multi-component
bandage systems (Szewczyk 2010).
2.6.4 Tubular compression compared with inelastic bandages (the
SSB) (Jünger 2004a).
2.6.5 Tubular compression compared with or added to elastic ban-
dages(Milic 2007)(Milic 2010).
Figure 1 shows all the comparisons included in the review, and the
number of evaluations for each comparison.
Figure 1. This figure shows all the comparisons included in the review, and the number of evaluations for
each comparison. The green shaded areas represent comparisons between similar compression systems. The
numbers shown refer to numbers of comparisons, not numbers of RCTs.Key:4LB = four-layer bandageThe
abbreviations A-N at the head of each column refer to the corresponding types of compression shown at the
start of each row.
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Risk of bias in included studies
The risk of bias for each included RCT has been tabulated
(Characteristics of included studies). A graphical representation of
this information can be found in Figure 2 and an overall summary
in Figure 3.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Figure 3. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
In some respects, the methodological quality of clinical trials of
compression appears to be improving over time, with evaluations
published within the last ten years being more likely to include
an appropriate method of randomisation, with attempts to gen-
erate balanced groups at baseline, use of allocation concealment
and analysis by intention to treat. Most trials do not report use
of blinded outcome assessment. One RCT was classified as being
at low risk of bias overall, with all risk of bias domains judged to
be low risk (Iglesias 2004). Figure 4 represents a graphical presen-
tation of risk of bias information with RCTs ordered chronologi-
cally.
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Figure 4. Methodological quality summary with trials presented in chronological order Methodological
quality summary with trials presented in chronological order Risk of bias summary figure with RCTs
presented in chronological order.
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Twenty-three RCTs were classified as having an unclear risk of
bias overall (Hendricks 1985; Eriksson 1986; Rubin 1990; Charles
1991; Callam 1992b; Travers 1992; Duby 1993; Knight 1996;
Zuccarelli 1997; Danielsen 1998; Moffatt 1999; Moody 1999;
Meyer 2002;Meyer 2003; O’Brien 2003; Harley 2004; Polignano
2004a; Polignano 2004b; Blecken 2005; Taradaj 2007; Moffatt
2008; Milic 2010; Szewczyk 2010). Six of these RCTs had all
risk of bias domains rated as ’unclear’, indicating poor reporting
of methodological details (Eriksson 1986; Charles 1991; Knight
1996; Zuccarelli 1997; Moody 1999; Taradaj 2007). Twenty-
four RCTs were classified as being at a high overall risk of bias
(Eriksson 1984; Kikta 1988; Cordts 1992; Colgan 1995; Kralj
1996;Wilkinson 1997; Gould 1998;Morrell 1998; Scriven 1998;
Taylor 1998; DePalma 1999; Vowden 2000; Partsch 2001; Koksal
2003; Moffatt 2003a; Ukat 2003; Franks 2004; Jünger 2004a;
Jünger 2004b; Milic 2007; Nelson 2007a; Mariani 2008; Taradaj
2009; Brizzio 2010); in all cases, there was one key individual do-
main assessed as being at high risk of bias (usually blinded outcome
assessment or incomplete outcome data). The following sections
report details of risk of bias according to each domain.
Allocation
Generation of the randomisation sequence
Ten trials employed computer-generated randomisation lists (
Meyer 2002; Meyer 2003; Moffatt 2003a; O’Brien 2003; Iglesias
2004; Polignano 2004a; Milic 2007; Moffatt 2008; Taradaj 2009;
Milic 2010), and one used random number tables to generate the
randomisation sequence (Wilkinson 1997). Other trials deemed
likely to have used a satisfactory randomisation method were
Morrell 1998; Scriven 1998; Taylor 1998; Moffatt 1999; Partsch
2001; Ukat 2003; Franks 2004 and Jünger 2004a. In the remain-
ing 29 trials, treatment allocation was described as being random
with no other information provided, and so they were classified as
having an unclear risk of bias for this domain.
Three trials were factorial and included additional randomised
comparisons of other interventions used concurrently with com-
pression: i.e. knitted viscose dressing versus foam dressing (Callam
1992b); two different foam dressings (Franks 2004); and knit-
ted viscose dressing versus hydrocolloid dressing and oral pentox-
ifylline versus placebo (Nelson 2007a). In the majority of trials,
the patient was the unit of study, but in five RCTs limbs were ran-
domised and analysed (Kikta 1988; Duby 1993;Wilkinson 1997;
Scriven 1998; Blecken 2005). The methods of analysis used in
these trials ignored the highly-correlated healing data frompatients
with both limbs included, with one exception that used within-
individual randomisation and employed an appropriate method
for analysis of healing rate (Blecken 2005).
Allocation concealment
Sixteen out of 48 RCTs (33%) were deemed to have incorpo-
rated adequate allocation concealment. These included three that
used a remote telephone randomisation service (Wilkinson 1997;
Iglesias 2004; Jünger 2004a), and one that used a minimisation
programme which we assumed would be computerised and so
include allocation concealment (Taylor 1998). In addition, 11
studies reported the use of sealed envelopes with some other de-
tail about this method (i.e. opaque envelopes and/or opened in
sequential order) and we assumed that this would amount to
adequate allocation concealment (Morrell 1998; Scriven 1998;
Vowden 2000; Partsch 2001; O’Brien 2003; Ukat 2003; Jünger
2004b; Polignano 2004a; Franks 2004; Nelson 2007a; Taradaj
2009). Another RCT provided sufficient information about con-
cealment in the trial report for us to assume that procedures were
satisfactory (Rubin 1990). In one evaluation, the trial authors
confirmed that allocation was unconcealed (Moffatt 2003a). In
the remaining 31 trials, allocation concealment was either was by
sealed envelopes with no further description of the exact proce-
dures followed (Kralj 1996), or described as “blind” randomisa-
tion with no further details (Danielsen 1998), or more commonly,
not mentioned at all (Eriksson 1984; Hendricks 1985; Eriksson
1986; Kikta 1988; Charles 1991; Callam 1992b; Cordts 1992;
Travers 1992; Duby 1993; Colgan 1995; Knight 1996; Zuccarelli
1997; Gould 1998; DePalma 1999; Moffatt 1999; Moody 1999;
Meyer 2002; Meyer 2003; Koksal 2003; Harley 2004; Polignano
2004b; Blecken 2005; Milic 2007; Taradaj 2007; Mariani 2008;
Moffatt 2008; Brizzio 2010; Milic 2010; Szewczyk 2010). We
have labelled these 31 trials as ’unclear’ in terms of adequacy of
allocation concealment.
Blinding
Four trials reported using blinded outcome assessment of healing
(Gould 1998; Koksal 2003; Jünger 2004b; Moffatt 2008), and
one incorporated blinded confirmation of healing (Iglesias 2004).
For nine trials, outcome assessment was not blind (Colgan 1995;
Wilkinson 1997;Morrell 1998; Scriven 1998; Partsch 2001; Ukat
2003; Franks 2004; Nelson 2007a; Taradaj 2009), and for all
other studies the relevant information was either not clear or not
mentioned at all.
Incomplete outcome data
Just over half of the trials (26/48 or 54%) were classified as being
at low risk of bias in terms of completeness of outcome data. Of
these, 24 trials conducted analysis by intention to treat (Callam
1992b; Travers 1992; Duby 1993; Colgan 1995; Morrell 1998;
Scriven 1998; Moffatt 1999; Partsch 2001; Meyer 2002; Meyer
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2003; Moffatt 2003a; O’Brien 2003; Ukat 2003; Franks 2004;
Harley 2004; Iglesias 2004; Polignano 2004a; Polignano 2004b;
Blecken 2005; Nelson 2007a; Moffatt 2008; Taradaj 2009; Milic
2010; Szewczyk 2010). One trial presented raw data so that the
review authors could analyse data according to intention to treat
(Hendricks 1985). In another trial, a small number of patients
were not included in the analysis because of ineligibility, the num-
bers being similar across treatment groups; we considered that the
overall risk of bias was low (Danielsen 1998). For the remaining
trials, it was either unclear whether the intention-to-treat principle
had been employed, or else it was obvious that this was not the
case.
Other potential sources of bias
Several prognostic studies have suggested that baseline ulcer area
and duration are significant independent predictors of delayed
healing of venous leg ulcers (Skene 1992; Franks 1995; Margolis
2000;Margolis 2004; Brown 2004). Therefore, each included trial
was examinedwith reference to the balance of these variables across
treatment groups. In ten trials, treatment groups appeared to be
comparable at baseline (Scriven 1998; Partsch 2001; Ukat 2003;
Franks 2004; Iglesias 2004; Jünger 2004a; Nelson 2007a; Milic
2007; Brizzio 2010; Milic 2010). Overall, 26 evaluations were
rated as ’unclear’ for this criterion for the following reasons: no
data or very limited information provided (nine trials) (Eriksson
1984; Eriksson 1986; Kikta 1988; Knight 1996; Gould 1998;
Moody 1999;Meyer 2002;Harley 2004; Polignano 2004b);mean
rather than median values presented (medians are preferable since
baseline ulcer area and duration data are usually positively skewed)
(12 trials) (Charles 1991; Callam 1992b; Cordts 1992; Travers
1992; Kralj 1996; Zuccarelli 1997; Morrell 1998; Koksal 2003;
Blecken 2005; Taradaj 2007; Moffatt 2008; Taradaj 2009); and
insufficient information provided for at least one of the prognostic
variables (e.g. data presented in categorical format which is less
useful for group comparisons) (five trials) (Moffatt 1999; Meyer
2003; Moffatt 2003a; Mariani 2008; Szewczyk 2010). Scrutiny
of baseline ulcer area and duration suggested imbalances which
could confound the treatment effect in the 12 remaining stud-
ies (Hendricks 1985; Rubin 1990; Duby 1993; Colgan 1995;
Wilkinson 1997; Danielsen 1998; Taylor 1998; DePalma 1999;
Vowden 2000; O’Brien 2003; Jünger 2004b; Polignano 2004a).
Effects of interventions
Review Question 1: Does the application of
compression bandages or stockings aid venous ulcer
healing?
Overall, eight RCTs were identified that compared compression
with no compression. These studies were grouped according to the
type of comparator: primary dressing only (Eriksson 1984; Kikta
1988; Taradaj 2007); non-compressive bandages (Rubin 1990);
and usual care that did not routinely include compression (Charles
1991; Taylor 1998; Morrell 1998; O’Brien 2003).
1.1 Compression compared with primary dressing alone
(three RCTs)
Three trials compared the use of compression with primary dress-
ings alone (Eriksson 1984; Kikta 1988; Taradaj 2007). All were
small, with two classified as being at high risk of bias (Eriksson
1984; Kikta 1988), and the other at an unclear risk of bias (Taradaj
2007). Eriksson 1984 recruited 44 participants and reportedmean
percentage decrease in ulcer area and volume at eight weeks, which
were both greater for compression.The values, as read froma figure
with no available variability estimates, were: porcine skin dressing
65% (area) and 75% (volume); aluminium foil dressing 10% and
0%; and compression 80% and 90% respectively. The estimates
for the group receiving the porcine skin dressing are difficult to in-
terpret as the randomised intervention ceased mid-study because
of lack of availability of the dressing. At this point, patients in
this group crossed over to the compression treatment. Six patients
receiving the aluminium foil dressing discontinued treatment be-
cause of ulcer deterioration. None of the patients randomised to
compression discontinued treatment.
The second study recruited 84 patients with 87 venous leg ulcers
(Kikta 1988). More participants healed with Unna’s boot (some
compression) than hydrocolloid dressing alone though this differ-
ence was not statistically significant at six months when analysed
for this review using the assumption that those lost to follow-up
were unhealed: RR 1.50 (95% CI 0.90 to 2.50), P value 0.12
(Analysis 1.1). None of the patients receiving compression dis-
continued treatment because of adverse events compared with 10
patients in the hydrocolloid group.
The third evaluationwas a three-armed trial, but only one compar-
ison was relevant to this review (49 participants) (Taradaj 2007).
All patients were recruited post-operatively having undergone lig-
ation and stripping of the saphenous or sagittal veins. Patients in
both groups received moist normal saline dressings and pharma-
cotherapy in the form of a combined tablet preparation of dios-
min 450 mg and hesperidin 50 mg (2 tablets daily). This prepara-
tion has been marketed as an agent to improve venous circulation
(Stragen Chemical 2011; Belmont Pharmacy 2012). The group
allocated compression received a two-component system compris-
ing an elastic bandage and an outer stocking. After seven weeks
of treatment, no statistically significant differences were observed
between treatment groups in terms of mean percentage change in
ulcer area relative to baseline: -62.6% for the non-compression
group and -69.4% for compression, P value > 0.05 (reported by
trial authors). The finding was similar for mean percentage change
in ulcer area per week: -8.9% and -9.9% respectively, P value >
0.05 (reported by trial authors). No variability estimates were pro-
vided. Withdrawals were not reported.
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1.2 Compression compared with non-compressive bandages
(one RCT)
A multicentred RCT classified as unclear in terms of risk of bias
compared Unna’s boot with polyurethane foam dressing (36 par-
ticipants) (Rubin 1990). All patients received elastic bandages as
a retaining layer that did not provide compression. Significantly
more patients completely had healed at 12 months with compres-
sion: RR2.30 (95%CI 1.29 to 4.10), P value 0.005 (Analysis 2.1).
None of the patients randomised to compression withdrew from
treatment, whereas nine of those allocated to the non-compressive
regimen withdrew because of malodorous wound exudate. Six of
these nine patients experienced an increase in ulcer size during the
trial.
1.3 Compression compared with usual care that did not
routinely include compression (four RCTs)
One UK trial compared a SSB applied by a specialist nurse with
usual district nurse care (not involving compression) (Charles
1991). The other three studies compared packages of specialised
leg ulcer care that included provision of the 4LB, with usual pri-
mary care management that generally did not involve compres-
sion; two were conducted in the UK (Taylor 1998; Morrell 1998)
and one in Ireland (O’Brien 2003). Two trials were classified as
being at high risk of bias (Taylor 1998; Morrell 1998), whilst the
other two were classified as unclear (Charles 1991; O’Brien 2003).
In the evaluation of SSB versus usual care (53 participants), more
patients achieved complete healing at three months in the SSB
group (71% versus 25%) (Charles 1991). The authors stated that
this difference was statistically significant, but did not report the P
value (data not plotted, as raw numbers unavailable). Twenty-one
per cent of the usual care group experienced an increase in ulcer
area during the trial versus none in the SSB group. Three patients
withdrew from each group.
Three trials compared the 4LB provided in the context of a spe-
cialist leg ulcer community service with usual management by the
general practitioner (GP) and district nurse (Taylor 1998; Morrell
1998; O’Brien 2003). In one trial (36 participants), significantly
more patients experienced complete healing at three months in
the compression group: RR 4.0 (95% CI 1.35 to 11.82), P value
0.01 (Analysis 3.1) (Taylor 1998). Further analyses reported in the
paper suggested that healing occurred more rapidly with the 4LB.
Two patients withdrew from this treatment, compared with four
in the usual care group. Cost analyses based on consumables, dis-
trict nurse time and mileage estimated significantly lower values
for the 4LB both per week and for the whole trial duration.
The second trial (233 participants) found no statistically signifi-
cant difference in complete healing at one year (Morrell 1998): RR
1.18 (95%CI 0.96 to 1.47), P value 0.12 (Analysis 3.2). However,
survival analyses conducted by the trial authors suggested signif-
icantly faster time to healing for the compression group (median
weeks to healing 20 versus 43, P value 0.03, log rank test). An
adjusted HR estimate was also in favour of compression: HR 1.65
(95% CI 1.15 to 2.35) (P value < 0.05, exact value not reported).
Ulcer recurrence during the one-year trial period was not signifi-
cantly different between groups: RR1.53 (95%CI 0.88 to 2.66), P
value 0.13 (Analysis 3.3) and the log rank test of difference in time
to recurrence was also not significantly different between groups
(P value 0.38). No significant differences were detected between
groups either for change in health status during the trial, or for
mean NHS cost per patient per year. Seventeen patients withdrew
from the 4LB group and 23 from usual care.
Another RCT (200 participants) estimated shorter healing time
with compression (P value 0.006, log rank test and P value 0.015
from adjusted Cox model) (O’Brien 2003). Costs per leg healed
were significantly lower for the compression group: median (in-
terquartile range) cost (presumeprice year 1999-2000)EUR209.7
(137.5 to 269.4) versus EUR 234.6 (168.2 to 345.1), P value
0.04. In addition, the compression group experienced statistically
significant increases in some domains of health-related quality of
life at six weeks relative to the usual care group, detected in both
disease-specific (including global score) and generic instruments.
Findings from the three evaluations of the 4LB are difficult to in-
terpret because some patients in the usual care group could have
received compression, but full details (e.g. number of patients,
type of compression) are not always documented. In addition, the
bandage application is not the only systematic difference between
the two groups; other aspects, such as the provision of specialist
care to the compression groups could have influenced the out-
comes.
Summary of evidence for Review Question 1: Does the
application of compression bandages or stockings aid venous
ulcer healing?
Overall, there is some evidence that venous ulcers healmore rapidly
with compression than without. The overall risk of bias for all
eight RCTs was either high or unclear. For the comparisons of
compression with primary dressing alone and non-compressive
bandages all the RCTs were small. The evidence for compression
versus usual care (not routinely including compression) included
two large trials (Morrell 1998; O’Brien 2003). Some of the ob-
served benefits for patients receiving a specialised package of care
that included application of the 4LB when compared with usual
care could be explained by aspects other than compression, for
example, a higher level of staff expertise resulting in better clinical
management of leg ulceration overall. The evidence on relative
costs of compression versus usual care was conflicting, with two
trials suggesting that management with compression generated
lower costs (Taylor 1998; O’Brien 2003), and one indicating no
significant difference between treatment groups (Morrell 1998).
Review Question 2: Which compression bandage or
stocking system is the most effective?
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2.1 Single-component compression bandage systems (seven
RCTs)
For the purposes of this review, it has been assumed that a sin-
gle-component compression system consists of one type of com-
pression bandage that may be used with, or without, a primary
dressing. When used, primary dressings have been recorded, but
are not considered as part of the compression system. Seven tri-
als were identified overall. Two compared different single-compo-
nent compression systems (Cordts 1992; Zuccarelli 1997), and
five compared single-component systems with multi-component
compression (Eriksson 1986;Travers 1992; Colgan 1995; Kralj
1996; Nelson 2007a).
2.1.1 Comparison between different single-component
bandage systems (two RCTs)
One RCT compared a cohesive elastic bandage used in conjunc-
tion with a hydrocolloid primary dressing versus a zinc oxide
and calamine paste-impregnated bandage (Unna’s boot) (Cordts
1992). This trial was small (30 participants analysed) and had an
overall high risk of bias. No statistically significant between-group
differences were found for complete healing at 12 weeks, RR 1.17
(95% CI 0.54 to 2.54) (Analysis 4.1), and pain score (not plot-
ted). Adverse events were reported in two patients receiving the
elastic bandage and in three patients allocated the paste bandage,
but none of these necessitated withdrawal from treatment. There
were seven withdrawals in the elastic bandage group and six for
the paste bandage.
In an RCT with unclear risk of bias, 48 participants were ran-
domised to receive either an elastic bandage or a SSB for two
months (Zuccarelli 1997). Bandages were removed at night in
both groups and primary dressings were not described. At two
months, the mean reduction in ulcer area was 3.1 cm 2 for the
elastic bandage and 1.6 cm2 for SSB (values calculated by the re-
view authors from baseline and follow-up ulcer area data provided
in the paper). The number of patients remaining in the trial at
two months was not clear. No secondary outcomes were reported.
2.1.2 Single-component bandage systems compared with
multi-component bandage systems (five RCTs)
Five trials compared a single-component compression bandage
systemwithmulti-component compression bandages. In one trial,
the single-component system was an inelastic bandage (Kralj
1996), whilst all the others evaluated elastic bandages (Eriksson
1986; Travers 1992; Colgan 1995; Nelson 2007a). The multi-
component systems included two components (Eriksson 1986),
three components (Travers 1992), and the 4LB (Colgan 1995;
Nelson 2007a; Kralj 1996). One RCT included a third study arm
where patients received four-component compression based on a
paste-bandage system (Colgan 1995). Three RCTs were at high
risk of bias (Colgan 1995; Kralj 1996; Nelson 2007a), whilst the
other two were unclear (Eriksson 1986; Travers 1992).
One trial (34 participants) compared single-component compres-
sion (elastic bandage plus hydrocolloid dressing) with two compo-
nents (zinc oxide paste-impregnated stocking plus an outer elastic
bandage) (Eriksson 1986). In the single-component group, the
elastic bandage was removed at night and reapplied in themorning
by the patient. There was no significant difference between groups
at 12 weeks for complete healing: RR 1.29 (95% CI 0.62 to 2.65)
(Analysis 5.1). Two patients receiving the single-component sys-
tem withdrew, compared with three from the other group.
When a single-component system (elastic cohesive bandage) was
compared with a three-component bandage (paste bandage, non-
cohesive elastic bandage and elastic tubular overlay; 27 partici-
pants) there was no statistically significant difference detected at
seven weeks for percentage change relative to baseline ulcer area
(difference in means -7.0%, 95% CI -18.38 to 4.38, based on
values read from graph) (Analysis 5.2) (Travers 1992). There were
no withdrawals.
Another trial (30 participants) evaluated three types of com-
pression: a single-component compression system consisting of
polyurethane foamprimary dressing plus elastic bandage; the 4LB;
and a modified Unna’s boot consisting of four components (paste
bandage, cotton crepe bandage, elastic adhesive bandage and class
II compression sock) (Colgan 1995). In terms of complete healing
at 12 weeks, no significant difference was found between groups
for the comparison between single-component compression and
the 4LB, RR 0.33 (95% CI 0.09 to 1.27) (Analysis 5.1), or for
single-component versus modified Unna’s boot, RR 0.29 (95%
CI 0.08 to 1.05) (Analysis 6.1). There were no cases of ulcer re-
currence during a six month follow-up period. Three participants
withdrew from the single-component group, one from the Unna’s
boot group and none from the 4LB group. The average cost of
the bandages per participant over 12 weeks in IEP (Irish pounds)
(price year not stated) was: single-component IEP 58.33, Unna’s
boot IEP 66.24, and 4LB IEP 82.54.
A large trial (245 participants) with 2 x 2 x 2 factorial design eval-
uated pentoxifylline versus placebo, knitted viscose versus hydro-
colloid dressings as well as single-component compression (hy-
drocolloid-lined elastic adhesive bandage) versus the 4LB (Nelson
2007a). Initially analyses were conducted on all participants, i.e.
those with both simple and non-simple venous ulceration (non-
simple defined as serologically confirmed rheumatoid arthritis or
venous pathology not confirmed with hand-held Doppler). The
estimate for complete healing at 24 weeks suggested a statistically
significant difference in favour of the 4LB over the single-compo-
nent bandage: RR 0.74 (95% CI 0.59 to 0.92) (Analysis 5.1). A
Kaplan-Meier estimate of median days to healing showed faster
wound closure for the 4LB group (78 versus 168 days, log rank
test not reported) and a HR estimate from an adjusted Cox pro-
portional hazards model was 2.0 (95% CI 1.4 to 2.9), P value <
0.0005, indicating a greater probability of healing with the 4LB.
The proportion of participants who changed bandage during the
trial because of an adverse event was 28% for the single-compo-
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nent compression and 15% for the 4LB. Further analyses (com-
plete healing, withdrawal rate and quality of life) were conducted
on a subset of participants with simple venous ulceration (200
participants). The estimate for complete healing at 24 weeks was
similar to that for the total study population: RR 0.70 (95% CI
0.55 to 0.89) (Analysis 5.3). The proportion of participants who
withdrew from the bandage system with or without simultane-
ous withdrawal from the randomised drug and dressing treatment
was 20% for the single-component group and 5% for the 4LB.
Health-related quality of life was assessed using the Nottingham
Health Profile and showed significantly greater improvements in
some domains for the 4LB group at 24 weeks.
A small trial (40 participants) found similar rates of complete heal-
ing at six months with an inelastic bandage (used with a hydrocol-
loid primary dressing) and the 4LB (Kralj 1996): RR 1.14 (95%
CI 0.51 to 2.55), P value 0.74 (Analysis 5.1).Mean days to healing
were 57.6 for the 4LB and 84.9 for the inelastic bandage (statisti-
cal methods of deriving these values not stated). Four participants
withdrew from the 4LB group and two from the single-compo-
nent group.
Analysis 5.1 includes outcomes for four trials reporting complete
healing. Estimates have not been pooled because of differences in
interventions and length of follow-up.
Summary of evidence for Section 2.1: Single-component
compression systems
No differences were found between different types of single-com-
ponent compression evaluated in two small RCTs. Findings from
the largest trial suggested better healing outcomes for the 4LB
compared with single-component compression in terms of fre-
quency of complete healing and time to healing. In addition, ad-
verse event rates were lower and quality of life scores higher for
the 4LB. The other four RCTs (all small) involving a comparison
with multi-component compression did not detect significant dif-
ferences between groups for healing outcomes. All RCTs had high
or unclear risk of bias.
2.2 Two-component compression bandage systems (six
RCTs)
Of six trials identified, two compared alternative two-component
systems (Danielsen 1998; Moody 1999), and four compared two-
component systems with the 4LB (Moffatt 2003a; Harley 2004;
Moffatt 2008; Szewczyk 2010).
2.2.1 Comparison between different two-component bandage
systems (2 RCTs)
Two trials compared elastic and inelastic (SSB) outer bandages
placed over padding of the lower limb (Danielsen 1998; Moody
1999). Both had unclear risk of bias. When data were pooled for
complete healing at three to six months (95 participants), there
was no statistically significant difference between groups: RR 1.23
(95%CI 0.67 to 2.25), P value 0.51 (test for heterogeneity P value
0.47, I2 = 0%) (Analysis 7.1).
In the first trial (43 participants), complete healing was also re-
ported at one month and one year (Danielsen 1998). At one
month, there was no statistically significant difference between the
alternative two component systems, RR 3.48 (95% CI 0.42 to
28.63, Analysis 7.2), however, at one year more people had healed
in the system with the elastic outer bandage: RR 3.48 (95% CI
1.14 to 10.60), P value 0.03 (Analysis 7.3). Also, a Kaplan-Meier
estimate of proportions healed at one year were 81% for the elastic
bandage and 31% for SSB (P value 0.03).
The second trial (52 participants) reported mean times to healing
of 9.3 weeks for the group receiving an elastic bandage and 9.9
weeks for the SSB (Moody 1999). The percentages of participants
with increased ulcer size and clinical infection during the study
period were 23% and 15% respectively for those receiving an elas-
tic bandage and 15% and 12% for SSB. One participant receiving
SSB withdrew, but there were no withdrawals reported for those
receiving the elastic bandage.
2.2.2 Two-component bandage systems compared with the
4LB (four RCTs)
Four RCTs compared two-component compression (consisting of
a padding or cushioning layer followed by an elastic bandage) with
the 4LB (Moffatt 2003a; Harley 2004; Moffatt 2008; Szewczyk
2010). One RCT was at high risk of bias (Moffatt 2003a), and the
other three were unclear (Harley 2004; Moffatt 2008; Szewczyk
2010).
One cross-over RCT (81 participants) of eight weeks’ duration
stipulated the primary outcome for the trial as degree of bandage
slippage (Moffatt 2008). Complete healing was assessed at four
weeks, just prior to the cross-over, and there were no statistically
significant difference between groups: RR 2.15 (95% CI 0.58
to 8.03) (Analysis 8.1). In terms of adverse events assessed over
the whole 8-week trial period, 68 occurred whilst using the two-
component system and 67 with the 4LB. Prior to cross-over, two
participants withdrew from the group receiving two-component
compression (both due to adverse events) and one withdrew from
the group allocated the 4LB (participant request). Health-related
quality of life was assessed using theCardiffWound Impact Sched-
ule. During the first four weeks, no significant between-groups
differences were detected for overall health-related quality of life.
However, significant differences were observed in favour of the
two-component system for one domain, i.e. physical symptoms
and daily living, (P value < 0.05, based on per protocol analysis
by trial authors).
The second and largest of these trials (112 participants) reported
a statistically significant difference in favour of the 4LB for com-
plete healing at six months when participants were analysed up
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to end of the randomised treatment: RR 0.56 (95% CI 0.41 to
0.77), P value 0.0003 (Analysis 8.3) (Moffatt 2003a). This analy-
sis was repeated, this time including participants who had healed
following withdrawal from the randomised treatment, some of
whom switched bandage systems; the between group difference
was not statistically significant: RR 0.88 (95% CI 0.73 to 1.05)
(Analysis 8.4). The adjusted HR was 1.18 (95% CI 0.69 to 2.02),
P value 0.55. In the group receiving the two-component system,
19 participants reported 21 bandage-related adverse events com-
pared with seven participants with eight events in the 4LB group.
Withdrawal rates were 54% for the two-component system and
12% for 4LB. The mean weekly cost of treatment per participant
(clinic costs and home care costs) was lower in the 4LB group
(GBP 79.91 versus GBP 83.56) and the same trend was observed
for mean cost per participant over the six-month trial (GBP 876
versus GBP 916) (price year 2000). Assessment of health-related
quality of life using SF-36 data at 24 weeks and at healing/with-
drawal adjusted for baseline score suggested no significant differ-
ences between groups.
The third trial recruited 30 participants and reported a shorter
average time on treatment for the group receiving the two-com-
ponent compression (63 versus 87 days, difference described as
not statistically significant but no P value or confidence interval
presented) (Harley 2004). The methods used for estimating the
time on treatment were not explained, and it was not clear whether
mean or median values were reported. A chi-squared analysis of
quintiles of healing times suggested no statistically significant as-
sociation between treatment group and healing duration (P value
0.7), but this is not surprising given the very small numbers of
participants in each time interval category per treatment group
(maximum of five participants). In relation to adverse events, out-
comes were better for participants treated with the 4LB for: the
number of participants reporting at least one adverse event (63%
versus 100%); average number of adverse events per participant
(1.64 versus 0.75); and average number of incidents of inappro-
priate pressure (2.31 versus 5.43) (all differences were described
as significant but P values and confidence intervals were not pro-
vided). Withdrawal rates favoured the 4LB (6% versus 43%, P
value 0.018); reasons for withdrawal were not provided. The esti-
mated costs of six week’s treatment excluding dressings was AUD
35.00 for the two-component system and AUD 114.00 for the
4LB (price year appeared to be 1999 to 2000). The trial follow-
up period was unclear (possibly three months).
The fourth trial (31 participants) compared a compression stock-
ingwith a two-component bandage system and the 4LB (Szewczyk
2010); comparisons between the two types of bandage and the
stocking are considered later (Section 2.6.3). No statistically sig-
nificant differences were detected between groups at three months
for mean percentage reduction in ulcer area (98% for the group
receiving the two-component bandage system versus 94% for the
4LB) or mean healing rate (0.55 and 0.63 cm2 per week respec-
tively). No variance data were provided for either outcome. No
secondary outcomes were reported.
Data from three of the four trials were pooled for the outcome
of complete healing at three months (170 participants) (Moffatt
2003a; Harley 2004; Szewczyk 2010), the estimate suggested no
statistically significant difference in healing between two-compo-
nent systems and the 4LB: RR 0.83 (95% CI 0.66 to 1.05), P
value 0.12 (test for heterogeneity P value 0.59, I2 = 0%) (Analysis
8.2, Figure 5). Data from Moffatt 2008 were not included in the
pooled analysis because of the shorter follow-up period (4 weeks).
Figure 5. Forest plot of comparison: 8 Two-component system vs four-layer bandage (4LB), outcome: 8.2
Patients with complete healing at 3 months.
Summary of evidence for Section 2.2: Compression systems
comprising two components
When alternative two-component compression systemswere com-
pared (the difference being elastic and inelastic outer bandages),
there was no evidence of a between-group difference for complete
healing at three to six months (Danielsen 1998; Moody 1999).
Further findings from one RCT suggested a better performance
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for the system including an elastic bandage in terms of complete
healing at one year (Danielsen 1998). Both trials were small with
unclear risk of bias.
Pooled data from three trials for the outcome of complete healing
at three months suggested no significant difference between two-
component compression and the 4LB (Moffatt 2003a; Harley
2004; Szewczyk 2010). There was some evidence to suggest fewer
adverse events and fewer withdrawals for the 4LB (Moffatt 2003a;
Harley 2004) although groups were similar with respect to both
these outcomes in another RCT (Moffatt 2008). Moffatt 2008
reported findings in favour of the two-component compression
for quality of life changes i.e. physical symptoms and daily living.
Harley 2004 reported that costs were greater for the 4LB, however,
a detailed economic evaluation was not provided. Risk of bias was
high for one RCT (Moffatt 2003a), and unclear for the other three
(Harley 2004; Moffatt 2008; Szewczyk 2010).
2.3 Three-component compression bandage systems (four
RCTs)
2.3.1 Comparison between different three-component ban-
dage systems
Four trials compared alternative three-component compression
systems (Duby 1993; Callam 1992b; Gould 1998; Meyer 2002).
One RCT was at high risk of bias (Gould 1998), and the other
three were unclear. In three RCTs, treatment groups were mainly
distinguished by themiddle component being an elastic or inelastic
bandage (Callam 1992b; Gould 1998; Meyer 2002). The fourth
trial compared a SSB system with a paste-bandage system (Duby
1993).
Pooling of two RCTs suggested significantly more participants
(Callam1992b), and ulcers (Gould 1998), were completely healed
by three to four months when the compression system incorpo-
rated an elastic - rather than inelastic - bandage (171 participants/
ulcers): RR 1.83 (95% CI 1.26 to 2.67), P value 0.002 (test for
heterogeneity P value 0.75, I2 = 0%) (Analysis 9.1; Figure 6). The
possibility of highly correlated healing data influencing the esti-
mate of effect should be noted in the trial that used ulcers as the
unit of randomisation/analysis (Gould 1998). The thirdRCT(112
participants) did not detect a statistically significant difference in
healing at six months (Meyer 2002): RR 0.94 (95% CI 0.69 to
1.27), P value 0.67 (Analysis 9.1; Figure 6), and reported similar
median time to healing for both groups: 9.0 versus 9.5 weeks for
groups receiving elastic and inelastic middle components, respec-
tively. One RCT reported that two participants in each group had
a minor degree of damage related to the bandage (Callam 1992b),
and also reported that a greater proportion of those receiving the
inelastic component complained of ulcer pain at all clinic visits
(48% versus 29%, P value 0.03). Callam 1992b reported that
more participants discontinued treatment in the group receiving
the inelastic middle component (30% versus 12%), whilst Meyer
2002 presented similar withdrawal rates for both groups (around
14%), and Gould 1998 did not provide data per group.
Figure 6. Forest plot of comparison: 9 3 components including elastic bandage vs 3 components including
inelastic bandage, outcome: 9.1 Patients/limbs with complete healing during trial.
The fourth RCT (51 limbs) suggested no statistically significant
difference between the groups in complete healing at threemonths:
RR 1.73 (95% CI 0.74 to 4.06), P value 0.20 (Analysis 10.1)
(Duby 1993). Since limbs rather than participants were allocated,
and this was not adjusted for in any analyses, the possibility of
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biased estimates of treatment effect should be considered.
Summary of evidence for Section 2.3: Compression systems
comprising three components
Four RCTs compared alternative three-component compression
bandage systems (Duby 1993; Callam 1992b; Gould 1998;Meyer
2002). In three, the main difference between study arms was
whether the middle component was elastic or inelastic (Callam
1992b; Gould 1998; Meyer 2002). A pooled estimate from two
trials for complete healing at three to four months suggested a bet-
ter outcome for the system including an elastic bandage (Callam
1992b; Gould 1998). The third trial found no difference between
groups for complete healing at six months and median times to
healing (Meyer 2002). A fourth trial that compared short-stretch
and paste-bandage systems did not report any significant differ-
ences between groups (Duby 1993). One trial was considered to
be at high risk of bias (Gould 1998), while risk of bias was unclear
for the other three (Duby 1993; Callam 1992b; Meyer 2002).
2.4 Compression systems comprising four components
including an elastic component (the ’4LB’)
2.4.1 Comparison between different versions of the 4LB
(three RCTs)
Three trials compared variants of the 4LB (Wilkinson 1997;
Moffatt 1999; Vowden 2000). Two were at high risk of bias
(Wilkinson 1997; Vowden 2000), and the other was at unclear
risk of bias (Moffatt 1999). Data from two trials were plotted for
the comparison of the original Charing Cross 4LB with an alter-
native system, but were not pooled as the comparators differed.
Individual trial estimates showed no statistically significant differ-
ences at three months for complete healing (participants or limbs)
(Wilkinson 1997; Moffatt 1999), or at six months in one evalua-
tion (232 participants): RR 0.96 (95% CI 0.83 to 1.12), P value
0.6 (Moffatt 1999) (Analysis 11.1). Moffatt 1999 also reported
an adjusted HR estimate of 1.18 (95% CI 0.87 to 1.59), P value
0.28.
The third RCT (149 participants) compared three different four-
component systems: the original Charing Cross 4LB; a modi-
fied 4LB (alternative devices were substituted for the two middle
components, but appeared to have similar characteristics to the
originals); and a proprietary kit (Robinson Ultra-Four) (Vowden
2000). No statistically significant differences between groups were
reported for complete healing, respective rates being 60%, 76%
and 60% at three months, and 87%, 84% and 83% at fivemonths
(data not plotted as raw numbers unclear).
Moffatt 1999 reported similar health-related quality of life scores
(NottinghamHealth Profile) between groups for all domains at six
months. A small number of withdrawals because of bandage dis-
comfort were noted for all three trials and there were no apparent
differences between treatment groups. Two trials reported pressure
damage arising from the bandage: this affected one participant in
each of the two arms receiving alternatives to the original Charing
Cross system (Vowden 2000), and one participant receiving the
Charing Cross system (Wilkinson 1997).
Summary of evidence from Section 2.4.1: Comparison
between different versions of the 4LB
Overall, there is no evidence of a difference in outcomes between
different versions of the 4LB system from three RCTs with high
or unclear risk of bias.
2.4.2 4LB compared with multi-component systems
including an inelastic bandage (the SSB) (six RCTs)
Individual patient data meta-analysis
Six RCTs were identified from database searches that compared
the 4LB with a multi-component system that included a SSB
(Duby 1993; Scriven 1998; Partsch 2001; Ukat 2003; Franks
2004; Iglesias 2004). In these RCTs, the 4LB systems all com-
prised orthopaedic wool, crepe bandage, an elastic bandage and
an elastic cohesive bandage as the outer layer. The comparator
systems usually consisted of orthopaedic wool, one or two SSBs
and sometimes a retaining layer (e.g. a cohesive bandage or tubu-
lar device). An additional eligible unpublished trial was identified
at a wound management conference. These seven trials recruited
887 participants in total. Patient-level data were unavailable for
Duby 1993 and the unpublished trial; these two RCTs recruited
83/887 (9.4%) of the eligible participants. Table 1 shows details
of all seven RCTs.
In terms of the five RCTs with available IPD, ten participants
were excluded from the original investigators’ own analyses (1.1%
of known randomised participants), of whom three were rein-
stated by the review authors for the meta-analysis. Data for the
seven other participants were not available (Table 1). In total, data
from 797 participants were included in the meta-analysis. Table 2
shows participants’ characteristics for the five trials with available
IPD (89.8% of known randomised participants); most partici-
pants were ambulant. The reported follow-up periods for RCTs
ranged from three to 12 months. The overall median follow-up of
participants who did not heal during the trial period was around
13 weeks (estimate derived from IPD, Table 1).
Four of the five RCTs with available IPD were classified as being
at overall high risk of bias because of non-blinded outcome as-
sessment (Scriven 1998; Partsch 2001; Ukat 2003; Franks 2004).
The remaining RCT was deemed to be at low risk of bias, con-
firming healing from photographs at the trial office by an investi-
gator blinded to treatment allocation (Iglesias 2004). Checks on
the IPD for each RCT suggested that baseline comparability was
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generally satisfactory and that data were mostly complete, free of
duplication, consistent and feasible. The small number of queries
raised were resolved through discussion with the relevant trialist.
The results of model-checking procedures indicated that the pro-
portional hazards assumption was upheld for all potentially pre-
dictive covariates. The only continuous covariate included in the
final models (baseline ulcer surface area) was entered as a natural
log transformation. Outcomes were similar for early and late ac-
cruals when we took into account differences between study cen-
tres in four trials assessed (Iglesias 2004; Partsch 2001; Ukat 2003;
Franks 2004). To assess the adequacy of model fit, we assessed the
number of events (an event being a healed wound) against the
number of covariates entered at the start of each model. At least
10 events per variable are required in logistic regression to reduce
bias in regression coefficients (Peduzzi 1996). All models gener-
ated from the meta-analysis data set met this recommendation.
Primary outcomes: findings from preliminary analyses of IPD
When data were pooled for the outcome of complete healing (un-
adjusted) during the trial period (797participants fromfiveRCTs),
no significant difference between treatment groups was observed:
fixed-effect RR 0.96 (95% CI 0.88 to 1.05), P value 0.34 (chi-
squared test for heterogeneity P value 0.54, I2 = 0%) (Analysis
12.1, Figure 7). For the trial without available IPD, complete heal-
ing at three months was similar for the 4LB and the SSB (NB unit
of analysis was limbs, not participants): RR 1.10 (95% CI 0.57 to
2.11), P value 0.77 (Analysis 12.2; Duby 1993).
Figure 7. Forest plot of comparison: 12 4LB vs multi-layer short-stretch bandage (SSB), outcome: 12.1
Patients with complete healing during trial period based on IPD.
The median time to healing (based on IPD) estimated from un-
stratified Kaplan-Meier survival analysis (797 participants) was 90
days (95% CI 79 to 101) for the 4LB and 99 days (95% CI 82
to 116) for the SSB, P value 0.133 for logrank test for difference
between survival curves (Figure 8).
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Figure 8. 4LB versus SSB: Kaplan-Meier survival curves (unstratified analysis) based on IPD
An initial Cox proportional hazards model was generated from
the IPD with time to healing (days) as the dependent variable,
healing as the event, study centres as strata, and bandage type as
the only covariate. The result of this unadjusted analysis indicated
no significant difference between bandage types: HR 1.15 (95%
CI 0.97 to 1.37), P value 0.11.
Primary outcomes: findings from main analyses of IPD
The final Cox model contained type of bandage, ulcer dura-
tion,and ulcer area (Table 3). The HR for bandage type was 1.31
(95%CI1.09 to 1.58), P value 0.005, indicating that the estimated
probability of healing with the 4LB was around 1.3 times that of
healing with the SSB, assuming similar values for other covariates.
There was significant evidence that larger ulcers (P value < 0.001)
and ulcers of longer duration (P value < 0.001) predicted longer
time to healing independently of one another and of treatment.
The chance of healing was reduced by a factor of 0.44 for each 10-
fold increase in area. Baseline ulcer duration was divided into the
following four categories: a month or less; more than one month
up to and including six months; more than six months up to and
including 12 months; and over 12 months. The data suggested
that the hazard of healing was reduced for each step up to a longer
duration interval. We found no significant interactions between
bandage and baseline ulcer area, and bandage and baseline ulcer
duration.
Analysis 12.3 and Figure 9 illustrate the relative contribution of
each RCT to the meta-analysis, showing HR estimates for each
trial individually and for all trials when pooled. The estimates
were derived from the IPD and were adjusted for baseline ulcer
area and baseline ulcer duration. The pooled HR estimate was
very close to that derived from the Cox regression: fixed-effect HR
1.32 (95% CI 1.09 to 1.60) P value 0.004. Some heterogeneity
between trials was detected: chi-squared P value 0.11, I2 = 48%.
When the analysis was repeated using a random-effects model no
statistically significant difference was detected between bandages:
HR 1.30 (95% CI 0.94 to 1.80) P value 0.11 (Analysis 12.4).
Visual inspection of the forest plot suggested that one trial was
likely to be the source of heterogeneity (Partsch 2001). When this
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trial was removed, a sensitivity analysis showed the heterogeneity
was eliminated and the observed treated effect was in favour of
the 4LB in both fixed-effect (Analysis 12.5) and random-effects
models (Analysis 12.6).
Figure 9. Forest plot of comparison: 12 4LB vs multi-layer short-stretch bandage (SSB), outcome: 12.3
Hazard ratio estimates for time to healing based on IPD (fixed-effect).
The Cox proportional hazards model was re-run on a subset of
four trials (747 participants) for which additional covariates were
available: primary or recurrent ulceration and participants’ mobil-
ity (Iglesias 2004; Partsch 2001; Ukat 2003; Franks 2004). The
final model contained bandage type, ulcer area, ulcer duration and
primary or recurrent ulceration. The estimated HR for type of
bandage was similar to the model based on five trials: 1.29 (95%
CI 1.06 to 1.57), P value 0.011. The model suggested that larger
ulcers (P value < 0.001), ulcers of longer duration (P value < 0.001)
and previous ulceration (P value < 0.005) were independent pre-
dictors of longer time to healing (Table 4). No significant interac-
tion was found between: bandage and baseline ulcer area; bandage
and baseline ulcer duration; and bandage and primary or recurrent
ulceration.
Secondary outcomes: findings from IPD - adverse events and recurrence
IPD for adverse events were retrieved for two trials (Iglesias 2004;
Franks 2004). For incidence of any type of adverse event, the
pooledOR (fixed-effect) was 1.15 (95% CI: 0.81 to 1.62), P value
0.43, providing no evidence of a difference between bandage types
(Analysis 12.7). Some heterogeneity was detected (chi-squared test
P value 0.24, I2 = 28%) and so the analysis was repeated using a
random-effects model which showed a similar estimate: OR 1.11
(95% CI 0.72 to 1.72), P value 0.64 (Analysis 12.8).
The two trials differed in their definitions of bandage-related ad-
verse events. In one, maceration, allergic reaction, eczema of peri-
ulcer skin and infection were coded as bandage-related (Iglesias
2004). The second trial, comparing primary dressings as well as
bandages, attributed these events to dressings (Franks 2004). In
view of this difference, data were not pooled. ORs were estimated
for each trial individually and neither demonstrated a statistically
significant between-group difference: 1.41 (95%CI: 0.94 to 2.11)
(Iglesias 2004), and 0.78 (95% CI: 0.30 to 2.04) (Franks 2004)
(Analysis 12.9).
Analysis of the number of all types of adverse events per participant
did not showadifference between the twobandage systems: pooled
difference inmeans (fixed-effect) -0.10 (95%CI−0.32 to 0.12), P
value 0.38 (Analysis 12.10). Since someheterogeneitywas detected
(chi-squared test P value 0.12, I2 = 58%) the meta-analysis was
repeated using a random-effects model which generated a similar
estimate: difference in means -0.21 (95% CI -0.68 to 0.27), P
value 0.39 (Analysis 12.11).
Data were not pooled for the number of adverse events related to
bandaging for the reasons mentioned above. No significant dif-
ferences were detected between groups for the trials individually:
difference in means -0.45 (95% CI -1.01 to 0.11) (Iglesias 2004),
and 0.04 (-0.09 to 0.17) (Franks 2004) (Analysis 12.12).
Data on time to recurrence were provided for one RCT (Iglesias
2004); the trial authors had previously published a Kaplan-Meier
survival analysis for recurrence. No statistically significant differ-
ence was detected between the survival curves for time to recur-
rence for 4LB and SSB (27 versus 29 recurrences respectively, log
rank test P value 0.22). No further analyses were performed by the
original investigators due to the low event rate precluding explo-
ration of the impact of covariates. Since the meta-analysis data set
did not contain any additional information on time to recurrence
relative to this trial’s findings, no further analyses were undertaken.
Secondary outcomes: findings from aggregate data - health-related
quality of life, costs and withdrawals
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Two trials included an assessment of quality of life (Franks 2004;
Iglesias 2004). One used the Nottingham Health Profile and ob-
served no statistically significant differences between treatment
groups for scores for any domain at six months (Franks 2004).
The other trial had a large amount of missing data for this out-
come and so reported a descriptive analysis of findings obtained
using the SF-12 and the Hyland Leg and Foot Ulcer Question-
naire (Iglesias 2004). Overall, there did not appear to be marked
differences between treatment groups.
Three trials included an analysis of costs (Scriven 1998;Ukat 2003;
Iglesias 2004), but only one reported a rigorously conducted cost-
effectiveness analysis (Iglesias 2004). Cost estimates were based on
NHS and Personal Social Services costs and health benefits were
measured as differences in ulcer-free days and quality-adjusted
life years (QALYs). The following estimates were reported, all in
favour of the 4LB: mean between-group difference in healing time
10.9 days (95% CI -6.8 to 29.1); difference in mean in QALYs -
0.02 (95% CI -0.08 to 0.04); and difference in mean in total cost
(price year 2001): GBP 227.32 (95% CI 16.53 to 448.30) per
patient per year. Sensitivity analyses showed the cost-effectiveness
estimate to be robust to variation in the number of bandages used
and unit costs of compression systems. The 4LB emerged as the
dominant treatment strategy. The second trial calculated the cost
per patient and cost per ulcer healed, based on costs of bandages
and other disposables (e.g. primary dressings, wadding) and 30
minutes of nursing time per bandage change (Ukat 2003). Costs
per patient were EUR 587 for the 4LB and EUR 1345 for the
SSB; and per ulcer healed EUR 1845 and EUR 5502 respectively.
Statistical tests for between group differences and price year were
not reported. The third trial estimated the cost of treatment over
six months as GBP 392.60 for the 4LB and GBP 184.56 for the
SSB (estimates based on cost of bandage systems only, price year
not stated) (Scriven 1998).
Five trials reported on withdrawals (Scriven 1998; Partsch 2001;
Ukat 2003; Franks 2004; Iglesias 2004). Two found similar with-
drawal rates for both treatment groups: 18% for Ukat 2003, and
around22%for Franks 2004.Twoothers foundhigherwithdrawal
rates in participants allocated to the SSB: 3%versus 6% (represents
proportion of limbs withdrawn) (Scriven 1998); and 24% versus
34% (Iglesias 2004). The fifth trial reported more withdrawals in
the group receiving the 4LB, 12% versus 23% (Partsch 2001).
Summary of evidence from Section 2.4.2: Comparison
between the 4LB and multi-component systems that include
an inelastic bandage (the SSB)
Analysis of IPD from five trials indicated that the estimated prob-
ability of healing with the 4LB was around 1.3 times that of heal-
ing with the SSB (statistically significant difference). One trial
included a rigorous cost-effectiveness analysis that indicated that
the 4LB was the dominant (more cost-effective) treatment strat-
egy (Iglesias 2004). The adverse event profile, recurrence rates and
changes in health-related quality of life scores were similar for the
two bandage types. Withdrawal rates were approximately similar
between groups. Risk of bias was high in four RCTs because of
non-blinded outcome assessment (Scriven 1998; Partsch 2001;
Ukat 2003; Franks 2004); the other RCT had low risk of bias
(Iglesias 2004). One RCT recruited groups which may not have
been comparable at baseline (Scriven 1998); the Cox regression
performed on the IPD took account of between-group differences
in prognosis.
2.4.3 4LB compared with compression systems having a
paste bandage as the base (five RCTs)
Five trials were identified for this comparison (Duby 1993; Colgan
1995; Knight 1996;Meyer 2003; Polignano 2004a). In all studies,
the 4LB consisted of orthopaedic wool, a crepe bandage, an elastic
bandage and an elastic cohesive bandage as the final retaining com-
ponent. Three trials used a proprietary 4LB kit (Profore) (Colgan
1995; Knight 1996; Polignano 2004a). The paste-bandage sys-
tem (sometimes referred to as Unna’s Boot) varied between trials,
consisting of: paste bandage applied over a foam primary dressing
with no other compression components (Knight 1996); a two-
component system with an elastic cohesive bandage applied after
the paste bandage (Polignano 2004a); three-component systems
comprising either a paste, a crepe, and an elastic tubular bandage
(Duby 1993), or a paste, an elastic, and an elastic tubular bandage
(Meyer 2003); and finally, a four-component system consisting
of a paste, a crepe and an elastic-cohesive bandage and a class II
compression sock (Colgan 1995).
Four RCTs had unclear risk of bias (Duby 1993; Knight 1996;
Meyer 2003; Polignano 2004a), and one was at high risk of bias
(Colgan 1995).
Pooled data from two trials (71 participants/limbs) that reported
complete healing at three months (fixed-effect model) suggested
no significant difference between groups: RR 1.34 (95% CI 0.78
to 2.28), P value 0.29 (test for heterogeneity P value 0.11, I2 =
60%) (Analysis 13.1) (Duby 1993; Colgan 1995). The estimate
generated froma random-effectsmodel was similar: RR1.23 (95%
CI 0.54 to 2.82) (Analysis 13.2). Likewise, the observed between-
group difference for complete healing at other time points did not
suggest a statistically significant difference: RR 1.13 (0.82 to 1.57)
at six months, 68 participants (Polignano 2004a) (Analysis 13.1);
and RR 0.82 (95% CI 0.66 to 1.01) at one year (133 participants)
(Meyer 2003) (Analysis 13.1).
Survival analysis was undertaken for two trials (Meyer 2003;
Polignano 2004a). One suggested a shorter time to healing with
paste bandage (median values 12 versus 16 weeks, P value 0.04),
with the difference in probability of healing becoming signifi-
cant after 20 weeks post-randomisation (P value 0.036) (Meyer
2003). The second trial estimated similar values for median days
to healing for each study arm (53 for the 4LB and 56 for the
paste bandage) (Polignano 2004a). This trial also presented a HR
estimate that suggested no significant difference between groups:
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1.62 (95% CI 0.87 to 3.02), P value 0.13.
Two trials reported rate of healing as follows: percentage daily
healing rate (Polignano 2004a); and the absolute rate in cm2 per
week (Knight 1996). These data were pooled using standardised
mean difference (SMD), and suggested a significant treatment
effect in favour of the 4LB: SMD 0.52 (95% CI 0.06 to 0.97), P
value 0.03 (test for heterogeneity P value 0.47, I2 = 0%) (Analysis
13.4).
One RCT reported recurrence, stating that there were no cases
of ulcer recurrence during a six month follow-up period (starting
from the end of the 12 week treatment period) (Colgan 1995).
The same RCT presented costs of bandages per patient over the
12-week trial period (nursing time not included) (Colgan 1995).
The estimates for average values (price year not stated) were IEP
82.54 for the 4LB and IEP 66.24 for the paste bandage (statistical
tests not reported). Another RCT found no significant difference
between groups in change in patient-reported pain score assessed
by visual analogue scale from baseline to final assessment (P value
0.32) (Polignano 2004a). Three trials reported withdrawal rates
andobserved similar rates for both study groups, with a small num-
ber due to adverse events (Colgan 1995; Meyer 2003; Polignano
2004a).
Summary of evidence for Section 2.4.3 Comparison
between the 4LB and compression systems with a paste
bandage as the base
No significant differences were found between the 4LB and paste
bandages for complete healing at three months (Duby 1993;
Colgan 1995), sixmonths (Polignano 2004a), and one year (Meyer
2003). Estimates of time to healing showed no difference between
groups in one trial (Polignano 2004a), and a significant difference
in favour of the paste-bandage system in another (Meyer 2003).
This difference in outcome could be explained by variation in the
components of the paste-bandage systems, two components be-
ing used in one trial (Polignano 2004a), and three components
in the other (Meyer 2003); different systems could exert differ-
ent amounts of compression. Different RCTs individually assessed
different secondary outcomes, finding no between-group differ-
ences for recurrence, pain, withdrawals and adverse effects. Find-
ings from one RCT suggested lower costs for the paste-bandage
system (Colgan 1995). All RCTs had unclear risk of bias apart
from Colgan 1995 which had high risk of bias.
2.5 Adjustable compression boots compared with
compression bandages (two RCTs)
Two small trials were identified for this comparison (DePalma
1999; Blecken 2005). Both studies described the adjustable boot
as an inelastic compression garment, and both evaluated different
versions of the CircAid proprietary device. One had a high risk of
bias (DePalma 1999), while risk of bias for the other was unclear
(Blecken 2005).
2.5.1 Adjustable compression boots compared with paste ban-
dages
The first trial (38 participants) evaluated an adjustable compres-
sion boot consisting of a series of interlocking, non-elastic bands
that encircled the leg, held in place by hook and loop fasteners, to-
gether with a foot-piece made of very low stretch bands (DePalma
1999). Participants were instructed to adjust the straps in order to
maintain compression. This was compared with a paste-bandage
system. Three different estimates of healing rate were reported:
mean area healed (cm2) per day;mean area healed (%) per day; and
the linear healing rate of the wound edge towards the wound cen-
tre (mean cm per day). No statistically significant differences were
observed for any of these outcomes (Analysis 14.1). The mean to-
tal cost per patient completing the trial based on costs of clinician
time and materials suggested a lower cost for patients receiving the
adjustable compression boot: USD 559.41 versus USD 901.73,
P value 0.05 (price year not stated). Two participants withdrew
from the group receiving the adjustable boot, and five withdrew
from the paste bandage group.
2.5.2 Adjustable compression boots compared with the 4LB
The second study entailed within-individual randomisation
whereby 12 participants with bilateral venous leg ulcers were re-
cruited (Blecken 2005). One limb per participant was randomised
to receive the adjustable compression boot, similar to the device
used in the above study, except that the adjustable bands were
made of Velcro. Application of the boot was preceded by a paraf-
fin-impregnated gauze primary dressing, sterile absorbent gauze,
and a felt pad cushion, all retained with a cotton stockinette. An
elastic anklet was applied over the boot. The second limb was al-
located a four-component compression system; this differed from
the traditional 4LB, consisting of paraffin-impregnated gauze pri-
mary dressing, sterile absorbent gauze, felt pad, gauze bandage
and elastic bandage. At 12 weeks, four limbs out of 12 healed in
each group, these limbs belonging to the same participants in each
group. There were no withdrawals.
Summary of evidence from Section 2.5: Adjustable
compression boots compared with compression bandages
Two RCTs found no evidence of a difference in healing between
adjustable compression boots and compression bandage systems.
Both trials were small with high (DePalma 1999) and unclear
(Blecken 2005) risk of bias. The compression boot may be a less
costly option (DePalma 1999).
2.6 Compression stockings or tubular devices compared
with compression bandage systems (11 RCTs)
Eight trials compared compression stockings with compres-
sion bandages (Hendricks 1985; Koksal 2003; Jünger 2004b;
Polignano 2004b; Mariani 2008; Taradaj 2009; Brizzio 2010;
Szewczyk 2010), and three compared tubular compression de-
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vices with compression bandages (Jünger 2004a;Milic 2007;Milic
2010).
Compression stockings are usually garments which are fashioned
to the shape of the lower leg, with open or closed, tailored toes
and heels. Different sizes are available to correspond to varying
limb sizes. They are designed to provide graduated compression,
with higher pressures exerted at the ankle, diminishing up to the
top of the calf. Tubular compression devices are usually available
as lengths of close weave stretch cotton, open at the toe and some-
times also at the heel; they can provide either uniform or graduated
compression, depending on device specifications. Again, different
sizes are available to fit different size limbs.
Compression stockings were compared with paste bandages (
Hendricks 1985; Koksal 2003), the SSB (Jünger 2004b; Polignano
2004b; Mariani 2008; Taradaj 2009; Brizzio 2010), a two-com-
ponent bandage system (Szewczyk 2010), and the 4LB (Szewczyk
2010). In the evaluations of tubular compression, the comparators
were the SSB (Jünger 2004a), elastic bandages (Milic 2007), and
elastic bandages and tubular compression combined (Milic 2010).
2.6.1 Compression stockings compared with paste bandages
(two RCTs)
Two trials compared a single-layer compression stocking with a
paste bandage: Hendricks 1985 which had unclear risk of bias;
and Koksal 2003, which was classified as being at high risk of
bias. In the Hendricks 1985 trial (21 participants), the device was
designed to provide graduated compression from 24 mm Hg at
the ankle to 16 mm Hg at the calf. In the Koksal 2003 trial (60
participants), the stocking was designed to provide 30 to 40 mm
Hg compression.
No significant differences were detected between groups in terms
of complete healing at four months, RR 1.05 (95% CI 0.74 to
1.48) (Koksal 2003), or 18 months, RR 0.91 (95% CI 0.64 to
1.29) (Hendricks 1985) (Analysis 15.1). One trial report included
presentation of raw data, allowing the review authors to calculate
estimates from Kaplan-Meier survival analysis (Hendricks 1985).
The estimated cumulative proportions healed at 18 months were
73% for participants randomised to the stocking and 90% for
those allocated to the paste-bandage system. The estimates for me-
dian time to healing were 18 weeks versus seven weeks respectively
(P value 0.39, log rank test). The other trial reported no significant
difference between groups for mean weeks to healing: 6.65 for
stocking and 6.85 for the paste bandage (P value > 0.05) (Koksal
2003). In terms of secondary outcomes, one trial demonstrated
significantly lower mean pain scores for participants allocated the
stocking (P value < 0.0001) (Koksal 2003). One treatment-related
adverse event was reported in the group receiving the stocking, but
the nature of this was not described. Four participants allocated
the stocking withdrew compared with three from the paste ban-
dage group, one of these having a severe reaction to the dressing.
In the Hendricks 1985 trial, there were no withdrawals from the
paste bandage group and one from the stocking group; the reason
was not described.
2.6.2 Compression stockings compared with inelastic
bandages (the SSB) (five RCTs)
2.6.2.1 Compression stockings (low compression) compared
with inelastic bandages (the SSB)
One trial (60 participants) compared a single-layer compression
stocking designed to exert 15 to 20 mmHg at the ankle with an
inelastic bandage system (three short-stretch slings), both devices
being left in place day and night (Brizzio 2010). This trial was
classified as being at high risk of bias.
No significant difference was detected between treatment groups
in terms of complete healing at three months RR 0.67 (95% CI
0.35 to 1.29) (Analysis 16.1), or six months RR 0.68 (95% CI
0.42 to 1.10) (Analysis 16.2). Median days to healing were similar
in both groups (56 days for the group receiving stockings and 60
days for SSB). Analyses of quality of life scores (using the Chronic
Venous Insufficiency Quality of Life questionnaire) did not de-
tect any statistically significant between group differences at 35
days, or at final assessment in participants with healed ulcers. Four
participants withdrew from the group allocated the stocking (one
death, one did not attend clinic and two had systemic infections),
whilst one withdrew from the group allocated SSB because his/
her condition deteriorated rapidly.
2.6.2.2 Compression stockings (high compression) compared
with inelastic bandages (the SSB)
Four trials compared high compression stockings with the SSB
(Jünger 2004b; Polignano 2004b; Mariani 2008; Taradaj 2009).
Three were at high risk of bias (Jünger 2004b; Mariani 2008;
Taradaj 2009), and one was unclear (Polignano 2004b). One trial
reported the mean (standard deviation) ankle pressure for the
stocking system as 42.7 (13.0) mmHg (Jünger 2004b). In the
other three trials, the devices were designed to provide 25 to 32
mmHg (Taradaj 2009 ), 35 mmHg (Polignano 2004b) and 39
mmHg (Mariani 2008).
Data from all four trials (317 participants) were pooled using a
fixed-effect model and showed that significantly more participants
achieved complete healing with stockings at two to four months
than with the SSB: RR 1.62 (95% CI 1.26 to 2.10), P value
0.0002 (test for heterogeneity P value 0.06, I2 = 60%) (Analysis
17.1, Figure 10) (Jünger 2004b; Polignano 2004b; Mariani 2008;
Taradaj 2009). The between-group difference remained statisti-
cally significant when the analysis was repeated using a random-ef-
fectsmodel: RR1.66 (95%CI1.07 to 2.58), P value 0.02 (Analysis
17.2).
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Figure 10. Forest plot of comparison: 17 Higher compression stockings versus SSB, outcome: 17.1 Patients
with complete healing at 2-4 months (fixed-effect).
Three of the above trials reported outcomes relating to time toheal-
ing (Jünger 2004b; Polignano 2004b; Mariani 2008). In Jünger
2004b the cumulative proportions healed at three months (as read
from a plot of survival curves) were 51% for the group receiving
stockings and 30% for the SSB (P value 0.057, log rank test). The
same trial reported no significant difference between groups for
median (range) days to healing: 47 (10 to 83) for stockings versus
52 (6 to 80) for SSB (P value 0.82, Mann-Whitney U-test). The
other two trials reported the less useful mean time to healing: 72
days for stockings versus 101 days for SSB (P value 0.027, log
rank test) (Polignano 2004b), and 56 versus 61 days respectively
(P value 0.52) (Mariani 2008).
Three of the four trials reported a variety of secondary outcomes
(Jünger 2004b; Polignano 2004b; Mariani 2008). In Polignano
2004b, both decrease in ulcer pain during the trial and comfort
while wearing compression were significantly better for the group
receiving stockings (P value 0.017 and P value 0.038, respectively).
A higher withdrawal rate was noted in the SSB group in this trial
(38% versus 15%). Of five participants withdrawing from the SSB
group, one was considered to be related to compression (bullous
dermatitis); there were no reported withdrawals due to adverse
events in the group receiving stockings. The Jünger 2004b trial
reported 29 adverse events (two serious) in 20 of the 65 (31%) par-
ticipants receiving stockings and 42 adverse events (four serious)
in 26 of the 67 (39%) participants receiving the SSB. Withdrawal
rates were similar between groups. This trial also estimated cost
of procedures including labour and associated resources. The es-
timated mean cost per percentage reduction in wound area (price
year 2003) was EUR 2.57 for the group receiving stockings and
EUR 4.58 for the SSB group. The Mariani 2008 trial reported
significantly worse performance for the SSB for inhibition of ac-
tivities (P value 0.025), pain at donning and removal of device (P
value 0.001), and number of problems reported in terms of pain,
discomfort and hindrance of activities (P value < 0.0001). No sig-
nificant differences, however, were detected between groups for
daytime pain and discomfort. There were four withdrawals from
the group receiving stockings (one withdrew consent and three
had difficulty putting on the stockings) and none among those
allocated the SSB.
2.6.3 Compression stockings compared with multi-
component bandage systems (one RCT)
A three-armed trial (46 participants) at unclear risk of bias com-
pared a compression stocking with a two-component compression
bandage system and the 4LB (Szewczyk 2010). The comparison
between the two types of bandage was considered earlier (Section
2.2.2). The stocking was described as Class II, presumably de-
signed to deliver pressure of 18 to 24 mmHg, although this was
not specified in the trial report, which also did not describe char-
acteristics such as the number of layers. No details were provided
about whether the devices were worn both day and night.
No statistically significant between-group difference was detected
for complete healing at three months for either comparison: RR
0.85 (95% CI 0.47 to 1.57) for the stocking versus the two-com-
ponent bandage system (Analysis 18.1); and RR 0.89 (95% CI
0.47 to 1.67) for stockings compared with 4LB (Analysis 19.1).
No secondary outcomes were reported.
2.6.4 Tubular compression compared with inelastic
bandages (the SSB) (one RCT)
Aheel-less, open-toed, graduated, tubular compressiondevice pro-
viding 30 to 40 mmHg at the ankle was compared with an inelas-
tic bandage (the SSB) in a non-inferiority trial (178 participants)
(Jünger 2004a). This RCT was classified as being at high risk of
bias.
There was no statistically significant difference between groups
for complete healing at three months: RR 0.98 (95% CI 0.76 to
1.26), P value 0.86 (Analysis 20.1). Kaplan-Meier analysis sug-
gested a median estimate of 42 days to healing in both groups and
found no significant difference in probability of healing derived
from survival curves (P value 0.41). In terms of adverse events,
14% of participants receiving tubular compression complained of
pain or tightness during treatment which was resolved in all cases
by using a larger-sized device; the participants receiving the SSB
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did not experience such problems, and no other adverse events
were reported. Assessment of health-related quality of life using
the Nottingham Health Profile suggested no difference between
treatment groups.
2.6.5 Tubular compression compared with, or added to,
elastic bandages (two RCTs)
Two trials from the same research team evaluated tubular com-
pression systems: Milic 2007 was classified as being at high risk
of bias; and Milic 2010 at being at unclear risk of bias. The first
trial compared two four-component systems consisting of gauze
bandage, crepe bandage, a graduated tubular device and an elas-
tic bandage versus gauze bandage, crepe bandage and two elastic
bandages (Milic 2007). The second trial included three arms and
compared: gauze bandage, crepe bandage and a tubular device;
gauze bandage, crepe bandage, a tubular device and an elastic ban-
dage; gauze bandage, crepe bandage, a tubular device and two elas-
tic bandages (Milic 2010). In both trials, the tubular devices pro-
vided an ankle pressure of 30 to 40 mmHg; all participants wore
compression day and night and received mechanical debridement
using sterile gauze, a dry dressing for non-exuding wounds and
application of boric acid in cases of exudation. At first scrutiny the
participant populations from these two RCTs appear very similar;
the trial authors confirmed that the two RCTs are entirely separate
(personal communication).
In the first trial (150 participants) the cumulative proportions of
participants healed at 16 months were 93% for tubular compres-
sion and 51% for the system including two elastic bandages (P
value < 0.01) (Milic 2007). This trial also reported shorter median
days to healing for the group receiving tubular compression: 133
(range 28 to 464) versus 211 (range 61 to 438) , P value not re-
ported. There were significantly lower recurrence rates at one year
for the group receiving tubular compression (24% versus 53%,
P value < 0.05). Amongst the participants who received tubular
compression, 17% experienced skin excoriation of the ankle or leg
and 47% experienced pressure or pain caused by slippage of the
device; details of adverse events were not provided for the group
that received compressionbandages. Therewere fewerwithdrawals
in the tubular system group (4% versus 12%), with the majority
of withdrawals (8/9 participants) from the bandage group being
due to participants requesting change to the alternative treatment
(Milic 2007).
In the second trial (131 participants) that evaluated the effects
of adding elastic bandages to a base system of gauze bandage,
crepe bandage and tubular compression (Milic 2010), the number
of participants experiencing complete healing at six months was
significantly greater for the addition of both one and two elastic
bandages. The respective RR estimates were 0.46 (95% CI 0.28
to 0.75), P value 0.002 (88 participants) (Analysis 21.1), and 0.42
(95% CI 0.26 to 0.68), P value 0.0004 (85 participants) (Analysis
22.1). No significant difference, however, was detected between
the addition of one versus two elastic bandages: RR 0.91 (95%
CI 0.69 to 1.18), P value 0.47 (89 participants) (Analysis 23.1).
Median weeks to healing were similar in all three groups: 12 weeks
(range 5 to 24) in the group receiving the base system; 11 weeks
(range 3 to 25) with one elastic bandage added; and 14 weeks (5 to
24) for two additional elastic bandages. The trial authors reported
that estimates from adjusted Cox regression indicated significantly
higher probability of healing among participants receiving two
added elastic bandages when compared with the other two groups
(P value < 0.001 versus the base system, and P value 0.017 versus
one elastic bandage). Eleven participants withdrew from the trial:
one from the group receiving the base system, one from the group
receiving one additional elastic bandage (2% of participants in
both cases), and nine (21%) from the group allocated two elastic
bandages.
Summary of evidence from Section 2.6: Compression
stockings or tubular devices compared with compression
bandage systems
All RCTswere at high or unclear risk of bias.When compared with
the SSB, use of a high compression stocking was associated with:
better healing at up to four months (four RCTs pooled) (Jünger
2004b; Polignano 2004b; Mariani 2008; Taradaj 2009); better
outcomes for some aspects of pain/discomfort (Jünger 2004b;
Mariani 2008); and lower costs (Jünger 2004b).
Healing outcomes were better at 16 months for participants re-
ceiving a four-component system that included a tubular device
plus elastic bandage when compared with four components that
included two elastic bandages; there were fewer withdrawals and
a lower rate of ulcer recurrence at one year for the tubular de-
vice, however, more adverse events were reported in this group
(Milic 2007). When one or two elastic bandages were added to a
base three-component system that included an outer tubular layer,
healing outcomes were better for the two groups receiving elastic
bandages. There was no significant difference in healing between
the two elastic bandage groups. There were more withdrawals in
the group receiving two elastic bandages relative to the other two
groups (Milic 2010). When a tubular compression system was
compared with the SSB no differences in healing or quality of life
outcomes were detected at three months; however, adverse events
were more frequent in the tubular compression group (Jünger
2004a).
No significant between-group differences were found for the fol-
lowing comparisons (all small RCTs): single-layer stockings and
paste bandages for complete healing at fourmonths (Koksal 2003),
and at 18 months (Hendricks 1985); low compression stocking
and SSB for healing at three or six months, nor in quality of life
outcomes (Brizzio 2010); stockings and two-component bandages
for healing at three months (Szewczyk 2010); stockings and the
4LB for healing at three months (Szewczyk 2010).
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D I S C U S S I O N
Summary of main results
The evidence suggests that venous ulcers heal more rapidly with
compression than without, and that multi-component bandage
systems achieve better healing outcomes than single-component
bandages. When competing systems comprising two-component
bandages were compared, there was some evidence to suggest that
those that included an elastic component might be more effec-
tive; a similar finding was noted for alternative three-component
bandage systems. No differences were observed in terms of heal-
ing between a two-component bandage system and the 4LB, nor
between different variations of the original 4LB. Estimates from
survival analyses of IPD indicated faster healing for the 4LB com-
pared with the SSB. No differences were observed between the
4LB and paste-bandage systems, but interpretation could have
been hampered by differential performance of variants of the paste
bandages. There was no difference in healing outcomes between
the adjustable compression boot and compression bandages, nor
between a single-layer stocking and a paste-bandage system, how-
ever, overall the evidence was not of high quality and had low
statistical power for detection of clinically important differences.
When high-compression stocking systems were compared with
the SSB, healing outcomes were in favour of the stockings, but
there was no difference seen between low compression stockings
and the SSB. One small trial compared stockings with two-com-
ponent bandages and the 4LB and found no between-group dif-
ferences between stockings and bandages. A large ongoing trial
comparing compression stockings with the 4LB will inform this
comparison further (Dumville 2009). Less pain was observed for
all types of stockings when compared with bandages. There was no
difference between tubular compression and the SSB for healing.
Better healing outcomes were achieved when elastic bandages were
added to tubular compression. In terms of cost-effectiveness, most
evaluations were of costs only. One trial conducted a rigorous cost-
effectiveness analysis in which the 4LB emerged as the dominant
treatment strategy when compared with the SSB.
There was limited evidence on ulcer recurrence, with three trials
reporting this outcome (Colgan 1995;Morrell 1998;Milic 2007).
One reported no cases of recurrent ulceration in participants re-
ceiving single-component elastic compression, the 4LB or four-
component compression comprising a paste bandage when rates
were assessed during a six-month follow-up period following 12
weeks of treatment (Colgan 1995). Another trial that compared
application of the 4LB in the context of a specialist clinic with
usual care by the district nurse did not detect a statistically sig-
nificant difference between groups for recurrence rates, or time to
recurrence, during the one-year trial period (Morrell 1998). In an
evaluation of tubular compression versus compression bandages,
significantly lower recurrence rates were detected in the group re-
ceiving tubular compression at one year (Milic 2007). It is likely
that the majority of included trials lacked the statistical power and
duration of follow-up required to detect meaningful recurrence
rates following treatment with compression therapy.
This review has attempted to take account of recent recommen-
dations concerning the classification and description of different
systems of compression (Partsch 2008b). This update refers to the
numbers of components in compression systems rather than the
number of layers, as it has been argued that the number of com-
ponents is more meaningful.
Overall completeness and applicability of
evidence
Co-interventions, confounding factors and external
validity
The study selection criteria stipulated that the bandages being
studied should be the only systematic difference between treat-
ment groups. In practice, this criterion has been difficult to apply
without excluding many trials of important types of compression
therapy from the review. One example of this is where a specialised
package of care incorporating multi-component compression is
comparedwith usual care that does not routinely include compres-
sion (Charles 1991; Taylor 1998; Morrell 1998; O’Brien 2003).
In these trials, application of the bandage is not the only difference
between treatment arms since the characteristics of care providers
vary between groups with compression in one arm being provided
by staff with specialist training and experience who could advise
patients more generally about the management of their venous
leg ulcer, for example, regarding limb elevation and mobility. The
evaluations of paste bandages and Unna’s boot also introduce an
additional, non-bandage difference between groups (for example
Duby 1993; Colgan 1995; Knight 1996; Meyer 2003; Polignano
2004a). These devices normally provide a primary wound con-
tact layer as well as compression bandaging. The alternative study
arm is likely to receive a different type of primary dressing (e.g.
foam dressing or hydrocolloid) prior to application of bandages or
stockings. Factors such as additional aspects of care used together
with compression, or different primary dressings between treat-
ment arms may obscure the treatment effect due to the compres-
sion, and so hinder the interpretation of findings.
In many of the included trials, the observed treatment effect may
have been influenced further by imbalance of treatment groups
at baseline with respect to independent prognostic factors. The
literature on healing prognosis has shown consistentIy that base-
line ulcer area and ulcer duration are significant independent pre-
dictors of delayed healing (Skene 1992; Franks 1995; Margolis
2000; Margolis 2004; Brown 2004). Some of the more recent tri-
als addressed this by using stratified randomisation and undertak-
ing analyses that adjusted for covariates, such as Cox proportional
hazards models (for example Franks 2004; Iglesias 2004; Brizzio
2010; Milic 2010), or logistic regression (Brizzio 2010). When
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such methods are not used, and particularly when trials are small
in size, the estimated treatment effect may be prone to bias be-
cause of chance differences in the baseline prognostic profiles of
treatment groups.
Several trial reports stated that venous leg ulcers above certain
dimensions would not be eligible for inclusion, for example,
maximum eligible baseline ulcer surface area 15 cm2 (Szewczyk
2010), and 50 cm2 (Cordts 1992; Brizzio 2010). Six RCTs with
this type of restriction reported comparisons involving compres-
sion stockings or tubular devices (Jünger 2004a; Jünger 2004b;
Polignano 2004b; Mariani 2008; Brizzio 2010; Szewczyk 2010);
other comparisons were alternative single-component bandages
(Cordts 1992), and three-component bandage systems (Meyer
2002), also paste bandages compared with an adjustable compres-
sion boot (DePalma 1999) and the four-layer bandage (Meyer
2003). Patients with much larger wounds may present in clinical
practice and so some findings may have limited external validity.
Quality of bandage application
It has been suggested that the clinical effect of compression is
partly dependent on the skill of the bandager in achieving the
correct amount of sub-bandage pressure and a pressure graduated
from toe to knee (Feben 2003). Findings from an online survey
of 304 clinicians in the UK, USA and Germany suggested that
challenges in the use of compression included difficulty in obtain-
ing precise pressures; also, the need for training in application of
compression bandages was highlighted. The survey authors also
observed variation in the use of different types of compression
systems across the countries studied (Cullen 2009). It is possible
that the performance of certain compression systems may be en-
hanced because of greater staff familiarity and experience in that
setting. The differential effects of 4LB and SSB seen in the IPD
meta-analysis could be partly explained by skill and experience of
bandagers; three out of the five included trials (representing 75%
of included participants) were based in the UK, where the 4LB
is standard (Scriven 1998; Franks 2004; Iglesias 2004), whilst the
others were based in continental Europe, where the SSB is stan-
dard treatment (Partsch 2001; Ukat 2003). Information regarding
bandager skill was not collected during these trials, and so the ef-
fect of this variable could not be investigated further. As far as we
could ascertain, the methods used for application of both types of
bandage were in line with manufacturers’ recommendations, rel-
evant clinical guidelines, and expert guidance. It would be useful
if future trials could collect data on staff skills at baseline, and this
information could be included as a covariate in the modelling of
treatment effect.
It is also difficult to estimate what influence staff skills may have
had on the observed estimates of treatment effect for other com-
parisons in this review . Some trials indicate a possible move to-
wards compression systems that are less dependent on practitioner
skill, where patients and their relatives may contribute more to
application of devices, namely compression stockings (Hendricks
1985; Jünger 2004b; Polignano 2004b; Mariani 2008).
A related aspect which may influence the effectiveness of treat-
ment is patient concordance with compression regimens. A mixed
methods study combining semi-structured interviews with clini-
cians with an online survey found that patient concordance with
compression is a major concern amongst care providers (Cullen
2009). A literature review of studies evaluating patient concor-
dance with compression therapy for ulcer healing reported rates of
non-concordance from observational studies in the range of 10%
to 80% and also suggested that healing was delayed in patients
defined as having lower levels of concordance. It should be noted
that these findings were based on a small number of studies of
uncertain methodological quality (Moffatt 2009).
Quality of the evidence
Themethodological quality of evidence in this field is variable. All
RCTs except one were classified as being at high or unclear overall
risk of bias. A general observation is that quality appears to be
improving over time, with trials published within the last ten years
more likely to have taken important steps to reduce bias in esti-
mates of treatment effect by using proper methods of randomisa-
tion (i.e. unpredictable allocation to treatment groups), allocation
concealment, blinded outcome assessment and performing anal-
ysis by intention to treat. More recent trials are more likely to be
larger and to have been based on prior estimation of the required
sample size to detect a defined difference in outcome between
groups. Interpretation of older trials is often difficult because of
small sample sizes and problems with methodological quality. Fur-
thermore small trials aremore likely to result in chance estimates of
treatment effect because of imbalances between treatment groups
for prognostic factors such as ulcer surface area or duration. The
possible impact of such baseline imbalances is usually difficult to
interpret post hoc, and ideally would be adjusted for in the primary
analysis (an approach more commonly taken inmore recent, high-
quality studies). Shortcomings in the statistical analysis of trial
data were frequently encountered. Some studies report the mean
(rather than median) time to healing which could result in biased
estimates as such analysis is based on all participants having healed
and/or the survival curve having an assumed shape (the shape is
not assumed in non-parametric survival analysis). For continuous
outcomes such as healing rate and change in ulcer area, data are
likely to be skewed but transformation is usually not mentioned.
Again, this could have influenced the derived estimates of effect
(Bland 2000). More recent trials include survival analyses for time
to healing (for example Scriven 1998; Franks 2004; Iglesias 2004;
Jünger 2004a; Jünger 2004b; Nelson 2007a; Brizzio 2010; Milic
2010), and this provides a more meaningful estimate of treatment
effect, particularly if HR estimates are provided, adjusted for prog-
nostic factors. All future trials should incorporate such analyses.
34Compression for venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Frequently interventions are not described comprehensively in
trial reports, so it can be difficult to judge the degree of compres-
sion being applied, and impossible for readers to apply the evi-
dence directly. A typical example of this is the term “Unna’s boot”
which is used to characterise the compression system, but is often
not described further. It is clear from studying the trials included
in this review that the definition of Unna’s boot varies, and there
does not appear to be an agreed definition in the literature. The
basis for this type of compression is a paste-impregnated bandage
(usually zinc oxide and calamine) (Kikta 1988), and in some cases
this is the sole component. However, the paste bandage can also
be applied as part of a multi-component system comprising two,
three or four components, all of which could perform differently.
Trial reports should include details of the number and type of
components, the materials used, the dimensions of bandages and
the technique of application (e.g. spiral, figure-of-eight), as rec-
ommended by an expert consensus group (Rabe 2008).
Potential biases in the review process
Although the search strategy was comprehensive, it is possible
that eligible unpublished trials could remain unidentified. One
unpublished trial of compression came to light during a wound
management conference (Nelson 2007b). Communication with
the trial authors confirmed that: the trial was small (40 partici-
pants), compared the 4LB with SSB, and had terminated prema-
turely (personal communication, Professor Charles McCollum).
Since no baseline or outcome data were available, it is not possible
to judge the potential effect of including this trial in the review.
Other eligible unpublished evaluations may exist that have not
been identified by the review process. Therefore, the effect of pub-
lication bias on this review should not be discounted.
Agreements and disagreements with other
studies or reviews
This updated review includes new evidence concerning competing
multi-component bandage systems (two-component bandage ver-
sus the 4LB) aswell as comparisons between compressionbandages
and stockings. In addition, a rigorously conducted and informa-
tive IPD meta-analysis of the comparison between four-layer and
SSBs has been incorporated into the review. The findings of the
previous version of this review are largely upheld, and this update
provides some additional evidence to indicate that multi-compo-
nent systems that include an elastic bandage are more effective in
terms of wound healing compared with multi-component systems
with inelastic constituents. This finding conflicts with some as-
pects of consensus-based recommendations of compression clas-
sification, where it was suggested that multi-component systems
that include elastic constituents will perform similarly to inelas-
tic systems overall because of friction between different elements
(Partsch 2008b). The findings of this review suggest that com-
pression stockings may perform better than the SSB in terms of
wound healing; however, data are still lacking on the important
comparison of compression stockings versus the 4LB. A large RCT
addressing this comparison is ongoing (Dumville 2009).
Updates of this review, in contrast with the parent review, have
included only those trials where treatment allocationwas described
as random. Consequently two studies that were included in the
original version of the review are now excluded. The comparisons
involved were: compression (Unna’s Boot) versus no compression
(dressing alone) (Sikes 1985); and compression stockings versus
SSB (Horakova 1994). A third trial that evaluated two different
three-component systems was excluded because we became aware
that participants in one treatment arm also received steroids (
Northeast 1990).
We identified two other systematic reviews of compression ther-
apy for venous leg ulceration (Palfreyman 1998; Amsler 2009).
The study selection criteria of the Palfreyman review differed from
this review in that quasi-randomised studies, evaluations of inter-
mittent pneumatic compression and those with recurrence as the
primary outcome were included, whereas studies where venous
disease was not confirmed by vascular assessment were excluded.
In addition, the literature searchwas restricted to English language
articles. This resulted in eight trials being identified as eligible for
inclusion and these were sub-grouped for meta-analysis purposes
according to the type of compression evaluated. Some findings
reflected those of the current review in terms of healing: multi-
component compression was more effective than single-compo-
nent systems (based on Nelson 1995, a secondary reference to
Nelson 2007a in this Cochrane review); and multi-component
compression comprising an elastic bandage performed better than
that consisting of non-elastic devices (based on Callam 1992b,
included as a primary reference in this review). However, the Pal-
freyman review included only one trial in the comparison of com-
pression versus no compression (Kikta 1988), estimating no sta-
tistically significant difference between groups. Two further stud-
ies were described as comparing Unna’s Boot with ’other thera-
pies’, whereas in the current review these were included within
the following comparisons: compression versus no compression
(non-compressive bandages) (Rubin 1990); and competing sin-
gle-component compression systems (Cordts 1992). Of the re-
maining studies included in the Palfreyman review, one focused
on ulcer recurrence and the other two evaluated the effectiveness
of intermittent pneumatic compression. We took the view that it
was more helpful to include studies not reporting vascular assess-
ment of venous disease since methods of diagnosis vary between
studies and are also likely to vary in clinical practice, meaning that
a standardised definition may not be realistic.
The second review included comparisons of compression ban-
dages with compression stockings in patients with venous leg ul-
cers (Amsler 2009). This review had some systematic elements but
did not include a structured assessment of risk of bias and did not
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mention checking of study selection decisions and data extrac-
tion by a second, independent reviewer. Eight trials were included,
seven of which were also included in our review. We excluded
the eighth trial because it used quasi-randomisation (Horakova
1994); Amsler and colleagues also expressed concern about the
quality of randomisation for this trial. The reviewers confidently
concluded that stockings were significantly better than bandages
in terms of complete healing at 12 to 16 weeks, time to healing
and pain scores. However, there were problems with the analyses
underpinning these conclusions. The meta-analysis of complete
healing pooled all eight included studies, despite substantial clin-
ical heterogeneity in terms of the types of stockings and bandages
used across the group of trials. Time to healing was analysed as
a continuous outcome and survival analyses were not considered.
The meta-analysis of pain scores was based on three trials, and
showed significant statistical heterogeneity. We feel that slightly
more cautious conclusions are warranted, given the methodolog-
ical quality and clinical heterogeneity of this group of trials.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Compression increases the healing rates of venous leg ulcers com-
pared with no compression. Multi-component compression sys-
tems are more effective than single-component systems. Multi-
component systems containing an elastic bandage appear to be
more effective than those composed mainly of inelastic con-
stituents. Two-component bandage systems appear equivalent to
the four-layer bandage (4LB) in terms of healing. Variations of
the 4LB achieve similar outcomes. The 4LB heals ulcers faster and
is more cost-effective than multi-component systems comprising
a short stretch bandage (SSB). There does not appear to be any
difference between the 4LB and paste-bandage systems, but in-
terpretation of data is impaired by differences in the paste-ban-
dage systems. There is currently no evidence of a difference in
the effectiveness of adjustable compression boots and compression
bandage systems, or between single-layer stockings and paste-ban-
dage systems. Two-layer stockings appear to be more effective than
the SSB. The relative effectiveness of compression stockings and
the 4LB is currently unclear. The relative effectiveness of tubular
compression and compression bandages is currently unclear. The
limited evidence on the effects of different compression systems
on venous ulcer recurrence precludes definitive conclusions at the
current time. The performance of any type of compression ban-
dage might be influenced by operator skill; this is likely to be less
of an issue for compression stockings.
Implications for research
Some of the research concerning management of venous leg ul-
ceration is of poor quality, but methodological improvements are
seen in more recent trials, possibly as a result of the CONSORT
Statement, a document that provides guidance regarding the re-
porting of randomised controlled trials (Schulz 2010). The fol-
lowing are recommended for future studies:
• Recommendations outlined in the CONSORT Statement
should be adopted as far as possible.
• If possible, future trials should be conducted in
collaboration with a clinical trials unit in order to provide the
optimal infrastructure for trial design, conduct, data
management and analysis.
• Recruitment numbers should be based on an a priori
sample size calculation. In many trials the sample size is too small
to detect clinically important differences between treatments as
statistically significant. In order to recruit sufficient patient
numbers, multicentred trials should be considered more
frequently. When these trials are commissioned, a strong
infrastructure will be required to provide support and promote
collaboration.
• A proper method of randomisation should be used and
reported (e.g. computer-generated list), and allocation to
treatment should be concealed (e.g. using remote telephone
randomisation service).
• The primary endpoint of treatment trials should be
complete ulcer healing, and, preferably, the primary outcome
should be time to healing. Assistance should be sought from a
suitably qualified statistician regarding the design and analysis of
the trial in relation to survival analysis. In addition, the length of
follow-up needs to be of sufficient duration to capture a
meaningful proportion of events. If time-to-event analysis is not
feasible, other outcomes could include frequency of complete
healing during the trial period, or (less preferably) healing rate
and change in ulcer surface area.
• A single reference ulcer should be selected for each patient.
Multiple ulcers on a patient should not be studied unless the trial
has been specifically designed to accommodate this, and
appropriate statistical analysis prespecified to account for
clustering.
• Treatment groups should be comparable at baseline for
prognostic factors such as ulcer area and duration. In small RCTs
randomisation alone may not achieve balance for prognostic
factors. Statistical analysis should adjust for baseline imbalance.
• A complete and thorough description of concurrent
treatments, including primary dressings, should be given in trial
reports.
• Assessment of outcomes should be undertaken either by
assessors masked to trial treatment, or independently confirmed
by assessors masked to treatment.
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• Analysis should be according to intention to treat.
• Evaluations should provide sufficiently full details of the
interventions used, including descriptions of all components of
compression, such that readers would be able to apply the
treatments described (with training where necessary).
• Evaluations should report the skill level of staff providing
care.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Blecken 2005
Methods RCT(within individual randomisation, no other details aboutmethodof randomisation)
. Trial conducted in USA, type of setting not described
Participants Recruited 12 patients with post-thrombotic bilateral venous leg ulcers (7men, 5 women)
. All had history of DVT.
Inclusion criterion: ABPI ≥ 1.00.
Exclusion criteria: chronic or acute systemic disease; and impaired mobility secondary
to rheumatoid arthritis.
Mean patient age 61 years; range 45-82 (breakdown/group not reported).
At baseline, patients had had active ulcers for 1-6 years.
Mean ± SE baseline ulcer area (cm2): Group 1: 48.98 ± 14.13; Group 2: 50.08 ± 18.30
(95% CI of difference Group 1 minus Group 2: -27.25-25.07)
Interventions All patients: prior to bandage application, ulcers cleansed with neutral soap and water
and skin lubricated with lanolin. Compression reapplied every 72 h
Group 1: adjustable-compression boot system consisting of: fine mesh paraffin-impreg-
nated gauze primary dressing (Aquafor); single layer of sterile absorbent gauze;1 cm-thick
felt pad cushion; surgical cotton stockinette; non-elastic compression garment compris-
ing a series of individually adjustable Velcro bands 5.1 cm wide extending from ankle to
knee (CircAid); and elastic anklet (Medi) applied from base of toes to 5 cm above the
malleolus (n = 12 limbs)
Group 2: 4-layer bandage (4LB) comprising: fine mesh paraffin-impregnated gauze pri-
mary dressing (Aquafor); single layer of sterile absorbent gauze; 1 cm-thick felt pad over-
lapping at least 3 cm of ulcer area; thick gauze bandage (Kerlix); and 15 cm wide elastic
bandage (n = 12 limbs)
Outcomes Number (%) limbs with complete healing at 12 weeks: Group 1: 4/12 (33%); Group 2:
4/12 (33%). Note: the same 4 individuals healed in each group
Mean ± SE ulcer area reduction rate (cm2 per week): Group 1: 2.93 ± 0.60; Group 2: 2.
30 ± 0.70 (95% CI of difference Group 1 minus Group 2: 0.05-1.21), P = 0.037 (paired
t-test)
HR for area reduction rate: 0.56 (95%CI 0.33-0.96), P = 0.017 (indicating faster healing
rate in Group 1). The authors reported that patient age and sex were not associated with
reduction rate, but statistics for covariates were not shown
Mean ± SE patient satisfaction score, assessed with scoring sheet at 12 weeks (1 = not
satisfied; 2 = moderately satisfied; 3 = very satisfied): Group 1: 2.92 ± 0.08; Group 2: 2.
58 ± 0.15 (95% CI of difference Group 1 minus Group 2: -0.08-0.75), P = 0.104
Notes Ulcer area assessed at baseline then every 4 weeks by direct grid tracing combined with
digital imaging. 4LB system was not the traditional one. No withdrawals. Skill of care
provider not explained. HR for area reduction rate difficult to interpret as outcome
variable was continuous rather than time-to-event
Risk of bias
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Blecken 2005 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “This was a randomised study . . .”.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 12 people recruited and all appear in results
(individual patient data)
Blinded outcome assessment (healing) Unclear risk No details provided.
Baseline comparability Unclear risk Mean values reported for baseline ulcer
area, and so difficult to judge comparabil-
ity; no ulcer duration data presented
Brizzio 2010
Methods Single-centred RCT. Randomisation stratified according to presence/absence of deep
venous reflux (assessed using duplex ultrasound) using blocks of 4 and 6 respectively.
Setting: an outpatient clinic in Argentina. A statistical power calculation was reported,
but methods used for estimation not clear
Participants 60 patients recruited by referral from outpatient clinics of general hospitals
Inclusion criteria: venous leg ulcer (diagnosed clinically and by duplex ultrasound) with
surface area 3-50 cm2, present for at least 2 months and not treated with compression
during previous 2 months
Exclusion criteria: malignancy, respiratory or cardiac failure, liver disease, kidney disease,
mental illness, severe peripheral neuropathy, peripheral arterial disease and osteoarthritis
of hips or knees
Baseline data from 55 patients analysed:
Number of male:female patients: Group 1: 19:9; Group 2: 17:10
Mean ± SD (median) patient age in years: Group 1: 62.1 ± 9.9 (62.0); Group 2: 61.4 ±
13.1 (64.0)
Number (%) patients with recurrent ulceration: Group 1: 12/28 (43%); Group 2: 15/
27 (56%)
Mean ± SD (median) baseline ulcer duration in months: Group 1: 26.9 ± 44.7 (11.5);
Group 2: 26.7 ± 29.7 (12.0)
Mean ± SD (median) baseline ulcer surface area in cm2: Group 1: 13.1 ± 14.5 (5.0);
Group 2: 12.2 ± 12.8 (6.0).
Mean ± SD (range) score for pain in ulcer area/lower leg assessed using Likert scale with
range 0-100 (0 = no pain, 100 = maximum pain): Group 1: 44.2 ± 33.1 (0-100); Group
2: 45.8 ± 26.4 (0-100)
Mean ± SD quality of life score assessed using the Spanish version of Chronic Venous
InsufficiencyQuality of Life (CIVIQ) questionnaire with range 20-100 (20 = best quality
of life, 100 = worst quality of life): Group 1: 53 ± 18; Group 2: 53 ± 15
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Brizzio 2010 (Continued)
Interventions All patients: at each visit ulcers were cleaned with Ringer’s lactate solution and debrided
using wound lavage (Jetox-ND, TavTech Ltd, Israel). Surrounding skin treated with
gentian violet, moisturised and the ulcer covered with paraffin gauze (Bactigras, Smith
& Nephew, UK). In order to provide additional compression, a rubber-foam pad (5 cm
thick) was cut to fit the space above insufficient perforating and/or large communicating
veins identified by duplex ultrasound. Compression then applied and left in situ day and
night. Ulcer care performed by experienced staff at the clinic. Both compression devices
changed weekly
Group 1: graduated compression stocking with open toe (prototype stocking provided
by Sigvaris Inc.) with fibre consisting of 92% nylon and 8% Lycra and available in 4
ankle sizes. Applied over a gauze bandage using a donning device (n = 28 patients)
Group 2: short-stretch bandage (SSB), consisting of 3 “short-stretch slings” (Tesadur,
40% elongation, 10 cm width, 7 m length, Filmar, Italy). Method of application not
stated (n = 27 patients)
Outcomes Number (%) patients with complete healing at 90 days: Group 1: 10/32 (31%); Group
2: 13/28 (46%)
Logistic regression suggested the following as significant (at 5% level), independent
predictors of non-healing at 90 days: lower BMI and larger baseline ulcer surface area
Number (%) patients with complete healing at 180 days: Group 1: 14/32 (44%); Group
2: 18/28 (64%)
Logistic regression suggested the following as significant (at 5% level), independent
predictors of non-healing at 180 days: older patient age, larger baseline ulcer surface
area, longer baseline ulcer duration and recurrent ulceration
Median days to healing: Group 1: 56; Group 2: 60.
Cox regression did not detect any significant (at 5% level), independent predictors of
delayed healing
Mean ± SD (range) pain score at 13 weeks: Group 1: 17.7 ± 18.8 (0-63), P < 0.001 for
within-group change from baseline; Group 2: 11.1 ± 15.6 (0-63), P < 0.01 for within-
group change from baseline. P value for between-group difference not reported
Mean ± SD quality of life score (CIVIQ) at 35 days: Group 1: 44 ± 16; Group 2: 44 ±
19, P = 0.944 for between-group difference
Mean ± SD quality of life score (CIVIQ) at 90 days in patients with healed ulcers: Group
1: 44 ± 18; Group 2: 45 ± 17, P = 0.825 for between-group difference
Mean ± SD quality of life score (CIVIQ) at final assessment in patients with healed
ulcers: Group 1: 39 ± 18; Group 2: 30 ± 17, P = 0.109 for between-group difference
Linear regression did not detect any significant (at 5% level), independent predictors of
quality of life score at 35 days or final assessment
Notes Ulcers assessed weekly using photography and measurement of surface area using trans-
parent foil
Compression stockings were designed to exert pressure above the ankle of 15-20 mm
Hg
Pressuremeasurements were taken from a sub-group of randomly selected patients (num-
ber not stated). Immediately after application, themean ± SDpressure in mmHg exerted
by compression devices worn over dressings and pads was: Group 1: 28.6 ± 9.2; Group
2: 48.6 ± 15.1
The CIVIQ questionnaire included 4 dimensions of quality of life: pain, physical, social
and psychological. Further analysis of patients with both healed and unhealed ulcers
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Brizzio 2010 (Continued)
in relation to individual dimensions of CIVIQ scores at 90 days suggested that pain
decreased by 50%with treatment regardless of healing. Physical, social and psychological
dimensions showed significant improvement over time only in patients with healed
ulcers. Total score showed significant improvement over time in both healed andunhealed
patients
Numbers of patients (with reasons)whowithdrewbefore completion:Group1: 4patients
(1 sudden death deemed unrelated to venous disease or its treatment; 1 did not attend
clinic after 11 weeks; 2 had systemic infection requiring hospital treatment). Group 2:
1 patient (rapid deterioration)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Leg compression was carried out ran-
domly with either stockings or bandages”
“Patients with and without deep venous
reflux were randomised separately using
sealed envelopes in blocks of four and six,
respectively”
Allocation concealment (selection bias) Unclear risk “Patients with and without deep venous
reflux were randomised separately using
sealed envelopes in blocks of four and six,
respectively”
It was not clear whether envelopes were
opaque and/or opened in sequential order
Incomplete outcome data (attrition bias)
All outcomes
High risk 60 patients randomised; 55 patients anal-
ysed. Withdrawal rate higher in group re-
ceiving stockings (12.5% vs 3.6%)
Blinded outcome assessment (healing) Unclear risk “This randomised open-label trial was per-
formed at a specialized outpatient clinic . .
.”
It was not clear whether outcome assess-
ment was blinded.
Baseline comparability Low risk Groups appeared comparable at baseline.
Callam 1992b
Methods RCT, factorial design. Setting was 2 hospital outpatient clinics in Scotland, UK
Participants 132 patients recruited from those attending hospital-based leg ulcer clinics in 2 hospitals
in Scotland, UK.
Inclusion criteria: not stated.
Exclusion criteria: ABPI < 0.8, diabetes, sero-positive rheumatoid arthritis, lived too far
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away, refused consent.
Number of male:female patients: Group 1: 33:32; Group 2: 26:41.
Mean patient age in years: Group 1: 62; Group 2: 65.
Mean ± SD baseline ulcer area in cm2: Group 1: 8.2 ± 12.9; Group 2: 11.0 ± 15.9.
Number of patients with baseline ulcer duration < 6 months; 6-11 months; 1-2 years;
≥ 3 years: Group 1: 27; 19; 13; 6; Group 2: 37; 17;12; 1.
Number (%) patients walking with difficulty: Group 1: 15/65 (23%); Group 2: 17/67
(25%)
Interventions Group 1: 3-component compression system consisting of: orthopaedic wool (Soffban
Natural), elastic bandage (Tensopress), and cotton-elastic graduated compression tubular
support bandage (Tensoshape) (n = 65 patients)
Group 2: 3-component compression system consisting of: orthopaedic wool (Soffban
Natural), non-elastic cotton-elastic bandage (Elastocrepe), and non-elastic cotton-Lycra
cohesive bandage (Tensoplus Forte) (n = 67 patients)
All bandages applied by experienced research nurses using a spiral technique
Patients were further randomised within the above groups to a knitted viscose dressing
(Tricotex) or a hydrocellular polyurethane foam dressing (Allevyn)
Outcomes Number (%) patients with complete healing at 12 weeks: Group 1: 35/65 (54%); Group
2: 19/67 (28%), P = 0.01, Cox proportional hazards model
No statistically significant interaction detected between dressings and bandages (P = 0.
87, Cox proportional hazards model)
Mean ± SD number of bandage changes during the 12-week trial period: Group 1: 11.
7 ± 6.7; Group 2: 12.3 ± 6.5 (reported as not significant, but P value not shown)
Trial authors reported that: “two patients in each group sustained bandage damage
although this was minor in all cases”
Proportion of patients reporting ulcer pain at all clinic visits: Group 1: 29%; Group 2:
48% (P = 0.03, Wilcoxon two-sample test)
Number (%) patients who withdrew (> 1 reason/patient): Group 1: 8/65 (12%) (2
sensitivity; 3 exudate; 7 deterioration of ulcer; 1 social; 3 other - included bandage
slippage and patient intolerance); Group 2: 20/67 (30%) (8 sensitivity; 10 exudate;
17 deterioration of ulcer; 1 social; 7 other - included bandage slippage and patient
intolerance), P = 0.025, chi-squared test, for difference between groups in proportions
of patients who withdrew
Notes Ulcer areameasured using transparency tracing and computerised planimetry at baseline,
then every 4 weeks. Possible imbalance in baseline variables: larger ulcers in Group 2,
but more ulcers of longer duration in Group 1:
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided.
Allocation concealment (selection bias) Unclear risk No details provided.
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Incomplete outcome data (attrition bias)
All outcomes
Low risk All patients randomised appear in the anal-
ysis.
Blinded outcome assessment (healing) Unclear risk Not stated.
Baseline comparability Unclear risk Difficult to assess from data presented.
Mean ulcer area slightly greater inGroup 2,
but slightly more ulcers of longer duration
in Group 1
Charles 1991
Methods RCT, no details of methods. Outpatient setting in inner London, UK
Participants 53 patients with venous leg ulcers.
Inclusion criterion: ABPI > 0.8.
Mean (range) patient age in years: Group 1: 78 (55-99); Group 2: 75 (37-91).
Mean (range) baseline ulcer area in cm2: Group 1: 12.0 (1.5-52.0); Group 2: 15.0 (1.0-
88.0).
Mean (range) baseline ulcer duration in months: Group 1: 32 (4-336); Group 2: 25 (4-
120)
Interventions Group 1: compression system applied by project nurse. Application consisted of: primary
dressing (not defined); foam padding covered with gauze; further padding (Cellona) to
bony prominences, as required; SSB (Rosidal K) applied spirally with 50% overlap and
no more than 90% stretch from toes to knee. 1 bandage (10 cm x 5 m) used except for
5 patients with a higher degree of mobility who had 2 bandages. Bandages changed 1-3
times/week; washed by the patient and reused (n = 27 patients).
Group 2: continuation of usual care by district nurse (no patients received SSB) (n = 26
patients)
Outcomes Proportion of patients with complete healing at 3 months: Group 1: 71%; Group 2:
25%. Authors reported that between-group difference was statistically significant (chi-
squared test) but did not report P value.NB: rawdata for number of patients experiencing
complete healing not provided in the paper, and review authors have not extrapolated
these values from the reported percentages, as group denominators were unclear
Proportion of patients with increase in ulcer area during the 3-month trial: Group 1:
0%; Group 2: 21%
Number (%) patients who withdrew during the trial (reasons): Group 1: 3/30 (10%) (2
refused treatment, 1 referred for surgery); Group 2: 3/29 (10%) (3 admitted to hospital
for leg ulcer treatment). NB: it was unclear whether these 6 patients were included in
the 53 patients described above
Notes Ulcer area measured weekly using transparency tracing. Cost of 1 SSB = GBP 3.75.
Mean pressure under SSB = 33 mmHg (measured by Oxford monitor)
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients . . . were randomly divided into a
control and an experimental group”
Allocation concealment (selection bias) Unclear risk “Patients . . . were randomly divided into a
control and an experimental group”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 6 people withdrew from treatment, but un-
clear whether they were included in the
analysis; only % healed reported for out-
come - no raw numbers
Blinded outcome assessment (healing) Unclear risk No detail regarding outcome assessment,
however, implied that the treating nurses
assessed outcome
Baseline comparability Unclear risk Onlymeandata presented, but possible im-
balance: larger ulcers in Group 2; ulcers of
longer duration in Group 1
Colgan 1995
Methods RCT (single-centred). Outpatient setting in Ireland. Outcome assessment was non-blind
Participants 30 patients from routine venous ulcer out-patient clinics.
Inclusion criteria: diagnosis of venous aetiology; ulcer size > 1 cm2.
Exclusion criterion: arterial disease (no definition provided).
Number of male:female patients: Group 1: 4:6; Group 2: 2:8; Group 3: 2:8.
Mean patient age in years: Group 1: 65.5; Group 2: 67.5; Group 3: 56.0.
Median (mean) baseline ulcer area in cm2 : Group 1: 9 (48.5); Group 2: 7 (27.5); Group
3: 20 (42.8).
Median (mean) baseline ulcer duration in months: Group 1: 24 (66.5); Group 2: 10 (9.
3); Group 3: 12 (53.5)
Interventions Group 1: modified Unna’s boot, a compression system with 4 components: paste ban-
dage; cotton crepe bandage (Elastocrepe); elastic adhesive bandage (Elastoplast); class II
compression sock) (n = 10 patients).
Group 2: 4LB (Profore) (n = 10 patients).
Group 3: polyurethane foamdressing (Lyofoamdressing) plus elastic bandage (Setopress)
(n = 10 patients)
All patients: treatment delivered by clinic nurse. Treatment duration =12 weeks
Outcomes Number (%) patients with complete healing at 12 weeks: Group 1: 7/10 (70%); Group
2: 6/10 (60%); Group 3: 2/10 (20%) (statistical tests not reported).
Number (%) patients who withdrew (reasons): Group 1: 1/10 (10%) (allergy); Group
2: 0/10 (0%); Group 3: 3/10 (30%) (3 inability to tolerate bandage)
No cases of ulcer recurrence in any group during the 6-month follow-up period that
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followed completion of the 12-week treatment period
Costs of bandages were calculated, but not did not include nursing time, due to wide
variation in services.
Average (range) cost/patient/12 weeks: Group 1: IEP 66.24 (18.14-108.84); Group 2:
IEP 82.54 (27.94-177.20); Group 3: IEP 58.33 (19.11-83.24)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “We undertook a prospective randomised
study . . .”.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 30 patients randomised and 30 patients
analysed.
Blinded outcome assessment (healing) High risk Author correspondence: “ . . . assessor was
not blinded”.
Baseline comparability High risk Initial ulcer size larger in Group 3; ulcer
duration greater in Group 1
Cordts 1992
Methods RCT (no details about methods). Set in an out-patient clinic in Boston, USA
Participants 43 patients with chronic venous insufficiency.
Inclusion criteria: > 18 years, venous leg ulcer confirmed by duplex scanning
Exclusion criteria: signs and symptoms of clinical infection, arterial ulcers, ulcer area >
50 cm2, uncontrolled diabetes mellitus, venous surgery within 1 month on affected leg,
ulcer with exposed muscle, tendon or bone, pregnancy, patients on antibiotics, steroids
or chemotherapy, known HIV positive patients.
Groups were stated to be comparable for patient age, sex, race, general health and asso-
ciated medical problems (data not shown).
Number (%) of patients with history of DVT: Group 1: 3/16 (19%); Group 2: 1/14
(7%).
Mean ± SE baseline ulcer area in cm2: Group 1: 9.1 ± 1.7; Group 2: 6.0 ± 2.4.
Mean ± SE baseline ulcer duration in weeks: Group 1: 95 ± 29; Group 2: 96 ± 34
Interventions Group 1: hydrocolloid dressing (Duoderm) plus cohesive elastic bandage (Coban) (n =
16 patients).
Group 2: Unna’s boot (Dome-Paste, a zinc oxide and calamine impregnated bandage)
(n = 14 patients)
All patients: dressings changed weekly or more often, if required
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Outcomes Analysis based on 30/43 patients.
Number (%) of patients with complete healing at 12 weeks (data reported for study
completers only): Group 1: 8/16 (50%); Group 2: 6/14 (43%), P = 0.18, chi-squared
test
Mean ± SE days to healing (not derived from survival analysis): Group 1: 61.1 ± 10.1;
Group 2: 55.1 ± 10.8 (P = 0.69, Student’s t-test)
Mean ± SE percentage change relative to baseline ulcer area at 12 weeks (values read
from figure): Group 1: -90 ± 5; Group 2: -25 ± 50 (P = 0.9, ANOVA)
Mean ± SE healing rate in cm2 per week adjusted for baseline ulcer perimeter in cm (i.
e. healing rate divided by baseline ulcer perimeter): Group 1: 0.049 ± 0.007; Group 2:
0.0201 ± 0.017 (P = 0.11, Student’s t-test)
Mean ± SE pain score based on 1-10 scale where 0 = no pain: Group 1: 1.0 ± 0.16; Group
2: 1.0 ± 0.21 (authors reported no significant difference, but did not show P value).
Number (%) of patients with adverse events not requiring withdrawal from treatment
(description): Group 1: 2/16 (13%) (1 necrosis at ulcer edge, 1 wound infection); Group
2: 3/14 (21%) (all had wound infection).
Number (%) of patients who withdrew from the trial: Group 1: 7/16 (44%); Group 2:
6/14 (43%). All withdrawals were because of failure to attend clinic
Notes Ulcer area determined by photography and computerised planimetry. Costs not reported.
Patient acceptance of bandage higher for Duoderm than Unna’s boot
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomly assigned to treat-
ment . . .”.
Allocation concealment (selection bias) Unclear risk “Patients were randomly assigned to treat-
ment . . .”.
Incomplete outcome data (attrition bias)
All outcomes
High risk 43 people randomised; analysis of only 30
people. Withdrawal rates similar in both
groups; reason for eachwas non-attendance
at clinic
Blinded outcome assessment (healing) Unclear risk Not stated.
Baseline comparability Unclear risk Mean (not median) ulcer areas given and
larger in Group 1; durations similar
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Methods RCT (randomisation stratified by baseline ulcer area, larger or smaller than 20 cm2). Set
in a hospital outpatient clinic in Copenhagen, Denmark
Participants 43 patients were randomised.
Inclusion criteria: lipodermatosclerosis, leg ulcers and incompetent veins demonstrated
by Doppler and/or clinical examination.
Exclusion criteria: significant arterial insufficiency (systolic blood pressure in 1st toe <
60 mmHg or ABPI < 0.9), immunological aetiology of ulcer, diabetes, uncompensated
heart disease, inability to walk unassisted.
Number of male:female patients (of 40 patients included in authors’ analyses): Group
1: 12:9; Group 2: 8:11.
Median (range) patient age in years: Group 1: 72 (38-85); Group 2: 71 (37-90).
Mean [median] (range) baseline ulcer area in cm2: Group 1: 19.7 [2.4] (0.3-124.5);
Group 2: 16.5 [6.3] (0.4-66.1).
Mean [median] (range) baseline ulcer duration in months: Group 1: 22.2 [12] (2-120);
Group 2: 27.8 [15] (2-84)
Interventions Group 1: lower leg padded with gauze then long stretch, non-adhesive compression ban-
dage (Setopress) applied in a spiral with 50% overlap and approximately 86% extension.
Usually 1 bandage used (3.5 m unstretched). Bandage changed every 1-7 days, according
to wound exudate (left unchanged for as long as possible). All bandages applied by study
nurse (n = 23 patients)
Group 2: lower leg padded with gauze then non-adhesive, compressive SSB (Comprilan)
applied in a spiral with 50%overlap, using similar tension to that in long stretch bandage.
Usually 1½ SSBs were used (total unstretched length 4.5 m). Bandages changed every
1-2 days; usually applied by community nurse (n = 20 patients)
All patients: hydrocolloid primary dressing (Comfeel) used, if possible. Patients with
large ulcers, or maceration of the surrounding skin, treated with an non-antibacterial
ointment/gel. When local infection was suspected, used mupirocin, silver sulphadiazine
cream (Flamazine) or cadexomer iodine (Iodosorb). Systemic antibiotics given for cel-
lulitis. Eczema of peri-ulcer skin treated with a steroid ointment. Patients continued with
randomised bandage system after healing
Outcomes NB: the analyses of complete healing, incidence of cellulitis and withdrawals are as
calculated by the review authors, according to intention-to-treat (complete case analysis)
. All other analyses are as reported by the trial authors, and are based on 40 patients
overall (excluding 3 patients who were ineligible, Group 1: n = 21 and Group 2: n = 19)
Number (%) patients with complete healing at 1 month: Group 1: 4/23 (17%); Group
2: 1/20 (5%).
Number (%) patients with complete healing at 6 months: Group 1: 9/23 (39%); Group
2: 5/20 (25%).
Number (%) patients with complete healing at 1 year: Group 1: 12/23 (52%); Group
2: 3/20 (15%).
Kaplan-Meier estimate of the proportions of patients healed at 1 year: Group 1: 81%;
Group 2: 31% (P = 0.03, log rank test)
Mean [median] (range) relative ulcer area at 12 months: Group 1: 0.25 [0] (0-3.11);
Group 2: 0.95 [0.77] (0-4.04) (P < 0.01 for between group difference, Mann-Whitney
test)
Number of patients who developed cellulitis: Group 1: 7/23 (30%); Group 2: 8/20
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(40%)
Number of patients using: hydrocolloid; mupirocin; silver sulphadiazine; cadexomer
iodine: Group 1: 6; 5; 3; 1; Group 2: 3; 2; 5; 2
Number (%) of patients who withdrew during trial period (reasons): Group 1: 7/23
(30%) (2 ineligible; 2 preferred compression stockings post-healing; 2 preferred other
treatment; 1 knee pain/swelling because of bandage); Group 2: 10/20 (50%) (1 ineligible;
1 preferred compression stockings post-healing; 3 preferred other treatment; 3 had poor
compliance; 1 changed address; 1 died)
Notes Ulcer area measured using transparency tracing and planimetry (instrument not stated)
at baseline, 1, 6 and 12 months. The authors stated that values for the total area of
ulceration on the reference limb were studied
Ankle sub-bandage pressure measured using an Oxford pressure monitor. Group 1:
maintained mean pressure of 40 mmHg at 1 week; Group 2: decreased mean pressure
by 10 mmHg during first 24 h. The between-group differences at 2 h and 24 h was
significant (P < 0.001 and P < 0.017 respectively)
This trial assessed incidence of healing and also maintenance of healing. Ulcers could
have healed and recurred before the assessment points. It appears that 2 ulcers recurred
after the 6-month assessment in Group 2
Use of a variety of primary dressings and topical agents could have confounded the
treatment effect
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “. . . patients were randomised to receive
treatment . . .”.
Allocation concealment (selection bias) Unclear risk The authors reported that “randomisation
was blind” but did not provide any other
details
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3 patients excluded from analysis by trial
author, as deemed ineligible. These were re-
instated in denominators for the outcome
of complete healing by the review authors
Blinded outcome assessment (healing) Unclear risk No detail.
Baseline comparability High risk Baseline median ulcer area and duration
greater in Group 2:
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DePalma 1999
Methods RCT (multicentred, method of randomisation not stated). Setting: outpatients, USA
Participants 38 outpatients recruited from 6 study centres.
Inclusion criteria: patient age≥ 18 years; unilateral venous leg ulcer diagnosed by duplex
examination
Exclusion criteria: ulcers of non-venous or mixed aetiology; ulcer diameter > 5 cm;
severe arterial, metabolic or neuropathic disease; not expected to heal with conservative
treatment; poor general health; using medications inhibiting wound healing; acute deep
venous thrombosis within last 3 months; venous surgery within the last month; allergy
to study materials; pregnant; likely to be non-compliant; deemed by investigators to be
better treated by methods other than those used in the study
Mean ± SD patient age (years): Group 1: 63.95 ± 9.73; Group 2: 58.15 ± 9.60.
Mean ± SD baseline ulcer area (cm2): Group 1: 3.59 ± 3.54; Group 2: 3.28 ± 4.08.
Mean ± SD baseline ulcer duration (months): Group 1: 27.42 ± 54.72; Group 2: 12.28
± 14.54
Number of patients with chronic deep venous obstruction: Group 1: 4; Group 2: 5
Interventions All patients: ulcers cleansed and debrided (no further details given), dressedwith paraffin-
impregnated gauze (Adaptic) covered by 4 x 4 inch gauze pad (Curity), retained with a
conforming gauze wrap (Kling)
Group 1: Unna’s Boot consisting of zinc oxide, glycerin and gelatin-impregnated 10 cm
x 9 m roller gauze bandage (Medicopaste) covered by an elastic Ace type bandage (n =
19)
Group 2: Thera-Boot - a device consisting of a series of interlocking, non-elastic bands
encircling the leg and held in place by hook and loop fasteners, plus a foot piece made
of very low stretch bands. Patients adjusted the straps as necessary in order to maintain
compression between clinic visits (n = 19)
Outcomes Patients followed-up until healing, or for 12 weeks, and were seen as often as the inves-
tigator felt was appropriate. Ulcer area measured using transparency tracing
Mean ± SD area healing rate (cm2/day): Group 1: 0.0239 ± 0.0534; Group 2: 0.0433 ±
0.0910, P = 0.27
Mean ± SD area healing rate (%/day): Group 1: 1.0493 ± 1.5583; Group 2: 2.0357 ±
1.9520, P = 0.56
Mean ± SD linear healing rate (cm/day)*: Group 1: 0.0060 ± 0.0092; Group 2: 0.0109
± 0.0125, P = 0.27
Mean ± SD weeks from enrolment to healing: Group 1: 9.69 ± 3.28; Group 2: 7.98 ±
4.41, P = 0.41
Mean ± SD total cost/completed patient (price year not stated, based on clinician time
plus materials plus number of visits at USD 35/visit): Group 1: USD 901.73 ± 576.45;
Group 2: USD 559.41 ± 290.75, P = 0.05
Notes *This was the linear healing rate of the wound edge toward the wound centre. It is
calculated as the change in wound area from baseline to endpoint divided by the average
of baseline and endpoint wound perimeter measurements, after the method proposed
by Gilman 1990.
Completed trial: Group 1: 11 patients; Group 2: 17 patients.
Numbers of patients (with reasons)whowithdrewbefore completion:Group1: 5patients
(1 allergy to Unna’s Boot; 1 weeping dermatitis; 1 left town; 1 enrolled with exclusion
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criterion - immunosuppression; 1 had increasing ulcer size and was referred to surgeon)
. Group 2: 2 patients (1 enrolled with exclusion criterion - low ABPI; 1 not healing,
referred to surgeon). 3 patients not accounted for in the paper
Restricting selection of patients to those with relatively small ulcers is not likely to be
representative of the target population seen in clinical practice
Ulcers in Group 2: were of shorter baseline duration. No information about skill of care
providers
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided. “A multicenter,
prospective, randomised, parallel-group
study was conducted . . .”
Allocation concealment (selection bias) Unclear risk No details provided. “A multicenter,
prospective, randomised, parallel-group
study was conducted . . .”
Incomplete outcome data (attrition bias)
All outcomes
High risk 38 people randomised; 10 withdrew, but
unclear whether included in analysis; 3 of
the withdrawals unaccounted for (unclear
from which group they came)
Blinded outcome assessment (healing) Unclear risk “At each . . . a tracing of the ulcer outline
was made on clear film . . .” “Data sheets
and ulcer tracings were sent to the study
coordinator for tabulation and analysis . . .
”
Baseline comparability High risk Ulcers in Group 2 were of shorter mean
duration.
Duby 1993
Methods RCT (no details on methods). Setting: UK, no other details reported
Participants 67 patients (76 legs) recruited (source population not described).
Inclusion criterion: ABPI ≥ 0.9. No other patient selection criteria stated.
Number of male:female patients (limbs) : Group 1: 4 (5 limbs):16 (20 limbs); Group 2:
7 (7 limbs):16 (18 limbs); Group 3: 11 (12 limbs):13 (14 limbs).
Mean (range) patient age in years: Group 1: 72.6 (47-89); Group 2: 70.1 (47-85); Group
3: 72.9 (56-86).
Mean (range) baseline ulcer area in cm2: Group 1: 13.1 (1.1-29.4); Group 2: 11.9 (1.0-
40.3); Group 3: 12.3 (1.5-30.1).
Mean baseline ulcer duration in months: Group 1: 26.7; Group 2: 20.5; Group 3: 34.5
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Interventions Group 1: SSB system comprising: orthopaedic wool; 2 or more layers of SSB applied in
counter-rotating directions (Comprilan); and net covering (Tricofix). Bandages washed
and reused. (n = 20 patients/25 limbs)
Group 2: 4LB system comprising: orthopaedic wool; crepe bandage; elastic bandage
(Elset); and elastic cohesive bandage (Coban). New bandages applied at each dressing
change. (n = 23 patients/25 limbs)
Group 3: paste-bandage system comprising: zinc and ichthammol paste bandage (Ic-
thopaste); cotton crepe bandage (Elastocrepe); and elastic tubular bandage (Tubigrip) (n
= 24 patients/26 legs)
All patients: ulcers irrigated with saline, then a non-adherent dressing was applied (Cu-
ticerin). Bandages changed as required, according to exudate and slippage (mean rate
twice weekly for all groups)
Outcomes Number (%) limbs with complete healing at 12 weeks: Group 1: 10/25 (40%); Group
2: 11/25 (44%); Group 3: 6/26 (23%). Authors reported that the differences for Group
1 versus Group 3, and Group 2 versus Group 3, were significant, but P values not shown
Mean percentage reduction in baseline ulcer area at 12 weeks: Group 1: 60%; Group 2:
76%; Group 3: 43%. Authors reported that the difference between Groups 1 and 2 was
not significant, but P value not shown
Notes Higher proportion of males in Group 3: 11/24 compared to 11/43 in other 2 groups
combined. Longer baseline ulcer duration in Group 3. Ulcer area determined weekly
using tracings from photographs combined with computerised planimetry. Change in
leg volume during the 12-week trial was reported. Data from limbs of same patient are
likely to be highly correlated and could bias estimates of treatment effect
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The treatments were randomised to each
patient in the following manner . . .” (goes
on to give only numbers receiving each
treatment)
Allocation concealment (selection bias) Unclear risk No details provided. “The treatments were
randomised to each patient in the following
manner . . .” (goes on to give only numbers
receiving each treatment)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Complete healing reported on all 67 peo-
ple randomised; less clear for continuous
outcomes
Blinded outcome assessment (healing) Unclear risk No details given.
Baseline comparability High risk Baseline ulcer duration varied across 3
groups, longer in Group 3
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Eriksson 1984
Methods RCT, open design, outpatient setting, Sweden.
Participants 53 patients recruited to Part I of the trial (13 male, 40 female; mean age 70.1 years).
44 patients recruited to Part II (9 patients excluded because of ulcer healing or reasons
unrelated to the trial).
Inclusion criteria: not stated.
Exclusion criteria: overt diabetes mellitus, arterial insufficiency defined as ABPI < 0.75,
erysipelas, cellulitis
Interventions Part I (2 weeks’ duration): patients randomised to receive either gauze moistened with
normal saline or dextranomer beads (Debrisan). Numbers of patients/group not clear
Part II (8 weeks’ duration): patients were re-randomised to the following groups:
Group 1: ulcer cleansed with saline followed by application of freeze-dried porcine skin
dressing (Skintec). Dressings changed every other day. No compression applied (n = 11)
. Patients crossed over to the bandage system received by Group 3 mid study, because
the porcine skin dressing was no longer available.
Group 2: ulcer cleansed with saline, followed by application of non-adherent aluminium
foil dressing (Metallina). Dressings changed every other day. No compression applied (n
= 20).
Group 3: zinc oxide paste-impregnated inner stocking (ACO) plus outer elastic bandage
(Tensoplast) applied after resting with legs elevated for 30 minutes. Changed every 1-2
weeks (n = 13)
Outcomes Part I: no statistically significant differences between groups for changes in ulcer area
and volume
Part II: mean (presumed, not stated) decrease in ulcer area:volume at 8 weeks: Group 1:
65%:75%; Group 2: 10%:0%; Group 3: 80%:90% (NB: values recorded from figure;
findings of tests of statistical significance for between-group differences not reported)
Notes Ulcer area and volume measured using stereophotogrammetry every 2 weeks. Baseline
ulcer area:volume and duration not stated. Withdrawals: Group 1: no information;
Group 2: 6 patients had treatment interrupted because of increase of the ulcers and/or
signs of clinical infection; Group 3: no patients discontinued treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The investigation was designed as a ran-
domised open trial”.No further details pro-
vided
Allocation concealment (selection bias) Unclear risk “The investigation was designed as a ran-
domised open trial”.No further details pro-
vided
Incomplete outcome data (attrition bias)
All outcomes
High risk “The treatment with porcine skin had to
be stopped in the middle of the study
as the dressing was no longer available .
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. . Treatment with double layer bandage
was then introduced . . . ”. 6 patients in
Group2had treatment interrupted because
of increase of the ulcers and/or signs of
clinical infection; no patients in Group 3
had treatment discontinued - however, un-
clear whether these people were analysed.
There was no information about with-
drawals from Group 1
Blinded outcome assessment (healing) Unclear risk Not stated.
Baseline comparability Unclear risk No baseline data presented.
Eriksson 1986
Methods RCT, open design. Outpatient setting in Sweden.
Participants 34 outpatients with chronic venous leg ulcers (9 males,mean age 66.9 years; 25 females,
mean age 74.3 years). 3 diabetic patients in Group 2
Inclusion and exclusion criteria not specified.
Interventions All patients: ulcerated limb immersed for 15 minutes in a bath of tepid potassium
permanganate solution, then crusts and debris removed
Group 1: inner stocking impregnated with zinc oxide paste (ACO) plus an outer elastic
bandage (Tensoplast or Porelast Acryl). Bandages changed every 1-2 weeks (n = 17)
Group 2: hydrocolloid dressing (Duoderm) plus elastic bandage (Wero). Dressing re-
newed 1-2 times/week. Bandage removed at night and reapplied in the morning by pa-
tients (n = 17)
Outcomes Number (%) patients with complete healing at 12 weeks: Group 1: 7/17 (41%); Group
2: 9/17 (53%). Statistical tests not reported
Mean decrease in ulcer area:volume at 12 weeks: Group 1: 75%:75%; Group 2: 70%:
55% (NB: values recorded from figure; all between-group differences reported as not
statistically significant, but P values not shown)
Number (%) patients who discontinued treatment (with reasons): Group 1: 3/17 (18%)
(1 withdrew, 2 had infection of peri-ulcer skin); Group 2: 2/17 (12%) (1 withdrew, 1
had enlargement of study ulcer and development of new ulcer)
Notes Ulcer area and volume measured using stereophotogrammetry every 2 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The study was designed as a randomised
open trial . . .”.
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Allocation concealment (selection bias) Unclear risk “The study was designed as a randomised
open trial . . .”.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk For healed outcome, only numerators
given, therefore unclearwhether all patients
followed-up. Numbers for continuous out-
comes unclear
Blinded outcome assessment (healing) Unclear risk Not stated.
Baseline comparability Unclear risk No baseline data reported.
Franks 2004
Methods RCT (multicentred) with stratification according to study centre and baseline ulcer area
(≤ 10 cm2 or > 10 cm2). Patients randomised to 1 of 2 bandage systems and to 1 of
2 primary dressings, using a factorial design. Sample size: target sample of 240 patients
overall could not be recruited. The authors estimated that 159 patients overall provided
81% power to detect 15% difference in healing rates at 5% significance level
Participants 159 patients recruited from 12 community leg ulcer clinics in the UK (156 patients were
evaluated).
Inclusion criteria: patient age ≥ 18 years; venous leg ulceration with wound aetiology
confirmed using clinical history and ABPI ≥ 0.8; minimum baseline ulcer duration 2
weeks; maximum baseline ulcer duration 52 weeks.
Exclusion criteria: pregnancy; causes of ulceration other than venous disease; active
cellulitis treated with systemic antibiotics; dry, non-exuding wounds; previous entry to
trial.
Number of male:female patients: Group 1: 27:47; Group 2: 34:48.
Mean ± SD patient age in years: Group 1: 67.5 ± 14.3; Group 2: 70.9 ± 13.4.
Proportions of patients with baseline ulcer size ≤10 cm2:>10 cm2: Group 1: 80%:20%;
Group 2: 82%:18%.
Baseline median (range) baseline ulcer area in cm2: Group 1: 5.0 (0.3-115.8); Group 2:
3.5 (0.5-123.1).
Median (range) baseline ulcer duration in weeks: Group 1: 8 (2-40); Group 2: 8 (2-40).
Number (%) patients with previous ulceration: Group 1: 29/74 (39%); Group 2: 28/82
(34%).
Number (%) patients with DVT: Group 1: 14/74 (19%); Group 2: 8/82 (10%).
Number (%) patients chair or bed bound; walking with aid; walking freely:
Group 1: 0/74 (0%); 18/74 (24%); 56/74 (76%);
Group 2: 1/82 (1%); 14/82 (17%); 67/82 (82%).
Number (%) patients with limb: fully mobile; limited; fixed:
Group 1: 54/74 (73%); 17/74 (23%); 2/74 (3%);
Group 2: 73/82 (89%); 9/82 (11%); 0/82 (0%).
Interventions All patients: study limb washed using emollient dissolved in tap water, wound debrided
where necessary, and a hypoallergenic hydrating cream applied to the surrounding skin.
In addition to the bandage comparison, patientswere randomised to 1 of 2 foamdressings
65Compression for venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Franks 2004 (Continued)
(Allevyn or Mepilex) prior to bandaging. Dressings and bandages were reapplied at least
weekly
Group 1: foam dressing as above (52.7% patients received Allevyn) plus 4LB (Flexiban,
Setocrepe, Elset, Coban) (n = 74)
Group 2: foam dressing as above (51.2% patients received Allevyn) plus SSB (Flexiban,
Actico) (n = 82)
Patients with ulcer closure before the end of the trial provided with class II compression
stockings and followed-up until 24 weeks. Patients who withdrew from randomised
treatmentwere allocated to an alternative treatment and followed-up until wound closure
or 24 weeks
Outcomes Number (%) patients with complete healing at 24 weeks (for those remaining on ran-
domised treatment): Group 1: 51/74 (69%); Group 2: 60/82 (73%) (P value not re-
ported)
Number (%) patients with complete healing at 24 weeks (intention-to-treat analysis):
Group 1: 59/74 (80%); Group 2: 62/82 (76%)
Kaplan-Meier analysis: cumulative healing rates at 12 weeks were 56% in both groups;
and at 24 weeks Group 1: 85%; Group 2: 83%
HR for healing adjusted for study centre, treatment and baseline ulcer area, by intention-
to-treat was 1.08 in favour of Group 2 (95% CI 0.63-1.85), P = 0.79
HR for healing for subgroup of patients requiring aid with walking (Group 1: n = 18;
Group 2: n = 14), by intention-to-treat was 1.35 in favour of Group 2 (95% CI 0.60-
3.03), P = 0.46
Quality of life assessment: patients completed Nottingham Health Profile at baseline, at
healing or withdrawal and at 24 weeks (scores 0-100, with lower scores indicating better
quality of life). Domains include: energy; bodily pain; emotional reactions; sleep; social
isolation; and physical mobility. Mean differences in final scores calculated using linear
regressionwith adjustment for baseline scores. 139/156 (89%) patients completed at least
1 follow-upquestionnaire (66 inGroup1, 73 inGroup2).Overall, statistically significant
improvements were observed for all scores at 24 weeks. Improvement was greater for
patients with healed limbs (n = 114) compared to those who remained unhealed (n =
40), the mean difference for the following domains were statistically significant: bodily
pain (MD 13.2, 95% CI 3.6-22.9, P = 0.008), emotional reactions (MD 10.5, 95%
CI 2.8-18.1, P = 0.007) and social isolation (MD 8.5, 95% CI 1.2-15.9, P = 0.024);
a clinically significant difference was seen for sleep (MD 11.2, 95% CI 0.0-22.5, P =
0.051). No statistically significant differences observed between scores for any domain
from the 2 treatment groups
Notes In patients with bilateral ulceration, the limb with the largest total ulcerated area was
studied
3/159 patients excluded from the analysis (2 ineligible; 1 withdrew after 1 week)
Of 156 remaining patients, number (%) withdrawals during trial: Group 1: 16/74 (22%)
; Group 2: 17/82 (21%)
Reasons for withdrawal: Group 1: infection 3; peri-ulcer skin maceration 2; other ban-
dage-related reason 2; patient request 2; lost to follow-up 6; dressing-related 1. Group 2:
infection 1; peri-ulcer skin maceration 2; other bandage-related reason 3; patient request
2; lost to follow-up 9
Adverse events: Group 1: 23 patients experienced 30 adverse events; Group 2: 22 patients
experienced 36 adverse events
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Number of adverse events related to bandage (none; possible; definite): Group 1: 18; 6;
6; Group 2: 27; 2; 7
Number of different types of adverse events possibly or definitely device-related: Group
1: tissue damage or new ulcer 2; eczema or reaction to bandage 2; pain 2; maceration 2;
other 4; Group 2: tissue damage or new ulcer 3; eczema or reaction to bandage 2; pain
2; maceration 2
All bandages applied according to the manufacturers’ instructions
Ulcers measured using transparency tracing combined with computerised planimetry
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Information from published trial report
was unclear:
“Patients were randomised to a bandage
system . . .”, however, standard data checks
undertaken for the IPD meta-analysis sug-
gested that the random sequence genera-
tion was satisfactory
Allocation concealment (selection bias) Low risk “Randomization took place . . . by means
of opening sealed envelopes in sequential
order”. The trial investigators told us that
these envelopes were numbered
Incomplete outcome data (attrition bias)
All outcomes
Low risk “The analysis based on ITT meant that
patients remained in their original ran-
domised groups irrespective of subsequent
treatments applied”
3 randomised patients were excluded from
the analysis “. . . two due to significant arte-
rial disease . . . and one who had not given
informed consent and who withdrew at 1
week”
All 3 patients were reinstated for the IPD
meta-analysis.
Blinded outcome assessment (healing) High risk Trial authors confirmed that assessment of
healing was not blind to treatment
Baseline comparability Low risk Groups appeared balanced at baseline; ran-
domisation was stratified for ulcer area
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Methods RCT in outpatient leg ulcer clinic in Truro, UK. Blinded outcome assessment (3 sep-
arate treatment rooms used for removal of bandages, clinical evaluation of ulcer, and
reapplication of bandage)
Participants 39 patients with 46 ulcers (7 had bilateral ulcers) recruited from local GPs.
Inclusion criteria: venous ulcers, ABPI > 0.8, ambulatory.
Exclusion criteria: arterial or mixed ulcers, diabetes mellitus, peripheral neuropathy, con-
gestive heart failure, chronic renal or liver disease, infected wounds, ankle circumference
< 18 cm or > 25 cm, known sensitivity to paste bandages, ulcer duration < 2 months.
Mean (range) patient age: 71.5 years (44-87).
Mean (range) baseline ulcer area: 7.44 cm2 (0.2-60.2).
Mean baseline duration of ulcers: 10 months.
Trial authors reported no statistically significant differences between groups in relation
to baseline variables, but data were not presented per group
Interventions Group1: 3-component compression systemcomprising:medicated paste bandage, elastic
bandage (Setopress), and elasticated viscose stockinette (n = 19 patients)
Group 2: 3-component compression system comprising: medicated paste bandage, cot-
ton crepe bandage (Elastocrepe), and elasticated viscose stockinette (n = 20 patients)
All patients: elastic bandage (Setopress) for 1 week prior to start of randomised treat-
ment; potassium permanganate soaks for 5 minutes prior to application of compression;
provided with class II compression stockings post-healing and followed up by GP
Outcomes Analyses based on 32 patients with 39 ulcers.
Number (%) patients with complete healing at 15 weeks: Group 1: 11/19 (58%); Group
2: 7/20 (35%), P = 0.24
Withdrawals: 7/39 (18%) patients withdrew overall (full breakdown/group not reported)
. 4 withdrew following initial assessment, 1 after 3 weeks because of ulcer deterioration
(Group 2), and 2 excluded because ineligible (ulcers < 2 months duration at baseline)
Notes When there were several ulcers on one leg, the largest wound was included in the trial. In
the case of bilateral ulceration, each leg was considered separately, and the largest ulcer
on each leg was studied; long-stretch bandage applied to 1 leg at random and SSB to the
other leg
Some healing data highly correlated because of those patients with two ulcerated limbs;
no adjustment made for this in the statistical analysis
Ulcer areas measured using transparency tracing and computerised planimetry. Ulcers
photographed every 2 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided. “The trial was a
prospective, randomised, observer-blind,
parallel group study . . . ”
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Allocation concealment (selection bias) Unclear risk No details provided. “The trial was a
prospective, randomised, observer-blind,
parallel group study . . . ”
Incomplete outcome data (attrition bias)
All outcomes
High risk 39 patients randomised “. . . 32 patients
were available for analysis”. Withdrawals
not reported by group
Blinded outcome assessment (healing) Low risk “Assessments were undertaken weekly at
the clinic . . . Three separate rooms were
used respectively for the removal of the ban-
dages, for the clinical evaluation and for
the application of new bandages. This en-
sured that clinical evaluation was carried
out blind to the bandage system used”
Baseline comparability Unclear risk Described as comparable, but data by
group not presented.
Harley 2004
Methods RCT, no further details of methods. Community setting in Tasmania, Australia. No
sample size estimation presented. Initially sought 40 patients, but only 30 recruited
Participants 30 patients attending a hospital leg ulcer clinic for the first time for treatment of chronic
venous ulceration
Inclusion criteria: venous ulceration confirmed by clinical assessment, Doppler ultra-
sound and ABPI at least 0.8; not previously treated with compression; ulcer of at least 1
months’ duration and 2 cm or more at widest point
Exclusion criteria: not stated.
Number of male:female patients: Group 1: 8:6; Group 2: 5:11.
Average - unclear whether this was mean or median - (range) patient age in years: Group
1: 75 (46-91); Group 2: 71 (38-95)
Trial authors stated that average number of co-morbidities/patient did not differ signif-
icantly between treatment groups, but no further details provided
No information on baseline ulcer area or duration.
Interventions Group 1: 2-component compression with wool layer and elastic bandage (Surepress) (n
= 14 patients)
Group 2: 4LB consisting of wool layer, crepe bandage, elastic bandage (Elset) and elastic
cohesive bandage (Coban) (n = 16 patients)
All patients: treatment provided by community nursing services; patients attended leg
ulcer clinic every 6weeks for assessment.Ulcers that healed between clinic visits examined
by a specialist nurse from the leg ulcer clinic. All patients followed-up until healing
Outcomes Number (%) patients with complete healing during trial - follow-up point unclear (3
months?): Group 1: 8/14 (57%);Group 2: 13/16 (81%) (P = 0.151, chi-squared analysis)
Average days spent on treatment (unclear whether mean or median, and unclear whether
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this related to time to healing): Group 1: 63; Group 2: 87 (difference described as not
significant at 5% level but P value and CIs not shown; chi-squared analysis of quintiles
of healing times P = 0.702)
Number (%) patients reporting at least one adverse event: Group 1: 14/14 (100%);
Group 2: 10/16 (63%)
Chi-squared analysis of 3 categories of number of adverse events (0; 1; 2 or more) P =
0.013 in favour of Group 2
Average number of adverse events/patient (unclear whether mean or median): Group 1:
1.64; Group 2: 0.75 (difference described as significant at 1% level but P-value and CIs
not reported)
Types of adverse events in order of prevalence (numbers not reported): Group 1: slipping,
pain, pressure to length of shin, wound infection; Group 2: slipping, excess firmness
reported by patient, itching, venous eczema
Average number of incidents of inappropriate pressure defined as pain, redness or hori-
zontal wrinkles on limb (unclear whether mean or median): Group 1: 5.43; Group 2: 2.
31 (difference described as significant at 5% level but P value and CIs not shown; chi-
squared analysis of quintiles P = 0.03 in favour of Group 2)
Number (%) patients who withdrew (reasons not reported): Group 1: 6/14 (43%);
Group 2: 1/16 (6%) (P = 0.018, chi-squared analysis)
Total cost of 6 weeks’ treatment based on bandage costs excluding primary dressings
(AUD, price year appears to be 1999-2000): Group 1: AUD 35.00; Group 2: AUD 114.
00
Notes Ulcers measured using “graphing” at baseline, then every 6 weeks (measurement method
not explained further)
Held a series of workshops with community nurses to educate them with regard to
the trial and bandaging systems prior to commencement of data collection; further
support provided during trial from the leg ulcer clinic. Community nurses were already
experienced in applying the 4LB at the start of the trial
Additional outcomes assessed in the trial were:
Ease of application of bandages: assessed by nurses completing a questionnaire at each
dressing change, indicating that nurses were confident in applying both compression
systems
Patient comfort: categorised as completely comfortable vs not completely comfortable:
Group 1: 2 vs 12; Group 2: 12 vs 4 (P = 0.001)
Non-routine bandage changes required/group significantly higher for Group 1 in terms
of both number of patients requiring this and average number of non-routine changes/
patient
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Those consenting were randomly allo-
cated to one of the two groups”
“The patient was then randomly allocated
to a treatment method”
Allocation concealment (selection bias) Unclear risk No information provided.
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Incomplete outcome data (attrition bias)
All outcomes
Low risk “The study . . . followed all patients . . .
through to healing of the ulcer, cessation of
compression bandaging and transfer of the
patient into compression stockings”
Blinded outcome assessment (healing) Unclear risk No information provided.
Baseline comparability Unclear risk No information provided about baseline
wound area and duration
Hendricks 1985
Methods RCT (no details about allocation methods). Setting: outpatients, USA
Participants 21 patients recruited from outpatient clinics.
Inclusion criterion: stasis leg ulcers (no definition provided).
Exclusion criteria: not stated.
Number of male:female patients: Group 1: 5:5; Group 2: 7:4.
Mean ± SD, median (range) patient age in years: Group 1: 59 ± 16, 61 (35-86); Group
2: 64 ± 12, 62 (49-86).
Mean ± SD, median (range) baseline total ulcerated area/patient in cm2: Group 1: 28.
28 ± 57.99, 2.55 (0.09-186.18); Group 2: 45.35 ± 121.78, 4.68 (0.33-391.31).
Mean ± SD, median (range) baseline ulcer duration in months: Group 1: 29.5 ± 35.5,
16.0 (0.5-108.0); Group 2: 11.9 ± 17.9, 5.5 (0.5-60.0).
Number of patients with predisposing factors at baseline (cellulitis; trauma; varicosities;
thrombophlebitis; diabetes; anaemia):
Group 1: 2; 7; 7; 5; 3; 0;
Group 2: 5; 4; 6; 4; 2; 1.
Number of patients with unilateral vs bilateral ulceration: Group 1: 10 vs 0; Group 2: 6
vs 5.
Some patients had multiple ulcers on the same limb.
Interventions Group 1: Unna’s Boot compression system consisting of: zinc oxide and calamine paste-
impregnated bandage (Dome-Paste); gauze bandage (Kerlix); and elastic bandage. Prior
to bandage application, sharp debridement of ulcer was undertaken followed by wound
cleansing with 3%H202 and bacitracin/polymyxin ointment (Polysporin) application to
ulcer surface. For exuding ulcers, the wound was dried using a hair-dryer and 1% gentian
violet applied. A low-potency corticosteroid cream (Tridesilon 0.05%) was applied to
the peri-wound skin. The ulcer was covered with gauze, and sometimes foam dressing.
Dressings and bandages were changed during clinic visits every 3-9 days, depending on
exudate (n = 10 patients)
Group 2: open-toe, below-knee, elastic compression stocking (24 mmHg at ankle grad-
uating to 16 mmHg at calf ) (Futuro) applied by patients each morning and removed
at bedtime. Patients were instructed to dry ulcers following bath or shower using gauze
dressing, prior to cleansing ulcers twice daily using 3% H2O2. Then Polysporin oint-
ment was applied to the ulcer surface, and Tridesilon 0.05% to peri-wound skin. A
gauze dressing, retained with cloth tape (Dermicel), was applied, and sometimes a foam
dressing was used. Patients attended clinic every 1 or 2 weeks, when sharp debridement
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was carried out (n = 11 patients)
All patients: concurrent treatments included: systemic antibiotics as deemed appropriate
following ulcer cultures; oral zinc sulphate in cases of zinc deficiency; diuretics as neces-
sary; reducing diet if overweight
If patients were not deemed to be making progress at the end of each month - in terms
of decreasing ulcer size and also other outcomes relating to changing limb volume - they
were re-assigned to the alternate study group
Outcomes Outcomes as reported by trial authors
Complete healing at 78 weeks: Group 1: 7/10 (70%) patients healed. 3 patients switched
to the alternative treatment - 2 healed
Group 2: 10/14 (71%) patients healed (3 of these had been transferred from Group 1).
6 patients healed just with the stockings (2 bilateral, 2 healed on 1 leg only). 4 patients
received the Unna’s Boot system
P = 0.94 for difference between groups.
Average healing time in weeks: Group 1: 7.3; Group 2: 18.4 (11.8 when one outlier,
who took 78 weeks to heal, was excluded)
Withdrawals: Group 1: none reported; Group 2 1 patient withdrew (reason not given)
Outcomes recalculated by review author (analysed by intention-to-treat)
Number (%) patients with complete healing at 78 weeks: Group 1: 9/10 (90%); Group
2: 9/11 (82%)
Cumulative proportions healed at 78 weeks estimated from Kaplan-Meier survival anal-
ysis: Group 1: 90%; Group 2: 73%
Median (95% CI) time to healing in weeks: Group 1: 7.0 (0.80-13.2); Group 2: 18.0
(5.05-30.95), P = 0.39 (log rank test)
Notes The descriptive statistics on patient age, baseline ulcer area and baseline ulcer duration
were calculated by the review authors from raw data reported in the paper. Patients
in Group 1 had smaller ulcers at baseline, but on average the wounds were of longer
duration
The compression stockings were fitted according to the manufacturer’s instructions
One patient in Group 2 used acetic acid instead of H202 for ulcer cleansing because of
wound colonisation with Pseudomonas aeruginosa.
Ulcers photographed at baseline, then every 2 weeks.
Some patients switched back and forth several times between treatments
Other reported outcomes included change in leg volume and calf circumference
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The 21 patients were randomly assigned
to two groups . . . ”
Allocation concealment (selection bias) Unclear risk “The 21 patients were randomly assigned
to two groups . . . ”
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Incomplete outcome data (attrition bias)
All outcomes
Low risk 21 participants were randomised and end-
point data is presented for 20 participants
(1 withdrawal from Group 2)
Blinded outcome assessment (healing) Unclear risk “Pictures of the ulcers were taken initially
and every 2 weeks”
Baseline comparability High risk Imbalances for baseline ulcer area (larger in
Group 2) and duration (older in Group 1)
Iglesias 2004
Methods RCT (multicentred, pragmatic, i.e. reflecting everyday clinical practice as far as possible)
. Randomisation stratified by study centre, previous ulceration (yes/no), ulcer area (≤
or > 10 cm2) and ulcer duration (≤ or > 6 months). Randomisation code developed
using computer-generated permuted blocks (randomly sized 4 or 6). Patients and nurses
aware of allocated treatment after assignment. Sample size estimation: 200 patients/arm
would provide 80% power to detect 15% difference in healing rates at 12 weeks at 5%
significance level. Patients were followed-up for a minimum of 12 months
Participants 387 patients recruited from 9 community (leg ulcer services, district nursing or general
practice) and outpatient (vascular surgery) centres in the UK.
Inclusion criteria: patients with venous leg ulcer ≥ 1 cm diameter.
Exclusion criteria: age < 18 years; ABPI < 0.8; diabetes mellitus; previous unsuccessful
use of a trial bandage.
Number of male:female patients: Group 1: 79:116; Group 2: 80:112.
Mean ± SD (range) age in years: Group 1: 71.9 ± 12.3 (25-97); Group 2: 71.3 ± 14.1
(23-96).
Number (%) patients fully mobile; needing assistance; immobile: Group 1: 123 (63%);
72 (37%); 0 (0%); Group 2: 115 (60%); 70 (37%); 3 (2%).
Number (%) patients with full ankle mobility vs impairment vs fixed: Group 1: 131
(67%) vs 59 (30%) vs 3 (2%); Group 2: 128 (67%) vs 58 (30%) vs 2 (1%).
Median (range) number of ulcer episodes since first ulcer: Group 1: 2 (0-50); Group 2:
2 (0-64).
Mean ± SD (range) ankle circumference in cm: Group 1: 23.9 ± 2.9 (16.2-34.0); Group
2: 23.9 ± 2.9 (16.0-32.3).
Median (range) ulcer duration in months: Group 1: 3 (0.5-456); Group 2: 3 (0.5-768).
Median (range) ulcer area in cm2: Group 1: 3.81 (0.19-254.58); Group 2: 3.82 (0.35-
143.93).
Interventions All patients: ulcers cleansed using tap water or saline and covered with simple low-
adherent dressing. Dressings and bandages renewed by the usual nursing staff at least
weekly
Group 1: 4LB: orthopaedic wool padding, crepe retention bandage, class 3A compression
bandage and cohesive compression bandage, all applied with 50% overlap. The original
4LB system and 2 proprietary kits (Profore and System 4) were randomly allocated (n =
195)
Group 2: SSB: orthopaedic wool padding covered with 1 or 2 100% cotton short-stretch
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compression bandages (Comprilan or Rosidal K), applied using spiral, figure-of-8 or
modified Putter techniques (n = 192)
Outcomes Number (%) patients with complete healing at 4 months: Group 1: 107/195 (55%);
Group 2: 86/192 (45%) (P value not reported - these data were shown as part of the
discussion section for comparison with other trials)
Number (%) patients with complete healing at 1 year: Group 1: 152/195 (78%); Group
2: 138/192 (72%) (P value not reported - these data were shown as part of the discussion
section for comparison with other trials)
Kaplan-Meier estimate of median (95% CI) time to healing in days: Group 1: 92 (71-
113); Group 2: 126 (95-157), log rank comparison P = 0.117
Cox regression model used to assess impact of treatment centre, ulcer area, ulcer du-
ration, ulcer episode, age weight, mobility, ankle mobility and ABPI on time to heal-
ing. Following adjustment for treatment centre, number of previous episodes, weight,
baseline ulcer area, ulcer duration and ankle mobility, there was a statistically significant
increase in the probability of healing in Group 1: HR 0.72 (95% CI 0.57-0.91)
Kaplan-Meier estimate of cumulative proportion of legs healed at 12 weeks: Group 1:
46.3%; Group 2: 36.7%. Difference 9.6% (95% CI 0-20), P = 0.1
Kaplan-Meier estimate of cumulative proportion of legs healed at 24 weeks: Group 1:
67.5%; Group 2: 55.4%. Difference 12.1% (95% CI 2-22), P = 0.02
Number (%) withdrawals: Group 1: 46/195 (24%); Group 2: 66/192 (34%)
Number (%) patients with non-bandage related adverse events: Group 1: 33/195 (17%)
; Group 2: 39/192 (20%)
Number (%) patients with adverse events possibly related to compression treatment:
Group 1: 76/195 (39%); Group 2: 91/192 (47%)
Cost-effectiveness and cost-utility analyses: perspective was UKNHS and Personal Social
Service; time horizon was 1 year after recruitment; price year 2001; health benefit mea-
sured as differences in ulcer-free days (Kaplan-Meier estimate) and quality-adjusted life
years (QALYs) estimated from patients’ responses to the EuroQol-5D questionnaire. To
account for censoring, QALYs were adjusted by the Kaplan-Meier survival estimate over
the 1-year time horizon. Mean difference in healing time for ulcers was 10.9 days (95%
CI -6.8-29.1) in favour of Group 1: MD between treatment groups in QALYs was -0.
02 (95% CI -0.08-0.04). The MD in total cost between compression systems was GBP
227.32/patient/year (95% CI 16.53-448.30) in favour of Group 1. Sensitivity analyses
showed cost-effectiveness estimate to be robust to variation in number of bandages used
and unit costs of compression systems. The 4LB emerged as the dominant strategy
Notes When patients had multiple ulcers, the limb with the largest eligible ulcer was studied.
Healing defined as complete epithelial cover in the absence of a scab. At healing, the
ulcer was photographed and healing was confirmed at the trial office by an investigator
blind to treatment allocation. Training in the application of both types of bandages was
provided during trial set-up
This trial included an assessment of health-related quality of life. Since there was a large
amount of missing data for this outcome, a descriptive analysis of findings was reported.
The instruments used for data collection were the SF-12 and the Hyland Leg and Foot
Ulcer Questionnaire. For the SF-12, scores between treatment groups appeared similar
at baseline and over time for physical and mental components. For the Hyland Leg and
Foot Ulcer Questionnaire, the scale was scored using 2 factors: practical, and emotional.
Baseline and follow-up scores were similar between groups for both factors
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomisation code was devel-
oped using computer generated permuted
blocks, which were randomly of size four
or six . . . The allocation sequence was gen-
erated by the trial statistician . . . ”
Allocation concealment (selection bias) Low risk “After the baseline clinical assessment . . .
the nurse recruiting the patient telephoned
the randomisation service . . . ”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Withdrawals from the trial and from allo-
cated treatment were included in the anal-
ysis by intention-to-treat (ITT)”
Blinded outcome assessment (healing) Low risk “Neither the patients nor the nurses admin-
istering the bandages and giving the asso-
ciated care could be blinded . . . The nurse
providing the regular leg ulcer care was re-
sponsible for documenting the assessments
of ulcer progress every 4 weeks, including
tracing the ulcer outline. These outcome
assessors were therefore not blinded. The
ulcer tracing was sent to the Trial Coordi-
nation Office where the ulcer area was de-
termined by computerised planimetry by a
researcher masked to bandage allocation”
“At the point of healing the nurse respon-
sible for the patient’s care of the leg ulcer
took a Polaroid photograph of the healed
ulcer and sent this to the Trial Coordina-
tion Office. An investigator unaware of the
bandage allocation confirmed ulcer heal-
ing. This partially masked outcome assess-
ment as the clinician only took a photo-
graph when he/she had already decided the
ulcer was healed”
Baseline comparability Low risk Randomisation was stratified by ulcer area,
ulcer duration, ulcer episode and clinical
centre and resulted in good balance across
groups. The primary analysis was also ad-
justed for important prognostic factors
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Methods RCT (multicentred) with allocation by remote telephone service using a previously
prepared centre-stratified randomisation list
Aim of trial was to assess non-inferiority between 2 compression systems. Sample size:
authors stated that non-inferiority was evaluated by comparing the 90% CI for between-
group difference in complete healing with the non-inferiority limit of 15%, assuming
65%healing rate, 80%power and 5% significance level. The required number of patients
was not stated
Participants 178 patients recruited from4 study centres in France, Germany, Austria and Switzerland.
Inclusion criteria: ambulatory ≥ 1 h/day; patient age 18-80 years; venous leg ulceration
confirmed using Doppler ultrasound; ulcer < 3months’ baseline duration and maximum
diameter ≤ 5 cm; ABPI > 0.9.
Exclusion criteria: ulcers of diabetic, arterial or mixed aetiology; infected ulcers; co-
morbidities (decompensated heart failure, cancer, chronic or autoimmune infection,
insulin-dependent diabetes, diabetic neuropathy); restricted ankle movement.
Number of male:female patients: Group 1: 37:51; Group 2: 35:55.
Mean ± SD (range) patient age in years: Group 1: 64.9 ± 12.6 (33-82); Group 2: 65.1
± 11.7 (24-80).
Number (%) patients with recurrent ulceration: Group 1: 68/88 (77%); Group 2: 69/
90 (77%).
Number (%) patients with history of DVT: Group 1: 30/88 (34%); Group 2: 29/90
(32%).
Mean ± SD (range) baseline ulcer surface area in mm2: Group 1: 240.3 ± 229.7 (27-
1356); Group 2: 239.6 ± 230.1 (23-1042).
Mean ± SD (range) baseline ulcer duration in weeks: Group 1: 5.8 ± 3.5 (1-12); Group
2: 6.0 ± 3.3 (1-12)
Interventions The following were disallowed for all participants during the trial: antibiotics, immuno-
suppressants, cytotoxic agents and venoactive drugs; new prescriptions or changes in
dosage of all types of anti-inflammatory drugs; sclerotherapy, venous surgery and skin
grafts. Patients were seen weekly and were asked to wear the compression device contin-
uously between clinic visits. All patients had manual debridement, ulcer cleansing with
normal saline and a non-medicated, non-adherent gauze primary dressing
Group 1: tubular compression device; device was knitted, knee length, heel-less, open-
toed, exerted graduated pressure, highest at ankle (30-40 mmHg), corresponding to class
III compression stockings (n = 88)
Group 2: SSB (Rosidal K) (n = 90).
Outcomes Number (%) patients with complete healing: Group 1: 51/88 (58.0%); Group 2: 51/90
(56.7%). Between-group difference in proportion with complete healing -1.3% (90%
CI -13.5%-10.9%)
Mean ± SD, median (range) time to healing in days: Group 1: (n = 51) 43.0 ± 18.3,
42 (13-84); Group 2: (n = 51) 43.6 ± 18.3, 42 (13-85). Between-group difference for
median P = 0.80
The Kaplan-Meier estimate showed no between-group difference in probability of heal-
ing (P = 0.41)
Number (%) unhealed patients with reduction in ulcer area: Group 1: 25/37 (67.6%);
Group 2: 23/39 (59.0%)
Cox regression indicated that baseline ulcer area had a significant effect on time to healing
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(P = 0.002), but baseline ulcer duration and patient age were not significant predictors
(P = 0.35 and P = 0.82 respectively)
Compliance with bandaging regimen (calculated as number of days compression device
worn as a percentage of the number of days’ participation in the study): Group 1: 96.
8%; Group 2: 96.4% (P = 0.42)
Tolerability: Group 1: 12/88 (14%) patients complained of pain in lower limb or sen-
sation of tightness on the day after first application of compression, or 1-2 weeks later.
This was resolved in all cases by using larger-sized devices. Group 2: no such problems
Health-related quality of life assessed using the Nottingham Health Profile showed no
difference between treatment groups (information taken from conference abstract,so
only brief details available)
Notes 188 patients randomised, this comprised the intention-to-treat population, but data
were presented on a total per protocol sample of 178. Reasons for exclusion: patient did
not consent to use bandages 1; lost to follow-up 1; compression treatment used for < 1
week 7; diabetes 1 (breakdown/group not reported)
Authors reported that results for the intention-to-treat population were comparable with
those for the per protocol population, but did not report statistics
Compression applied by investigator (described as ’experienced’) or medical staff (’expe-
rienced andwell trained’) according tomanufacturers’ instructions. In discussion section,
authors reiterated that all investigators were specialists, reducing problems with bandage
application such as insufficient pressure or non-graduated pressure. Patients and family
members were asked not to change the compression device
Wounds measured weekly using transparency tracing combined with computerised
planimetry
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Once a patient was eligible, the investi-
gator received the corresponding treatment
number (by telephone from an external
randomisation centre) in accordance with
a previously prepared centre-stratified ran-
domisation list”
Allocation concealment (selection bias) Low risk “Once a patient was eligible, the investi-
gator received the corresponding treatment
number (by telephone from an external
randomisation centre) in accordance with
a previously prepared centre-stratified ran-
domisation list”
Incomplete outcome data (attrition bias)
All outcomes
High risk Not an ITT analysis. 188 participants were
randomised and as this was deemed by the
trialists a “non inferiority trial” they under-
took a per protocol analysis on only 178
participants
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Blinded outcome assessment (healing) Unclear risk “Change in ulcer size was evaluated by
physicians drawing an outline of the study
ulcer on tracing paper. These tracings were
then used to calculate the area and diame-
ter of the ulcers”
Baseline comparability Low risk Groups appeared comparable at baseline.
Jünger 2004b
Methods RCT (multicentred) with allocation achieved using blocks of 4 patients compiled by a
contract research organisation prior to patient recruitment. Non-inferiority trial (non-
inferiority margin set at 15% of healing rate)
No a priori power calculation presented, but planned an interim analysis of first 120
patients to complete therapy to estimate final sample size or to terminate the study pre-
maturely. Since the between-group difference in frequency of complete healing exceeded
15%, the study was stopped after the interim analysis
Assessment of healing was conducted by investigators blind to treatment allocation
Participants 134 patients randomised at 16 study centres (German medical practices specialising in
phlebology and German and Dutch phlebology outpatient clinics).
Inclusion criteria: venous ulcer, WIDMER stage III, CEAP 6; breadth 1-10 cm; baseline
ulcer duration < 12 months; reflux of extrafascial cutaneous saphenous veins or deep
conducting veins or perforating veins confirmed by Doppler or Duplex sonography;
ABPI > 0.9; patient age 18-80 years.
Exclusion criteria: ambulatory < 1 h/day; ulcer clinically infected; ulcers of diabetic,
arterial or combined aetiology; insulin-dependent diabetes mellitus; diabetic polyneu-
ropathy; DVT in last 3 months; uncontrolled hypertension; advanced coronary disease;
primary chronic polyarthritis; ankle dorsal flexion < 5°; vascular surgery or sclerotherapy
within last 3 months; concomitant venous medication, immunosuppressants or cyto-
statics; BMI > 35 kg/m2; general risk factors; non-compliance.
All patients were Caucasian.
Number of male:female patients: Group 1: 21:40; Group 2: 26:34.
Mean ± SD patient age in years: Group 1: 63 ± 11; Group 2: 63 ± 13.
Mean ± SD BMI in kg/m2: Group 1: 28 ± 4; Group 2: 28 ± 5.
Mean ± SD,median baseline ulcer surface area inmm2: Group 1: 562 ± 788, 274; Group
2: 595 ± 899, 370.
Mean ± SD baseline ulcer duration in days: Group 1: 116 ± 100; Group 2: 156 ± 120.
Number (%) patients with diabetes: Group 1: 7/61 (11%); Group 2: 7/60 (12%).
Number (%) patients who had compression prior to study: Group 1: 54/61 (89%);
Group 2: 54/60 (90%)
Interventions All patients given instructions and written information on how to apply their respective
compression system. Compression therapy to be applied for at least 8 h/day. Patients
could reapply compression between clinic visits, or could request professional assistance
Group 1: U-Stocking (Venotrain ulcertec), consisting of outer and inner stockings, with
size specified individually for each patient (3 ready-made widths available, each in 2
lengths) (n = 66)
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Mean ± SD ankle pressure of U-Stocking measured while supine was 42.7 ± 13.0 mmHg
Group 2: compression bandages (2 SSBs each 10 cmwide and 5m long, wrapped around
leg in opposite directions from metatarsophalangeal joint to the head of the fibula) (n =
68)
Ankle pressure not reported for compression bandages.
Outcomes Number (%) patients with complete healing at 12 weeks: Group 1: 29/61 (47.5%);
Group 2: 19/60 (31.7%) (95% CI for between-group differences weighted by centre 4.
3%-28.5%, one-sided P = 0.013)
Mean ± SD, median (range) days to healing: Group 1: 46 ± 20, 47 (10-83); Group 2:
46 ± 22, 52 (6-80), P = 0.82 (Mann-Whitney U-test)
Kaplan-Meier survival analysis indicated a trend in favour of Group 1: (P = 0.057, log
rank test). Cumulative proportions of patients healed at 12 weeks as read from survival
plot: Group 1: 51%; Group 2: 30%
Mean ± SD, median (range) % change in ulcer surface area at 12 weeks: Group 1: (n =
61) -74.8 ± 42.4, -98.4 (-100-83); Group 2: (n = 58) -51.4 ± 86.7, -82.9 (-100-396.2),
P = 0.068 (Mann-Whitney U-test)
Mean ± SD, median duration of compression therapy (h/day) assessed during the trial
Group 1: 12.7 ± 2.9, 12.2; Group 2: 16.9 ± 5.7, 15.9 (P = 0.0002)
Number (%) patients reporting difficulty in application of compression device (mild vs
moderate vs great):
Group 1 (n = 54): 11 (20%) vs 4 (7%) vs 2 (4%); Group 2 (n = 53): 12 (23%) vs 6
(11%) vs 0 (0%) (P = 0.9, chi-squared test)
Number of adverse events: Group 1: 29 adverse events in 20/65 (31%) patients; Group
2: 42 adverse events in 26/67 (39%) patients
Number of serious adverse events: Group 1: 2 serious adverse events, both resulting in
discontinuation of study treatment (ulcer bleeding/pain 1, gastrointestinal bleeding 1)
; Group 2: 4 serious adverse events (ulcer bleeding 1, lymph secretion from ulcer 1,
fractured neck of femur - discontinued treatment 1, thrombophlebitis - discontinued
treatment 1)
Number of non-serious adverse events: Group 1: 2 non-serious adverse events (increased
ulcer pain 1, increase in calf circumference and open sites around ulcer - treatment dis-
continued 1); Group 2: 4 non-serious adverse events (ulcer increased in size 1, ankle
flexibility restricted by pain 1, intolerance to compression material leading to discontin-
uation of treatment 1, phlegmon on lower leg - treatment discontinued 1)
Patient questionnaire on comfort of compression showed significantly more patients
reporting no problems in Group 1 for: constriction (P = 0.003); restricted freedom of
movement (P = 0.0009); sweating under dressing (P = 0.04); and itching of skin on leg
(P = 0.006). There were no significant between-group differences for tightness, leg pain,
burning in leg, heat sensation in leg and prickling of leg
Mean ± SD, median (25% and 75% quartiles) minutes taken for nurse to apply com-
pression: Group 1: 5.4 ± 5.4, 3 (2 and 5); Group 2: 8.5 ± 6.5, 6 (5 and 10), P < 0.001
Number (%) patients receiving professional support for bandage application: Group 1:
6/65 (9.2%); Group 2: 15/67 (22.4%), P = 0.065
Cost analysis based on cost of procedures and associated resources, including: application
of stockings or bandages; primary dressings (moist or gauze); debridement (enzymatic
or surgical); skin care with zinc paste; skin treatment with topical corticosteroids; phys-
iotherapy; and lymphatic drainage. Labour costs included; overhead costs excluded. The
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number and type of procedures were patient-reported. Estimated cost/% reduction in
wound area (EUR, price year 2003): Group 1: EUR 2.57; Group 2: EUR 4.58
Notes Largest wound studied in patients with multiple ulcers. Group 2 ulcers larger and more
chronic at baseline. Main analysis should be regarded as the Kaplan-Meier survival anal-
ysis: between-group difference in time to healing was tested using the Mann-Whitney
U-test but the log rank test would have been preferable
Ulcer surface areas estimated using a digital image of the wound perimeter traced onto
foil combined with computerised planimetry. The calculation was performed at a central
research office by a technician blind to treatment allocation. Ulcers were photographed
Withdrawals/exclusions from analysis: following randomisation 1 patient/group ex-
cluded (Group 1: additional thigh compression needed prior to start of study treatment;
Group 2: refused treatment prior to start of therapy). Safety analysis based on: Group 1:
n = 65; Group 2: n = 67. 11 of these patients withdrew early and had no efficacy data:
Group 1: n = 4 (serious adverse event 2, ineligible 2); Group 2: n = 7 (serious adverse
event 2, ineligible 2, lost to follow-up 3). The intention-to-treat population available
for the primary efficacy analyses was based on: Group 1: n = 61; Group 2: n = 60.
12 of these patients withdrew after at least 1 post-baseline assessment: Group 1: n = 6
(withdrawal of consent 4, poor compliance 2); Group 2: n = 6 (withdrawal of consent
2, poor compliance 2, adverse events 2)
The authors stated that: the bandaging method used for Group 2 was standardised in
all study centres; all persons involved in providing nursing care were given training in
applying compression
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomization used blocks of 4 patients
and was performed at the statistical depart-
ment of a contract research organisation . .
. prior to patient enrolment”
Allocation concealment (selection bias) Low risk “Numbered containerswere supplied to the
study sites; patients were assigned by the
investigators to one of the two treatments
by opening a code envelope with available
treatment numbers in ascending order”
Incomplete outcome data (attrition bias)
All outcomes
High risk 134 patients were randomised and 121
were analysed; 6 people withdrew from
each group
Blinded outcome assessment (healing) Low risk The calculations of ulcer surface area were
performed at a central research office by a
technician blind to treatment allocation
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Baseline comparability High risk Possible imbalances for ulcer area (median
ulcer larger in Group 2 and also mean du-
ration longer in Group 2)
Kikta 1988
Methods RCT (no further details of methods of allocation). Setting, outpatients, USA
Participants 84 patients with 87 leg ulcers caused by chronic venous insufficiency recruited from
hospital vascular surgery clinics.
Exclusion criteria: arterial insufficiency (ABPI < 0.7); uncontrolled diabetes mellitus; use
of cancer chemotherapeutic agents or systemic steroids; recent venous surgery; infected
ulcers; inability to comply with treatment or follow-up.
Mean ± SEM baseline ulcer area in cm2: Group 1: 9.0 ± 2.2; Group 2: 8.6 ± 2.1.
Mean ± SEM baseline ulcer duration in weeks: Group 1: 51 ± 17; Group 2: 45 ± 12.
Authors reported that groups were comparable for other baseline variables including:
patient age; sex; race; previous ulcer treatment; pre-randomisation use of antibiotics;
origin of chronic venous insufficiency; previous venous, arterial or orthopaedic surgery;
prior use of elastic stockings; ischaemic heart disease; congestive heart failure; obesity;
hypertension; diabetes mellitus; pulmonary, renal and hepatic diseases; use of oral con-
traceptives or tobacco; alcoholism; elevated levels of serum haemoglobin, glucose, al-
bumin and creatinine; ABPI; and whether ulcer was new or recurrent. Data were not
presented for these variables. The source population was described as “inner city, lower
socioeconomic class”
Interventions All patients received instructions about leg elevation, restriction of standing activities,
care of associated medical problems, and importance of compliance and follow-up. At
each clinic visit, ulcers were washed with dilute chlorhexidine solution followed by 3%
H202 , rinsed with normal saline and left to air dry.
Group 1: Unna’s boot (further details of components not provided (n = 42 ulcers);
Group 2: Duoderm hydrocolloid dressing (no compression applied) (n = 45 ulcers)
Outcomes Analysis based on 66 patients with 69 ulcers: Group 1: n = 30 ulcers; Group 2: n = 39
ulcers
Number (%) of ulcers completely healed at 6 months: Group 1: 21/30 (70%); Group
2: 15/39 (38%) (P = 0.01, chi-squared test).
Lifetable analysis of mean ± SEM proportion of ulcers healed at 15 weeks: Group 1:
64% ± 9%; Group 2: 35% ± 8% (P = 0.01, log rank test)
Mean ± SEM time to healing in weeks: Group 1: 8.4 ± 1.8; Group 2: 7.0 ± 1.5 (P = 0.
8, Student’s t-test)
Findings from logistic regression suggested that the following were significant predictors
of healing: dressing type (P = 0.002); and baseline ulcer area (P = 0.04). Other covariates
that were tested, but did not emerge as significant predictors included: baseline ulcer
duration, patient age, sex, race, obesity and diabetes
Number (%) ulcers withdrawn from study (all withdrew within 2 weeks of randomisa-
tion, reasons not provided): Group 1: 12/42 (29%); Group 2: 6/45 (13%) (P = 0.11,
Fishers’ exact test)
Number (%) of ulcers with adverse events resulting in discontinuation of treatment:
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Group 1: 0/30 (0%); Group 2: 10/39 (26%) (8 developed reddish-green exudate, 2
had associated cellulitis requiring hospital admission). P = 0.004 for difference between
groups (Fisher’s exact test)
Mean ± SEMpain score evaluated by patients post-healing using linear scale 1-10 (mean-
ing of values not explained): Group 1: 2.4 ± 0.4; Group 2: 1.2 ± 0.1 (P = 0.007, Student’s
t-test)
Mean ± SEM cost of treatment/week in USD (price year 1986) based on cost of all
dressing materials divided by time to healing (healed ulcers) or duration of therapy (non-
healed ulcers). Clinic visit costs and staff costs were excluded: Group 1: USD 11.76 ± 0.
59; Group 2: USD 14.24 ± 1.63 (P = 0.16, Student’s t-test)
Notes Ulcer area measured using tracing and computerised planimetry. Dressings applied ac-
cording to manufacturers’ instructions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients with leg ulcers . . . were ran-
domised to receive . . . ”
Allocation concealment (selection bias) Unclear risk “Patients with leg ulcers . . . were ran-
domised to receive . . . ”
Incomplete outcome data (attrition bias)
All outcomes
High risk 84 people were randomised, however, only
66 were analysed.
Blinded outcome assessment (healing) Unclear risk “Ulcer size was measured by tracing the ul-
cer outline and then measuring the area
with a computerised digital planimeter.”
Baseline comparability Unclear risk Appear similar for baseline area and dura-
tion (however only means presented). Au-
thors reported that groups were compa-
rable for other baseline variables includ-
ing: patient age; sex; race; previous ulcer
treatment; pre-randomisation use of an-
tibiotics; origin of chronic venous insuf-
ficiency; previous venous, arterial or or-
thopaedic surgery; prior use of elastic stock-
ings; ischaemic heart disease; congestive
heart failure; obesity; hypertension; dia-
betes mellitus; pulmonary, renal and hep-
atic diseases; use of oral contraceptives
or tobacco; alcoholism; elevated levels of
serum haemoglobin, glucose, albumin and
creatinine; ABPI; and whether ulcer was
new or recurrent. Data not presented for
these variables
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Methods RCT (no further details of methods). Setting was a wound care centre in the USA
Participants 10 patients randomly chosen from those attending a wound care centre.
Inclusion criteria: venous insufficiency (not defined); leg ulcer of venous aetiology.
Exclusion criteria: refused consent.
No information provided about baseline characteristics except venous filling index
Interventions Group 1: 4LB (Profore) (n = 5 patients);
Group 2: Unna’s boot (described as a paste-impregnated gauze compression dressing) (n
= 5 patients)
All patients received a foam dressing (Allevyn) as the primary dressing. Dressings and
bandages changed weekly
Outcomes At 6 weeks: Mean ± SD healing rate in cm2 per week: Group 1 1.139 ± 0.931; Group 2
0.339 ± 0.458.
These values were calculated by the reviewer using raw data from the study report
Notes Few details of this trial were available. Data were extracted from a conference abstract
and a brief, unpublished report provided by the trial authors. Ulcer surface area assessed
weekly using transparency tracing and computerised planimetry. Patients followed-up
for 6 weeks. Venous filling index, measured by air plethysmography, reported at baseline,
day 1 and day 7. This study is described as ongoing, but no follow-up reports have been
identified
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “. . . subjects for the study are randomly
assigned . . . ”.
Allocation concealment (selection bias) Unclear risk No details provided. “ . . . subjects for the
study are randomly assigned . . . ”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 10 patients recruited; data on 10 partici-
pants. This trial was ongoing at time of trial
report, but no further data received
Blinded outcome assessment (healing) Unclear risk Wounds were measured by transparency
tracing combined with computerised
planimetry, but unclear how these images
were assessed and whether observers were
blinded
Baseline comparability Unclear risk No baseline data presented.
83Compression for venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Koksal 2003
Methods RCT (method of randomisation not stated). Setting: university Hospital Clinic, Turkey
Participants 60 outpatients. Average (range) age in years: Group 1: 51 (24-70); Group 2: 49 (20-72)
.
Inclusion criterion: venous leg ulceration on gaiter area (diagnosed clinically) with area
5-8 cm2.
Exclusion criteria: ABPI < 0.8; clinical infection requiring treatment; diabetes; causes of
leg ulceration other than venous
Number of male:female patients: Group 1: 9:21; Group 2: 11:19
Previous ulcer recurrence: Group 1: 74%; Group 2: 73%.
Mean ± SD baseline ulcer area (cm2): Group 1: 6.38 ± 1.2; Group 2: 6.19 ± 0.8.
Mean ± SD baseline ulcer duration (weeks): Group 1: 16.6 ± 5.8; Group 2: 16.9 ± 6.2
Interventions Concurrent treatments: all ulcers cleansed with normal saline and debrided (no further
details of agents used), when necessary
Group 1: Unna’s Boot containing calamine, zinc oxide, glycerine, sorbitol, gelatine and
magnesium aluminium silicate (n = 30)
Group 2: hydrocolloid dressing (Comfeel) plus class II elastic compression stocking
providing 30-40 Hgmm (n = 30)
Dressings changed every 3-7 days.
Outcomes Ulcer area measured by transparency tracing and planimetry (instrument not stated).
Areas calculated by an investigator blind to treatment allocation
Patients with complete healing at 4 months: Group 1: 20/27 (74%); Group 2: 21/26
(81%), P > 0.05
Mean ± SD healing rate (cm2 per week): Group 1: 1.28 ± 0.72; Group 2: 1.16 ± 0.38,
P > 0.05
Mean ± SD weeks to healing: Group 1: 6.85 ± 3.60; Group 2: 6.65 ± 3.31, P > 0.05
Mean ± SD pain score during application (measured with visual analogue scale 0-10,
where 0 = no pain and 10 = worst imaginable pain): Group 1: 3.69 ± 1.35; Group 2: 1.
88 ± 1.48, P < 0.0001
Mean ± SD pain score at home (measured as above): Group 1: 3.27 ± 1.08; Group 2: 1.
88 ± 1.11, P < 0.0001
Notes Unclear whether patients in Group 2 removed stockings when going to bed. Concerning
skill of care provider, the paper reported that “two dedicated and trained outpatient
nurses applied both treatment modalities”
Withdrawals: Group 1: 3 (infected ulcers 2, hospitalised 1); Group 2: 4 (infection 1;
severe reaction to dressing 1; did not attend clinic 1; lost to follow-up 1)
No patient experienced a serious adverse event during the trial. One treatment-related
adverse event reported in Group 2:
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The patients were randomly assigned into
two groups”.
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Allocation concealment (selection bias) Unclear risk “The patients were randomly assigned into
two groups”.
Incomplete outcome data (attrition bias)
All outcomes
High risk 60 patients recruited and complete healing
analysis based on 53 participants. Denom-
inator unclear for continuous outcomes. 3
patients withdrew from Group 1, and 4
from Group 2
Blinded outcome assessment (healing) Low risk Ulcer tracings and planimetry performed
by a technician who was unaware of the
treatment allocation
Baseline comparability Unclear risk Mean ulcer area and duration were similar,
however, medians were not presented and
data are likely to be skewed
Kralj 1996
Methods RCT (open design). Setting included both in-patients and out-patients in Slovenia
Participants 40 patients recruited.
Inclusion criteria: stasis leg ulcer, age < 86 years, complete mobility, written, informed
consent.
Exclusion criteria: ABPI < 0.8, systemic connective tissue disease, serological positive
rheumatoid arthritis, severe concurrent diseases.
Number of male:female patients: Group 1: 6:10; Group 2: 8:10.
Mean (range) patient age in years: Group 1: 65 (40-86); Group 2: 61 (36-85).
Mean (range) baseline ulcer area in cm2: Group 1: 18.6 (1-57); Group 2: 17.2 (1-47).
Mean (range) duration of ulcers in months: Group 1: 7.9 (1-24); Group 2: 6.9 (1-36)
Interventions Group 1: 4LB (Profore): wool, crepe, Litepress, Co-Plus (n = 20 patients).
Group 2: hydrocolloid dressing (Tegasorb) and single layer inelastic bandage (Porelast)
(n = 20 patients)
Bandages were changed at least weekly for all patients.
Outcomes Number (%) patients with complete healing during 6-month trial (NB patients started
treatment at different points within this 6-month period): Group 1: 7/20 (35%); Group
2: 8/20 (40%)
Mean (range) days to healing: Group 1: 57.6 ( 7-106); Group 2: 84.9 (28-180)
Number (%) patients withdrawing from trial (reasons): Group 1: 4/20 (20%) (admitted
to hospital with heart condition 1, no transport to clinic 1, unknown reason 2); Group
2: 2/20 (10%) (cerebrovascular apoplexy 1, unknown reason 1)
Notes Maximum length andwidth of ulcermeasured at each bandage change. Ulcer surface area
calculated as follows: a33 x b x pi/4 (where a = maximum length (cm) and b = maximum
width (cm)). If patients had multiple ulcers, the total ulcerated area was studied. Study
described as ongoing
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Communication with trialists confirmed
that randomisation was by sealed enve-
lope, but not clear if opaque or numbered.
Method of sequence generation unclear
Allocation concealment (selection bias) Unclear risk Communication with trialists confirmed
that randomisation was by sealed envelope,
but not clear if opaque or numbered
Incomplete outcome data (attrition bias)
All outcomes
High risk 40 patients recruited; 4 people withdrew
from Group 1 and 2 from Group 2: These
people were not included in the analysis
Blinded outcome assessment (healing) Unclear risk “Wounds were assessed by authors . . . ”
(personal correspondence)
Baseline comparability Unclear risk Mean ulcer areas and durations similar, but
not very informative, since data skewed
Mariani 2008
Methods RCT performed at 3 specialist leg ulcer care centres in Italy (Siena, Lucca and Ferrara).
Trial authors stated that there was no stratification at randomisation. Block randomisa-
tion was used (2 blocks of 10 patients/centre)
Participants 60 patients recruited from specialist leg ulcer care centres
Inclusion criteria: presence of venous leg ulcer confirmed by clinical examination and
duplex ultrasound; maximum ulcer diameter 8 cm, minimum duration 1 month; no
effective compression treatment prior to trial; patient able and willing to follow study
protocol
Exclusion criteria: effective compression therapy started prior to trial; arterial insuffi-
ciency (defined as non-palpable foot pulse and ABPI < 0.8); neuropathy of diabetic or
other origin; varicose vein or ulcer surgery within 3 months of enrolment; acute DVT
or varico-thrombosis requiring anticoagulation; ulcer of dermatological cause; primary
lymphoedema; pregnancy; life expectancy < 90 days
Baseline data apply to 56/60 patients:
Number of male:female patients: Group 1: 13:13; Group 2: 10:20
Mean ± SD patient age in years: Group 1: 62.4 ± 14.0; Group 2: 65.2 ± 15.3
Mean ± SD ulcer diameter in cm: Group 1: 3.38 ± 2.73; Group 2: 2.76 ± 2.37
Mean ± SD ulcer duration in months: Group 1: 3.2 ± 2.96; Group 2: 3.6 ± 4.01
Number of patients with primary vs recurrent ulceration: Group 1: 22 vs 4; Group 2:
24 vs 6
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Pain: absent vs weak vs moderate vs strong: Group 1: 2 vs 10 vs 12 vs 2; Group 2: 0 vs
15 vs 9 vs 6
Interventions Group 1: 2-layer compression stocking kit (Sigvaris® Ulcer X® kit). Understocking
consisted of a fabric with an inner cotton layer and an outer knitted layer. Top stocking
consisted of double-covered natural rubber (information gleaned from manufacturer’s
brochure; this stocking in isolation has the proprietary name Sigvaris® Traditional®)
. Sub-stocking ankle pressure with both layers in place was designed to be 39 mmHg.
Top stocking removed at night. Kit washed every 2 days on average (n = 30 patients)
Group 2: SSB applied with spiral or figure-of-8 application, worn day and night (n = 30
patients)
All patients: planned to assess all patients weekly with longer or shorter intervals allowed
according to patient need. Primary dressings and other topical treatments were applied
according to the judgement of treating physician. Surgery was not permitted during the
trial
Outcomes Number (%) of patients with complete healing at 4 months: Group 1: 25/30 (83%);
Group 2: 21/30 (70%)
Mean ± SD time to healing in days: Group 1: 56.0 ± 29.1; Group 2: 61.1 ± 22.7 (P =
0.52)
Trial authors reported that smaller ulcers healed more rapidly with the stockings, whilst
the time to healing of larger ulcers was similar for both treatment groups
Pain, discomfort and hindrance of activities were assessed with the Venous Leg Ulcer
Questionnaire applied at the last clinic visit (either at healing or at 4 months). Mean
scores from 5-point Likert scales suggested that the following were significantly worse at
the 5% level forGroup2: inhibition of activities (P = 0.025), pain at donning and removal
(P = 0.001) and number of problems reported (P < 0.0001). Mean scores for daytime
discomfort and pain suggested no significant difference between treatment groups (P =
0.086)
Number (%) patient withdrawals (reasons): Group 1: 4/30 (13%) patients excluded
within 1st week after randomisation (withdrew consent 1, had restricted anklemovement
and could not put on the stockings 3); Group 2: 0/30 (0%)
Notes Ulcer diameter measured using a tape at baseline and at each assessment
Bandages applied by an expert study physician (noother details of staff expertise provided)
Use of stocking kit associated with longer intervals between clinic visits (mean ± SD 8.
2 ± 1.8 versus 6.7 ± 1.0, P = 0.002); mean number of clinic visits until healing similar
between groups (P = 0.157)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The study is a prospective, randomised,
open-label, parallel-group clinical trial . . .
”
“No stratification is done, neither for the
size of the ulcer nor its presumed cause.
Randomization is done in two blocks of 10
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patients for each centre”
From secondary reference: “Sealed enve-
lope technique was used for randomisa-
tion”
Comment: no details reported on exact
methods used to generate the randomised
sequence
Allocation concealment (selection bias) Unclear risk From secondary reference: “Sealed enve-
lope technique was used for randomisa-
tion”
Comment: it was not clear whether the
sealed envelopes were consecutively num-
bered and opaque
Incomplete outcome data (attrition bias)
All outcomes
High risk “Four patients were excluded within the
first week after randomisation, all in the
stocking group.One patient refused to con-
tinue with any kind of compression ther-
apy. Three patients were unwilling to con-
tinue as donning of the second stockingwas
too difficult for them.”
Comment: withdrawal rate differed across
groups (Group 1: 13% and Group 2: nil)
, potentially related to treatment in Group
1
Blinded outcome assessment (healing) Unclear risk “The study is a prospective, randomised,
open-label, parallel-group clinical trial”
Comment: Itwas not clearwhether the out-
come assessment was blinded
Baseline comparability Unclear risk Ulcer diameter and duration appear simi-
lar at baseline. Ulcer area, however, would
have been a more informative measure-
ment. Mean and standard deviation values
were provided, rather than the preferred
medians and ranges
Meyer 2002
Methods RCT with randomisation by computer-generated tables and stratification by baseline
ulcer area. The strata were (cm2): small (0.25-2.5); medium (> 2.5-25); large (> 25-100).
For stratification purposes, ulcer area was measured using diameter product (multiplica-
tion of maximum length and width). A post-hoc statistical power analysis was presented
as part of the discussion section
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Participants Recruited 112 patients from a hospital leg ulcer outpatient clinic in the UK.
Number of patients with small vs medium vs large ulcers at baseline: Group 1: 18 vs 23
vs 16; Group 2: 17 vs 23 vs 15.
Exclusion criteria: ABPI < 0.8; diabetes; rheumatoid arthritis; systemic lupus erythe-
matosus; positive sickle cell test; HIV; ulcer size < 0.25 cm2 or > 100 cm2; known sensi-
tivity to Viscopaste; receiving drugs that might affect ulcer healing; non-venous diagnosis
of ulcer on clinical examination; no venous abnormality detected using haemodynamic
assessment, even if clinical examination indicated venous aetiology
Interventions Concurrent treatment for both groups: ulcer and surrounding skin cleansed with saline-
soaked cotton wool balls. Standardised figure-of-8 technique used for bandaging
Group 1: Viscopaste bandage plus Tensopress (elastic bandage) plus Tensoshape (grad-
uated cotton-elastic tubular retaining bandage) (n = 57)
Group 2: Viscopaste bandage plus Elastocrepe (inelastic bandage) plus Tensoshape (de-
scription as above) (n = 55)
All dressings undisturbed between clinic visits; frequency of clinic visits not stated
Outcomes Number of patients with complete healing (assessed by photograph) at 26 weeks: Group
1: 33/57 (58%); Group 2: 34/55 (62%), P = 0.623 (P value generated from Kaplan-
Meier estimates and log rank test)
Patients with large ulcers significantly less likely to heal within 26 weeks than those
with small or medium-sized ulcers (chi-squared test = 18.05, P < 0.001), and this was
independent of treatment effect
Further analysis at 40 weeks showed that 1 extra patient/group had healed - this did not
affect statistical significance of the between-group difference
Mean [range] (95% CI) weeks to healing: Group 1: 10 [2-23] (8-12); Group 2: 11 [3-
25] (9-13), not significant
Median weeks to healing: Group 1: 9; Group 2: 9.5, not significant
Notes Unclear whether photographic confirmation of healing done by assessor blind to treat-
ment allocation
Care providers were “seven experienced ulcer clinic nurses”.
Number of patients excluded post-randomisation because ineligible: Group 1: 4; Group
2: 5
Number of patients who withdrew from treatment during trial (with reasons): Group 1:
8 (bandage skin damage 1 (pretibial skin necrosis), refused treatment 1, lost to follow-
up 3, incomplete data record 3); Group 2: 8 (paste allergy 1; non-compliant 2; lost to
follow-up 3; incomplete data record 2)
Costs/bandage: Group 1: GBP 4.38; Group 2: GBP 2.54 (price year not stated)
Mean initial ankle pressures using the Borgnis medical stocking test apparatus: Group
1: 45 mmHg; Group 2: 24 mmHg
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer generated tables were used to
randomise patients”.
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Allocation concealment (selection bias) Unclear risk No further details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 112 people randomised and 112 analysed
for complete healing, however, other out-
comes unclear
Blinded outcome assessment (healing) Unclear risk No detail provided.
Baseline comparability Unclear risk Randomisation stratified by ulcer area at
baseline, however, neither mean nor me-
dian ulcer area presented by group
Meyer 2003
Methods RCT with randomisation by computer-generated tables and stratification by baseline
ulcer area. The strata were (cm2): small (0.25-2.5); medium (> 2.5-25); large (> 25-100)
. For stratification purposes, ulcer area measured using diameter product (i.e. multipli-
cation of maximum length and width). For patients with bilateral ulcers, the combined
area of the ulcers on both legs was used for stratification. Using an a priori power calcu-
lation, it was estimated that the study had 50% power to detect a difference of 20% in
frequency of complete healing at the 95% significance level
Participants Recrtuied 133 patients from a hospital leg ulcer outpatient clinic in the UK
Number of male:female patients: Group 1: 34:30; Group 2: 41:28
Median age in years: Group 1: 68 Group 2: 64.
Mean duration of ulcer in months: Group 1: 19.8 Group 2: 14.8.
Number of patients with small vs medium vs large ulcers at baseline: Group 1: 25 vs 18
vs 21 Group 2: 21 vs 21 vs 27.
Exclusion criteria: ABPI < 0.9; diabetes; rheumatoid arthritis; systemic lupus erythe-
matosus; positive sickle cell test; HIV; ulcer size < 0.25 cm2 or > 100 cm2; known sen-
sitivity to paste; ulcer not of venous aetiology; failure to comply with exit investigations
Interventions Concurrent treatment for both groups: ulcer and surrounding skin cleansed with saline-
soaked cotton wool balls. Standardised figure-of-8 technique used for bandaging
Group 1: 3-layer bandage consisting of: Steripaste bandage plus Setopress bandage plus
Tubgrip bandage (n = 64)
Group2: 4LBconsisting of: Velbandorthopaedicwool; crepe bandage; Elset compression
bandage; Coban bandage (n = 69)
All dressings left undisturbed between clinic visits; frequency of clinic visits initially
weekly, then extended to fortnightly in patients deemed to be making good progress in
terms of healing
Outcomes Patients followed-up to healing or until 52 weeks.
Number of patients with complete healing (assessed by photograph) at 52 weeks: Group
1: 51/64 (80%); Group 2: 45/69 (65%), P = 0.031
Median (95% CI) weeks to healing: Group 1: 12 (10-15); Group 2: 16 (13-21), P = 0.
04
Kaplan-Meier survival estimates showed that the difference in probability of healing
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between the 2 bandages did not become apparent until 20 weeks after randomisation, P
= 0.036 (log rank test). The authors reported that this estimate remained robust when
the analysis was repeated selecting only patients with venous ulceration confirmed with
haemodynamic assessment at completion or withdrawal, but full details not shown in
the paper
Authors stated that ulcer duration did not influence healing, but patients with large
ulcers were significantly less likely to heal than those with small or medium ulcers, this
effect being independent of treatment (full details of these analyses not shown)
Scores for bandage comfort, pain on bandaging and ease of putting on shoes over ban-
dages (all assessed using an un-validated scale of 1-4 at each visit) increased over the
study period, indicating improvement for both groups, but no significant differences
were detected between groups
Group 1 contained significantly more patients with post-thrombotic calf veins; this
was assessed at completion or withdrawal using ascending phlebography (full details of
analysis not shown)
Notes Number of patients who withdrew from treatment during trial (with reasons): Group 1:
10 (adverse events 4, non-compliant 2, lost to follow-up 3, refused treatment 1); Group
2: 11 (adverse events 2, non-compliant 5, lost to follow-up 3, refused treatment 1)
Unclear whether photographic confirmation of healing done by assessor blind to treat-
ment allocation
Care providers described as “seven experienced ulcer clinic nurses” and as “dedicated
nursing staff who are fully trained in four-layer bandaging”
Statistical calculations performed by 2 statisticians who were independent of one another
and of the study investigators
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated tables were used to
randomise patients.
Allocation concealment (selection bias) Unclear risk No further detail provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 133 people randomised and complete heal-
ing data provided for 133 participants; un-
clear for other outcomes. 10 people with-
drew from Group 1 and 11 from Group 2
Blinded outcome assessment (healing) Unclear risk Unclear whether photographic confirma-
tion of healing was done by an assessor
blinded to treatment allocation
Baseline comparability Unclear risk Randomisation was stratified by ulcer area
at baseline, however, neither mean nor me-
dian ulcer area by group presented
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Methods RCT with computer-generated randomisation. Some details of sample size calculation
provided (80% power, significance level 5%), but unclear what intended clinical differ-
ence was expected to be detected
Participants 150 patients recruited.
Inclusion criteria: patient age ≥18 years; venous leg ulceration diagnosed using ABPI
assessment and colour duplex ultrasonography; baseline ulcer surface area > 20 cm2;
baseline ulcer duration > 6 months.
Exclusion criteria: ABPI < 0.8; causes of ulceration other than venous; heart failure
(ejection fraction < 35); pregnancy; cancer; diabetes
Number of male:female patients: Group 1: 39:36; Group 2: 34:41.
Median (range) patient age in years: Group 1: 55 (33-80); Group 2: 57 (34-81).
Median (range) number of previous episodes of ulceration: Group 1: 5 (2-10); Group
2: 5 (1-11).
Median (range) baseline ulcer surface area (cm2): Group 1: 72 (24-210); Group 2: 64
(20-195).
Median (range) baseline ulcer duration in years: Group 1: 7 (0.6-28); Group 2: 6 (0.6-
21).
Number (%) patients with previous DVT: Group 1: 25/72 (35%); Group 2: 20/66
(30%).
Number (%) patients who had previously undergone stripping of great saphenous vein:
Group 1: 14/72 (19%); Group 2: 12/66 (18%).
Number (%) patients who had previously undergone superficial endoscopic perforator
vein surgery: Group 1: 5/72 (7%); Group 2: 5/66 (8%).
Authors reported that groups were similar at baseline for CEAP classification.
None of the patients had previously received compression.
Interventions All patients: treated on an ambulatory basis andhadmechanical debridement using sterile
gauze. Dressings changed every 1-7 days, depending on exudate. Extensive exudation
treated with crystal acidum boricum applied to the wound following debridement. In
cases of no exudate, a dry dressing was applied. Bandage systems were worn day and
night. No antibiotics were used. All patients received aspirin (100 mg, we presume this
was a daily dose)
Group 1: cotton gauze without tension (50% overlap) plus cotton crepe bandage plus
knee-length tubular compression device (Tubulcus) providing 35-40 mm Hg at ankle
plus medium-stretch elastic compression bandage (Niva). After healing, patients contin-
ued to wear Tubulcus (n = 75)
Group 2: cotton gauze without tension (50% overlap) plus cotton crepe bandage plus 2
medium stretch elastic compression bandages (Niva). After healing, patients wore class
II compression stockings providing 20-25 mm Hg (Rudo) (n = 75)
Mean of 3 values (range) interface pressure in mm Hg, measured using Trickovic sensor
placed 8 cm above medial malleolus with patient in supine position: Group 1: 50 (46-
56); Group 2: 44 (37-49)
Outcomes Kaplan-Meier estimate of cumulative proportion of patients with complete healing of
study limb at 500 days: Group 1: 93%; Group 2: 51%, P < 0.01
Kaplan-Meier estimate ofmedian (range) days to healing: Group 1. 133 (28-464); Group
2: 211 (61-438)
Cox regression did not show a relationship between time to healing and any baseline
variable
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Recurrence rate during 1-year follow-up: Group 1: 16/67 (24%); Group 2: 18/34 (53%)
, P < 0.05
Number (%) patients healed following recurrence, after additional compression therapy
using the same regimen: Group 1: 16/16 (100%); Group 2: 16/18 (89%)
Number (%) with adverse events:
Skin excoriation on front of ankle or just below knee: Group 1: 12/72 (17%); Group 2:
not reported
Slippage of device at knee, causing pressure/pain: Group 1: 34/72 (47%); Group 2: not
reported
Patients complaining of pain at start of treatment: Group 1: 8/72 (11%); Group 2: 19/
66 (29%)
Notes Median participant ages/arm indicate relatively young patients in this trial.Withdrawals:
Group 1: 3 patients (lost to follow-up 2, stroke 1); Group 2: 9 patients (died in road-
traffic accident 1, requested to change treatment groups 8). Patients reviewed every 2
months during the 1-year follow-up period
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomizationwas computer generated”.
Allocation concealment (selection bias) Unclear risk No further details provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk Withdrawals: Group 1: 3 patients (2 lost
to follow-up, 1 had a stroke); Group 2: 9
patients (1 died in road-traffic accident, 8
requested to change treatment groups)
Blinded outcome assessment (healing) Unclear risk No details given.
Baseline comparability Low risk Groups appeared reasonably comparable at
baseline.
Milic 2010
Methods Single-centred RCT, conducted in Serbia. Randomisation possibly stratified according to
baseline calf circumference and ulcer area, but report not entirely clear (stratified results
presented)
Participants 131 patients randomised (source population not stated).
Inclusion criteria: patient age ≥ 18 years; venous leg ulceration confirmed with colour
Duplex scan and ABPI assessment; ulcer surface area > 3 cm2; ulcer duration > 3 months.
Exclusion criteria: ABPI < 0.8; cardiac insufficiency with ejection fraction < 35; preg-
nancy; cancer; diabetes; unidentified cause of leg ulcer
Number of male:female patients: Group 1: 20:22; Group 2: 21:25; Group 3: 19:24
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Median (range) patient age in years: Group 1: 60 (33-76); Group 2: 55 (35-77); Group
3: 57 (32-77)
Median (range) ulcer area in cm2: Group 1: 9 (4-160); Group 2: 9 (3-160); Group 3:
11 (3-150)
Number of patients with ulcer area in cm2< 5 vs 5-10 vs 11-20 vs > 20 cm2: Group 1:
12 vs 12 vs 11 vs 7; Group 2: 10 vs 14 vs 14 vs 8; Group 3: 9 vs 12 vs 13 vs 9
Median (range) ulcer duration in years: Group 1: 4.5 (0.3-28); Group 2: 3.5 (0.3-42);
Group 3: 4.0 (0.3-31)
Number of patients with calf circumference < 33 vs 33-38 vs 39-43 vs > 43 cm: Group
1: 8 vs 13 vs 13 vs 8; Group 2: 8 vs 14 vs 14 vs 10; Group 3: 7 vs 14 vs 13 vs 9
All patients had had previous episodes of ulceration.
Interventions Group 1: gauze bandage appliedwith 50%overlap; crepe bandage; elastic class III tubular
compression with open toes and heels designed to exert graduated compression with
30-40 mm Hg at ankle (Tubulcus, Laboratoires Innothera, Arcueil, France). Tubular
device available in 5 sizes and fitted according to ankle and calf measurements. If limb
dimensions changed during the trial, a tubular device of a different size was applied
accordingly (n = 42 patients)
Group 2: gauze bandage as above; crepe bandage; tubular compression as above; 1 elastic
bandage applied in a spiral configuration with 50% overlap, 15 cm wide, 5 m long,
200% stretch (Niva, Novi Sad, Serbia) (n = 46 patients)
Group 3: gauze bandage as above; crepe bandage; tubular compression as above; 2 elastic
bandages as above (n = 43 patients)
All patients: received treatment at a vascular surgery clinic in Nis, Serbia; received me-
chanical debridement using sterile gauze; dressings changed every 1-7 days depending
on exudate; extensive exudate treated with crystal acidum boricum applied topically to
wound; dry dressings applied to non-exuding wounds. Patients advised to walk for 30
minutes after bandaging. If limb size remained unchanged, tubular compression was re-
newed after 6 months; bandages renewed every 3 months; bandages worn day and night.
In cases where the original ulcer closed but a new ulcer developed on the same limb, the
limb was considered unhealed until the new area had closed. After ulcer healing patients
were instructed to continue wearing the tubular elastic stockings
Outcomes Number (%) patients with complete healing at 26 weeks: Group 1: 13/42 (31%); Group
2: 31/46 (67%); Group 3: 32/43 (74%)
Categorical analysis of baseline calf circumference in relation to complete healing:
Number (%) patients with complete healing at 26 weeks with calf circumference < 33
cm: Group 1: 6/8 (75%); Group 2: 5/8 (63%); Group 3: 1/7 (14%) (P < 0.05 for Group
1 vs Group 3)
Number (%) patients with complete healing at 26 weeks with calf circumference 33-38
cm: Group 1: 4/13 (31%); Group 2: 12/14 (86%); Group 3: 11/14 (79%) (P < 0.05 for
Group 1 vs Group 2, and for Group 1 vs Group 3)
Number (%) patients with complete healing at 26 weeks with calf circumference 39-43
cm: Group 1: 2/13 (15%); Group 2: 11/14 (79%); Group 3: 12/13 (92%) (P < 0.01 for
Group 1 vs Group 2, P < 0.001 for Group 1 vs Group 3)
Number (%) patients with complete healing at 26 weeks with calf circumference > 43
cm: Group 1: 1/8 (13%); Group 2: 3/10 (30%); Group 3: 8/9 (89%) (P < 0.01 for
Group 1 vs Group 3, P < 0.05 for Group 2 vs Group 3)
Categorical analysis of baseline ulcer area in relation to complete healing:
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Number (%) patients with complete healing at 26 weeks with ulcer area < 5 cm2: Group
1: 10/12 (83%); Group 2: 10/10 (100%); Group 3: 7/9 (78%) (no significant differences
between groups)
Number (%) patients with complete healing at 26 weeks with ulcer area 5-10 cm2:
Group 1: 3/12 (25%); Group 2: 9/14 (64%); Group 3: 9/12 (75%) (P < 0.05 for Group
1 vs Group 2, and for Group 1 vs Group 3)
Number (%) patients with complete healing at 26 weeks with ulcer area 11-20 cm2:
Group 1: 0/11 (0%); Group 2: 8/14 (57%); Group 3: 8/13 (62%) (P < 0.01 for Group
1 vs Group 2, and for Group 1 vs Group 3)
Number (%) patients with complete healing at 26 weeks with ulcer area > 20 cm2: Group
1: 0/7 (0%); Group 2: 4/8 (50%); Group 3: 8/9 (89%) (P < 0.01 for Group 1 vs Group
3)
Median (range) time to healing in weeks (all patients): Group 1: 12 (5-24); Group 2: 11
(3-25); Group 3: 14 (5-24) (median test P > 0.05 reported by trial authors)
Cox regression suggested larger values of calf circumference andulcer area to be significant
independent predictors of delayed healing (P = 0.01 and P < 0.001 respectively). The
probability of healing was significantly lower among patients in Groups 1 and 2 when
compared with Group 3 (P < 0.001 for Group 1 vs Group 3, P = 0.017 for Group 2 vs
Group 3)
Number (%) patients who withdrew from treatment (all because of non-concordance
with treatment): Group 1: 1/42 (2%); Group 2: 1/46 (2%); Group 3: 9/43 (21%)
Trial authors reported that there were no deaths or major complications during the study
period
Notes Wound surface area assessed at baseline and every 2 weeks during the trial using digital
photography and computerised planimetry
Ankle sub-bandage pressure measured in supine, sitting and standing positions. Mea-
surements taken at baseline, 4 and 10 weeks, straight after application of compression
using a pressure transducer (Kikuhime small probe; MediTrade, Soro, Denmark). Me-
dian resting values in supine vs standing positions in mm Hg: Group 1: 36.2 vs 43.9;
Group 2: 53.9 vs 68.2; Group 3: 74.0 vs 87.4. Average static stiffness index (difference
in pressure between standing and lying positions): Group 1: < 10; Group 2: > 10; Group
3: > 10
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was computer generated .
. . ”.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk During the treatment period, 1 patient in
Group 1, 1 patient in Group 2 and 9 pa-
tients in Group 3 “dropped out of the
study due to noncompliance to compres-
sion treatment”
Comment: a Kaplan-Meier plot, and tab-
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ulated information, in the trial report in-
dicated that all randomised patients were
included in all analyses of healing
Blinded outcome assessment (healing) Unclear risk “An open, randomised, prospective, single-
centre study was performed . . . ”
Comment: it was unclear whether outcome
assessment was blinded
Baseline comparability Low risk Groups appeared comparable at baseline.
Moffatt 1999
Methods RCT with allocation by sequential numbers on a randomisation list, stratified by study
centre and baseline total ulcerated area on reference limb (≤ or > 10 cm2). Authors esti-
mated that the study had 80% power, that the 95% CI for the between-group difference
in healing rates would not exceed a difference of 15%, assuming: equally effective treat-
ments; an overall healing rate of 80% difference in healing rates; and 5% significance
level
Participants Recruited 232 newly-presented patients from community leg ulcer services in the UK
(2 study centres).
Inclusion criteria: patient ≥ 18; not pregnant; venous ulceration.
Exclusion criteria: ABPI < 0.8; non-venous ulceration; patients who had entered the trial
previously.
Number of male:female patients: Group 1: 53:62; Group 2: 53:64.
Mean ± SD patient age in years: Group 1: 67.8 ± 13.5; Group 2: 67.1 ± 15.2.
Median (range) baseline ulcer duration in weeks: Group 1: 8 (0-2080); Group 2: 7 (0-
728).
Proportion of patients with baseline ulcer area < 10 cm2: Group 1: 82%; Group 2: 84%.
Proportion of patients able to walk freely: Group 1: 74%; Group 2: 79%.
Proportions of patients with mobile vs fixed limb: Group 1: 83% vs 17% Group 2: 92%
vs 8%
Interventions All patients: received a low-adherent primary dressing (Tricotex), bandages changed at
least weekly
Group 1: original Charing Cross 4LB comprising wool, crepe, Elset and Coban. Con-
stituents varied slightly according to ankle circumference (n = 115).
Group 2: Profore 4LB comprising wool, crepe, Litepress and Co-Plus. Constituents
varied slightly according to ankle circumference (n = 117)
Following healing, all patients were prescribed compression stockings and returned to
regular follow-up clinics
Outcomes Number (%) patients with complete healing at 12 weeks: Group 1: 69/115 (60.0%);
Group 2: 84/117 (71.8%). Difference 11.8% (95% CI -0.3%-23.9%)
Number (%) patients with complete healing at 24 weeks: Group 1: 84/115 (73%);
Group 2: 89/117 (76%). Difference 3.0% (95% CI -8.2%-14.2%)
Kaplan-Meier estimate of healing at 24 weeks: Group 1: 82%; Group 2: 84%
HR for healing showed a non-significant trend in favour of Group 2: 1.18 (95% CI 0.
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87-1.59), P = 0.28 (stated as adjusted for baseline variables, but unclear exactly which
ones)
Quality of life assessed using Nottingham Health Profile at baseline, 12 and 24 weeks
(scores 0-100, with lower scores indicating better quality of life). Domains include: en-
ergy; bodily pain; emotional reactions; sleep; social isolation; and physical mobility.Mean
differences in final scores calculated using ANOVA with adjustment for baseline scores.
208/232 (90%) patients completed at least 1 follow-up questionnaire (99 in Group 1,
109 in Group 2). There were no statistically significant between-group differences for
any domain
Notes In patients with bilateral ulceration, the limb with the larger area of ulceration was
studied
Number (%) withdrawals: Group 1: 18 (16%); Group 2: 17 (15%)
Reasons for withdrawal: Group 1: non-attendance for treatment 9; bandage discomfort
6; treatment changed by other clinician 1; adverse event 2 (exacerbation of arthritis 1;
below-knee skin irritation 1)
Group 2: non-attendance for treatment 3; bandage discomfort 9; treatment changed
by other clinician 2; death 1; adverse event 2 (profuse bleeding from ulcer 1; pressure
damage 1)
Adverse events: Group 1: 14 adverse events in total (infection 4, skin irritation 4, excess
exudate 2, new ulcer 1, skin irritation and pain 1, other 2); Group 2: 13 adverse events
in total (infection 2, skin irritation 3, pain 1, skin irritation and pain 2, skin irritation
and new ulcer 1, infection and pain 1, other 3)
Methods of wound measurement or assessment not stated.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomisation took place . . . by means
of sequential numbers on a randomisation
list which was stratified for ulcer size . . . ”
Allocation concealment (selection bias) Unclear risk No further details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 233 people recruited; 232 had at least 1
follow-up visit; 18 people from Group 1
and 17 from Group 2 withdrew. Analysis
by intention to treat
Blinded outcome assessment (healing) Unclear risk No detail given.
Baseline comparability Unclear risk Median baseline ulcer duration slightly
longer in Group 1.
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Methods RCT (multicentred), with computer-generated randomisation schedules provided to
study centres as sequential number lists. Randomisation stratified by study centre and
baseline ulcer area (≤ or > 10 cm2). Sample size: original target of 120 patients was not
recruited. It was estimated that 54 patients/arm provided 74% power to detect 25%
difference in healing rates at 5% significance level
Participants Recruited 112 newly-presented patients from community leg ulcer clinics in 5 UK study
centres.
109 patients comprised the intention-to-treat population (defined as those attending≥1
follow-up visit).
Inclusion criteria: signs and symptoms of chronic venous ulceration; ABPI≥ 0.8; patient
age ≥ 18 years; ankle circumference > 18 cm; baseline ulcer duration ≥ 2 weeks.
Exclusion criteria: pregnancy; causes of ulceration other than venous disease; active
cellulitis treated with systemic antibiotics; previously entered trial.
Number of male:female patients: Group 1: 24:33; Group 2: 23:29.
Mean ± SD patient age in years: Group 1: 70.2 ± 14.4; Group 2: 71.8 ± 11.3.
Number of patients with baseline ulcer area ≤10 cm2 vs >10 cm2: Group 1: 48 vs 9;
Group 2: 45 vs 7.
Median (range) baseline ulcer duration in weeks: Group 1: 6 (2-104); Group 2: 6 (2-
1040).
Number (%) patients with previous ulceration: Group 1: 24/57 (42%); Group 2: 24/52
(46%).
Number (%) patients with history of DVT: Group 1: 4/57 (7%); Group 2: 4/52 (8%).
Number (%) patients with diabetes: Group 1: 1/57 (2%); Group 2: 4/52 (8%).
Number (%) patients with rheumatoid arthritis: Group 1: 5/57 (9%); Group 2: 3/52
(6%).
Number of patients walking with aid vs walking freely: Group 1: 17 vs 40; Group 2: 7
vs 45.
Number of patients with limb fully mobile vs limited vs fixed: Group 1: 45 vs 12 vs 0;
Group 2: 43 vs 7 vs 2.
Number of patients using drugs that could affect healing: Group 1: 1 (steroids); Group
2: 0
Interventions All patients: study limb washed using emollient dissolved in tap water, wound debrided
and a simple hypoallergenic hydrating cream applied to the surrounding skin. A simple
non-adherent dressing was applied to the ulcer, followed by randomised bandage system.
Dressings and bandages were changed at least weekly
Group 1: 4LB (Profore) (n = 57);
Group 2: 2-layer bandage (Surepress) (n = 52).
All bandages applied according to manufacturers’ instructions
Patients who withdrew from randomised treatment were allocated to an alternative treat-
ment and continued to be followed-up for 24 weeks. After healing, patients were pre-
scribed compression stocking and returned to usual follow-up clinics
Outcomes Number (%) patients with complete healing at 12 weeks: Group 1: 40/57 (70%); Group
2: 30/52 (58%). Trial authors reported the following measure of effect for this outcome:
odds ratio 4.23 (95% CI 1.29-13.86), P = 0.02. Correspondence with trial authors
confirmed that this estimate was adjusted for the following baseline variables: sex, ulcer
area, ulcer duration, ankle circumference, whether patient taking medication, previous
ulceration and limb ABPI
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*Number (%) patients with complete healing when randomised treatment discontinued:
Group 1: 47/57 (82%); Group 2: 24/52 (46%). Difference 36% (95% CI 18%-55%),
P < 0.001
*Number (%) patients with complete healing at the end of the study period, including
withdrawals from randomised treatment, some of whom switched treatment groups:
Group 1: 50/57 (88%); Group 2: 40/52 (77%) (P value not reported)
Cox regression: HR for time to healing over 24 weeks 1.18 (95% CI 0.69-2.02), P = 0.
55 (correspondence with trial authors confirmed that this estimate was adjusted for the
following baseline variables: sex, ulcer area, ulcer duration, ankle circumference, whether
patient taking medication, previous ulceration and limb ABPI)
Number of adverse events: Group 1: 7 patients, 8 adverse events; Group 2: 19 patients,
21 adverse events. Number of adverse events described as severe: Group 1: 2; Group 2:
2
Frequency and description of device-related adverse events: Group 1: 6 patients with 7
events (irritation 2, pain/discomfort 1, slippage 1, tissue breakdown 1, excessive pressure
2); Group 2: 17 patients with 27 events (irritation 4, pain/discomfort 7, slippage 9, tissue
breakdown 3, excessive pressure 4)
Number (%) of withdrawals: Group 1: 7/57 (12%); Group 2: 28/52 (54%)
Mean days to withdrawal: Group 1: 32; Group 2: 21.
Number (%) withdrawals with complete healing: Group 1: 3/7 (43%); Group 2: 16/
28 (57%) (P value not reported but stated between-group difference not statistically
significant)
Mean number of dressing changes/week: Group 1: 1.1; Group 2: 1.5 (P = 0.0002)
Mean weekly cost of treatment/patient (based on clinic costs including dressings and
other materials, home care costs including nurse time, dressings and other materials,
taking into account frequency of dressing changes/week, price year 2000 using average
NHS costs): Group 1: GBP 79.91; Group 2: GBP 83.56
Mean cost/patient over 24 weeks (based on estimated mean cost per week and assuming
82.5% rate of wound closure at 24 weeks for both groups, and mean time to healing of
8.2 weeks for both groups): Group 1: GBP 876; Group 2: GBP 916
Assessment of health-related quality of life (information taken from conference abstract)
: patients completed SF-36 at baseline, 24 weeks and at healing/withdrawal. Analysis
adjusted for baseline scores; number of patients included in analysis not stated. No
significant differences between the 2 bandage systems
Notes Patients with bilateral ulceration were randomised to 1 treatment only; limb with largest
total area of ulceration was studied. Healing defined as full epithelialisation
Possible imbalance of baseline ulcer duration (range larger in Group 2, median similar
for both groups)
*Details of analyses of complete healing were confirmed through correspondence with
the author
The authors surmised that the lower costs in Group 1 were explained by less frequent
dressing changes when compared with Group 2
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk “Randomisation took place . . . by means
of sequential numbers on a randomisation
list that was stratified for ulcer size . . . ”
Allocation concealment (selection bias) High risk Information from the author suggested that
allocation concealment was not used
Incomplete outcome data (attrition bias)
All outcomes
Low risk 112 people were recruited; analysis by in-
tention to treat (“ . . .meant that patients re-
mained in their original randomised groups
irrespective of subsequent treatments ap-
plied . . .”), however only 109 people anal-
ysed
Blinded outcome assessment (healing) Unclear risk No detail provided.
Baseline comparability Unclear risk Median ulcer duration similar across
groups, although maximum value greater
in group receiving 2-component compres-
sion. Impossible to judge for ulcer area, as
neither mean nor median supplied
Moffatt 2008
Methods Multi-centred, cross-over RCT. 10 centres overall: 5 in USA, 3 in UK, 2 in Canada.
Participants followed for 8 weeks, with crossover at 4 weeks. Sample size estimation based
on trial’s primary outcome (bandage slippage)
Participants Recruited 81 participants with venous leg ulcers from free-standing wound clinics or
wound clinics associated with community hospitals or trusts
Inclusion criteria: patients aged ≥ 18 years (21 years in USA) with 1 or more venous
leg ulcers treated with compression for at least 2 weeks prior to study enrolment; able to
understand and answer questionnaire items
Exclusion criteria: patients unsuitable for compression therapy or study enrolment; ABPI
< 0.8 within 4 weeks of start of trial; circumferential leg ulcer; ulcer with signs of clinical
infection
Number of male:female patients: Group 1: 25:14; Group 2: 22:20
Mean ± SD patient age in years: Group 1: 62.5 ± 15.5; Group 2: 63.5 ± 12.5
Mean ± SD ulcer area in cm2: Group 1: 11.8 ± 19.7; Group 2: 5.7 ± 7.9.
Mean ± SD ulcer duration in weeks: Group 1: 186.3 ± 438.7; Group 2: 195.1 ± 512.1
Number of patients walking with vs without assistance: Group 1: 7 vs 32; Group 2: 6 vs
36
Mean ± SD health-related quality of life scores (overall): Group 1: 6.0 ± 2.0; Group 2:
7.1 ± 2.1
Interventions Group 1: 2-component compression bandage system consisting of 2 latex-free roll ban-
dages (3MT M CobanT M 2 Layer Compression System; 3MT M Health Care, St Paul,
MN, USA). Inner component of polyurethane foam laminated to a cohesive bandage;
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outer layer is a cohesive bandage (n = 39 patients)
Group 2: 4LB (ProforeTM Multi-Layer Bandaging System; Smith & Nephew Medical
Wound Management, Hull, UK) (n = 42 patients)
All patients: apart from the compression therapy, patients received standard care as
provided by each centre. All ulcers were covered with a foam dressing (TegadermT M
Foam Dressing; 3MTM Health Care). Other wound treatments such as antimicrobial
dressings were applied underneath the foam dressing. Bandages changed weekly, or more
frequently, as required. Medications and additional wound treatments permitted at the
discretion of the study investigator.Tubular support systems underneath the compression
systems were not permitted. Also, changes in treatment with mood-altering substances
were not allowed within 2 weeks prior to enrolment, or at any time during the trial
Outcomes Number (%) patients with complete healing at 4 weeks: Group 1: 6/39 (15%); Group
2: 3/42 (7%)
Median (range) % change in wound surface area at 4 weeks: Group 1: -27.8 (-100-233.
3); Group 2: -42.2 (-100-272.1), P = 0.88, Wilcoxon rank sum test
Median (range) linear healing rate in cm/week : Group 1: 0.04 (-0.16-0.40); Group 2:
0.04 (-0.27-0.19), P = 0.94, Wilcoxon rank sum test
Health-related quality of life assessed using the Cardiff Wound Impact Schedule for 3
domains (well-being; physical symptoms and daily living; social life) as well as overall
health-related quality of life and the patient’s satisfaction with their overall health-related
quality of life. Significant difference in favour of the 2-component system during the
pre-crossover period for physical symptoms and daily living scores (P < 0.05, 2-sample
pooled t-test, per protocol analysis). There were no other significant differences in either
the pre- or post-crossover period
Adverse events: overall, 41 patients reported at least 1 adverse event. Of 135 adverse
events, 67 occurred during use of the 4LB and 68 during use of the 2-component system.
92 adverse events deemed to be unrelated to compression and 43 as possibly, or probably,
related to compression. 2 patients hospitalised during the trial for reasons unrelated to
compression (intestinal bleeding and renal failure); these 2 patients had multiple adverse
events accounting for 45/135 reported adverse events
Patient withdrawals during 1st 4-week period: Group 1: 2 (both due to adverse events);
Group 2: 1 (patient request)
Patient withdrawals during 2nd 4-week period: Group 1 (received 2-component com-
pression first, then 4LB): 3 (lack of concordance 1, investigator decision 1, adverse event
1); Group 2 (received 4LB first then two-component compression): no withdrawals
Notes Patients with bilateral leg ulcers received the same compression system on both legs. For
patients with more than 1 ulcer, investigators used clinical judgement to choose which
ulcer or leg to follow in the study prior to randomisation. Exact criteria for choice of
ulcer or leg not explained
Primary outcome of trial was bandage slippage measured at each bandage change (signif-
icant difference in favour of 2-component system, mean slippage 2.48 vs 4.17 cm, P < 0.
001). Secondary outcomes were wound healing (assessed with tracings and computerised
planimetry), health-related quality of life, bandage wear time (no significant difference
between groups), patient mobility (available data were limited but suggested no signif-
icant difference between groups), and patient preference (72% preferred 2-component
system, 22% preferred 4LB, 6% had no preference)
Compression bandages applied by a trained study co-ordinator under supervision of the
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study investigator for each centre. Investigators selected on the basis of prior knowledge
and experience of using the 4LB. 4LB applied according to manufacturer’s instructions
and additional training deemed unnecessary. All staff and investigators were provided
with training in applying the 2-component system by manufacturer’s regional technical
expert; staff had to demonstrate proficiency in bandaging technique prior to start of
enrolment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomisation was stratified by study
site so that the treatment order assign-
ment was kept balanced within each site.
The randomisation schedule was computer
generated by the study biostatistician and
provided to the investigators in sealed en-
velopes andopened only after subject enrol-
ment and selection of the study leg/wound”
Allocation concealment (selection bias) Unclear risk “The randomisation schedule was com-
puter generated by the study biostatistician
and provided to the investigators in sealed
envelopes and opened only after subject
enrolment and selection of the study leg/
wound”
Comment: it was not stated whether the
sealed envelopes were consecutively num-
bered and opaque
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Unless otherwise stated, data from all en-
rolled subjects were analysed on an intent-
to-treat (ITT) basis”
“Wound healing . . . Of the 79 wounds
entered into the analysis . . . ”
Comment: 79/81 (98%) patients were in-
cluded in the analysis of healing. From
the flow diagram provided, we assumed
that the 2 excluded patients were those
noted as errors in randomisation (1/treat-
ment group)
Blinded outcome assessment (healing) Low risk “Subject or investigator blinding was not
possible because of the obvious differences
between the two-layer and four-layer sys-
tems; however, the individual conduct-
ing the wound-tracing measurements was
blinded to treatment”
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Baseline comparability Unclear risk Regarding “baseline patient and wound
characteristics . . . there were no signifi-
cant differences in any of the measured pa-
rameters, indicating that the two treatment
groups were similar in make up”
Comment: baseline ulcer area appeared
smaller inGroup 2, however, it was difficult
to judge with confidence, as means, rather
than medians, were presented
Moody 1999
Methods RCT (method of allocation not stated beyond ’randomised’). Study conducted in the
UK, other details of setting not reported
Participants 52 patients recruited
Inclusion criteria: patient age ≥18 years; mobile; venous leg ulcer > 2 cm at widest
perpendicular diameter; ABPI ≥ 0.8.
Number of male:female patients: Group 1: 7:19 Group 2: 7:19.
Average (range) patient age in years: Group 1: 73 (51-85); Group 2: 70 (45-88).
Mean baseline ulcer duration in months: Group 1: 55; Group 2: 46 (no variance data
presented)
Interventions Where possible, patients had study limb immersed in warm water with added emollient,
then dried. Ulcer was irrigated with a saline spray and a primary dressing applied (Solva-
line N for wounds with little exudate and Silicone NA Ultra for moderate to high levels
of exudate). Dressings and bandages changed according to need, taking in to account
exudate, bandage slippage and patient preference. Dressings/bandages re-applied either
at clinic or at patient’s home
Group 1: under cast padding (Cellona) plus SSB (Rosidal K) (n = 26)
Group 2: under cast padding (SurePress padding) plus long-stretch compression bandage
(SurePress bandage) (n = 26)
Both bandages applied using a simple spiral technique.
Outcomes Outcomes assessed at 12 weeks. Patients seen weekly by a research nurse. Wounds pho-
tographed at regular intervals
Number (%) patients with complete healing at 12 weeks: Group 1: 8/26 (31%); Group
2: 8/26 (31%)
Average (presumably mean, but not stated) weeks to healing: Group 1: 9.91; Group 2:
9.3 (no variance data presented)
Average (presumably mean, but not stated) percentage reduction in ulcer area at 12 weeks
(measured by a single assessor using computerised analysis of weight of cut-out acetate
tracing of wound perimeter): Group 1: 73%; Group 2: 52% (no variance data presented)
Number (%) patients with increase in ulcer size during study: Group 1: 4/26 (15%);
Group 2: 6/26 (23%)
Number (%) patients with clinical infection developing during study period: Group 1:
3/26 (12%); Group 2: 4/26 (15%)
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Notes 1 ulcer/patient included in the study.
Changes in sub-bandage pressure assessed over a 7-day period by means of an Oxford
pressure monitor. These measurements appear to have been performed on healthy vol-
unteers
Training in application of both types of bandages offered to study care providers. Ban-
dages applied according to manufacturers’ instructions. Authors reported that, by the
end of the study, around 7 patients/group (or their relatives) could apply the bandages
correctly
1 patient had an acute eczema episode during the study and 1 had a chest infection
(group allocation not stated)
3 patients in Group 1 experienced initial bandage slippage due to reduction of limb
oedema, necessitating re-application of the bandage within 6 h. 1 patient withdrew
because of difficulties in performing bandage re-application with adequate frequency
No information provided on baseline ulcer area. On average, patients in Group 1 had
ulcers of longer duration at baseline
Few details were provided on data analysis methods.
Changes in limb oedema were reported in the paper.
Unable to gain further information from trial author.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided beyond describing the
trial as “randomised”
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Report stated the number of people healed
in each group, but denominator at end of
follow-up unclear
Blinded outcome assessment (healing) Unclear risk No details provided.
Baseline comparability Unclear risk Little information. Mean ulcer duration
appeared to be longer in Group 1, but no
variance data presented or data on other
variables
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Methods RCT (multicentred, pragmatic, i.e. reflecting everyday clinical practice as far as possi-
ble). Patients allocated to treatment groups according to a random assignment schedule
prepared in advance of recruitment. Randomisation was separate for each study site.
Outcome assessment was non-blind. Sample size: estimated that 206 patients were re-
quired to provide 80% power to detect an increase in healing from 50%-70%, at 5%
significance level
Participants 233 patients recruited from 8 community-based research clinics in 4 health trusts in
Trent, UK.
Inclusion criteria: venous leg ulcer of at least 3 months’ duration at study entry; ability
to travel to clinic.
Exclusion criteria: ABPI < 0.8.
Number of male:female patients: Group 1: 43:77; Group 2: 35:78
Mean ± SD patient age in years: Group 1: 73.8 ± 10.9; Group 2: 73.2 ± 11.6.
Mean ± SD baseline ulcer surface area in cm2: Group 1: 16.2 ± 28.9; Group 2: 16.9 ±
40.8.
Mean ± SD baseline ulcer duration in months: Group 1: 27.5 ± 53.8; Group 2: 29.7 ±
82.3.
Mean ± SD body mass index (kg/m2): Group 1: 27.0 ± 6.7; Group 2: 27.1 ± 6.0.
Number (%) patients requiring aid with walking: Group 1: 66/120 (55%); Group 2:
57/113 (50%).
Number (%) patients with history of DVT: Group 1: 28/120 (23%); Group 2: 25/113
(22%).
Number (%) patients with diabetes mellitus: Group 1: 8/120 (7%); Group 2: 10/113
(9%).
Patients were assessed for health status at baseline using SF-36, EuroQol, the McGill
short formpain questionnaire and the Frenchay activities index. Groupswere comparable
at baseline for all domains
Interventions Group 1: weekly treatment with 4LB in a leg ulcer clinic. The Charing Cross technique
was used, comprising non-adherent primary dressing, absorbent orthopaedic wadding,
crepe bandage, elastic compression bandage, cohesive compression bandage. Clinic co-
ordinators all completed course on leg ulcer management (ENB N18), and additional
training in application of 4LBs. Each clinic employed support nurses trained in the
application of 4LB. After healing, patients received class II compression stockings and
were reviewed at the clinic every 3 months. Transport was provided free of charge to
patients (n = 120)
Group 2: usual care at home by district nursing service. Frequency of visits varied and
could be several/week. A variety of wound cleansers, primary dressings, topical agents,
securing agents and bandages were used. The bandages included compression, Tubigrip
and light support bandages, all of which could be used alone or with other devices. Access
to 4LBs was minimal (n = 113)
Outcomes Number (%) patients with complete healing at 12 months: Group 1: 78/120 (65%);
Group 2: 62/113 (55%)
Kaplan-Meier estimates of cumulative % healed at 12 weeks: Group 1: 34%; Group 2:
24% (difference 10%, 95% CI -2%-22%)
Kaplan-Meier estimate of median weeks to healing within 12 month follow-up period:
Group 1: 20; Group 2: 43 (P = 0.03, log rank test)
Cox regression: following adjustment for prognostic factors (patient age, baseline ulcer
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area, baseline ulcer duration, history of DVT) estimated hazard ratio was 1.65 (95% CI
1.15-2.35, P value not reported) (in favour of Group 1)
Number (%) patients with recurrence following initial healing during trial: Group 1:
27/78 (35%); Group 2: 14/62 (23%)
The between-group difference in time to recurrence was not statistically significant (P =
0.38, log rank test)
Mean ulcer-free weeks during 12 month follow-up: Group 1: 20.1; Group 2: 14.2
(difference 5.9, 95% CI 1.2-10.5)
No significant differences found between the groups in change in health status
Mean ± SD total NHS costs/patient/year (baseline analysis, GBP, price year 1995):
Group 1: GBP 877.60 ± 674.30; Group 2: GBP 863.09 ± 865.32 (P = 0.90). Baseline
analysis based on cost of treatment (staff time, materials, transport, overheads) and cost
of other health services (GP and hospital). Sensitivity analyses assessed effects of changing
treatment costs and overheads in Group 2, and changes in clinic attendance costs in
Group 1. Authors reported that changes in assumptions did not significantly alter the
magnitude of estimated costs (central estimates shown, no data on variance or statistical
tests of between-group differences)
Notes Withdrawals: Group 1: 17 (died 9, moved away 2, hospital admission 3, dropped out
with no further information available 3); Group 2: 23 (died 7, referred elsewhere 3,
moved away 6, hospital admission 3, nursing home admission 3, dropped out with no
further information available 1)
Complete healing defined as re-epithelialisation of all patient’s areas of ulceration.Wound
surface area measured every 4 weeks using tracing from photographs combined with
computerised planimetry. Fine indelible pens were used to obtain tracings. Assessors
were trained in an attempt to standardise measurement techniques and minimise inter-
rater error
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A random assignment schedule and seri-
ally numbered, sealed, opaque allocation
envelopes were prepared in advance for
each of the 8 clinic sites”
Allocation concealment (selection bias) Low risk “Serially numbered, sealed opaque alloca-
tion envelopes were prepared in advance for
each of the 8 study sites”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “All the data analysis was by intention to
treat”. Survival analysis
Blinded outcome assessment (healing) High risk “The nurse recorded the date of healing,
defined as the data of epithelialisation of all
ulcers . . .”
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Baseline comparability Unclear risk Only means presented; these appear simi-
lar, but data likely to be highly skewed
Nelson 2007a
Methods RCT with 2 x 2 x 2 factorial design evaluating: drugs - pentoxifylline vs placebo; dress-
ings - knitted viscose vs hydrocolloid; and compression bandages - 4LB vs single-layer.
Randomisation stratified by study centre and ulcer type (simple venous vs non-simple)
using permuted blocks of 8. Outcome assessment was non-blind. Sample size: assuming
40% healing rate at 24 weeks using 4LB or knitted viscose dressing, it was estimated
that 200 patients would provide 80% power to detect 20% difference in healing rates at
24 weeks at 5% significance level (2-tailed)
Participants Recruited 245 patients with venous leg ulcers treated in community or as outpatients
from 2 centres in Falkirk and Edinburgh (UK). All study centres had widespread use of
high compression prior to the trial.
Inclusion criteria: patient age > 18 years; clinical signs of venous disease; venous disease
confirmed with hand-held Doppler; venous leg ulcer ≥ 1 cm length and ≥ 8 weeks’
duration.
Exclusion criteria: severe concurrent disease; life expectancy < 6 months; immunosup-
pressed; immobile; ABPI < 0.8; diabetes mellitus; taking warfarin, steroids, pentoxi-
fylline, oxerutins or naftidrofuryl; infected or gangrenous ulcers; pregnancy, lactating or
premenopausal not using contraception; sensitivity to methylxanthines or caffeine.
Number of male:female patients: Group 1: 39:89; Group 2: 41:76.
Mean ± SD, median (range) patient age in years: Group 1: 71.5 ± 10.3, 73 (46-93);
Group 2: 68.3 ± 12.2, 68 (34-91).
Mean ± SD, median (range) baseline ulcer area in mm2: Group 1: 1025 ± 2637, 385
(54-26,311); Group 2: 661 ± 879, 393 (50-5560).
Mean ± SD, median (range) baseline ulcer duration in months: Group 1: 11.1 ± 17.3,
5.0 (2-96); Group 2: 15.1 ± 35.2, 5.0 (2-240).
Number (%) patients walking without aid: Group 1: 49/128 (38%); Group 2: 36/117
(31%).
Number (%) patients with simple vs non-simple venous disease (non-simple defined
as seropositive rheumatoid arthritis or venous pathology not confirmed with hand-held
Doppler): Group 1: 103 (80%) vs 25 (20%); Group 2: 97 (83%) vs 20 (17%).
Number (%) patients randomised to pentoxifylline vs placebo: Group 1: 64/128 (50%)
vs 64/128 (50%); Group 2: 57/117 (49%) vs 60/117 (51%).
Number (%) patients randomised to knitted viscose dressing vs hydrocolloid dressing:
Group 1: 62/128 (48%) vs 66/128 (52%); Group 2: 65/117 (56%) vs 52/117 (44%)
Interventions All patients: ulcers cleansedwith tapwater and surrounding skinmoisturised with arachis
or olive oil. Dressings and bandages renewed at least weekly
Group1: single-layer bandage (hydrocolloid-lined,woven, elastomeric, adhesive bandage
applied in a figure-of-8 technique from toe to knee) (n = 128).
Group 2: 4LB, Charing Cross technique comprising wool, crepe, Elset, Coban (n = 117)
.
Also randomised comparison of dressings (knitted viscose dressing or hydrocolloid) and
drug treatment (pentoxifylline or placebo)
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Outcomes Analyses based on 245 patients with simple and non-simple venous ulceration:
Number (%) patients with complete healing at 24 weeks: Group 1:63/128 (49%); Group
2: 78/117 (67%), P = 0.009
Median days to healing (Kaplan-Meier estimate): Group 1: 168; Group 2: 78 (P value
not reported)
Cox proportional hazards models: an initial model including terms for drug, dressing
and bandage and all possible interactions (but no terms for baseline characteristics) did
not detect any statistically significant interaction between the different treatments (P
> 0.14); a subsequent model adjusted for drug, dressing, bandage, study centre, ulcer
aetiology (simple or non-simple), baseline ulcer area, baseline ulcer duration, and history
of ulceration (years since first ulcer), HR 2.0 (95% CI 1.4-2.9), P < 0.0005, in favour
of Group 2. The following were significant independent predictors drug (P = 0.046),
baseline area (P < 0.0005), ulcer duration (P = 0.017) and ulcer history (P = 0.01)
Withdrawals (bandages and dressings considered together): overall, 68/245 (28%) with-
drew from original bandage or dressing or both. Number (%) patients changed bandage
due to adverse event: Group 1: 36/128 (28%); Group 2: 17/117 (15%). Estimates from
logistic regression indicated a statistically significant interaction between dressing and
bandage in terms of predicting withdrawal (P < 0.001)
Analyses based on 200 patients with simple venous ulceration:
Number (%) patients with complete healing at 24 weeks: Group 1: 50/103 (49%);
Group 2: 67/97 (69%)
Quality of life assessment: assessed with Nottingham Health Profile at baseline and 24
weeks (scores 0-100 with lower scores indicating better quality of life). Domains: energy;
pain; emotional reactions; sleep; social isolation; and physical mobility. Mean between-
group differences in final scores adjusted for baseline scores; analysis was by intention-
to-treat. Patients in Group 2 (n = 95 available) had significantly greater improvement
(adjusted mean difference, 95% CI) in the following when compared with Group 1 (n
= 98 available): energy 7.9 (0.2-15.6), P = 0.04; and physical mobility 4.5 (0.0-9.0), P =
0.046. Mean differences for the other domains were not statistically significant between
the 2 bandage groups
Withdrawals: overall 65/200 (32.5%). Number (%) patients who withdrew first from
bandage system with or without simultaneous withdrawal from the randomised drug
and dressing treatment: Group 1: 21/103 (20%); Group 2: 5/97 (5%)
Notes Treatment for all patients delivered by experienced leg ulcer nurses.
Healing defined as complete epithelial cover in the absence of scab for all ulcers on study
limb.
Ulcer area measured by transparency tracing and blind scanning
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details given.
Allocation concealment (selection bias) Low risk “Sealed, sequentially numbered opaque en-
velopes were used to allocate participants
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to placebo or pentoxifylline, knitted viscose
or hydrocolloid dressings, and four-layer or
adhesive single-layer bandages”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Primary analysis was by intention to
treat”. Survival analysis
Blinded outcome assessment (healing) High risk “Nurses completed a dressing log at each leg
ulcer dressing visit which recorded whether
or not an ulcer was healed”
Baseline comparability Low risk Medians provided for ulcer area and dura-
tion that appear fairly well balanced, plus
analysis was adjusted (Cox regression)
O’Brien 2003
Methods RCT (pragmatic, i.e. reflecting everyday clinical practice as far as possible). Randomi-
sation achieved by computer-generated list. Estimated a priori that the study had 80%
power of detecting a 20% between-group difference in healing rates at 12 weeks, at 5%
significance level. Trialists also considered the sample size appropriate to detect differ-
ences in quality of life (but statistics for this not provided)
Participants 200 patients recruited from community, Ireland.
Inclusion criteria: venous leg ulceration identified clinically; ABPI > 0.9; not treated with
4LB
Exclusion criteria: none stated.
Number of male:female patients: Group 1: 35:65; Group 2: 33:67.
Mean ± SD patient age in years: Group 1: 71.7 ± 9.8; Group 2: 71.4 ± 11.5.
Median (interquartile range) baseline ulcer area (cm2): Group 1: 3.5 (1.3-8.1); Group
2: 2.7 (1.6-6.2).
Median (interquartile range) ulcer duration at baseline (weeks): Group 1: 9 (4-27);
Group 11 (5-28).
Number of patients with history of DVT in affected leg: Group 1: 15/100 (15%); Group
2: 9/100 (9%).
Number of patients with diabetes: Group 1: 3/100 (3%); Group 2: 5/100 (5%).
Number of patients with rheumatoid arthritis: Group 1: 1/100 (1%); Group 2: 2/100
(2%).
Baseline quality of life scores for CIVIQ and SF-36 reported in secondary paper; groups
appeared to be comparable on most domains (Clarke-Moloney 2005).
In patients with bilateral leg ulcers, the leg with the larger surface area of ulceration was
included in the analysis
Interventions All treatments provided in a community setting.
Group 1: 4LB application standardised and comprised: sterile wound contact layer,
padding bandage, light conformable bandage, light compression bandage, and flexible
cohesive bandage. Combined system provided compression of 40 mmHg at the ankle
(measurement method not explained). 12 patients non-compliant due to intolerance
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of bandage. 11 patients had high absorbency dressings and 8 patients had desloughing
agents (n = 100)
Group 2: usual care - treatment not standardised, but determined by public health nurse
or GP. Treatment included assortment of topical applications such as hydrocolloids, algi-
nates, paraffin and iodine dressings; dressings of various absorbencies; and low-pressure
bandages and elasticated support. 1 patient had laser therapy; 5 patients had compression
at some stage during the trial (n = 100)
Outcomes All patients were followed-up for 12 weeks.
Patients in Group1 were 1.8 (95% CI 1.2-2.9) times more likely to heal by 12 weeks
than those in Group 2
Proportions healed at 12 weeks (from Kaplan-Meier analysis): Group 1: 54%; Group 2:
34% (P < 0.001)
Time to healing significantly better in Group 1 (P = 0.006, log rank test)
Healing rates remained significantly different after controlling for age, baseline ulcer
area, baseline ulcer duration, DVT, diabetes and rheumatoid arthritis in Cox regression
(P = 0.015)
The mean difference (95% CI) in reduction in ulcer size between the 2 groups was not
significantly different: -1.1 (-2.9-0.7)
Costs/leg healed based on dressing use, nursing time (for dressings, administration and
travel) and nurses’ mileage expenses. Median (interquartile range) overall cost/leg healed
in EUR (presume price year same as trial accrual period, i.e. 1999-2000): Group 1: EUR
209.7 (137.5-269.4); Group 2: EUR 234.6 (168.2-345.1), P = 0.04
Health-related quality of life assessed during treatment (at 6 weeks) in unhealed patients:
Group 1: 79/85 (93%); Group 2: 91/95 (96%). Overall, Group 1 achieved better quality
of life benefits compared with Group 2, particularly in areas of physical activity and
social functioning
Disease specific instrument (CIVIQ - 20 items covering 4domains: psychosocial, physical
functioning, social functioning, and pain; lower scores reflect better quality of life):
between-group difference at 6 weeks significant for physical functioning (P = 0.006),
social functioning (P = 0.001) and global score (P = 0.006), all differences in favour of
Group 1. Full statistics on scores in paper (Clarke-Moloney 2005)
Generic instrument (SF-36: 36 items covering 8 domains: physical functioning, role
limitation due to physical health, bodily pain, general health, vitality, social functioning,
role limitation due to emotional problems, and mental health; higher scores reflect
better quality of life). Between-group difference at 6 weeks was significant for physical
functioning (P = 0.001), role limitation - physical (P = 0.006) and mental health (P =
0.03), all differences in favour of Group 1. Full statistics on scores in paper (Clarke-
Moloney 2005)
Notes Stated that ulcerated area measured and photographed by a research officer, but wound
measurement instrument not described
All leg ulcer dressings done by usual community nurse. Before study started, all public
health nurses in the region given formal training (workshops and individual instruction)
in application of 4LB
Patient follow-up during trial: Group 1: 1 died, 2 lost to follow-up; 98 full or partial
data gathered; Group 2: 0 died, 0 lost to follow-up, 100 full or partial data gathered
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A random intervention and control list
was generated for 200patients by computer
. . .”
Allocation concealment (selection bias) Low risk “Before the study began, a random ’inter-
vention’ or ’control’ list was generated for
200 patients by computer, and the results
were entered sequentially into sealed num-
bered envelopes. These envelopes were as-
signed to consecutive patients once consent
had been obtained”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Intention to treat analysis was carried
out”.
Blinded outcome assessment (healing) Unclear risk “When complete healing occurred in the
12 week interval, a photograph of the site
was taken to provide an objective review of
outcome . . . ”. It is not clear if assessment
of photographs was masked
Baseline comparability High risk Median ulcer area larger in Group 1.
Partsch 2001
Methods RCT (multicentred) with stratification by study centre and total ulcerated area of study
limb (≤ or > 10 cm2). Sample size: estimated 112 patients would provide 77% power to
detect a 25% difference in proportion of patients healed at 16 weeks at 5% significance
level (2-sided test)
Participants 116 patients recruited from 7 outpatient clinics (2 in Austria, 5 in Netherlands). Trial
report based on 112 patients.
Inclusion criteria: patient age > 18 years; new episode of venous leg ulceration; ulcer
aetiology confirmed by Doppler or clinical history. Patients with infected ulcers eligible
if trial interventions considered appropriate.
Exclusion criteria: ABPI < 0.8; ulcer of diabetic, rheumatoid or malignant aetiology.
Number of male:female patients: Group 1: 20:33; Group 2: 22:37.
Median (range) patient age in years: Group 1: 68 (34-85); Group 2: 71 (32-87).
Number (%) patients bed or chair bound vs walking with aid vs walking freely: Group
1: 1 (2%) vs 3 (6%) vs 49 (92%); Group 2: 2 (3%) vs 4 (7%) vs 53 (90%).
Number (%) patients with history of hypertension; diabetes; DVT: Group 1: 13 (25%)
; 1 (2%); 14 (26%); Group 2: 12 (20%); 4 (7%); 12 (20%).
Mean baseline ankle circumference in cm: Group 1: 23.4; Group 2: 23.3.
Median (range) baseline ulcer duration in weeks: Group 1: 5 (1-1040); Group 2: 4 (1-
780).
Median (range) baseline ulcer area cm2: Group 1: 1.5 (0.4-72.7); Group 2: 1.9 (0.4-70.
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1).
Interventions All patients: ulcers cleansed with water or saline and covered with simple non-adherent
dressing. Ulcers in the hollow behind the malleolus also covered with a foam pad to
increase local pressure. Bandaging weekly unless more frequent dressing changes required
(median interval between visits = 7 days for both groups). Patients encouraged to walk
as much as possible
Group 1: 4LB (Profore) (n = 53).
Group 2: SSB comprising orthopaedic padding plus 2 SSBs (Rosidal K) applied using
the Putter technique (n = 59)
Outcomes Number (%) patients healed at 16 weeks: Group 1: 33/53 (62%); Group 2: 43/59 (73%)
. Difference in proportion healed 11% (95% CI -28-7%)
Kaplan-Meier estimates: cumulative proportions healed at 16 weeks Group 1: 78%
Group 2: 85%; median (95% CI) days to healing Group 1: 57 (47-85) Group 2: 63 (43-
70)
Cox regression: an initial model containing terms for treatment and study centre showed
a centre effect, with 4/7 centres having a higher healing rate than the other 3 (P = 0.003).
No evidence of a centre effect when models were re-fitted including terms for initial area
and duration of ulcer (P = 0.79). Final model included terms for treatment, study centre,
baseline ulcer area, baseline ulcer duration and the SF-36 dimension ’mental health. HR
1.19 (95% CI 0.73-1.91), P = 0.49 (represents non-significant trend towards higher
healing rate for Group 2)
Withdrawals for patients not included in analysis, breakdown/group not reported: 3
patients had no post-treatment follow-up data; 1 patient had basal cell carcinoma
Number of withdrawals during trial for patients included in analysis: Group 1: 12 (pa-
tient’s request 7, lost to follow-up 3, adverse event 1, other 1); Group 2: 7 (patient’s
request 2, lost to follow-up 2, lack of response 1, adverse event 1, other 1). Further details
of adverse events not reported
Notes Patients with bilateral ulceration randomised to 1 treatment only, limb studied had
the larger total area of ulceration. Ulcers measured using tracing and computerised
planimetry
Stated that whilst staff at all participating centres were trained in the application of 4LB
prior to the study, they all had many years of experience of applying the SSB
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Information from published trial report
was unclear:
“Randomisation was carried out separately
for each centre and further stratified ac-
cording to whether the total reference limb
ulcerated area was less than or equal to 10
cm2, or greater than 10 cm2.” No further
detail given, however, standard data checks
undertaken for the IPD meta-analysis sug-
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gested that the random sequence genera-
tion was satisfactory
Allocation concealment (selection bias) Low risk From published trial report: “Randomisa-
tion was carried out separately for each
centre and further stratified according to
whether the total reference limb ulcerated
area was less than or equal to 10 cm2,
or greater than 10 cm2”. Trial authors in-
formed us that sealed envelopes were used.
Standard data checks undertaken for the
IPD meta-analysis suggested that alloca-
tion concealment was satisfactory
Incomplete outcome data (attrition bias)
All outcomes
Low risk 116 people recruited and 112 people anal-
ysed. Of the 4 people excluded from the
analysis, 3 did not provide any follow-up
data and one was recruited in error. The
4 excluded patients were not reinstated for
the IPD meta-analysis
Blinded outcome assessment (healing) High risk Author correspondence.
Baseline comparability Low risk Median ulcer area and duration fairly well
balanced. Analysis by Cox model
Polignano 2004a
Methods RCT (multicentred), computerised randomisation list generated remotely, block ran-
domisation used. Intended sample of 100 patients not recruited because of changing
practice in the study clinics, so study was underpowered to detect between-group differ-
ences in healing outcomes
Participants 68 patients (1 wound each), inpatients and outpatients, all ambulant, recruited from 4
study centres in Italy.
Inclusion criteria: patient age ≥ 18 years; venous ulceration confirmed by Doppler.
Exclusion criteria: pregnancy; ABPI < 0.8; rheumatoid vasculitis; diabetic foot ulceration;
malignant ulceration; clinically infected ulcer; excessive exudate; ulcer area > 10 cm2.
Number of male:female patients: Group 1: 16:23; Group 2: 10:19.
Mean ± SD, median (range) patient age in years: Group 1: 68.4 ± 13.9, 72.0 (23.0-89.
0); Group 2: 68.6 ± 9.6, 69.0 (43.0-87.0).
Mean ± SD, median (range) baseline ulcer area (length x width) in cm2: Group 1: 10.1
± 11.4, 5.5 (0.8-52.5); Group 2: 9.3 ± 12.8, 3.6 (0.3-47.5).
Number (%) patients with baseline ulcer duration < 7 days vs 7 days-1 month vs 1-6
month vs 6-12 months:
Group 1: 3 (8%) vs 16 (41%) vs 5 (13%) vs 15 (38%); Group 2: 2 (7%) vs 16 (55%)
vs 5 (17%) vs 6 (21%)
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Interventions Bandages changed at least weekly in both groups.
Group 1: 4LB (Profore) (n = 39);
Group 2: Unna’s Boot, comprising zinc oxide paste bandage (Viscopaste) plus elastic
cohesive bandage (Tensoplast) (n = 29)
Outcomes Patients followed-up until healing or 24 weeks. Ulcer area measured every 4 weeks
Number (%) patients with complete healing at 24 weeks: Group 1: 29/39 (74%); Group
2: 19/29 (66%), P = 0.42. Estimate of difference between proportions healed 0.09 (95%
CI -0.13-0.31)
Estimate from Cox proportional hazards model including terms for bandage type, base-
line ulcer area and baseline ulcer duration: HR 1.62 (95% CI 0.87-3.02), P = 0.13.
Baseline ulcer area had a significant effect on healing with larger ulcers taking longer to
heal (P = 0.01), but ulcer duration did not have a significant effect (P = 0.12)
Kaplan-Meier estimate of median days to healing: Group 1: 53 (95% CI 35-84). Group
2: 56 (95% CI 49-84)
Mean ± SD, median (range) percentage reduction in ulcer area (estimated by ([Initial
ulcer area - final area]/initial area) x 100) at 24 weeks: Group 1: 79.1 ± 65.7, 100.0 (-
283.3-100.0); Group 2: 24.6 ± 165.5, 100.0 (-489.3-100.0), P = 0.30
Mean±SD,median (range) percentage reduction inulcer area/day (estimated by dividing
percentage reduction by number of days in trial): Group 1: 2.3 ± 3.7, 1.9 (-13.5-14.3);
Group 2: 0.0 ± 6.3, 1.3 (-22.2-7.7), P value not reported
The between-group difference for change in pain score from baseline to final assessment
(assessed with visual analogue scale) was not significant (P = 0.32)
Number (%) of patients experiencing no change in pain vs decrease in pain vs increase
in pain: Group 1 (n = 34): 12 (35%) vs 21 (62%) vs 1 (3%); Group 2 (n = 24): 3 (13%)
vs 19 (79%) vs 2 (8%)
Notes A nurse applied bandages in accordance with manufacturers’ instructions
Withdrawals: 3 patients/group discontinued treatment due to an unassociated medical
condition; 1 patient/group discontinued because of an adverse event (intolerance to
treatment and pain)
Numbers allocated to each group did not appear to be well balanced (57% in group 1).
Trial author explained that this was because difficulties with recruitment (see methods,
above)
Components of Unna’s Boot and details of randomisation and allocation concealment
confirmed by trial authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Author provided clarification: “ . . . the allo-
cationwas done by a remote computer. The
list of randomisation the computer pro-
vided was sealed in an envelope and opened
when a patient was recruited . . . ”
114Compression for venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Polignano 2004a (Continued)
Allocation concealment (selection bias) Low risk Author provided clarification: “ . . . the allo-
cationwas done by a remote computer. The
list of randomisation the computer pro-
vided was sealed in an envelope and opened
when a patient was recruited . . . ”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analysis for healing by intention to treat
though others e.g. pain, only on a subset of
participants. Difficult to judge complete-
ness of continuous outcome data
68 people recruited and healing data re-
ported on all 68.
Blinded outcome assessment (healing) Unclear risk No details provided.
Baseline comparability High risk Ulcers slightly larger inGroup 1 at baseline;
duration of ulcer data only presented cate-
gorically, however, appears that more peo-
ple with ulcers of longer duration in Group
1
Polignano 2004b
Methods RCT (multicentred) pilot study.
Participants 56 patients with venous leg ulcers recruited from 3 study centres in Italy
Inclusion criteria: venous leg ulcer with surface area > 2 cm2 but < 10 cm in any dimen-
sion; ABPI > 0.8; ankle circumference 18-30.5 cm.
Exclusion criteria: “champagne-bottle” shaped legs; severe arthritis; history of poor con-
cordance with therapy; hypersensitivity to any study material; immobility; systemic an-
tibiotic use; infected or mixed aetiology ulcers; recent history of participants in other
clinical investigations.
Number of male:female patients: Group 1: 8:21 Group 2: 13:14.
Mean ± SD (range) patient age in years: Group 1: 70.8 ± 10.5 (42-89); Group 2: 67.3
± 13.6 (38-92).
Mean ± SD (range) body weight in kg: Group 1: 75.2 ± 13.8 (55-120); Group 2: 78.3
± 15.9 (53-110).
Mean ± SD (range) height in cm: Group 1: 167 ± 9 (155-190); Group 2: 168 ± 11 (146-
188).
Mean ± SD (range) ABPI: Group 1: 1.0 ± 0.1 (0.80-1.10); Group 2: 1.0 ± 0.1 (0.9-1.
20).
Number (%) patients with major clinical condition present: Group 1: 16/29 (55%):
Group 2: 5/27 (19%).
Number (%) patients with history of allergy: Group 1: 1/29 (3%): Group 2: 2/27 (7%)
.
Number (%) patients with abnormalities present at clinical examination: Group 1: 9/
29 (31%): Group 2: 3/27 (11%).
115Compression for venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Polignano 2004b (Continued)
Mean ± SD (range) baseline ulcer surface area in cm2: Group 1: 9.7 ± 9.4 (0.4-40.0);
Group 2: 9.3 ± 8.1 (0.49-30.8).
Mean ± SD (range) baseline maximum ulcer diameter in cm: Group 1: 4.6 ± 2.9 (1.0-
11.8); Group 2: 4.4 ± 2.5 (1.2-12.5).
Number (%) patients with baseline ulcer duration ≤ 6 months vs > 6 months: Group
1: 10/29 (34%) vs 19/29 (66%); Group 2: 11/27 (41%) vs 16/27 (59%).
Number (%) patients with baseline exudate level assessed as none vs mild vs moderate
heavy:
Group 1: 7/29 (24%) vs 12/29 (41%) vs 9/29 (31%) vs 1/29 (3%);
Group 2: 8/27 (30%) vs 9/27 (33%) vs 7/27 (26%) vs 3/27 (11%)
Interventions All patients received wound cleansing as required and application of gauze
Group 1: SSB (Comprilan) (n = 29).
Group 2: SurePress Comfort (consists of 2 latex-free knee-high nylon and spandex stock-
ings; amedium compression overstocking and light compression understocking designed
to provide a high compression system overall). Can be applied by patients (n = 27)
Outcomes Study duration 12 weeks with assessments at baseline then 4-weekly thereafter. Wounds
measured at each visit using direct transparency tracing and photography
Efficacy analysis based on all 56 patients. Safety analysis based on 53 patients (Group 1:
28, Group 2: 25), 3 patients excluded because they failed to attend the first interview
Number (%) patients with complete healing during 12-week study period: Group 1: 5/
29 (17%, 95% CI 4-45%); Group 2: 12/27 (44%, 95% CI 21-71%), P = 0.027
Mean ± SD (95% CI) days to healing: Group 1: 101 ± 7 (87-114); Group 2: 72 ± 5 (62-
82), P = 0.027 (log rank test)
Mean ± SD (range) local ulcer pain intensity under compression assessed at the start
of treatment using 100 mm visual analogue scale: Group 1: 29.5 ± 34.0 (0.0-100.0);
Group 2: 33.4 ± 31.8 (0.0-100.0)
Local ulcer pain decreased significantly more in Group 2 (70% decrease) vs Group 1
(less than 20% decrease) (P = 0.017, unpaired t-test)
Number of patients with onset of new venous ulcers during the study period: Group 1:
2; Group 2: 3
Comfort while wearing compression (assessed with 4-point verbal rating scale at weeks
2-4): Group 2 had superior comfort during entire study period compared with Group 1
(P = 0.038, full statistics not reported in paper)
Self-rated patient concordance with compression (assessed using questions rated on a
3-point scale at weeks 2-4): no significant difference between groups, most patients
reported good concordance
Percentage of patients reporting good concordance (range over assessment week period)
: Group 1: 80.8%-92.9%; Group 2: 92.3-100.0%
Notes Number (%) of patients withdrawing from study overall with following reasons - adverse
event; inefficacy (development of new ulcer); consent withdrawn; lost to follow-up:
Group 1: 11/29 (38%) 5; 4; 1; 1; Group 2: 4/27 (15%) 0; 1; 1; 2
1 adverse event in Group 1 considered to be potentially related to compression therapy
(bullous dermatitis)
Withdrawals from either group because of inefficacy treated with an alterative compres-
sion system
Higher proportion of patients in Group 1 had amajor clinical condition or abnormalities
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present at baseline clinical examination. Difficult to judge whether these variables could
have influenced healing, as no further details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “This study was a multicentre (3) open label com-
parative randomised parallel group pilot trial”. No
further detail given
Allocation concealment (selection bias) Unclear risk No further details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Data were analysed according to the intention to
treat principle and included all patients recruited
into the study. The last observation carried forward
method was also used . . . Efficacy analysis was based
on the ITT data set of 56 patients . . . 3 patients (2 in
the test group and 1 in the reference group) failed to
report for the first interview so were excluded from
the safety data set. The safety data set thus included
53 patients, 25 in the test group and 28 in the refer-
ence group”
Blinded outcome assessment (healing) Unclear risk No details provided. “Acetate tracings and pho-
tographs of the ulcer were taken at each visit to eval-
uate the proportion of the wound that was healing”
Baseline comparability Unclear risk Mean ulcer area looked similar, but no median data
provided. Impossible to judge comparability of ulcer
duration as only presented as categorical data
Rubin 1990
Methods RCT (multicentred), outpatient setting, USA.
Participants 36 consecutive ambulatory patients with lower-extremity chronic venous stasis ulceration
recruited from hospital clinics.
Exclusion criteria: history of non-compliance; ABPI < 0.8; history of risk factors such as
collagen vascular disease, uncontrolled diabetes, ongoing dermatological disorders; and
chronic corticosteroid therapy.
Mean (range) baseline ulcer area in cm2: Group 1: 76.0 (0.02-600.0); Group 2: 32.2 (6.
0-270.0).
Interventions All patients: instructed regarding the need for leg elevation, signs and symptoms of
wound complications and the need for concordance with follow-up. Dressings changed
weekly or twice weekly by hospital-based nursing staff, in accordance with prescription.
Wounds cleansed with 20% poloxamer 188 solution (Shur-Cleans). Reapplication of
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elastic bandage performed, as necessary, between dressing changes, at home or at the
clinic
Group1:Unna’s boot (gauze bandage impregnatedwith glycerin, zinc oxide and calamine
lotion) plus elastic bandage applied from toes to knee (n = 19 patients)
Group 2: polyurethane foam dressing (Synthaderm) plus elastic bandage applied from
toes to knee (n = 17 patients)
Outcomes Number (%) of patients with complete healing at 12 months: Group 1: 18/19 (95%);
Group 2: 7/17 (41%) (P < 0.005, chi-squared test)
Mean healing rate in cm2/day: Group 1: 0.5; Group 2: 0.07 (P = 0.004, Student’s t-test)
Number (%) patient withdrawals from treatment during 12-month trial: Group 1: 0/
19 (0%); Group 2: 9/17 (53%) (all Group 2 withdrawals were because of malodorous
drainage resulting from autolytic debridement)
6 of the 9 patients who withdrew in Group 2 experienced enlargement of the ulcer during
the trial
Notes Wounds measured by same investigator at each dressing change using tracing and
planimetry (exact methods not specified)
Elastic bandages (used by all patients) appear to have been used as a retaining wrap; com-
ments in the discussion section suggest that these bandages did not provide compression
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided. Merely described the
trial as “randomised”
Allocation concealment (selection bias) Low risk “Each patient was randomised by the study
co-ordinator to either a polyurethane foam
dressing or Unna’s boot dressing treatment
protocol. The study co-ordinator did not
see the randomisation card and was there-
fore blinded as to the treatment cohort”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk All randomised patients contributed heal-
ing data, however, less clear for continuous
outcomes whether all participants were in-
cluded. 9 people classed as withdrawals in
Group 2, none in Group 1. It is somewhat
unclear whether withdrawal meant with-
drawal from trial treatment but trial out-
comes were observed, or merely that pa-
tients were withdrawn from follow-up but
included in the denominator as unhealed
Blinded outcome assessment (healing) Unclear risk No details provided.
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Baseline comparability High risk Mean area only presented, however, mean
area much larger in Group 1
Scriven 1998
Methods RCT (block method with stratification by ulcer area ≤ 10 cm2 vs >10 cm2). Patients
with bilateral ulceration had each limb randomised separately. Setting: leg ulcer clinic,
UK
Participants 53 ambulant patients with 64 ulcerated limbs recruited from a venous ulcer assessment
clinic.
Inclusion criteria: active lower limb ulceration; venous aetiology defined as venous reflux
> 0.5 s duration and ABPI > 0.8.
Exclusion criteria: not stated.
Number of male:female patients (breakdown/group not reported): 20:33.
Median (range) patient age in years: Group 1: 70 (45-91); Group 2: 73 (36-93).
Median [mean] (range) baseline ulcer area in cm2: Group 1: 13.3 [49.6] (2-378); Group
2: 8.3 [19.1] (2-104).
Number (%) limbs with baseline ulcer area > 10 cm2: Group 1: 21/32 (66%); Group 2:
14/32 (44%).
Median (range) baseline ulcer duration in months: Group 1: 13 (1-480); Group 2: 21
(3-360)
Interventions Group 1: 4LB comprising: orthopaedic wool (Velband); crepe bandage; elastic bandage
(Elset); and elastic cohesive bandage (Coban). Bandages replaced at each dressing change
(n = 32 limbs)
Group 2: SSB comprising: orthopaedic wool (Velband); SSB applied with 50% stretch
and50%overlap between turns (Rosidal K); and elastic cohesive bandage appliedwithout
stretch (Coban). Bandages washed, reused, and replaced after 20 washes (n = 32 limbs)
All patients: compression therapy applied for 12weeks. Standardised bandage application
carried out by nursing staff trained and experienced in compression bandaging. Primary
dressing a simple non-adherent dressing covered with gauze. Bandages changed once a
week unless strike through of exudate. After withdrawal (either due to ulcer deterioration
during the trial or failure to heal at 12 weeks), patients could opt to receive the alternative
bandage. Post-healing, class II compression stockings were provided
Outcomes Kaplan-Meier estimate of limbs with complete healing at 1 year: Group 1: 55%; Group
2: 57% (P = 1.0, log rank test)
Number of adverse events (description): Group 1: 1 (minor haemorrhagic blistering of
toes distal to bandage); Group 2: 4 (2 pressure-induced iatrogenic ulceration, 2 macer-
ation)
Number (%) limbs withdrawn (reasons): Group 1: 1/32 (3%) (did not attend follow-
up clinics 1); Group 2: 2/32 (6%) (died 1, did not attend follow-up clinics 1)
Unit cost and estimated cost of treatment over 6 months, based on costs of bandage
systems only (GBP, price year not stated): Group 1: GBP 15.10 and GBP 392.60; Group
2: GBP 7.10 and GBP 184.56
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Notes Ulcer areameasured every 2weeks using transparency tracing and computerised planime-
try. Ulcer healing defined as full re-epithelialisation. Limb volume assessed during the
trial. Ankle sub-bandage pressure assessed using the Oxford Pressure Monitor. Addition
of the unstretched cohesive bandage to the SSB system (Group 2) resulted in a pressure
increase of 11.5 mmHg
Trial authors’ analysis conducted on an ITT basis (the 3 withdrawals were included).
Data from both study arms were merged and subject to chi-squared analysis to examine
association between healing and the following: baseline ulcer area > 10 cm2; ulcer du-
ration > 6 months; previous DVT; and presence of deep venous reflux. No statistically
significant associations were detected
Ulcer area larger in Group 1 at baseline.
Since limbs are not independent with respect to healing, this may have influenced the
results
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Limb randomisation achieved using sealed
envelopes that specified the type of bandage
to be applied, determined by a block ran-
domisation method. Standard data checks
undertaken for the IPD meta-analysis sug-
gested that generation of the random se-
quence was satisfactory
Allocation concealment (selection bias) Low risk Limb randomisation achieved using sealed
envelopes that specified the type of bandage
to be applied, determined by a block ran-
domisation method
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information from trial report:
“During the study period one patient died
after two attendances and two patients re-
peatedly failed to attend . . . these two
patients represented two ulcerated limbs
randomised to 4 layer bandage one limb
and SSB one limb. They were subsequently
considered as treatment failures and are
thus included in the analysis of results on
an intention to treat basis”
Healing data available for all patients in-
cluded in the patient level meta-analysis.
Limbs, rather than patients, were the unit
of allocation. For 12 patients with both
limbs recruited to the trial, the limb with
the smaller area of ulceration was deleted
from the IPD meta-analysis data set
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Scriven 1998 (Continued)
Blinded outcome assessment (healing) High risk No details in study report, however, trial
authors confirmed that outcome assess-
ment was not blinded
Baseline comparability Low risk Examination of IPD indicated satisfactory
balance of baseline variables across groups
Szewczyk 2010
Methods RCT performed at hospital outpatient clinic in Bydgoszcz, Poland
Participants 46 patients recruited from a hospital-based venous leg ulcer outpatient clinic
Inclusion criteria: presence of venous leg ulceration confirmed by duplex scan and ABPI
0.9-1.3; maximum ulcer surface area 15 cm2.
Exclusion criteria: non-venous or mixed ulcer aetiology; pregnancy; presence of diabetes,
lower limb atherosclerosis, arterial hypertension, cardiovascular insufficiency, rheuma-
toid arthritis or other autoimmune diseases
Number of male:female patients: Group 1: 2:13; Group 2: 4:12; Group 3: 4:11
Mean ± SD patient age in years: Group 1: 66.4 ± 9.2; Group 2: 67.5 ± 9.0; Group 3:
65.9 ± 9.2
Mean ± SD ulcer surface area in cm2: Group 1: 4.7 ± 4.2; Group 2: 5.3 ± 3.9; Group 3:
6.0 ± 4.0
Interventions Group 1: knee-length, class II compression stockings fitted according to patient’s limb
dimensions (Maxis, PPH Real, Poland) (n = 15 patients)
Group 2: 2-component compression bandage system (ProGuide, Smith&Nephew,UK)
, comprising wool layer and elastic bandage (trial report states SSB, but this does not
agree with manufacturer’s description of ProGuide). Bandages applied using a spiral
technique and changed at least twice weekly. Bandages applied to achieve ankle sub-
bandage pressure of 40mmHg, and 20mmHg at widest part of the calf (n = 16 patients)
Group3: 4LB (Profore, Smith&Nephew,UK), bandages applied using a spiral technique
and changed at least twice weekly, to achieve ankle sub-bandage pressure of 40 mmHg,
and 20 mm Hg at the widest part of the calf (n = 15 patients)
All patients: received hydrotherapy and mechanical wound care (unclear whether this
information referred to ulcer debridement); at each clinic visit the affected limb and peri-
ulcer skin were washed, moisturised and foam or hydrocolloid dressing applied according
to requirements
Outcomes Number (%) of patients with complete healing at 12 weeks: Group 1: 8/15 (53%);
Group 2: 10/16 (63%); Group 3: 9/15 (60%)
Average (presume mean) % change in ulcer surface area at 12 weeks: Group 1: -83.1%;
Group 2: -98.1%; Group 3: -93.9% (trial authors reported P > 0.05 for between-group
differences)
Average (presumed mean) healing rate in cm2/week assessed at 12 weeks: Group 1: 0.
44; Group 2: 0.55; Group 3: 0.63 (trial authors reported P > 0.05 for between-group
differences)
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Szewczyk 2010 (Continued)
Notes Trial authors stated that compression bandages were applied by a qualified and trained
nurse, but no further details about skill, experience or training provided
In Groups 2 and 3, ankle sub-bandage pressure measured using a Kikuhime manometer.
Unclear whether this was assessed at every bandage change
Ulcer surface area assessed using digital planimetry (Visitrak, Smith & Nephew, UK) at
baseline and every 2 weeks thereafter
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “ . . . patients . . . were randomised into
three groups”.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No mention of study withdrawals, but the
report of complete healing appeared to be
based on all randomised patients
Blinded outcome assessment (healing) Unclear risk No details provided.
Baseline comparability Unclear risk Median and ranges not reported for ulcer
surface area, so comparability difficult to
judge. Baseline ulcer duration not reported
at all
Taradaj 2007
Methods RCT in an out-patient clinic in Poland.
Participants 73 patients with venous leg ulcers recruited after surgery for ligation and stripping
(Babcock procedure) on saphenous or sagittal veins
Inclusion criteria: venous leg ulcer confirmed with Doppler ultrasound
Exclusion criteria: presence of diabetes, atherosclerosis or rheumatoid arthritis; steroid
treatment; metal implants present at ultrasound application site; ulcer aetiology other
than venous
Number of male:female patients: Group 1: 9:15; Group 2: 9:16; Group 3: 13:11
Mean ± SD (range) patient age in years: Group 1: 62.0 ± 9.8 (47-85); Group 2: 61.6 ±
8.3 (43-78); Group 3: 62.3 ± 9.5 (40-79)
Number of patients with superficial vs superficial and deep venous insufficiency: Group
1: 9 vs 15; Group 2: 9 vs 16; Group 3: 9 vs 15
Mean ± SD ulcer area in cm2: Group 1: 26.5 ± 17.0; Group 2: 24.4 ± 12.9; Group 3:
22.0 ± 15.5
Mean ± SD (range) ulcer duration in weeks: Group 1: 33 ± 27 (4-124); Group 2: 36 ±
39 (6-176); Group 3: 32 ± 35 (2-120)
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Interventions Group 1: moist normal saline dressing, ultrasound therapy and pharmacotherapy (dios-
min 450 mg and hesperidin 50 mg combined as proprietary preparation (Detralex) (n
= 24 patients)
Group 2: moist normal saline dressing, 2-component compression system comprising an
elastic bandage (Sigvaris) applied at 30 mm Hg ankle pressure for superficial venous in-
sufficiency, and 40mmHg for superficial and deep venous insufficiency (unclear whether
pressure was verified) plus stocking (no further details of this) and pharmacotherapy as
above (n = 25 patients)
Group 3: moist normal saline dressing plus pharmacotherapy as above (n = 24 patients)
All patients: treatment duration 7 weeks.
Outcomes Mean % change in ulcer area (relative to baseline) at 7 weeks: Group 1: -53.6%; Group
2: -69.4%; Group 3: -62.6% (P > 0.05 for all 3 comparisons between groups)
Mean percentage change in ulcer area/week (NB: values read from figure): Group 1: -7.
6%; Group 2: -9.9%; Group 3: -8.9% (P > 0.05 for all 3 comparisons between groups)
Mean ± SD ulcer area in cm2 at 7 weeks (NB: comparisons are within group vs baseline)
: Group 1: 14.1 ± 11.7 (P = 0.00002); Group 2: 8.8 ± 10.0 (P = 0.00001); Group 3: 11.
4 ± 14.1 (P = 0.00002)
No secondary outcomes reported.
No report of withdrawals from the trial.
Notes Ulcers assessed at baseline and weekly during treatment using a digitiser combined with
computerised planimetry. In addition, ulcers were photographed (frequency and other
details of this unclear)
No information on experience or skill of care providers.
Patients were the unit of randomisation.
Trial report was in Polish; data were extracted with the assistance of a translator
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk From translator: “ . . . random assignment . .
. ”.
Comment: no randomisation method speci-
fied. Authors did not state whether patients
were randomised before or after surgery
Allocation concealment (selection bias) Unclear risk No details.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No report of withdrawals, and not clear from
report whether all patients included in the
analyses
Blinded outcome assessment (healing) Unclear risk No details.
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Baseline comparability Unclear risk Groups appear comparable, however, more
meaningful median values were not reported
for ulcer area and duration (mean values pre-
sented)
Taradaj 2009
Methods RCT conducted in 3 study centres in Poland in an outpatient setting
Participants 80 patients randomised.
Inclusion criteria: venous leg ulceration confirmed by duplex scan and ABPI
Exclusion criteria: ABPI < 0.9; presence of diabetes, arthritis or arrhythmia; pregnancy;
previous ulcer surgery; treatment with steroids; skin infection
Number of male:female patients: Group 1: 15:25; Group 2: 18:22 (NB: discrepancy in
numbers in Group 2 between main text and tabulated information; numbers here taken
from main text)
Mean ± SD (range) patient age in years: Group 1: 63.4 ± 8.9 (40-80); Group 2: 62.0 ±
8.3 (43-80)
Number of patients with superficial only vs superficial plus deep venous reflux: Group
1: 22 vs 18; Group 2: 22 vs 18
Mean ± SD (range) ulcer surface area in cm2: Group 1: 20.6 ± 14.0 (6.8-39.0); Group
2: 20.3 ± 9.7 (10.2-34.4)
Mean ± SD (range) ulcer volume in cm3: Group 1: 3.7 ± 4.0 (0.2-6.9); Group 2: 3.3 ±
4.2 (0.3-7.9)
Mean ± SD (range) ulcer duration in months: Group 1: 30.5 ± 23.3 (2-100); Group 2:
30.1 ± 25.1 (4-98)
Interventions Group 1: compression stockings (Sigvaris 702, Gianzoni &Cie AG, Switzerland) provid-
ing ankle pressure 25-32 mmHg. Stockings applied every morning at outpatient clinic,
worn all day (10-12 h) and removed at night. Patients also received Detralex (diosmin
450 mg plus hesperidin 50 mg), 2 tablets daily). Patients treated in hospital dermatology
department. 2-month duration of treatment (n = 40 patients)
Group 2: 2 SSBs applied in a spiral configuration on the foot and a figure-of-8 configu-
ration on the calf. Bandages worn during the day and removed at night. Ankle pressures
standardised using a Kikuhime manometer (30-35 mm Hg for superficial vein reflux
and 35-40 mm Hg for superficial plus deep venous reflux). Patients received drug ther-
apy as above. Patients treated in a medical university dermatology department. 2-month
duration of treatment (n = 40 patients)
All patients: ulcers bathed daily with potassium permanganate solution, then covered
with moist normal saline dressings as well as compresses of fibrolan, chloramphenicol
and colistin; dressings changed daily at the clinic
Outcomes Number (%) of patients with complete healing at 2 months: Group 1: 15/40 (37.5%);
Group 2: 5/40 (12.5%) (P ≤ 0.001, from trial authors’ report)
Number (%) of patients with isolated superficial venous reflux with complete healing
at 2 months: Group 1: 10/22 (45.5%); Group 2: 4/22 (18.2%) (P ≤ 0.01, from trial
authors’ report)
Number (%) of patients with superficial plus deep venous reflux with complete healing at
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2 months: Group 1: 5/18 (27.8%); Group 2: 1/18 (5.6%) (P ≤ 0.01, from trial authors’
report)
Mean % change in ulcer surface area at 2 months: Group 1: -61.5%: Group 2: -23.7%
(P ≤ 0.01, from trial authors’ report)
Mean % change in ulcer volume at 2 months: Group 1: -82.0%: Group 2: -40.0% (P
≤ 0.01, from trial authors’ report)
Notes Ulcer surface area measured using transparency tracings; wound volume assessed with
a micrometer. Both methods combined with a digitising tablet (Kurta XGT, Altek Inc,
USA) and modified computer software (C-GEO).Measurements taken at baseline, then
weekly
Data were provided on absolute change in ulcer surface area and volume during the trial,
but comparisons were within group relative to baseline and so are not reported here
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer generated random numbers
were sealed in sequentially numbered en-
velopes and group allocation was indepen-
dent of place and person delivering the
treatment”
Allocation concealment (selection bias) Low risk “Computer generated random numbers
were sealed in sequentially numbered en-
velopes and group allocation was indepen-
dent of place and person delivering the
treatment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No report of study withdrawals. Analyses
of complete healing were based on all ran-
domised patients
Blinded outcome assessment (healing) High risk “ . . . person who assessed parameters of
ulcers was not blinded to the therapy . . . ”
Baseline comparability Unclear risk Groups appeared comparable, however,
more meaningful median values were not
reported for ulcer area and duration (mean
values presented)
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Taylor 1998
Methods RCT with randomisation performed by minimisation of prognostic factors (age, sex,
body mass index, mobility, range of ankle movement, ulcer area, ulcer duration and
living alone). Community setting, Salford, UK
Participants 36 consecutive patients referred to UK leg ulcer clinic from GP.
Inclusion criteria: venous ulceration; ABPI > 0.8.
Exclusion criteria: none stated.
Number of male:female patients: Group 1: 7:9; Group 2: 4:10.
Median (range) patient age in years: Group 1: 73 (28-85); Group 2: 77 (60-84).
Number of patients with full vs limited mobility: Group 1: 10 vs 6; Group 2: 7 vs 7.
Median (range) degrees of ankle movement: Group 1: 40 (20-65); Group 2: 40 (26-60)
.
Median (range) baseline ulcer area in cm2: Group 1: 5.4 (0.4-74.8); Group 2: 4.2 (0.6-
76.0).
Number of patients with ulcer duration < 6months vs > 6months: Group 1: 7 vs 9;
Group 2: 9 vs 5
Interventions Group 1: 4LB based on Charing Cross system. Patients treated by a specialist nurse or a
district nurse, both of whom were experienced in leg ulcer management and application
of compression bandages. Patients with painful or sloughy ulcers initially received hy-
drocolloid as the primary dressing (Granuflex or Comfeel) and had twice weekly dress-
ing changes. Otherwise a non-adherent dressing was used and bandages were changed
weekly at the patient’s home or at the community leg ulcer clinic (n = 18 patients)
Group 2: continued with usual treatment by GP and district nurse. Patients treated 2-3
times weekly at their homes by their usual district nurse. A wide variety of preparations
were used including different cleansing agents, dressings, topical applications, skin treat-
ments and bandages (some of which could have provided compression). Application of
high-compression bandaging was not permitted (n = 18 patients)
All patients: those who healed within the trial period received class II compression
stocking and were followed-up in the leg ulcer review clinics
Outcomes Number (%) of patients with complete healing at 12 weeks (assuming losses did not
heal, calculated by review author):
Group 1:12/18 (66.7%); Group 2: 3/18 (16.6%).
Number (%) of patients with complete healing at 12weeks (study completers, as reported
in paper):
Group 1: 12/16 (75%); Group 2: 3/14 (21%), P = 0.003 for difference between groups
Median time to healing: Group 1: 55 days; Group 2: 84 days.
Comparison of healing distributions using the Lee-Desu statistic suggested that patients
in Group 1 healed faster than those in Group 2 (overall comparison statistic 8.603, P =
0.0034)
Number (%) patients who withdrew from trial (reasons): Group 1: 2/18 (11%) (died 1,
scabies 1); Group 2: 4/18 (22%) (died 1, healed before treatment 1, treated with 4LB 1,
developed cellulitis 1)
Cost analyses took account of consumables, district nurse time (including travel) and
mileage costs. Estimates are presented in GBP (price year not stated):
Median (range) weekly treatment costs: Group 1: GBP 17.26 (13.45-20.16); Group 2:
GBP 21.07 (8.71 - 42.47) (P = 0.042)
Mean (95% CI) between-group difference in weekly treatment costs: GBP 6.45 (1.22-
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11.68), P = 0.042
Median (range) whole trial costs: Group 1: GBP 116.87 (52.63-261.74); Group 2: GBP
240.28 (74.65-588.05), P = 0.016
Mean (95% CI) between-group difference in whole trial costs: GBP 113.51 (29.71-197.
31), P = 0.016
Notes In patients with multiple ulcers, the total ulcerated area was studied. Ulcer area was
measured weekly using transparency tracing and computerised planimetry
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Eighteen patients were randomly allo-
cated to each treatment group using the
method of minimisation of prognostic fac-
tors . . . ”
Allocation concealment (selection bias) Low risk We have assumed that the minimisation
programme resulted in allocation conceal-
ment
Incomplete outcome data (attrition bias)
All outcomes
High risk Authors did not undertake an ITT analysis;
2 people withdrew from Group 1 and 4
fromGroup 2, including 1 person who was
not included in the analysis because he/she
received the Group 1 treatment
Blinded outcome assessment (healing) Unclear risk “Weekly each patient had the perimeter
of their ulcer traced onto an acetate and
the area measured using a computerised
planimeter . . . ”
Baseline comparability High risk Ulcers in Group 1 had larger baseline area
and were also of longer duration
Travers 1992
Methods RCT (details of methods not provided). Setting: leg ulcer clinic, Nottingham, UK
Participants Recruited 27 patients attending leg ulcer clinic.
Inclusion criterion: venous ulcers (ABPI > 0.9).
Exclusion criteria: not stated.
Mean ± SD patient age in years: Group 1: 54 ± 3; Group 2: 59 ± 4.
Mean ± SD baseline ulcer area in mm2: Group 1: 3097 ± 1818; Group 2: 2304 ± 1221.
Mean ± SD baseline ulcer duration in months: Group 1: 23 ± 7; Group 2: 35 ± 13
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Interventions All patients: ulcers cleansedwith sterile normal saline, thenhydrocolloid primary dressing
applied. Bandages changed 1-2 times/week
Group1: single-component systemconsisting of elastic cohesive bandage (Panelast Acryl)
applied from foot to below-knee with 50% overlap (n = 15 patients).
Group 2: 3-component system applied from foot to below-knee consisting of: zinc
oxide and calamine paste bandage (Calaband); non-adhesive elastic bandage (Tensopress)
applied with 50% overlap and 50% stretch; and elasticated tubular bandage (Tensogrip)
(n = 12 patients)
Outcomes Mean ± SE% change relative to baseline ulcer area at 7 weeks (values taken from figure):
Group 1: -90 ± 3; Group 2: -83 ± 5 (authors report no statistically significant difference
between groups using Student’s t-test, but P value not shown)
All patients completed the trial.
Notes Ulcer area measured weekly using transparency tracing and computerised planimetry.
The variability statistics used in the trial report were not specified, but presumed by the
review authors to be standard deviation for baseline variables and standard error (shown
on figure) for the outcome
Sub-bandage ankle pressuremeasuredwith patients in a supine position using theOxford
Pressure Monitor. Average pressure at the start of treatment: Group 1: 50 mmHg; Group
2: 44 mmHg (between-group difference reported as not significant by authors, but P
value not shown). Average pressure after 1 week of treatment: Group 1: 23 mmHg;
Group 2: 35 mmHg (P < 0.01). This suggested better maintenance of compression by
the 3-component system
The authors stated that costs of the bandages were equivalent, but no data were shown
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “ . . . randomly allocated” - no further detail
provided.
Allocation concealment (selection bias) Unclear risk No further details provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All 27 patients recruited “completed the
trial”.
Blinded outcome assessment (healing) Unclear risk No detail provided.
Baseline comparability Unclear risk Greater mean area at baseline in Group
1 and longer mean duration in Group 2,
however, mean data not useful as highly
skewed
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Ukat 2003
Methods RCT (2 centres). Randomisation simple and unstratified. Sample size: estimated that
study had 80% power to detect 25% difference in healing rates at 12 weeks, at 5%
significance level
Participants 89 patients recruited from 2 study centres in Germany, 1 inpatient and 1 outpatient.
Inclusion criterion: venous leg ulceration.
Exclusion criteria: ABPI < 0.8; rheumatoid vasculitis; ulceration of diabetic or malignant
aetiology; use of corticosteroids; clinically-infected ulcer; circumferential ulcer.
Around 60% patients were female.
Mean patient age in years: Group 1: 67; Group 2: 70.
Mean BMI (kg/m2): Group 1: 27; Group 2: 28.
Number (%) of ulcers with baseline duration > 6months: Group 1: 23/44 (52%); Group
2: 25/45 (56%).
Mean ± SD, median (range) baseline ulcer area in cm2: Group 1: 17.7 ± 34.1, 6.5 (1.0-
220.5); Group 2: 12.2 ± 14.8, 6.6 (1.8-70.7)
Interventions All patients: ulcers cleanedwith Ringer-Lactate Solution and coveredwith a polyurethane
foam film dressing (Allevyn Hydrocellular)
Group 1: 4LB (Profore), reapplied weekly, or more often if required (n = 44)
Group 2: SSB comprising 2 bandages 10 cm wide. Bandages reapplied daily by patient,
family member or nurse (n = 45)
When healed, patients were prescribed class II compression stockings and returned to
the regular follow-up clinics
Outcomes Number (%) patients healed at 12 weeks: Group 1: 13/44 (30%); Group 2: 10/45 (22%)
Kaplan-Meier estimate indicated that patients in Group 1 healed significantly faster than
those in Group 2 (P = 0.03)
Cox regression: hazard ratio 2.9 (95% CI 1.1-7.5) in favour of 4LB during the 12-
week study period (with adjustment for bandage type, study centre, peri-wound skin
condition, baseline ulcer area, baseline ulcer duration, and including an interaction
term for study centre and bandage type); no statistically significant interaction between
treatment and study centre (P = 0.713); healing was significantly slower for wounds of
longer baseline duration (P = 0.01), and those with peri-wound skin affected by oedema,
dermatosclerosis or erythema (P = 0.03)
Median (mean) reduction in ulcer area between baseline and 12-week assessment: Group
1: 77% (58%); Group 2: 56% (46%)
Number of patients rating bandage comfort as ’excellent’ out of a total of 38 patients
completing this assessment (numbers assessed/group not reported): Group 1: 15; Group
2: 4
Comparison of costs based on cost/bandage, cost of other disposables (e.g. primary
dressings, wadding), and assumption of 30 minutes of nursing/bandage change @ 14
EUR/h
Cost/patient (EUR): Group 1: EUR 587; Group 2: EUR 1345.
Cost/ulcer healed (EUR): Group 1: EUR 1845; Group 2: EUR 5502
Number (%) withdrawals because of patient’s request or loss to follow-up: Group 1: 7/
44 (16%); Group 2: 7/45 (16%)
Withdrawals due to adverse events: Group 1: 1 withdrawal because of heart and lung
problems; Group 2: 1 withdrawal because of pain
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Notes Patients with bilateral ulceration randomised to receive 1 treatment only, and the limb
with the larger total area of ulceration was studied. Wound surface area measured using
tracing and computerised planimetry, and ulcers photographed at every clinic visit
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Information from published trial report
was unclear:
“This was a prospective randomised con-
trolled comparative study . . . ”
Standard data checks undertaken for the
IPDmeta-analysis, however, suggested that
generation of the random sequence was sat-
isfactory
Allocation concealment (selection bias) Low risk “Randomisation was performed by open-
ing sealed envelopes containing informa-
tion about the proposed treatment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information from published trial report:
“Patients were analysed according to the
treatment received . . . ”, “Dropouts were
included in the analysis . . .” (7 from each
Group), however, it was not clear how they
were included (may have been last observa-
tion carried forward, as the authors stated,
“dropouts were included in the analysis as
they formed part of the full analysis patient
population that is all patients who had a
venous leg ulcer, an initial baseline assess-
ment and at least one follow up assessment
. . . )”
All randomised patients were included in
the patient level analysis
Blinded outcome assessment (healing) High risk “The clinician took photographs of the ul-
cers at every follow up visit . . . ”. but no
mention of assessment of photographs by
anyone else
Baseline comparability Low risk Examination of individual patient data in-
dicated satisfactory balance of baseline vari-
ables across groups
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Vowden 2000
Methods RCT in vascular leg ulcer clinic setting, UK.
Participants 149 patients recruited.
Inclusion criteria: venous leg ulceration; ankle circumference < 25 cm; ABPI ≥ 0.8.
Number of male:female patients: Group 1. 29:21; Group 2: 27:23; Group 3: 23:26.
Mean (range) patient age in years: Group 1: 66.4 (39-88); Group 2: 67.1 (24-88); Group
3: 68.9 (29-86).
Mean (range) baseline ulcer area in cm2: Group 1: 4.9 (0.5-16.5); Group 2: 6.76 (0.5-
51); Group 3: 5.8 (1-28).
Mean (range) baseline ulcer duration in weeks: Group 1: 142 (1-1040); Group 2: 177
(1-2500); Group 3: 112 (1-1400).
Number (%) patients with recurrent ulceration at baseline: Group 1: 35/50 (70%);
Group 2: 33/50 (66%); Group 3: 33/49 (67%).
Number (%) patients with good vs moderate vs poor baseline ankle mobility:
Group 1: 22/50 (44%) vs 16/50 (32%) vs 12/50 (24%);
Group 2: 15/50 (30%) vs 18/50 (36%) vs 17/50 (34%);
Group 3: 20/49 (41%) vs 16/49 (33%) vs 13/49 (27%).
Number (%) patients with good vs moderate vs poor baseline general mobility:
Group 1: 24/50 (48%) vs 17/50 (34%) vs 9/50 (18%);
Group 2: 19/50 (38%) vs 20/50 (40%) vs 11/50 (22%);
Group 3: 19/49 (39%) vs 15/49 (31%) vs 15/49 (31%).
Number (%) patients with history of DVT: Group 1: 20/50 (40%); Group 2: 20/50
(40%); Group 3: 7/49 (14%)
Number (%) patients with popliteal reflux time > 0 ≤ 1.5 s vs > 1.5 s assessed by duplex
ultrasound:
Group 1: 10/42 (24%) vs 13/42 (31%);
Group 2: 11/44 (25%) vs 8/44 (18%);
Group 3: 10/37 (27%) vs 16/37 (43%).
Interventions All patients received disease-specific information and education (no further details about
this) and all received treatment on a weekly basis
Group 1: original Charing Cross 4LB system consisting of orthopaedic wool (Soffban,
Smith & Nephew), crepe bandage (Smith & Nephew), elastic bandage (Elset, Seton
Scholl) and elastic cohesive bandage (Coban, 3M) (n = 50)
Group 2: modified Charing Cross 4LB system consisting of orthopaedic wool (Soffban,
Smith & Nephew), elastic bandage (K-Lite, Parema), elastic bandage (K-Plus, Parema)
and adhesive elastic bandage (Coban, Smith & Nephew) (n = 50)
Group 3: 4LB kit (Robinson Ultra Four) consisting of wound dressing, Sohfast, K-Lite,
K-plus and Cohfast (n = 49)
At the end of the 20-week study period, patients who had healed received compression
stockings, and those who had withdrawn or remained unhealed were treated with the
original Charing Cross system
Outcomes Patients with complete healing at 12 weeks: Group 1: 60%; Group 2: 76%; Group 3:
60% (chi-squared analysis for comparison between the 3 groups, P = 0.16)
Patients with complete healing at 20 weeks: Group 1: 87%; Group 2: 84%; Group 3:
83% (chi-squared analysis for comparison between the 3 groups, P = 0.56)
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Notes Estimated cost/bandage system (presumed price year 1999-2000): Group 1: GBP 5.82;
Group 2: GBP 4.10; Group 3: GBP 5.83
There was baseline imbalance for ulcer duration, ulcer area, history of DVT and popliteal
reflux
Few details were provided about wound measurement except to say that ulcers were
photographed and mapped
3 patients withdrew because of non-compliance (breakdown/group not reported)
5 patients were withdrawn because of medical reasons: falling ABPI, skin malignancy on
another leg site, medical admission for respiratory disease, cellulitis and death unrelated
to treatment (breakdown/group not reported)
Number of patients withdrawn because of potential bandage-related complications,
namely persistent skin reddening and discomfort; superficial skin damage: Group 1: 0;
0; Group 2: 2; 1; Group 3: 1; 1. These 5 patients continued with compression bandaging
after withdrawal, using an extra padded Charing Cross system, and all healed within 4
weeks of withdrawal
Assessment of patients’ opinion of the bandages by direct questioning during weekly
bandage changes, indicated that participants were equally tolerant of all 3 compression
systems
Assessment of staff preference before, during and after the study initially showed a greater
preference for the original Charing Cross system, but there was no bandage preference by
the end of the 20-week study. This assessment was based on consideration of handling,
ease of application, bandage performance over the preceding 7 days and ease of removal
In the concluding comments, the authors mentioned that care had been provided by
expert bandagers
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided; merely described as a
“randomised, controlled study”
Allocation concealment (selection bias) Low risk Information from trial author: “randomi-
sation was by sealed envelopes”
Incomplete outcome data (attrition bias)
All outcomes
High risk 149 people recruited, however, outcomes
not presented with denominators, so im-
possible to judge extent of follow-up
3 patients withdrew because of non-com-
pliance (breakdown/group not reported)
5 patients were withdrawn because of med-
ical reasons: falling ABPI, skin malignancy
on another leg site, medical admission for
respiratory disease, cellulitis and death un-
related to treatment (breakdown/group not
reported)
Number of patients withdrawn because of
potential bandage-related complications,
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Vowden 2000 (Continued)
namely persistent skin reddening and dis-
comfort; superficial skin damage: Group
1: 0; 0; Group 2: 2; 1; Group 3: 1; 1.
These 5 patients continued with compres-
sion bandaging after withdrawal, using an
extra padded Charing Cross system, and all
healed within 4 weeks of withdrawal
Contact with the trial authors confirmed
that the analysis had been conducted on a
per protocol basis; information on denom-
inators not available
Blinded outcome assessment (healing) Unclear risk No details provided.
Baseline comparability High risk Smallermean ulcer area inGroup 1; shorter
mean duration in Group 3
Wilkinson 1997
Methods RCT (limbs allocated to study groups using a remote randomisation service with num-
bers generated by random number tables, using blocks of 4 and stratification according
to baseline ulcer area: < 9.9 cm2 and ≥ 10 cm2). Community setting, South Bucking-
hamshire, UK.
Participants 29 patients with 35 ulcerated legs recruited through district and practice nurses.
Inclusion criteria: uncomplicated venous leg ulcer (confirmed by dermatologist) being
treated by district or practice nurse.
Exclusion criteria: peripheral vascular disease, cellulitis, ABPI < 0.8, contact allergy
to latex, ulcer on foot or toes, rheumatoid arthritis, collagen vascular disease, ankle
circumference < 18 or > 25 cm
Number of limbs belonging to male:female patients: Group 1: 8:9; Group 2: 5:13.
Number of limbs with baseline ulcer area < 9.9 cm2 vs ≥ 10 cm2: Group 1: 12 vs 5;
Group 2: 12 vs 6.
Mean (range) patient age in years for baseline ulcer area < 9.9 cm2 vs ≥ 10 cm2: Group
1: 77 (62-86) vs 72 (49-92); Group 2: 75 (53-86) vs 76 (49-85).
Mean (range) baseline ulcer area in cm2: Group 1: 11.2 (0.25-49.6); Group 2: 8.6 (0.
25-45.0).
Mean (range) baseline ulcer duration in months for baseline ulcer area < 9.9 cm2 vs ≥
10 cm2: Group 1: 14.2 (1-48) vs 36.8 (6-60); Group 2: 18.3 (1-48) vs 28.2 (5-60)
Interventions Group 1: Charing Cross 4LB (Profore) comprising: knitted viscose primary dressing
(Tricotex), orthopaedic wool (Soffban), crepe bandage, elastic bandage (Litepress), and
cohesive elastic bandage (Coplus) (n = 17 legs)
Group 2: alternative 4LB comprising: knitted viscose primary dressing (Tricotex), elas-
ticated viscose stockinette (Tubifast), lint applied in separate strips horizontally around
the leg, elastic bandage (Setopress), and elasticated viscose stockinette (Tubifast) (n = 18
legs)
All patients: standardised wound cleansing solutions and emollients; bandages changed
weekly; patients supplied with class II compression stockings post-healing
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Wilkinson 1997 (Continued)
Outcomes Number (%) limbs with complete healing at 12 weeks: Group 1: 8/17 (47%); Group
2: 8/18 (44%) (P = 0.51, chi-squared test for between-group difference in proportions
healed, not healed and withdrawn)
OR (95% CI) estimated by trial authors for healing in Group 1 compared with Group
2: 1.11 (0.24-5.19)
Meanpercentage reduction inulcer area during trial, based onunhealed limbs completing
the trial: Group 1: (n = 5) 39%; Group 2: (n = 8) 34% (P = 0.89, t-test for between-
group difference)
Number (%) limbs withdrawn from treatment (reasons): Group 1: 4/17 (24%) (de-
veloped cellulitis 1, bandage uncomfortable/slipped 1, allergic to bandage 1, bandage
too painful 1); Group 2: 2/18 (11%) (leg painful and possibly infected 1, bandage too
painful 1)
Notes In limbs with more than 1 ulcer, the largest wound was included in the trial. Ulcer area
was estimated by diameter product (i.e. maximum length x maximum width of ulcer)
every 4 weeks. The trial authors stated that measurements of sub-bandage pressure were
not made. Ulcer healing was defined as a “continuous layer of epithelial cells across the
ulcer surface”. Outcome assessment was non-blind. Nurses were taught to apply the
bandages by the research nurse
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “ . . . patients’ ulcerated legs allocated to one
of two groups using numbers generated by
random number tables . . . ”
Allocation concealment (selection bias) Low risk “ . . . randomisation was based on random
numbers and was calculated in blocks of
four . . . the nurses ringing for randomisa-
tion were unaware of the block randomisa-
tion . . . ”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Recruited 29 patients with 35 limbs and
“all 35 limbs included in the healing anal-
ysis”. 4 limbs were withdrawn from Group
1 and 2 from Group 2, therefore, not clear
how withdrawals included in the analysis
(whether assumed unhealed or whether as-
certained healing status)
Blinded outcome assessment (healing) High risk “Not observer blind”.
Baseline comparability High risk Mean ulcer area greater in Group 1; mean
duration data impossible to interpret
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Zuccarelli 1997
Methods Multicentred RCT (5 centres in France).
Participants Recruited 48 patients with venous leg ulcers.
Inclusion criteria: post-thrombotic superficial venous leg ulcer present for > 4 weeks,
showing no signs of improvement according to clinical examination
Exclusion criteria: not stated.
Number of male:female patients: Group 1: 7:15; Group 2: 9:17
Mean ± SD patient age in years: Group 1: 70 ± 10; Group 2: 74 ± 13
Mean ± SD ulcer duration in months: Group 1: 7 ± 10; Group 2: 5 ± 5
Mean ± SD ulcer surface area in cm2: Group 1: 4.88 ± 4.25; Group 2: 3.38 ± 3.00.
Number (%) patients with ulcer surface area > 4 cm2: Group 1: 13/22 (59%); Group 2:
8/26 (31%).
Interventions Group 1: Elastic bandage (BIFLEX® 17, Thuasne, France) applied in spiral configura-
tion with 30% stretch, designed to provide 20-36 mm Hg compression (no report of
this being verified) (n = 22)
Group 2: SSB (Somos®, BSN Medical, France) applied as spiral (n = 26)
All patients: compression bandages removed at night and primary dressings retained
with a gauze bandage. Sclerotherapy, surgery and phlebotropicmedication not permitted
during the trial. Treatment duration was 2 months
Outcomes Mean change in ulcer surface area in cm2 at 2 months: Group 1: -3.1; Group 2: -1.6
(calculated by the review authors from baseline and follow-up ulcer area data provided
in the paper)
Number (%) patients with ulcer surface area decreasing by at least 2 cm2 at 2 months in
a subgroup of patients with baseline ulcer area > 4 cm2: Group 1: 12/13 (92%); Group
2: 5/8 (62%), between-group difference reported as not statistically significant by trial
authors
Number (%) patients with ulcer surface area decreasing by at least 25% at 2 months in
a subgroup of patients with baseline ulcer area > 4 cm2: Group 1: 12/13 (92%); Group
2: 5/8 (62%), between-group difference reported as not statistically significant by trial
authors
Notes Surface area of ulcers assessed at baseline, then every 2 weeks using tracing (no further
details)
No information provided about bandager skill or experience.
Trial authors mentioned that they had assessed tolerance of the bandages, but no report
of findings
Original language of report was French; data were extracted with the assistance of a
translator
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “ . . . a multicentre, randomised clinical trial
was conducted . . . ”
Comment: there were no further details of
exact methods used to generate the ran-
domised sequence
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Zuccarelli 1997 (Continued)
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The number of patients included in the as-
sessment of ulcer surface area was not explic-
itly stated
Blinded outcome assessment (healing) Unclear risk No details provided.
Baseline comparability Unclear risk Median and ranges not reported for baseline
ulcer area and duration, so difficult to judge
(mean values presented)
In previous versions of this review the study by Scriven 1998 was cited as London et al (1996).
In the previous version of this review Meyer (2000) was referred to (under the section ongoing studies) as Burnand.
In the previous version of this review Moffatt 1999 was cited as McCollum et al (1997). The latter is now a secondary reference of
Moffatt 1999.
In the previous version of this review Nelson 2007a was cited as Nelson 1995. The latter is now a secondary reference of Nelson 2007a.
Abbreviations
< = less than
≤ = less than or equal to
> = greater/more than
≥ = greater/more than or equal to
± = plus or minus
4LB = four-layer bandage
ABPI = ankle brachial pressure index
BMI = body mass index
CEAP = Clinical severity, Etiology or cause, Anatomy, Pathophysiology (CEAP is a method of classifying venous disease)
CI = confidence interval
CIVIQ = chronic venous insufficiency quality of life questionnaire
DVT = deep vein thrombosis
GP = general practitioner
h = hour(s)
H202 = hydrogen peroxide
HIV = human immunodeficiency virus
HR = hazard ratio
IPD = individual patient data
ITT = intention to treat (analysis)
MD = mean difference
NB = please note
RCT = randomised controlled trial
s = second(s)
SD = standard deviation
SE = standard error
SEM = standard error of the mean
SF-36 = Short Form 36
SSB = short stretch bandage
vs = versus
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alvarez 2005 Not randomised (confirmed through correspondence with the first author)
Baccaglini 1998 Not randomised.
Blair 1988 Primarily a dressings trial; comparison between bandages not randomised
Brizzio 2006 Not randomised.
Cameron 1996 Historical control, therefore not randomised.
Cherry 1990 Healing not measured as an outcome.
Falanga 1998 Treatment groups differed systematically other than in terms of the compression systems used. One
group received a topical application of human skin equivalent plus a nonadherent primary dressing and
an elastic bandage; the other received a nonadherent primary dressing, paste bandage and elastic bandage
Fuessl 2009 Brief commentary on meta-analysis (O’Meara 2009).
Hamel-Desnos 2010 Interventions designed to treat varicose veins, not ulceration
Heinen 2010 Did not evaluate compression (evaluated an intervention to promote patient concordance with com-
pression)
Hjerppe 2010 Prognostic study, not RCT.
Horakova 1994 Not randomised.
Ivanovic 2011 Not an RCT, a brief review of the previous version of this Cochrane review (confirmed by translator)
Jull 2009 Not a randomised comparison.
Jünger 2006 Patients did not have ulceration; primary outcome was skin condition
Kucharzewski 2003 Not randomised.
Kuznetsov 2009 Both groups had same method of compression, comparison was of dressings (confirmed by translator)
Lee 2009 Not an RCT; overview and study of bandage pressures in healthy volunteers
Luo 2009 Not an RCT (a case series - confirmed by translator).
Marston 1999 Not randomised.
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(Continued)
Nissinen-Paatsamala 1995 Not randomised.
Northeast 1990 Treatment effect confounded by use of steroids in one treatment group but not the other
Olofsson 1996 Treatment groups differed systematically other than in terms of compression systems used (one group
treated by a surgeon and the other by dermatologists). In addition, several different types of compression
were used within each group, meaning that the relative effectiveness of each system would be difficult
to estimate
Partsch 2008a Patients with leg ulceration were excluded.
Robson 2004 Trial of topical applications; all patients received same type of compression
Russo 1999 Have abstract only; randomisation not mentioned.
Sabolinski 1995 Both groups had compression, comparison was of dressings.
Scriven 2000 Case series that primarily assessed sub-bandage pressures.
Serra 2010 Dressings trial; all patients received same type of compression (confirmed by translator)
Sikes 1985 Not randomised.
Sironi 1994 Comparison of different protocols of delivering dressings and topical agents; patients in both study
groups received the same type of compression
Smith Strom 2006 Dressings trial; all patients received same type of compression
Szewczyk 2009 Quasi-randomised.
Torra i Bou 2003 Not randomised (uncontrolled before-after study).
Van Laere 2010 Quasi-randomised (author provided additional information).
Vowden 2001 Non-comparative study.
Walker 1996 Have abstract only; no objective wound healing data presented and attempts to obtain further informa-
tion from trial authors were unsuccessful
Zamboni 2004 Comparison is venous reflux surgery versus compression but both study groups received the same type
of compression system
Abbreviations
RCT = randomised controlled trial
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Characteristics of studies awaiting assessment [ordered by study ID]
Bertaux 2010
Methods Comparative study, unclear whether RCT.
Participants 60 patients with venous leg ulcers
Interventions SSB versus compression stockings
Outcomes Proportion of patients with complete healing
Notes Only abstract currently available; awaiting full report.
Harrison 2011
Methods RCT.
Participants 424 patients with venous leg ulcers.
Interventions 4LB vs SSB.
Outcomes Healing, recurrence, adverse events.
Notes Yet to contact trial authors regarding data retrieval.
Moffatt 2003b
Methods RCT.
Participants 300 patients with venous leg ulcers.
Interventions 4LB vs compression with 2 components (Proguide, Smith & Nephew)
Outcomes No data.
Notes Only abstract currently available; awaiting full report.
Mosti 2010
Methods RCT.
Participants Patients with non-infected leg ulcers eligible to receive compression
Interventions Different short-stretch compression systems and different dressings
Outcomes Healing mentioned, but no data provided.
139Compression for venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mosti 2010 (Continued)
Notes Only abstract currently available; awaiting full report.
Mosti 2011
Methods RCT.
Participants 100 patients with venous leg ulcers.
Interventions Paste bandage vs compression bandage with 2 components.
Outcomes Proportion of patients with complete healing.
Notes Seeking clarification from trial authors regarding components of compression
Taradaj 2011
Methods Unclear whether an RCT.
Participants 305 patients with venous leg ulcers.
Interventions 10 different treatment arms, including comparison of compression vs no compression
Outcomes Proportion of patients with complete healing.
Notes Unclear whether really randomised - seeking clarification from trial authors
Wong 2012
Methods RCT.
Participants 321 patients with venous leg ulcers.
Interventions 4LB vs SSB vs no compression (dressing only).
Outcomes Proportion of patients with complete healing.
Notes Yet to contact trial authors regarding data retrieval.
Abbreviations
4LB = four-layer bandage
RCT = randomised controlled trial
SSB = short stretch bandage
vs = versus
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Characteristics of ongoing studies [ordered by study ID]
Dumville 2009
Trial name or title VenUS IV: Compression hosiery versus compression bandaging in the treatment of venous leg ulcers
Methods RCT.
Participants Patients with venous leg ulceration confirmed by ABPI ≥ 0.8.
Interventions Compression hosiery versus 4LB.
Outcomes Time to healing, cost of treatment, quality of life, patient concordance with treatment, recurrence of ulceration
Starting date May 2009.
Contact information Dr Jo Dumville (jo.dumville@york.ac.uk)
Notes
Matos de Abreu 2011
Trial name or title None provided.
Methods RCT.
Participants Patients with venous ulcers.
Interventions Unna’s boot versus elastic bandages.
Outcomes Not specified.
Starting date Not specified.
Contact information Alcione Matos de Abreu (alci abreu@yahoo.com.br)
Notes This is a short paper, published in Portuguese. Information from this and the English language abstract
indicate a clinical trial which is about to start or is in progress
Weller 2010
Trial name or title None provided.
Methods Protocol for an RCT.
Participants Patients with venous leg ulceration confirmed by clinical assessment
Interventions Tubular compression bandage versus SSB.
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Weller 2010 (Continued)
Outcomes Proportion of patients with complete healing.
Starting date Recruitment commenced February 2009.
Contact information
Notes Secondary references identified: a sub-bandage pressure study and a conference abstract
Abbreviations
≥ = greater/more than or equal to
4LB = four-layer bandage
ABPI = ankle brachial pressure index
RCT = randomised controlled trial
SSB = short-stretch bandage
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D A T A A N D A N A L Y S E S
Comparison 1. Compression vs no compression (primary dressing only)




participants Statistical method Effect size
1 Ulcers completely healed at 6
months
1 87 Risk Ratio (M-H, Fixed, 95% CI) 1.50 [0.90, 2.50]
Comparison 2. Compression vs no compression (non-compressive bandage)




participants Statistical method Effect size
1 Patients with complete healing
at 1 year
1 36 Risk Ratio (M-H, Fixed, 95% CI) 2.30 [1.29, 4.10]
Comparison 3. Compression vs no compression (usual treatment)




participants Statistical method Effect size
1 Patients with complete healing
at 3 months
1 36 Risk Ratio (M-H, Fixed, 95% CI) 4.0 [1.35, 11.82]
2 Patients with complete healing
at 1 year
1 233 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.96, 1.47]
3 Patients with recurrence during
1 year follow-up
1 140 Risk Ratio (M-H, Fixed, 95% CI) 1.53 [0.88, 2.66]
Comparison 4. Single-component compression (elastic bandage) vs single-component compression (paste ban-
dage)




participants Statistical method Effect size
1 Patients with complete healing
at 3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Percentage change during trial
relative to baseline ulcer area
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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3 Healing rate (cm squared per
week adjusted for baseline ulcer
perimeter)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 5. Single-component compression vs multi-component compression (excluding paste bandages)




participants Statistical method Effect size
1 Complete healing during the
trial period
4 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2 Percentage change during trial
relative to baseline ulcer area
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 Complete healing during the
trial period (participants with
simple VLU only)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 6. Single-component compression vs multi-component compression (paste bandage)




participants Statistical method Effect size
1 Complete healing during the
trial period
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 7. Two-component (outer elastic) vs two-component (outer inelastic)




participants Statistical method Effect size
1 Patients with complete healing
at 3-6 months
2 95 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.67, 2.25]
2 Patients with complete healing
at 1 month
1 43 Risk Ratio (M-H, Fixed, 95% CI) 3.48 [0.42, 28.63]
3 Patients with complete healing
at 1 year
1 43 Risk Ratio (M-H, Fixed, 95% CI) 3.48 [1.14, 10.60]
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Comparison 8. Two-component system vs four-layer bandage (4LB)




participants Statistical method Effect size
1 Patients with complete healing
at 1 month
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Patients with complete healing
at 3 months
3 170 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.66, 1.05]
3 Patients with complete healing
at 6 months up to point of
withdrawal from randomised
treatment
1 109 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.41, 0.77]
4 Patients with complete healing
at 6 months including
withdrawals from randomised
treatment
1 109 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.73, 1.05]
Comparison 9. 3 components including elastic bandage vs 3 components including inelastic bandage




participants Statistical method Effect size
1 Patients/limbs with complete
healing during trial
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Complete healing at 3-4
months
2 171 Risk Ratio (M-H, Fixed, 95% CI) 1.83 [1.26, 2.67]
1.2 Complete healing at 6
months
1 112 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.69, 1.27]
Comparison 10. 3 components including paste bandage vs 3 components including inelastic (short-stretch)
bandage




participants Statistical method Effect size
1 Limbs with complete healing at
3 months
1 51 Risk Ratio (M-H, Fixed, 95% CI) 1.73 [0.74, 4.06]
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Comparison 11. Charing Cross 4LB vs other 4LB




participants Statistical method Effect size
1 Patients/limbs with complete
healing during trial
2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Complete healing at 3
months
2 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Complete healing at 6
months
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 12. 4LB vs multi-layer short-stretch bandage (SSB)




participants Statistical method Effect size
1 Patients with complete healing
during trial period based on
IPD
5 797 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.88, 1.05]
2 Limbs completely healed at 3
months (Duby 1993, IPD
unavailable)
1 50 Risk Ratio (M-H, Random, 95% CI) 1.1 [0.57, 2.11]
3 Hazard ratio estimates for time
to healing based on IPD
(fixed-effect)
5 797 Hazard Ratio (Fixed, 95% CI) 1.32 [1.09, 1.60]
4 Hazard ratio estimates for time
to healing based on IPD
(random-effects)
5 797 Hazard Ratio (Random, 95% CI) 1.30 [0.94, 1.80]
5 Hazard ratio estimates for time
to healing based on IPD
(fixed-effect, Partsch 2001
removed)
4 685 Hazard Ratio (Fixed, 95% CI) 1.47 [1.20, 1.81]
6 Hazard ratio estimates for time
to healing based on IPD
(random-effects, Partsch 2001
removed)
4 685 Hazard Ratio (Random, 95% CI) 1.47 [1.20, 1.81]
7 Incidence of any type of
adverse event based on IPD
(fixed-effect)
2 546 Odds Ratio (M-H, Fixed, 95% CI) 1.15 [0.81, 1.62]
8 Incidence of any type of adverse
event based on IPD (random
effects)
2 546 Odds Ratio (M-H, Random, 95% CI) 1.11 [0.72, 1.72]
9 Incidence of bandage-related
adverse events based on IPD
2 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
10 Number of adverse events
(any type) based on IPD
(fixed-effect)
2 546 Mean Difference (IV, Fixed, 95% CI) -0.10 [-0.32, 0.12]
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11 Number of adverse events
(any type) based on IPD
(random-effects)
2 546 Mean Difference (IV, Random, 95% CI) -0.21 [-0.68, 0.27]
12 Number of adverse events
(bandage-related) based on
IPD
2 Mean Difference (IV, Random, 95% CI) Subtotals only
Comparison 13. Four-layer bandage (4LB) vs compression system with paste bandage as the base




participants Statistical method Effect size
1 Patients/limbs with complete
healing during trial
4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Patients/limbs with
complete healing at 3 months
2 71 Risk Ratio (M-H, Fixed, 95% CI) 1.34 [0.78, 2.28]
1.2 Patients with complete
healing at 6 months
1 68 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.82, 1.57]
1.3 Patients with complete
healing at 1 year
1 133 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.66, 1.01]
2 Patients/limbs with complete
healing at 3 months
(random-effects)
2 71 Risk Ratio (M-H, Random, 95% CI) 1.23 [0.54, 2.82]
3 Percentage reduction of baseline
ulcer area at 6 months
1 68 Mean Difference (IV, Fixed, 95% CI) 54.50 [-9.17, 118.
17]
4 Healing rate (pooled) 2 78 Std. Mean Difference (IV, Fixed, 95% CI) 0.52 [0.06, 0.97]
Comparison 14. Adjustable inelastic compression boot vs other compression system




participants Statistical method Effect size
1 Healing rate 2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 cm2 per week 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 cm2 per day 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 percentage per day 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 cm per day (linear rate) 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Comparison 15. Single-layer compression stocking vs paste bandage system




participants Statistical method Effect size
1 Complete healing in trial period
(varying lengths)
2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Patients with complete
healing at 4 months
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Patients with complete
healing at 18 months
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Healing rate (cm2 per week) 1 60 Mean Difference (IV, Fixed, 95% CI) -0.12 [-0.41, 0.17]
Comparison 16. Low-compression stocking vs short-stretch bandage (SSB)




participants Statistical method Effect size
1 Patients with complete healing
at 3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Patients with complete healing
at 6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 17. High-compression stockings vs short-stretch bandage (SSB)




participants Statistical method Effect size
1 Patients with complete healing
at 2-4 months (fixed-effect)
4 317 Risk Ratio (M-H, Fixed, 95% CI) 1.62 [1.26, 2.10]
2 Patients with complete healing
at 2-4 months (random-effects)
4 317 Risk Ratio (M-H, Random, 95% CI) 1.66 [1.07, 2.58]
3 Percentage reduction of baseline
ulcer area at 3 months
1 119 Mean Difference (IV, Fixed, 95% CI) 23.4 [-1.32, 48.12]
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Comparison 18. Compression stocking vs two-component bandage system




participants Statistical method Effect size
1 Patients with complete healing
at 3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Comparison 19. Compression stocking vs 4LB




participants Statistical method Effect size
1 Patients with complete healing
at 3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Comparison 20. Tubular compression vs short-stretch bandage (SSB)




participants Statistical method Effect size
1 Patients with complete healing
at 3 months
1 178 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.76, 1.26]
Comparison 21. Tubular compression vs tubular plus 1 elastic bandage




participants Statistical method Effect size
1 Patients with complete healing
at six months
1 88 Risk Ratio (M-H, Fixed, 95% CI) 0.46 [0.28, 0.75]
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Comparison 22. Tubular compression vs tubular plus 2 elastic bandages




participants Statistical method Effect size
1 Patients with complete healing
at six months
1 85 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.26, 0.68]
Comparison 23. Tubular plus 1 elastic bandage vs tubular plus 2 elastic bandages




participants Statistical method Effect size
1 Patients with complete healing
at six months
1 89 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.69, 1.18]
Analysis 1.1. Comparison 1 Compression vs no compression (primary dressing only), Outcome 1 Ulcers
completely healed at 6 months.
Review: Compression for venous leg ulcers
Comparison: 1 Compression vs no compression (primary dressing only)
Outcome: 1 Ulcers completely healed at 6 months
Study or subgroup Compression Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kikta 1988 21/42 15/45 100.0 % 1.50 [ 0.90, 2.50 ]
Total (95% CI) 42 45 100.0 % 1.50 [ 0.90, 2.50 ]
Total events: 21 (Compression), 15 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours control Favours compression
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Analysis 2.1. Comparison 2 Compression vs no compression (non-compressive bandage), Outcome 1
Patients with complete healing at 1 year.
Review: Compression for venous leg ulcers
Comparison: 2 Compression vs no compression (non-compressive bandage)
Outcome: 1 Patients with complete healing at 1 year
Study or subgroup Compression Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Rubin 1990 18/19 7/17 100.0 % 2.30 [ 1.29, 4.10 ]
Total (95% CI) 19 17 100.0 % 2.30 [ 1.29, 4.10 ]
Total events: 18 (Compression), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.83 (P = 0.0047)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Compression vs no compression (usual treatment), Outcome 1 Patients with
complete healing at 3 months.
Review: Compression for venous leg ulcers
Comparison: 3 Compression vs no compression (usual treatment)
Outcome: 1 Patients with complete healing at 3 months
Study or subgroup Compression Usual treatment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Taylor 1998 12/18 3/18 100.0 % 4.00 [ 1.35, 11.82 ]
Total (95% CI) 18 18 100.0 % 4.00 [ 1.35, 11.82 ]
Total events: 12 (Compression), 3 (Usual treatment)
Heterogeneity: not applicable
Test for overall effect: Z = 2.51 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Compression vs no compression (usual treatment), Outcome 2 Patients with
complete healing at 1 year.
Review: Compression for venous leg ulcers
Comparison: 3 Compression vs no compression (usual treatment)
Outcome: 2 Patients with complete healing at 1 year
Study or subgroup Compression Usual treatment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Morrell 1998 78/120 62/113 100.0 % 1.18 [ 0.96, 1.47 ]
Total (95% CI) 120 113 100.0 % 1.18 [ 0.96, 1.47 ]
Total events: 78 (Compression), 62 (Usual treatment)
Heterogeneity: not applicable
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Compression vs no compression (usual treatment), Outcome 3 Patients with
recurrence during 1 year follow-up.
Review: Compression for venous leg ulcers
Comparison: 3 Compression vs no compression (usual treatment)
Outcome: 3 Patients with recurrence during 1 year follow-up
Study or subgroup Compression Usual treatment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Morrell 1998 27/78 14/62 100.0 % 1.53 [ 0.88, 2.66 ]
Total (95% CI) 78 62 100.0 % 1.53 [ 0.88, 2.66 ]
Total events: 27 (Compression), 14 (Usual treatment)
Heterogeneity: not applicable
Test for overall effect: Z = 1.51 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Single-component compression (elastic bandage) vs single-component
compression (paste bandage), Outcome 1 Patients with complete healing at 3 months.
Review: Compression for venous leg ulcers
Comparison: 4 Single-component compression (elastic bandage) vs single-component compression (paste bandage)







paste Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cordts 1992 8/16 6/14 1.17 [ 0.54, 2.54 ]
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Analysis 4.2. Comparison 4 Single-component compression (elastic bandage) vs single-component
compression (paste bandage), Outcome 2 Percentage change during trial relative to baseline ulcer area.
Review: Compression for venous leg ulcers
Comparison: 4 Single-component compression (elastic bandage) vs single-component compression (paste bandage)












N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cordts 1992 16 -90 (20) 14 -25 (187) -65.00 [ -163.44, 33.44 ]
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Analysis 4.3. Comparison 4 Single-component compression (elastic bandage) vs single-component
compression (paste bandage), Outcome 3 Healing rate (cm squared per week adjusted for baseline ulcer
perimeter).
Review: Compression for venous leg ulcers
Comparison: 4 Single-component compression (elastic bandage) vs single-component compression (paste bandage)












N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cordts 1992 16 0.049 (0.028) 14 0.02 (0.064) 0.03 [ -0.01, 0.07 ]
-1 -0.5 0 0.5 1
Favours elastic bandage Favours paste bandage
Analysis 5.1. Comparison 5 Single-component compression vs multi-component compression (excluding
paste bandages), Outcome 1 Complete healing during the trial period.
Review: Compression for venous leg ulcers
Comparison: 5 Single-component compression vs multi-component compression (excluding paste bandages)
Outcome: 1 Complete healing during the trial period








Colgan 1995 2/10 6/10 0.33 [ 0.09, 1.27 ]
Eriksson 1986 9/17 7/17 1.29 [ 0.62, 2.65 ]
Kralj 1996 8/20 7/20 1.14 [ 0.51, 2.55 ]
Nelson 2007a 63/128 78/117 0.74 [ 0.59, 0.92 ]
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Analysis 5.2. Comparison 5 Single-component compression vs multi-component compression (excluding
paste bandages), Outcome 2 Percentage change during trial relative to baseline ulcer area.
Review: Compression for venous leg ulcers
Comparison: 5 Single-component compression vs multi-component compression (excluding paste bandages)
Outcome: 2 Percentage change during trial relative to baseline ulcer area





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Travers 1992 15 -90 (12) 12 -83 (17) -7.00 [ -18.38, 4.38 ]
-20 -10 0 10 20
Favours single-component Favours multi-component
Analysis 5.3. Comparison 5 Single-component compression vs multi-component compression (excluding
paste bandages), Outcome 3 Complete healing during the trial period (participants with simple VLU only).
Review: Compression for venous leg ulcers
Comparison: 5 Single-component compression vs multi-component compression (excluding paste bandages)
Outcome: 3 Complete healing during the trial period (participants with simple VLU only)
Study or subgroup Single-component Multi-component Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Nelson 2007a 50/103 67/97 0.70 [ 0.55, 0.89 ]
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Analysis 6.1. Comparison 6 Single-component compression vs multi-component compression (paste
bandage), Outcome 1 Complete healing during the trial period.
Review: Compression for venous leg ulcers
Comparison: 6 Single-component compression vs multi-component compression (paste bandage)







comp Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Colgan 1995 2/10 7/10 0.29 [ 0.08, 1.05 ]
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Analysis 7.1. Comparison 7 Two-component (outer elastic) vs two-component (outer inelastic), Outcome 1
Patients with complete healing at 3-6 months.
Review: Compression for venous leg ulcers
Comparison: 7 Two-component (outer elastic) vs two-component (outer inelastic)







(inelastic) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Danielsen 1998 9/23 5/20 40.1 % 1.57 [ 0.63, 3.91 ]
Moody 1999 8/26 8/26 59.9 % 1.00 [ 0.44, 2.26 ]
Total (95% CI) 49 46 100.0 % 1.23 [ 0.67, 2.25 ]
Total events: 17 (Two-component (elastic)), 13 (Two-component (inelastic))
Heterogeneity: Chi2 = 0.51, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 7.2. Comparison 7 Two-component (outer elastic) vs two-component (outer inelastic), Outcome 2
Patients with complete healing at 1 month.
Review: Compression for venous leg ulcers
Comparison: 7 Two-component (outer elastic) vs two-component (outer inelastic)







(inelastic) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Danielsen 1998 4/23 1/20 100.0 % 3.48 [ 0.42, 28.63 ]
Total (95% CI) 23 20 100.0 % 3.48 [ 0.42, 28.63 ]
Total events: 4 (Two-component (elastic)), 1 (Two-component (inelastic))
Heterogeneity: not applicable
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Not applicable
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Analysis 7.3. Comparison 7 Two-component (outer elastic) vs two-component (outer inelastic), Outcome 3
Patients with complete healing at 1 year.
Review: Compression for venous leg ulcers
Comparison: 7 Two-component (outer elastic) vs two-component (outer inelastic)







(inelastic) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Danielsen 1998 12/23 3/20 100.0 % 3.48 [ 1.14, 10.60 ]
Total (95% CI) 23 20 100.0 % 3.48 [ 1.14, 10.60 ]
Total events: 12 (Two-component (elastic)), 3 (Two-component (inelastic))
Heterogeneity: not applicable
Test for overall effect: Z = 2.19 (P = 0.028)
Test for subgroup differences: Not applicable
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Analysis 8.1. Comparison 8 Two-component system vs four-layer bandage (4LB), Outcome 1 Patients with
complete healing at 1 month.
Review: Compression for venous leg ulcers
Comparison: 8 Two-component system vs four-layer bandage (4LB)







(4LB) Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Moffatt 2008 6/39 3/42 2.15 [ 0.58, 8.03 ]
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Analysis 8.2. Comparison 8 Two-component system vs four-layer bandage (4LB), Outcome 2 Patients with
complete healing at 3 months.
Review: Compression for venous leg ulcers
Comparison: 8 Two-component system vs four-layer bandage (4LB)







(4LB) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Harley 2004 8/14 13/16 20.4 % 0.70 [ 0.42, 1.17 ]
Moffatt 2003a 30/52 40/57 64.0 % 0.82 [ 0.62, 1.10 ]
Szewczyk 2010 10/16 9/15 15.6 % 1.04 [ 0.59, 1.83 ]
Total (95% CI) 82 88 100.0 % 0.83 [ 0.66, 1.05 ]
Total events: 48 (Two-component system), 62 (Four-layer bandage (4LB))
Heterogeneity: Chi2 = 1.04, df = 2 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.57 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 8.3. Comparison 8 Two-component system vs four-layer bandage (4LB), Outcome 3 Patients with
complete healing at 6 months up to point of withdrawal from randomised treatment.
Review: Compression for venous leg ulcers
Comparison: 8 Two-component system vs four-layer bandage (4LB)







(4LB) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Moffatt 2003a 24/52 47/57 100.0 % 0.56 [ 0.41, 0.77 ]
Total (95% CI) 52 57 100.0 % 0.56 [ 0.41, 0.77 ]
Total events: 24 (Two-component system), 47 (Four-layer bandage (4LB))
Heterogeneity: not applicable
Test for overall effect: Z = 3.59 (P = 0.00033)
Test for subgroup differences: Not applicable
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Analysis 8.4. Comparison 8 Two-component system vs four-layer bandage (4LB), Outcome 4 Patients with
complete healing at 6 months including withdrawals from randomised treatment.
Review: Compression for venous leg ulcers
Comparison: 8 Two-component system vs four-layer bandage (4LB)







(4LB) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Moffatt 2003a 40/52 50/57 100.0 % 0.88 [ 0.73, 1.05 ]
Total (95% CI) 52 57 100.0 % 0.88 [ 0.73, 1.05 ]
Total events: 40 (Two-component system), 50 (Four-layer bandage (4LB))
Heterogeneity: not applicable
Test for overall effect: Z = 1.45 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 9.1. Comparison 9 3 components including elastic bandage vs 3 components including inelastic
bandage, Outcome 1 Patients/limbs with complete healing during trial.
Review: Compression for venous leg ulcers
Comparison: 9 3 components including elastic bandage vs 3 components including inelastic bandage







(inelastic) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Complete healing at 3-4 months
Callam 1992b 35/65 19/67 73.3 % 1.90 [ 1.22, 2.95 ]
Gould 1998 11/19 7/20 26.7 % 1.65 [ 0.81, 3.36 ]
Subtotal (95% CI) 84 87 100.0 % 1.83 [ 1.26, 2.67 ]
Total events: 46 (3 components (elastic)), 26 (3 components (inelastic))
Heterogeneity: Chi2 = 0.10, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 3.16 (P = 0.0016)
2 Complete healing at 6 months
Meyer 2002 33/57 34/55 100.0 % 0.94 [ 0.69, 1.27 ]
Subtotal (95% CI) 57 55 100.0 % 0.94 [ 0.69, 1.27 ]
Total events: 33 (3 components (elastic)), 34 (3 components (inelastic))
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
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Analysis 10.1. Comparison 10 3 components including paste bandage vs 3 components including inelastic
(short-stretch) bandage, Outcome 1 Limbs with complete healing at 3 months.
Review: Compression for venous leg ulcers
Comparison: 10 3 components including paste bandage vs 3 components including inelastic (short-stretch) bandage




component Paste component Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Duby 1993 10/25 6/26 100.0 % 1.73 [ 0.74, 4.06 ]
Total (95% CI) 25 26 100.0 % 1.73 [ 0.74, 4.06 ]
Total events: 10 (Short-stretch component), 6 (Paste component)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 11.1. Comparison 11 Charing Cross 4LB vs other 4LB, Outcome 1 Patients/limbs with complete
healing during trial.
Review: Compression for venous leg ulcers
Comparison: 11 Charing Cross 4LB vs other 4LB
Outcome: 1 Patients/limbs with complete healing during trial
Study or subgroup Charing Cross 4LB Other 4LB Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Complete healing at 3 months
Moffatt 1999 69/115 84/117 0.84 [ 0.69, 1.01 ]
Wilkinson 1997 8/17 8/18 1.06 [ 0.51, 2.18 ]
2 Complete healing at 6 months
Moffatt 1999 84/115 89/117 0.96 [ 0.83, 1.12 ]
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Analysis 12.1. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 1 Patients with
complete healing during trial period based on IPD.
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 1 Patients with complete healing during trial period based on IPD
Study or subgroup SSB 4LB Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Franks 2004 63/84 60/75 22.4 % 0.94 [ 0.79, 1.11 ]
Iglesias 2004 147/192 157/195 55.1 % 0.95 [ 0.86, 1.06 ]
Partsch 2001 43/59 33/53 12.3 % 1.17 [ 0.90, 1.52 ]
Scriven 1998 12/23 17/27 5.5 % 0.83 [ 0.51, 1.35 ]
Ukat 2003 10/45 13/44 4.6 % 0.75 [ 0.37, 1.53 ]
Total (95% CI) 403 394 100.0 % 0.96 [ 0.88, 1.05 ]
Total events: 275 (SSB), 280 (4LB)
Heterogeneity: Chi2 = 3.13, df = 4 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
Test for subgroup differences: Not applicable
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Analysis 12.2. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 2 Limbs
completely healed at 3 months (Duby 1993, IPD unavailable).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 2 Limbs completely healed at 3 months (Duby 1993, IPD unavailable)








Duby 1993 11/25 10/25 100.0 % 1.10 [ 0.57, 2.11 ]
Total (95% CI) 25 25 100.0 % 1.10 [ 0.57, 2.11 ]
Total events: 11 (4LB), 10 (SSB)
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
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Analysis 12.3. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 3 Hazard ratio
estimates for time to healing based on IPD (fixed-effect).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 3 Hazard ratio estimates for time to healing based on IPD (fixed-effect)
Study or subgroup 4LB SSB log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Franks 2004 75 84 0.439 (0.272) 12.8 % 1.55 [ 0.91, 2.64 ]
Iglesias 2004 195 192 0.349 (0.123) 62.7 % 1.42 [ 1.11, 1.80 ]
Partsch 2001 53 59 -0.347 (0.256) 14.5 % 0.71 [ 0.43, 1.17 ]
Scriven 1998 27 23 0.438 (0.417) 5.5 % 1.55 [ 0.68, 3.51 ]
Ukat 2003 44 45 0.7 (0.454) 4.6 % 2.01 [ 0.83, 4.90 ]
Total (95% CI) 394 403 100.0 % 1.32 [ 1.09, 1.60 ]
Heterogeneity: Chi2 = 7.65, df = 4 (P = 0.11); I2 =48%
Test for overall effect: Z = 2.88 (P = 0.0039)
Test for subgroup differences: Not applicable
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Analysis 12.4. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 4 Hazard ratio
estimates for time to healing based on IPD (random-effects).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 4 Hazard ratio estimates for time to healing based on IPD (random-effects)
Study or subgroup 4LB SSB log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Franks 2004 75 84 0.439 (0.272) 20.3 % 1.55 [ 0.91, 2.64 ]
Iglesias 2004 195 192 0.349 (0.123) 36.0 % 1.42 [ 1.11, 1.80 ]
Partsch 2001 53 59 -0.347 (0.256) 21.7 % 0.71 [ 0.43, 1.17 ]
Scriven 1998 27 23 0.438 (0.417) 11.7 % 1.55 [ 0.68, 3.51 ]
Ukat 2003 44 45 0.7 (0.454) 10.3 % 2.01 [ 0.83, 4.90 ]
Total (95% CI) 394 403 100.0 % 1.30 [ 0.94, 1.80 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 7.65, df = 4 (P = 0.11); I2 =48%
Test for overall effect: Z = 1.58 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 12.5. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 5 Hazard ratio
estimates for time to healing based on IPD (fixed-effect, Partsch 2001 removed).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 5 Hazard ratio estimates for time to healing based on IPD (fixed-effect, Partsch 2001 removed)
Study or subgroup 4LB SSB log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Franks 2004 75 84 0.439 (0.272) 15.0 % 1.55 [ 0.91, 2.64 ]
Iglesias 2004 195 192 0.349 (0.123) 73.3 % 1.42 [ 1.11, 1.80 ]
Scriven 1998 27 23 0.438 (0.417) 6.4 % 1.55 [ 0.68, 3.51 ]
Ukat 2003 44 45 0.7 (0.454) 5.4 % 2.01 [ 0.83, 4.90 ]
Total (95% CI) 341 344 100.0 % 1.47 [ 1.20, 1.81 ]
Heterogeneity: Chi2 = 0.62, df = 3 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 3.68 (P = 0.00024)
Test for subgroup differences: Not applicable
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Analysis 12.6. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 6 Hazard ratio
estimates for time to healing based on IPD (random-effects, Partsch 2001 removed).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 6 Hazard ratio estimates for time to healing based on IPD (random-effects, Partsch 2001 removed)
Study or subgroup 4LB SSB log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Franks 2004 75 84 0.439 (0.272) 15.0 % 1.55 [ 0.91, 2.64 ]
Iglesias 2004 195 192 0.349 (0.123) 73.3 % 1.42 [ 1.11, 1.80 ]
Scriven 1998 27 23 0.438 (0.417) 6.4 % 1.55 [ 0.68, 3.51 ]
Ukat 2003 44 45 0.7 (0.454) 5.4 % 2.01 [ 0.83, 4.90 ]
Total (95% CI) 341 344 100.0 % 1.47 [ 1.20, 1.81 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.62, df = 3 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 3.68 (P = 0.00024)
Test for subgroup differences: Not applicable
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Analysis 12.7. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 7 Incidence of any
type of adverse event based on IPD (fixed-effect).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 7 Incidence of any type of adverse event based on IPD (fixed-effect)
Study or subgroup SSB 4LB Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Franks 2004 22/84 23/75 29.8 % 0.80 [ 0.40, 1.60 ]
Iglesias 2004 103/192 92/195 70.2 % 1.30 [ 0.87, 1.93 ]
Total (95% CI) 276 270 100.0 % 1.15 [ 0.81, 1.62 ]
Total events: 125 (SSB), 115 (4LB)
Heterogeneity: Chi2 = 1.39, df = 1 (P = 0.24); I2 =28%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable
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Analysis 12.8. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 8 Incidence of any
type of adverse event based on IPD (random effects).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 8 Incidence of any type of adverse event based on IPD (random effects)








Franks 2004 22/84 23/75 32.0 % 0.80 [ 0.40, 1.60 ]
Iglesias 2004 103/192 92/195 68.0 % 1.30 [ 0.87, 1.93 ]
Total (95% CI) 276 270 100.0 % 1.11 [ 0.72, 1.72 ]
Total events: 125 (SSB), 115 (4LB)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.39, df = 1 (P = 0.24); I2 =28%
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 12.9. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 9 Incidence of
bandage-related adverse events based on IPD.
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 9 Incidence of bandage-related adverse events based on IPD
Study or subgroup SSB 4LB Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Franks 2004 9/84 10/75 0.78 [ 0.30, 2.04 ]
Iglesias 2004 91/192 76/195 1.41 [ 0.94, 2.11 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 100 (SSB), 86 (4LB)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
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Analysis 12.10. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 10 Number of
adverse events (any type) based on IPD (fixed-effect).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 10 Number of adverse events (any type) based on IPD (fixed-effect)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Franks 2004 75 0.4 (0.68) 84 0.43 (0.87) 86.3 % -0.03 [ -0.27, 0.21 ]
Iglesias 2004 195 1.57 (2.64) 192 2.11 (3.38) 13.7 % -0.54 [ -1.14, 0.06 ]
Total (95% CI) 270 276 100.0 % -0.10 [ -0.32, 0.12 ]
Heterogeneity: Chi2 = 2.36, df = 1 (P = 0.12); I2 =58%
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 12.11. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 11 Number of
adverse events (any type) based on IPD (random-effects).
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 11 Number of adverse events (any type) based on IPD (random-effects)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Franks 2004 75 0.4 (0.68) 84 0.43 (0.87) 65.4 % -0.03 [ -0.27, 0.21 ]
Iglesias 2004 195 1.57 (2.64) 192 2.11 (3.38) 34.6 % -0.54 [ -1.14, 0.06 ]
Total (95% CI) 270 276 100.0 % -0.21 [ -0.68, 0.27 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 2.36, df = 1 (P = 0.12); I2 =58%
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 12.12. Comparison 12 4LB vs multi-layer short-stretch bandage (SSB), Outcome 12 Number of
adverse events (bandage-related) based on IPD.
Review: Compression for venous leg ulcers
Comparison: 12 4LB vs multi-layer short-stretch bandage (SSB)
Outcome: 12 Number of adverse events (bandage-related) based on IPD





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Franks 2004 75 0.16 (0.47) 84 0.12 (0.36) 0.04 [ -0.09, 0.17 ]
Iglesias 2004 195 1.31 (2.41) 192 1.76 (3.14) -0.45 [ -1.01, 0.11 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 13.1. Comparison 13 Four-layer bandage (4LB) vs compression system with paste bandage as the
base, Outcome 1 Patients/limbs with complete healing during trial.
Review: Compression for venous leg ulcers
Comparison: 13 Four-layer bandage (4LB) vs compression system with paste bandage as the base







system Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Patients/limbs with complete healing at 3 months
Colgan 1995 6/10 7/10 54.3 % 0.86 [ 0.45, 1.64 ]
Duby 1993 11/25 6/26 45.7 % 1.91 [ 0.83, 4.37 ]
Subtotal (95% CI) 35 36 100.0 % 1.34 [ 0.78, 2.28 ]
Total events: 17 (Four-layer bandage (4LB)), 13 (Paste bandage system)
Heterogeneity: Chi2 = 2.51, df = 1 (P = 0.11); I2 =60%
Test for overall effect: Z = 1.07 (P = 0.29)
2 Patients with complete healing at 6 months
Polignano 2004a 29/39 19/29 100.0 % 1.13 [ 0.82, 1.57 ]
Subtotal (95% CI) 39 29 100.0 % 1.13 [ 0.82, 1.57 ]
Total events: 29 (Four-layer bandage (4LB)), 19 (Paste bandage system)
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
3 Patients with complete healing at 1 year
Meyer 2003 45/69 51/64 100.0 % 0.82 [ 0.66, 1.01 ]
Subtotal (95% CI) 69 64 100.0 % 0.82 [ 0.66, 1.01 ]
Total events: 45 (Four-layer bandage (4LB)), 51 (Paste bandage system)
Heterogeneity: not applicable
Test for overall effect: Z = 1.85 (P = 0.064)
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Analysis 13.2. Comparison 13 Four-layer bandage (4LB) vs compression system with paste bandage as the
base, Outcome 2 Patients/limbs with complete healing at 3 months (random-effects).
Review: Compression for venous leg ulcers
Comparison: 13 Four-layer bandage (4LB) vs compression system with paste bandage as the base















Colgan 1995 6/10 7/10 54.8 % 0.86 [ 0.45, 1.64 ]
Duby 1993 11/25 6/26 45.2 % 1.91 [ 0.83, 4.37 ]
Total (95% CI) 35 36 100.0 % 1.23 [ 0.54, 2.82 ]
Total events: 17 (Four-layer bandage (4LB)), 13 (Paste bandage system)
Heterogeneity: Tau2 = 0.22; Chi2 = 2.51, df = 1 (P = 0.11); I2 =60%
Test for overall effect: Z = 0.49 (P = 0.62)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 13.3. Comparison 13 Four-layer bandage (4LB) vs compression system with paste bandage as the
base, Outcome 3 Percentage reduction of baseline ulcer area at 6 months.
Review: Compression for venous leg ulcers
Comparison: 13 Four-layer bandage (4LB) vs compression system with paste bandage as the base












N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Polignano 2004a 39 79.1 (65.7) 29 24.6 (165.5) 100.0 % 54.50 [ -9.17, 118.17 ]
Total (95% CI) 39 29 100.0 % 54.50 [ -9.17, 118.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.68 (P = 0.093)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
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Analysis 13.4. Comparison 13 Four-layer bandage (4LB) vs compression system with paste bandage as the
base, Outcome 4 Healing rate (pooled).
Review: Compression for venous leg ulcers
Comparison: 13 Four-layer bandage (4LB) vs compression system with paste bandage as the base














N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Knight 1996 5 1.139 (0.931) 5 0.34 (0.458) 11.4 % 0.98 [ -0.37, 2.34 ]
Polignano 2004a 39 2.3 (3.7) 29 0.01 (6.3) 88.6 % 0.46 [ -0.03, 0.94 ]
Total (95% CI) 44 34 100.0 % 0.52 [ 0.06, 0.97 ]
Heterogeneity: Chi2 = 0.52, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 2.20 (P = 0.027)
Test for subgroup differences: Not applicable
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Analysis 14.1. Comparison 14 Adjustable inelastic compression boot vs other compression system,
Outcome 1 Healing rate.
Review: Compression for venous leg ulcers
Comparison: 14 Adjustable inelastic compression boot vs other compression system




















DePalma 1999 19 0.0433 (0.091) 19 0.02 (0.0534) 0.02 [ -0.03, 0.07 ]
3 percentage per day
DePalma 1999 19 2.0357 (1.952) 19 1.05 (1.5583) 0.99 [ -0.14, 2.11 ]
4 cm per day (linear rate)
DePalma 1999 19 0.0109 (0.0125) 19 0.01 (0.0092) 0.00 [ 0.00, 0.01 ]
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Analysis 15.1. Comparison 15 Single-layer compression stocking vs paste bandage system, Outcome 1
Complete healing in trial period (varying lengths).
Review: Compression for venous leg ulcers
Comparison: 15 Single-layer compression stocking vs paste bandage system





bandage Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Patients with complete healing at 4 months
Koksal 2003 21/30 20/30 1.05 [ 0.74, 1.48 ]
2 Patients with complete healing at 18 months
Hendricks 1985 9/11 9/10 0.91 [ 0.64, 1.29 ]
0.1 0.2 0.5 1 2 5 10
Favours bandages Favours stockings
Analysis 15.2. Comparison 15 Single-layer compression stocking vs paste bandage system, Outcome 2
Healing rate (cm2 per week).
Review: Compression for venous leg ulcers
Comparison: 15 Single-layer compression stocking vs paste bandage system
















sq/week] IV,Fixed,95% CI IV,Fixed,95% CI
Koksal 2003 30 1.16 (0.38) 30 1.28 (0.72) 100.0 % -0.12 [ -0.41, 0.17 ]
Total (95% CI) 30 30 100.0 % -0.12 [ -0.41, 0.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 16.1. Comparison 16 Low-compression stocking vs short-stretch bandage (SSB), Outcome 1
Patients with complete healing at 3 months.
Review: Compression for venous leg ulcers
Comparison: 16 Low-compression stocking vs short-stretch bandage (SSB)




stocking SSB Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brizzio 2010 10/32 13/28 0.67 [ 0.35, 1.29 ]
0.02 0.1 1 10 50
Favours SSB Favours stocking
Analysis 16.2. Comparison 16 Low-compression stocking vs short-stretch bandage (SSB), Outcome 2
Patients with complete healing at 6 months.
Review: Compression for venous leg ulcers
Comparison: 16 Low-compression stocking vs short-stretch bandage (SSB)




stocking SSB Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brizzio 2010 14/32 18/28 0.68 [ 0.42, 1.10 ]
0.1 0.2 0.5 1 2 5 10
Favours SSB Favours stocking
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Analysis 17.1. Comparison 17 High-compression stockings vs short-stretch bandage (SSB), Outcome 1
Patients with complete healing at 2-4 months (fixed-effect).
Review: Compression for venous leg ulcers
Comparison: 17 High-compression stockings vs short-stretch bandage (SSB)







bandage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ju¨nger 2004b 29/61 19/60 38.3 % 1.50 [ 0.95, 2.37 ]
Mariani 2008 25/30 21/30 42.0 % 1.19 [ 0.90, 1.58 ]
Polignano 2004b 12/27 5/29 9.6 % 2.58 [ 1.05, 6.35 ]
Taradaj 2009 15/40 5/40 10.0 % 3.00 [ 1.20, 7.47 ]
Total (95% CI) 158 159 100.0 % 1.62 [ 1.26, 2.10 ]
Total events: 81 (HIgh-compression stocking), 50 (Short-stretch bandage)
Heterogeneity: Chi2 = 7.47, df = 3 (P = 0.06); I2 =60%
Test for overall effect: Z = 3.70 (P = 0.00021)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours SSB Favours stockings
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Analysis 17.2. Comparison 17 High-compression stockings vs short-stretch bandage (SSB), Outcome 2
Patients with complete healing at 2-4 months (random-effects).
Review: Compression for venous leg ulcers
Comparison: 17 High-compression stockings vs short-stretch bandage (SSB)















Ju¨nger 2004b 29/61 19/60 30.6 % 1.50 [ 0.95, 2.37 ]
Mariani 2008 25/30 21/30 38.3 % 1.19 [ 0.90, 1.58 ]
Polignano 2004b 12/27 5/29 15.7 % 2.58 [ 1.05, 6.35 ]
Taradaj 2009 15/40 5/40 15.4 % 3.00 [ 1.20, 7.47 ]
Total (95% CI) 158 159 100.0 % 1.66 [ 1.07, 2.58 ]
Total events: 81 (High-compression stocking), 50 (Short-stretch bandage)
Heterogeneity: Tau2 = 0.11; Chi2 = 7.47, df = 3 (P = 0.06); I2 =60%
Test for overall effect: Z = 2.26 (P = 0.024)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours SSB Favours stockings
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Analysis 17.3. Comparison 17 High-compression stockings vs short-stretch bandage (SSB), Outcome 3
Percentage reduction of baseline ulcer area at 3 months.
Review: Compression for venous leg ulcers
Comparison: 17 High-compression stockings vs short-stretch bandage (SSB)
Outcome: 3 Percentage reduction of baseline ulcer area at 3 months








N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Ju¨nger 2004b 61 74.8 (42.4) 58 51.4 (86.7) 100.0 % 23.40 [ -1.32, 48.12 ]
Total (95% CI) 61 58 100.0 % 23.40 [ -1.32, 48.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.86 (P = 0.064)
Test for subgroup differences: Not applicable
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Analysis 18.1. Comparison 18 Compression stocking vs two-component bandage system, Outcome 1
Patients with complete healing at 3 months.
Review: Compression for venous leg ulcers
Comparison: 18 Compression stocking vs two-component bandage system






bandage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Szewczyk 2010 8/15 10/16 0.85 [ 0.47, 1.57 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 8 (Compression stocking), 10 (2-component bandage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours bandage Favours stocking
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Analysis 19.1. Comparison 19 Compression stocking vs 4LB, Outcome 1 Patients with complete healing at
3 months.
Review: Compression for venous leg ulcers
Comparison: 19 Compression stocking vs 4LB






(4LB) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Szewczyk 2010 8/15 9/15 0.89 [ 0.47, 1.67 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 8 (Compression stocking), 9 (Four-layer bandage (4LB))
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours 4LB Favours stocking
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Analysis 20.1. Comparison 20 Tubular compression vs short-stretch bandage (SSB), Outcome 1 Patients
with complete healing at 3 months.
Review: Compression for venous leg ulcers
Comparison: 20 Tubular compression vs short-stretch bandage (SSB)




bandage Tubular compression Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ju¨nger 2004a 51/90 51/88 100.0 % 0.98 [ 0.76, 1.26 ]
Total (95% CI) 90 88 100.0 % 0.98 [ 0.76, 1.26 ]
Total events: 51 (Short-stretch bandage), 51 (Tubular compression)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.86)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
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Analysis 21.1. Comparison 21 Tubular compression vs tubular plus 1 elastic bandage, Outcome 1 Patients
with complete healing at six months.
Review: Compression for venous leg ulcers
Comparison: 21 Tubular compression vs tubular plus 1 elastic bandage
Outcome: 1 Patients with complete healing at six months
Study or subgroup Tubular
Tubular + 1
elast
bandage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Milic 2010 13/42 31/46 100.0 % 0.46 [ 0.28, 0.75 ]
Total (95% CI) 42 46 100.0 % 0.46 [ 0.28, 0.75 ]
Total events: 13 (Tubular), 31 (Tubular + 1 elast bandage)
Heterogeneity: not applicable
Test for overall effect: Z = 3.08 (P = 0.0020)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
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Analysis 22.1. Comparison 22 Tubular compression vs tubular plus 2 elastic bandages, Outcome 1 Patients
with complete healing at six months.
Review: Compression for venous leg ulcers
Comparison: 22 Tubular compression vs tubular plus 2 elastic bandages
Outcome: 1 Patients with complete healing at six months
Study or subgroup Tubular
Tubular +2
elast
bandages Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Milic 2010 13/42 32/43 100.0 % 0.42 [ 0.26, 0.68 ]
Total (95% CI) 42 43 100.0 % 0.42 [ 0.26, 0.68 ]
Total events: 13 (Tubular), 32 (Tubular +2 elast bandages)
Heterogeneity: not applicable
Test for overall effect: Z = 3.55 (P = 0.00039)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours tubular + 2 elast Favours tubular
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Analysis 23.1. Comparison 23 Tubular plus 1 elastic bandage vs tubular plus 2 elastic bandages, Outcome 1
Patients with complete healing at six months.
Review: Compression for venous leg ulcers
Comparison: 23 Tubular plus 1 elastic bandage vs tubular plus 2 elastic bandages







bandages Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Milic 2010 31/46 32/43 100.0 % 0.91 [ 0.69, 1.18 ]
Total (95% CI) 46 43 100.0 % 0.91 [ 0.69, 1.18 ]
Total events: 31 (Tubular + 1 elast bandage), 32 (Tubular +2 elast bandages)
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours tubular + 2 elast Favours tubular + 1 elast
A D D I T I O N A L T A B L E S




































43 (4.8%) 1 Venous leg ulcer;
ABPI ≥ 0.9.








and ABPI ≥ 0.8
4LB 13.0
SSB 17.3
4LB: 1 vs 0
SSB: 2 vs 0
4LB no follow-
up data.
SSB 1 no follow-
up data, 1 died
early in trial.
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Overall 4 vs 0* 3 had no follow-
up data.
1 ineligible.
Ukat et al (2003)
Germany
89 (10.0%) 2 Venous leg ulcer-




4LB: 0 vs 0












4LB: 1 vs 1





387 (43.6%) 9 Venous leg ulcer
≥ 1 cm diame-
ter; ABPI ≥ 0.8.
4LB 55.0
SSB 54.0
4LB: 0 vs 0
SSB: 0 vs 0
Total 887 (100%) 32 4LB 13.0
SSB 12.3
Overall 10 vs 3
Abbreviations
4LB = four-layer bandage
ABPI = ankle brachial pressure index
IPD = individual patient data
NA = not applicable as unable to retrieve individual patient data
SSB = short-stretch bandage- SSB
Note
* breakdown per group not provided.
Table 2. Characteristics of patients from trials with available IPD
Variable Four-layer bandage (n = 394) Short-stretch bandage (n =
403)
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DVT = deep vein thrombosis
max = maximum value in range
min = minimum value in range
SD = standard deviation.
Note
Figures are numbers (percentages) of patients unless stated otherwise.
Table 3. Final model based on five trials
Variable fi SE (fi) HR 95% CI for HR P value
Bandage 0.27 0.10 1.31 1.09 to 1.58 = 0.005










-0.53 0.19 0.59 0.40 to 0.85 = 0.005
Duration category >
12 months versus 0-
1 month
-1.07 0.19 0.35 0.24 to 0.50 < 0.001
Loge ulcer area -0.36 0.05 0.70 0.64 to 0.77 < 0.001
Abbreviations
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β = regression coefficient
CI = confidence interval
HR = hazard ratio
Loge = natural logarithm
SE = standard error of regression coefficient
Table 4. Final model based on four trials
Variable fi SE (fi) HR 95% CI for HR P value
Bandage 0.25 0.10 1.29 1.06 to 1.57 = 0.011










-0.51 0.20 0.60 0.41 to 0.90 = 0.013
Duration category >
12 months versus 0-
1 month
-1.17 0.21 0.31 0.21 to 0.47 < 0.001
Loge ulcer area -0.35 0.05 0.70 0.64 to 0.78 < 0.001
Recurrent
ulceration
-0.45 0.16 0.64 0.47 to 0.87 = 0.005
Abbreviations
β = regression coefficient
CI = confidence interval
HR = hazard ratio
Loge = natural logarithm
SE = standard error of regression coefficient
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A P P E N D I C E S
Appendix 1. Search strategy - Original version
The search strategy of the Cochrane Wounds Group was used to identify RCTs and CCTs of bandages or stockings in the treatment
of venous leg ulcer trials (see Scope of Wounds Group). This includes electronic searches of MEDLINE, CINAHL, EMBASE, The
Cochrane Controlled Trials Register, as well as hand searches of conference proceedings and wound care journals.
Experts in wound care and pharmaceutical companies were contacted to enquire about unpublished, ongoing and recently published
trials.
Citations within obtained reviews and papers were scrutinised to identify additional studies.An Advisory Panel was established at the
outset of a series of reviews of which this is one. They assisted by checking our lists of trials for any omissions, and to inform us of any
unpublished, ongoing or recently completed trials.
Appendix 2. Ovid MEDLINE search strategy
1 exp Stockings, Compression/
2 exp Occlusive Dressings/
3 (compression or bandag$ or stocking$ or hosiery or wrapp$).ti,ab.
4 or/1-3
5 exp Leg Ulcer/
6 (varicose ulcer$ or venous ulcer$ or leg ulcer$ or foot ulcer$ or (feet adj ulcer$) or stasis ulcer$).ti,ab.
7 or/5-6
8 4 and 7
Appendix 3. Ovid EMBASE search strategy
1 exp Compression Therapy/
2 (compression or bandag$ or stocking$ or hosiery or wrapp$).ti,ab.
3 or/1-2
4 exp Leg Ulcer/
5 (varicose ulcer$ or venous ulcer$ or leg ulcer$ or foot ulcer$ or (feet adj ulcer$) or stasis ulcer$).ti,ab.
6 or/4-5
7 3 and 6
Appendix 4. Ovid CINAHL search strategy
1 exp Bandaging Techniques/
2 exp Compression Therapy/
3 (compression or bandag$ or stocking$ or hosiery or wrapp$).ti,ab.
4 or/1-3
5 exp Leg Ulcer/
6 (varicose ulcer$ or venous ulcer$ or leg ulcer$ or foot ulcer$ or (feet adj ulcer$) or stasis ulcer$).ti,ab.
7 or/5-6
8 4 and 7
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Note: differences between this review and the previous versions:
1. Controlled clinical trials (CCTs) were eligible for inclusion in the original version of the review. Updated versions of the review
have restricted inclusion to studies describing treatment allocation as random. In consequence, two studies have been excluded from
this review that were previously included. The comparisons involved were: compression (Unna’s Boot) versus no compression
(dressing alone) (Sikes 1985), and compression stockings versus SSB (Horakova 1994).
2. A third trial that evaluated two different three-component systems was excluded from updated versions of the review because of
confounding of the treatment effect by administration of steroids in one treatment arm (Northeast 1990).
3. Previously, the trial by Eriksson 1986 was entered as a secondary reference for Eriksson 1984. Further scrutiny revealed that
these are two separate evaluations. In the current review, the two trials have been included and reported separately.
4. Previously the trial by Rubin 1990 was described as comparing compression with primary dressing alone. Further study of the
report suggested that the comparison group received a primary dressing plus elastic bandage used as a retaining wrap. Comments in
the trial authors’ discussion section suggest that these bandages did not provide compression. Therefore, this trial has now been
reviewed in a section comparing compression with non-compressive bandages
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bandages [economics]; ∗Stockings, Compression [economics]; Cost-Benefit Analysis; Randomized Controlled Trials as Topic; Varicose
Ulcer [∗therapy]; Wound Healing
MeSH check words
Humans
192Compression for venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
